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ABSTRACT 
In the present work we focus into the potential relevance of PUFAs in some models and human 
samples from patients suffering amyotrophic lateral sclerosis (ALS). Due to its pathological 
implication, oxidative stress was our first goal. We started from simple oxidative methodology 
screening to search for an antioxidant substance (among 21 different candidates) available in a 
Mediterranean diet. The results demonstrated high heterogeneity in carbonyl (measured by 
DNP) accumulation, regarding the oxidative source, substrate suffering it and the antioxidant 
structure. Further, thanks to GC/MS and LCQTOF, we detailed the protection over specific 
accrual of protein and lipid peroxidation markers as well as lipid profile modifications (as % of 
total fatty acids -FA) in oxLDL thanks to those dietary compounds. Moreover, we demonstrated 
its in vitro relevance, in terms of survival, when two cell lines (HMEC-1, HepG2) were treated 
with this oxidized (and protected) compounds, and finally address in vivo importance of those 
findings, demonstrating decreased carbonyl and oxidative accumulation in hamsters under an 
atherogenic diet supplemented with antioxidants. Once described the protective effect of 
antioxidants and specific signatures found regarding lipid oxidation markers, we extend the 
study focusing in different ALS samples. From previous work, we demonstrated an altered 
docosohexaenoic acid (DHA) composition in different location for patients suffering sporadic 
ALS. Hence, we though necessary to define whether the enzymatic machinery aimed to 
synthesize DHA from its precursors, are affected in sALS. Interestingly, we found a tissue 
specific variation (spinal cord vs cortex), compatible with our previous FA results. Further, 
thanks to inmunohistochemistry, differential involvement was unveiled for motor neurons (MN) 
and surrounding glia. Therefore, trying to depict cellular contribution, we switch to a neuronal 
model (N2A under oxidative stressors and/or aggregation-prone-TDP-43) and a tissular one 
(OT). There, we showed decreased desaturase (∆6) and drebrin expression as well as increased 
DHA synthesis and an unreported inverse correlation of drebrin loss and aberrant p-TDP-43 
expression under oxidative conditions in the cell culture. In the OT model, lipidomic analysis 
showed specific accretion of 8-iso-PGF2α and NPD1 as well as increased DHA (and 
dramatically decreased precursors) and reduced AA concentrations (GC measured). Analysis of 
slice O2 consumption showed decreased O2 levels under excitotoxic treatment and alleviation by 
antioxidant (tocopherol) addition. Treatment of OT slices with Ω-3 precursors (better than final 
products) and DHA plus tocopherol ameliorated MNs number. Finally, we wanted to disclose 
PUFA’s implication and phenothype of an animal model (SODG93A) under a dietary 
intervention with opposed FA unsaturation levels. Not surprisingly, FA profile was difficult to 
be altered in nervous system, although subtle specific variations were found. More importantly, 
differences in survival and clinical manifestations, UPR (Ubiquitin inclusions), mt-DNA (8-
oxo-dG) and protein oxidative modifications revealed sex as a relevant factor in lipid handling 
for this model. Hence, whereas male under a low PUFA diet showed increased survival, females 
lack this beneficial outcome. Last but not least, we wanted to dig deeper regarding this sexual 
dimorphism. For this purpose, we focused in mitochondria and analyzed spinal cord oxygen 
consumption, oxidative damage to proteins and lipid profile along disease progression and also 
in a neuronal model (N2A overexpressing SODG93A, treated with 17β-estradiol).We could 
demonstrate a clear sexual implication, with females having late onset clinical symptoms 
concomitant to an upgraded mitochondrial function and lower protein and mitochondrial 
damaged proteins compared with males. Finally, to further confirmed steroid potential as a 
protective element in disease progression, in vitro estradiol pretreatmet of N2A showed 
increased oxygen consumption, with no relation with the mitochondrial complex expression.  
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RESUMEN 
En el trabajo que aquí se presenta se ha profundizado en la relevancia que los ácidos grasos 
poliinsaturados (PUFA) puedan tener en el tratamiento de la esclerosis lateral amiotrófica 
(ALS). Dada su implicación en el desarrollo de la patología, el estudio del estrés oxidativo 
asociado fue uno de nuestros primeros objetivos. Para ello hemos empezado por un cribado 
metodológico simplista, tratando de encontrar una sustancia antioxidante (entre 21), 
biodisponible en una dieta Mediterránea equilibrada y que fuese capaz de reducir un daño 
oxidativo generado desde diversos frentes (medido como acumulación de carbonilos) y sobre 
diferentes substratos. Los resultados demostraron una alta heterogeneidad, dificultando así la 
elección de un único antioxidante. Aún así, gracias a la GCMS y la LCQTOF pudimos detallar 
la acumulación específica diferenciada de marcadores de daño oxidativo proteico y daño 
lipoxidativo producido cuando partículas de lipoproteínas de baja densidad (LDL) son oxidadas 
bajo la acción de diversos compuestos. Además se pudo objetivar el cambio en la composición 
lipídica de estas LDL (medida como % del total presente) y su relevancia biológica in vitro, 
medida en términos de supervivencia, cuando se exponen a dos líneas celulares (HMEC-1, 
HepG2). Por último se demostró la importancia in vivo, puesto que se pudo observar una menor 
acumulación de productos carbonílicos en hámsters alimentados con una dieta aterogénica, pero 
suplementada con antioxidantes. Una vez se demostró el papel jugado por estos antioxidantes en 
la acumulación diferenciada de productos de oxidación, extendimos el estudio a muestras y 
modelos de ALS. En trabajos previos habíamos evidenciado una composición tisular 
diferenciada en diversas localizaciones del sistema nervioso en pacientes diagnosticados de 
ALS. Por ello consideramos interesante el estudio de la expresión de la maquinaria enzimática 
necesaria para la síntesis lipídica. De un modo destacado, pudimos ver de nuevo una variación 
tisular, compatible con niveles reducidos de docosohexaenoico (DHA), y gracias a la 
inmunohistoquímica también se observaron diferencias entre las motoneuronas (MNs) y la glia 
circundante. Así pues, para poder revelar las aportaciones diferenciales de los distintos tipos 
celulares, utilizamos una línea celular (N2A) a la que sometíamos a diferentes estresores (daño 
oxidativo y sobreexpresión de una versión de TPD-43 que causa agregados) y a un cultivo 
tisular de médula espinal (OT), dónde se produce una muerta progresiva y selectiva de las MNs. 
Tras estos experimentos, observamos un descenso tanto en la expresión de la ∆6 desaturasa 
como de drebrin (marcador presináptico) tras la sobreexpresión de TDP-43, así como una mayor 
síntesis de DHA y una correlación inversa entre la pérdida de drebrina y la expresión de pTDP-
43 bajo condiciones de estrés oxidativo. Por otro lado, en el modelo OT, el análisis lipidómico 
reveló la acumulación especifica de 8-iso-PGF2α y NDPD1 (posiblemente en respuesta a un 
incremento del daño oxidativo) así como el aumento en la concentración de DHA (con un 
descenso muy marcado de sus precursores) y el descenso de araquidónico. Quisimos analizar 
también el consumo de oxígeno, tanto en tejido intacto como permeabilizado, pudiendo 
observar como la excitoxicidad reducía considerablemente su capacidad y como ésta era, en 
parte, rescatada con el uso de tocoferol. Además, el tratamiento del OT con precursores Ω-3 
mejoró también el número de MNs. Por último, quisimos caracterizar la implicación que los 
PUFA dietarios podrían tener en un modelo animal bien conocido (SODG93A). No fue 
sorprendente encontrar que el perfil lipídico en el sistema nervioso fue muy difícil de alterar. 
Aún así, se observaron diferencias en supervivencia, en el devenir clínico, la respuesta UPR 
(con acumulaciones de Ub), el daño al DNA mitocondrial (8-oxo-dG) y modificaciones 
oxidativas en las proteínas y cómo éstas tenían un grado de afectación diferencial cuando 
considerábamos el sexo de los animales. Esto es, mientras que los machos sometidos a una dieta 
baja en PUFAs de cadena larga demostraron una mayor supervivencia, en las hembras no se 
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apreció mejoría. Por último, pero no menos importante, quisimos profundizar más respecto a 
este dimorfismo. Centrándonos en la mitocondria, pudimos hacer un seguimiento del consumo 
de oxígeno a lo largo de la enfermedad, el daño oxidativo a proteínas y el perfil lipídico. Por lo 
tanto pudimos demostrar una clara implicación sexual, siendo las hembras las que más tarde 
comienzan su manifestación clínica, con mejores funciones mitocondriales asociadas a un 
menor daño oxidativo. Finalmente, la relevancia del papel protector de los estrógenos se pudo 
comprobar in vitro, mediante el pretratamiento con 17β-estradiol en la línea N2A que 
sobreexpresa SOD1G93A, relacionado con la ALS familiar, proponiéndose el estradiol como un 
nuevo elemento que juega un papel relevante en el desarrollo de la enfermedad.  
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RESUM 
En aquest treball s’ha intentat profunditzar en la possible rellevància dels àcids grassos 
poliinsaturats (PUFA) en el tractament de l’esclerosi lateral amiotròfica (ELA). Atesa la seva 
implicació en el desenvolupament de la patologia, l’estudi de l’estrès oxidatiu associat fou un 
dels primers objectius. Per això, es va començar amb un cribratge metodològic simplista, 
intentant trobar una substància antioxidant biodisponible en una dieta mediterrània equilibrada i 
que fos capaç de reduir el dany oxidatiu generat des de diferents fronts i sobre diferents 
substrats. Els resultats van demostrar una alta heterogeneïtat, dificultant així l’elecció d’un únic 
antioxidant. Malgrat això, mercès a tècniques de GC-MS i LC-QTOF, es va poder detallar 
l’acumulació específica diferenciada de marcadors de dany oxidatiu proteic i dany lipoxidatiu 
produït quan partícules de lipoproteïna de baixa densitat (LDL) s’oxiden per l’acció de diversos 
compostos. A més, es va poder objectivar el canvi en la composició lipídica d’aquestes LDL i la 
seva rellevància in vitro, mesurada en termes de supervivència, quan es cocultiven amb les 
línies cel· lulars. Per últim, es va demostrar la importància in vivo, atès que es va observar una 
menor acumulació de productes carbonílics en hàmsters alimentats amb una dieta aterogènica 
suplementada amb antioxidants. Un cop es va demostrar el paper d’aquests antioxidants en 
l’acumulació diferenciada de productes d’oxidació, es va estendre l’estudi a mostres i models 
d’ELA. En treballs previs s’havia evidenciat una composició tissular diferenciada en diverses 
localitzacions del sistema nerviós central en pacients d’ELA (respecte l’àcid docosahexaenoic 
(DHA),  depleció en medul·la espinal i acumulació en còrtex). Per aquesta raó es va considerar 
interessant l’estudi de l’expressió de la maquinària enzimàtica necessària per la síntesi lipídica. 
D’una manera destacada, es va poder veure de nou una variació tissular, compatible amb nivells 
reduïts de DHA i, per tècniques d’immunohistoquímica, es van observar diferències entre les 
motoneurones i la glia circumdant. Per tant, per poder revelar les aportacions diferencials dels 
diferents tipus cel·lulars, es va utilitzar la línia cel·lular N2A, sotmesa a diferents estressos 
(dany oxidatiu i sobreexpressió d’una forma de TDP-43 que causa agregats) i un cultiu tissular 
de medul·la espinal, en el que es produeix una mort progressiva i selectiva de les motoneurones. 
Es va observar un descens en l’expressió de FADS2 i de drebrina, un marcador sinàptic, així 
com una major síntesi de DHA i una correlació inversa entre la pèrdua de drebrina i l’expressió 
de TDP-43 sota condicions d’estrès oxidatiu. Per altra banda, en el model organotípic, l’anàlisi 
lipidòmica va revelar l’acumulació específica de 8-isoPGF2α i NDPD1, així com l’augment de la 
concentració de DHA i el descens motl marcat del seus precursors a mes del àcid araquidònic. 
Es va mesurar també el metabolisme oxidatiu, observant-se que l’excitotoxicitat reduïa 
considerablement la seva capacitat i, en part, es rescatava amb l’ús de tocoferol. A més, el 
tractament dels cultius organotípics amb precursors d’àcids grassos n-3 va millorar el nombre de 
motoneurones. Per últim, es va caracteritzar la implicació dels PUFA dietaris en un model 
animal d’ELA. Malgrat que el perfil lipídic del sistema nerviós central era difícil d’alterar, es 
van observar diferències en supervivència, fenotip clínic, resposta al malplegament de proteïnes 
(UPR) amb acumulació d’ubiquitina, dany en el DNA mitocondrial i modificacions oxidatives 
en les proteïnes, amb un grau d’afectació diferencial quan es considerava el sexe dels animals. 
En aquest sentit, mentre que els mascles sotmesos a una dieta baixa en PUFA de cadena llarga 
van mostra una major supervivència, en les femelles nomes va apreciar cap efecte millora. Per 
profunditzar en el dimorfisme sexual en ELA, i especialment la disfunció mitocondrial, es va 
analitzar mitjançant respirometria d’alta resolució la medul·la espinal durant tot el 
desenvolupament de la malaltia. Es va revelar una clara diferència de gènere, amb una 
manifestació clínica més tardana en femelles que correlaciona amb una millor conservació de la 
funció mitocondrial i un menor dany oxidatiu. El possible paper protector dels estrògens es va 
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demostrar in vitro mitjançant el pretractament amb estradiol de cèl· lules N2A que 
sobreexpressen una forma de SOD1 humana mutada associada a l’ELA familiar (G93A-SOD1). 
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Os meus pais, 
a miña irmá, 
a minmesmo 
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Unas cuantas verdades que ya dijeron otros,… 
 
La duda es la base de todo conocimiento. 
Aristóteles 
 
 
Mide lo que sea medible y haz medible lo que no lo sea. 
 
Todas las verdades son fáciles de entender, una vez descubiertas. 
El caso es descubrirlas. 
Galileo Galilei 
 
 
True ignorance is not the absence of knowledge, but the refusal to acquire it. 
 
Science is always seeking, not a real discovery. It is continuous travelling for never 
arrival.  
Karl Popper 
 
 
Books permit us to voyage through time, to tap the wisdom of our ancestors. 
 
There are many hypotheses in science that are wrong. That's perfectly alright; it's the 
aperture to finding out what's right. Science is a self-correcting process. To be 
accepted, new ideas must survive the most rigorous standards of evidence and scrutiny. 
 
Carl Sagan 
 
 
On the whole, human beings want to be good, but not too good and not quite all the time. 
 
George Orwell 
 
 
Cuando creíamos que teníamos todas las respuestas, de pronto,  
cambiaron todas las preguntas. 
Mario Benedetti 
 
 
Existe al menos un rincón del universo que con toda seguridad puedes mejorar,  
y eres tú mismo. 
 
El secreto de la genialidad es el de conservar el espíritu del niño hasta la vejez, lo cual 
quiere decir nunca perder el entusiasmo.  
Aldous Huxley 
 
 
La religión explica los miedos del hombre, la ciencia descubre las verdades de la 
naturaleza, la ciencia es para valientes. 
 Anónimo 
13 
Agradecementos, 
 
Well, bueno, ben, bè … Por fin me toca a mí! 
 
Como es de rigor, pero además en este caso de verdad, me gustaría comenzar 
agradeciendo el calor y conocimientos que mis directores Manel y Reinald me han brindado, sin 
su apoyo esto hubiese sido imposible. Gracias Maestros! 
 
Pero el grupo era una familia numerosa, muy extensa, por la que he ido viendo pasar 
mucha gente en estos años. Desde el principio, Mª Josep y Viki ya estabais por ahí, menudas 
charlas arreglamundos nos echamos en la mesada o en la cola del rancho por 2,12 leuros en el 
Santamaria, y los cafeses en el Kemdefer o en la Caseta… y cómo me olvidare de todo lo que 
aprendí para poder llevar la “colonia” de ratones, las inmmunos y el dichoso confocal, el OT y 
demás técnicas! También estaba ya por allí el “socio fundador” Joan Prat, recuerdo felizmente 
el día que encontramos una foto de los tres Manel, Reinald y él haciendo butifarras o que se 
yo… Muchos de mis compis ya son doctores, pero los comienzos conociendo la cuidad y sus 
recovecos nocturnos y descubriendo el mundo de la ciencia (y sus recovecos aún más oscuros ;) 
de la mano de Katia, Alba y Mariona son inolvidables. También andaban por allí el David y la 
Nuria -de aquellas todavía becaria de Calderó- y al poco llegaron la Saray, Mery y Jessica para 
darnos más apoyo, que buena falta hizo ;) . Pobre Jessica como la hacía sufrir con las bestias, 
pero bueno, le gustó … y se pudo quedar por el estabulario! Y al poco llego Jordi, siempre muy 
callado (pero por dentro se partía!), y tuve la suerte de compartir dos de sus pasiones (o tres si 
contamos el buen comer)  a mitocondria y el monte, que tantas alegrías (!) me han dado. Y el 
Huget, Claro que si! Lo veía de prácticas con la Mª Angeles y lo fuimos llevando al lado (que 
no cuarto) oscuro fisiopato-ilógico… y cayó. Que pisazo teníamos… éramos la envidia del 
vecindario, jeje…días de vino y rosas!! Un abrazo para el Gus! Creo que fue mi segundo 
Octubre cuando apareció por aquí un cuate que nos conquistó con su saber hacer, buen humor y 
su “exo-estomago”; grande Chamaco! … Dulces recuerdos de congresos de médicos, a todo Nu-
tren… historias preburbuja inmobiliaria y crisis…snif… DeLorenzo con la nutrigenomica por la 
casa y el Ribera con su radar! Y mientras iban viniendo gentes de estancias: el José y la Pilar de 
los madriles, el Jorge del grupo de Aurora Pujol (la Ione y el Stèphane después), la griega, el 
francés, los mexicanos (estos no pararon de llegar). Al ratín el Jose se pudo traer a la moza y 
vino una nueva pieza neuro- mitocondrial, la Ana y sus buenos embutidos de la querida extrema 
y dura… y como el Jose tenía debilidad, y era cosa de Annas (con una o dos enes), pues al poco 
también se vino p’acá la mejor Allmacellenca que conozco, Uber Alles! ;). Al tiempo, como ya 
habían pasado unos años sin “esclavos extranjeros”, fichamos a un cubano, y cuando 
pensábamos encontrarnos a un macizo negrote, nos vino el Omarito “café con leche”! Pobre 
heredero de la “colonia” de gran corazón y mejor conversación! Unas buenas escapadas nos 
hemos hecho! Y con la Rosana y la Liliana se completó la cuadrilla, por ahora, quedando el 
grupo compuesto por médicos, biólogos /bioquímicos, químicos, farmacéuticos, nutricionistas 
tecnólogos alimentarios y hasta ingenieros, madremía que lío! Es pura suerte que nos 
entendamos! Y las nuevas generaciones pisan fuerte, la Rosana misma, anda que no le pega al 
cromatógrafo la tía!, y el Pascual y la Lara y quién sabe quién más pasaran por acá. Solo espero 
que puedan disfrutar y aprender a su costado, como yo he hecho. 
 
Y las risas que nos echamos con los de BioQuímica!… No sé..., el hecho de estar tan 
cerca, ahí enfrente…pero lo suficientemente lejos también… Vero, Armando, Stef, MaAlbe y 
tod@s los becari@s de estancias que pasaron por allí, mimadriña! ... pero con todos 
congeniábamos… No fueron malos años, no! Myriam, no quedara muy bien, puesto que aun la 
tendrás que juzgar, pero que sepas que esoy encantado de los éxitos que te han brindado fuera, 
tú lo vales y lo mereces, animo! Lleida estará siempre aquí en nuestro corazón (y Álvaro 
también, jeje)...y que sepáis que el tipo del On the Rocks os hecha mucho de menos! Creo que 
Quim Ros me reservará un trocito de poyata, aunque también descansara al no verme tanto 
“revoloteando entre sus becarias”. Yo ya lo echo de menos… Y las Rosas? Saludos a la Sta. 
14 
Decana, que me animo a calificar de amiga, Rosa Soler y las nuevas generaciones con AnaG y 
Nuria (y Rosa -la mujer del Sera y por supuesto de Roser y nuestros comienzos en el 
estabulario) y como no recordar als molt honorables presidents (Elia y David, herederos de una 
dinastía de justos representantes ;) ) y los buenos momentos vividos (las grandes patxangas al 
futbol con Elia y los mano a mano de likor café con David… o era al revés) y mi compi de piso 
por unos meses, Saravanan, y Ambika… hay el idilio con la India … Indilio! El Bupesh abrió la 
brecha y anda que no ha habido éxito! Cuantas buenas gentes he podido conocer, que rica 
comida y cultura me brindaron, Hiren y Rinku, Charumathi, Arindan y Upasana, Depsheeka y 
Venki y Disha, un abrazo chavalada! 
 
De la segunda planta recuerdo muy gustosamente a Sara, Xenia y Eli que la pelearon 
conmigo y pude disfrutar sus defensas de tesis, así como alguna que otra cenuki …, y al Dr 
Esquerda y Anna Casanovas que me ayudaron al poco de llegar con el microscopio y la 
perfusión de los pobres “voluntarios”. Y del rock que se montan la Marta y Montse ni 
hablamos, no? Suerte que tienes Javi ;) . Del grupo de Loreta, con los que compartimos 
cuartucho algunos años, además del Bupesh no me quiero olvidar de Antonio y por supuesto de 
las mocicas: la rubia platino, compi hortolana y afines aficiones, Alba, y la morocha rizada 
albaceteña de profundos abrazos, que camina a Santiago más a menudo que yo, Bea, un beso a 
t’@s, maj@s! 
De la tercera, como olvidar el grupo mindundi y las competis de disfraces de carnavales 
que nos hacíamos con los del Arnau!! Muchos ya se han ido (Martí y Carme, Rita, Marcelí, 
Galal o Seba), pero otros aun siguen por aquí (Paco-quillo!, Jordi, Eloy, Marta, Sonia o Neus C) 
han vuelto hace poco (Serafí and family, Neus P) y parece que no han pasado los años o 
refrescan con sangre nueva (Irene y Noel)… y el grupo de Carme Espinet, con Peter, Anton y 
Gerard, donde luego vino a parar el Egea con sus becarios… la Catherine (cuantas veces habre 
firmado en tu nombre, salerosa ^!^ ) la Mariajo (y sus melocotones-de comer-;)) y la Disha y, 
cómo no, la técnico mas viajera y con la que siempre puedes conversar, la Imma. Como olvidar 
la tarta que pasó tantos años en el arcón-congelador! (bueno si hubiese un historial de lo que allí 
ha habido, Dios!), poco más y se viene al IRB como uno más! 
 
Este último año, ya recluido con la escritura de los papers y el ladrillo tesil, tuve la  
oportunidad de conocer a otra ilustre cubana, Idalmis, e intimar un poco más con Serafí, una 
suerte más que la vida me ha dado! Cuántas veces hemos desahogado las penas y arreglado el 
mundo con lixiviados germánicos fermentados por levaduras y destilados revolucionarios! 
Gracias majetes! 
 
No puedo dejarme fuera a gente como Isu o Berta, y las buenas conversaciones que nos 
echamos en cultivos y a los currantes de secretaria de IRB. La gente de conserjería, sin duda a 
Emeterio, Fini, Trillo (el seleccionador) y María, Mónica y Montse los informáticos Josep y 
Toni y demás gentes de secretaría (David, Yolanda y Sandra), con sus buenos días y tardes 
siempre podías contar, y a veces hasta una sonrisa ;)  Y por supuesto con el siempre 
excelentísimo e impecable servicio de limpieza, desde la Charo, Marcia o Daniela, pasando por 
Ani, Aisa y Loli, siempre estaban por ahí para amenizar cuando las tardes se hacían noches. Un 
gusto haberlas conocido! Algunos más que recuerdo,… el “gran jefe” de la biblioteca, Roland, 
Ánimo!, sin duda los maestros del estabulario Emilià y Manolo y los siempre eficientes JR y 
Joan ... Y otros que ya se han marchado, pero cerca Marina, Esteban, Maya o Alejandra... 
 
Mención especial me gustaría hacer a una gran compañera y amiga que me temo lo será 
lo que me quede de vida, la Colman. No sé qué decir que no intuyas, mas que fue una suerte 
haberme encontrado contigo y lo bien que nos caímos. Siempre p’alante leona! No sé que más 
decirte, porque sabés boluda que siempre era sho el que te pedía consejo! Muchos éxitos y un 
abrazo al Ahmed, otro león también, y a mi familia postiza Argenta; la Carlota y el Chingol 
(que gloria de personas de verdad!!) Alois, Alexia y su bichito y a papa Colman y lo bien que 
disfrutó de la vida. Abrazos para todos! Malditos, me pegaron el gusto por el asado lento y el 
mate o un Malbec en buena compañía! Y siguiendo por el cono sur, como olvidarme al Gualano 
15 
y MªAlbe, dos corazones que no paran de bombear pensando en los demás, un placer chavales, 
que la vida les sonría! Y si hablamos de corazones y cono sur, me toca hablar de la Noe 
también, un recuerdo para ti, guapisísima, allá donde estés, estate bien y se buena! 
 
And I would like also to thank the people in Norway. Lippid Gruppe kindly welcomed 
me a made my short stay in Bergen comfortable and very successful. Rolf, Bodil, Lena, Eline, 
Kari Wiliams, Pavol, Natalya, … thanks to everyone up there! 
 
Pero por suerte mi paso por Lleida fue largo y tuve la oportunidad de mezclarme con 
otras buenas almas que me entretuvieron para que esta tesis fuera tan larga como ha sido, y yo 
feliz! Quiero recordar a Iñaki (Mc Mardigan), que está justo hoy de cumple, y emigrado de 
nuevo en London, gran aventurero rapitense y mejor ser humano, sabio. Así como el frente 
variado que he ido atrayendo a los Pirineos: Gonzalo (alpinista trovador) y Ana (por muchas 
cosas…y la portada, gracias!), Pintor (gracias por las correcciones, las escapadas montañeras y, 
en general, que decir, la amistad desde la guardería!), Dopo (que viajes macho! Solo se vive una 
vez, pero que bien que la pasemos oiga, gracias por los mejores veranos de mi vida), Patmos 
(gracias por conocer tu familia villafranquina, y que bien que te veré por Ou, a patear O Courel 
y tomar botillo!!), Oier (Sr concejal euskaldune, a sus pies), Dani y Carol (viticultores 
rompiendo la velocidad del sonido!), els veïns Oriol y Mariona (bon viatge xiquets) Nodar y 
Truji, (ya papas dior mio!! Os veo con la mochila-niño), Fariña, Pow, Jimmy Po (y respectivas 
señoras, jeje), Anita, Paula (y respectivos maridos, juju), Zintia, Pauliña … las gentes de 
Pontevedra, miña casiña, meu lar, … Juanin, Ansel, Javiere, Toñil, Berni y vicesberzas … 
bueno para el frente galaico podría hacer otra tesis así que agradecidos quedáis con este brindis: 
por todos los LK que no me pude tomar con vosotros, ya nos iremos actualizando! 
 
También quisiera mencionar a una buena generación de estudiantes de medicina (Jesús, 
Samu, Cris, Paul, Jeong-Hu, Pili, Gonzalo, Clara, Ibai  …) que, cuando todavía no era muy 
cantoso que me juntase con ellos (ahora ya me ven como bicho raro, o yo quizás ya no pego…), 
me acogieron, permitiéndome prolongar un poco más mis mejores años universitarios. Muchas 
gracias por la compañía, el equipo de fútbol la facultad, las fiestas, los asados, las eskiadas… y, 
bien pensado, no está mal tener unos cuantos amigos médicos, que todos nos avejentamos! 
 
Por último quixera dedicarlle unhas verbas á miña familia. Os meus país, que me deron 
a vida e as ferramentas para afrontala e que incondicionalmente axudaronme a apoiaronme nas 
miñas decisións, ese compromiso e ese amor que me destes espero me fixeran bo rapaz, con iso 
xa sería dicir moito. Gracias porque moitas veces tivestes que elixir entre vos e os vosos fillos, e 
nunca o dudastedes. Ademáis, agora mesmo apetéceme moito pasar una tempadiña convosco y 
disfrutares de esta vida adulta que, como una parte mais do percorrer, teño o gusto de compartir 
con quen ma regalou. Así que xa sabes irmanciña, María, e certo que temén levamonos ben nas 
distancias, e que moitos días xuntos son como una bomba para nos, pero ben sabes o que che 
quero, e por un tempo xa é hora de tornares a casiña, pola miña parte estarei por ahí unha 
tempada, e sabes que alí sempre es (mais ben sodes, Miguel e mais ti ;) ) benbidos. E os meus 
avos (Constantino e Carmen e mais Feliciano e Asunción), que tanto loitaron e que tiven a sorte 
de coñecer polo menos algún tempo. Aínda que agora so disfruto da compañía de Asunción, 
labrega emigrada tamén polo ben dos seus fillos, como tantos outros! pero esta e a miña! … 
Mans tinguidas de terra traballada, ollos espertos que coñeceron boas persoas e percorreron 
mundo e mais o lombo truncado de tratar de arranxalo. Celi, padriños Manolo e Fina, Angela, 
Tita, Diego e Carmen, (Manolo e Paquita, descansade), Dolores, Ricardo, Diego e Marta, 
Mundy, Celia, Laura e Alberto! Moitos bicos a todos, pronto poderedes contar conmigo a full!. 
 
….Y mucha gente más me habrá ayudado, y quizás me los olvidé, pero vosotros sabéis quienes 
sois y lo que habéis hecho, a todos,  GRACIAS  y también a los que no me habéis ayudado, 
muchas gracias, puesto que con vuestra dejadez también me habré espabilado. 
 
Hasta pronto Lleida-Pirineus 
16 
 
17 
Index 
  Page 
 Abbreviation List 19 
 List of Tables 21 
 List of Figures 21 
  
 
 1. Introduction 23 
  
 
1.A  PUFA Physiology 25 
 1.A1 PUFA structure and relevance in phospholipids 25 
 1.A1.1.- Glycerophospholipids 27 
 1.A2 PUFA major functions 29 
 1.A2.1.- Energy substrates 30 
 1.A2.2.- Structural membrane actions 31 
 1.A2.3.- Signalling purposes 31 
 A) FA itself as second messengers 31 
 B) FAs as precursors of lipid mediators  32 
 C) Palmitoylation 33 
 D) FA direct interaction with transcription factors 33 
 1A2.4.- Cell Survival 36 
 Concluding: DHA and AA, two different motorways 37 
1.B  PUFA Maintenance 38 
 1.B1 PUFA systemic and cellular delivery 39 
 1.B1.1.- Systemic delivery 39 
 1.B1.2.- Regulation across cell membrane 40 
 1.B1.3.- FA inner trafficking 41 
 1.B1.4.- Lipid transport at membrane contact site 43 
 1.B2 PUFA biosynthetic pathways: desaturase and elongase 43 
 1.B2.1.-DHA synthesis 44 
 1.B2.2.- AA synthesis 46 
 1.B3 PUFA Reacylase and phospholipase systems 47 
 1.B3.1.- Phospholipase system 47 
 1.B3.2.- Reacylase system 49 
 A) ACS 50 
 B) ACH 50 
 C) ACL 51 
 1.B4 Essential FA dietary requirements 51 
 1.B4.1.- ω-3 defiency 53 
 1.B4.2.- Pregnancy and development. 53 
 1.B4.3.- Cardiovascular diseases 54 
 1.B4.4.- Neurodegenerative diseases 54 
 1.B4.5.- Sex dimorphism. 54 
  
1.B5 PUFA and Central Nervous System 55 
 1.B5.1 Delivery across brain blood barrier 55 
 1.B5.2 In situ synthesis 57 
 1.B5.3 Neurotransmitting 58 
18 
1.C  PUFA Pathophysiology 60 
 1.C1 Inflammation induction and resolving phase 61 
 1.C1.1.- Inflammation partners 61 
 1.C1.2.- Oxidative-derived inflammatory-relevant lipid species 63 
 A) Cyclooxygenases 64 
 B) Lipoxygenases 66 
 C) Aspirin triggered ω-6 anti-inflammatory mediators 67 
 D) ω-3 Proresolution mediators: Resolvins, Protectins and Maresins 68 
 E) Isoprostanes 68 
 1.C2 Lipid peroxidation: Friend or foe? 69 
 1.C2.1.-Chemistry of oxidative stress 69 
 1.C2.2.- Mitochondrial physiology 72 
 1.C2.3.- Lipid peroxidation events 73 
1.D  Amyotrophic Lateral Sclerosis 78 
 1.D1 ALS Introduction 79 
 1.D2 Mechanisms involved 80 
 1.D2.1.-Mitochondrial-Calcium-ER dysfunction  81 
 1.D2.2.- Energetic Energy storage 83 
 1.D2.3- Cell autonomous 87 
  
 
 2. Hypothesis 91 
  
 
 3. Objectives 95 
  
 
 4. Articles 99 
  
 
4.1 Plant-derived Phenolics Inhibit the Accrual of Structurally Characterized 
Protein and Lipid Oxidative Modifications. 101 
 
 
 
4.2 Interplay Between TDP-43 and Docosohexaenoic Acid-Related Processes in    n 
Amyotrophic Lateral Sclerosis. 123 
 
 
 
4.3 Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of 
an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner. 137 
 
 
 
4.4 Gender Specific Differences in Spinal Cord Mitochondrial Function and 
Oxidative Damage Markers in a Mouse Model of ALS in Early Stages of Disease. 161 
  
 
 5. Discussion 205 
  
 
 6. Conclusions 215 
  
 
 7. Bibliography 219 
  
 
 8. Annexes 257 
  
19 
Abbreviation List 
 
 
 
Arachidonic Acid AA AminoAdipic SemiAldehyde AASA 
Acyl-CoAHydrolase ACH Acyl-CoASyntetase 2,4,6 ACS2, 4, 6 
Alpha Linolenic Acid ALA Adenosin MonoPhosphate AMP 
Adenosin DiPhosphate ADP Adenosin TriPhosphate ATP 
AcetylCoA Acyltranferasa-1 ACAA1 Acyl-CoA Oxidase-1  ACOX1 
Amyotrophic Lateral Sclerosis ALS Acyl-CoALysophospholipid  ACL 
α-Amino-3-hydroxy-5-
Methylisoxazole Proprionic Acid 
AMPA acyltransferase  
    
Blood-Brain Barrier BBB B-cell lymphoma 2 Bcl-2 
    
Cardiolipins  CL Coenzime A CoA 
Cytochrome c Cyt c ClicloOXigenase 1 / 2 COX1, COX2 
Cholesterol CHO CerebroSpinal Fluid CSF 
Central Nervous System CNS Calcium Ca+2 
ClicloOXigenase 1 / 2 COX1, COX2 Cytochrome P450 CYP450 
cytosolic Phospholipase A2 cPLA2 Carbohydrate-Response Element- ChREBP 
CarboxyMethyl Lysine CML Binding Protein  
Cluster of Differentiation 36 CD36   
    
1,2-DiAcylGlycerol DAG DesoxiriboNucleid Acid DNA 
DocosoHexaenoic Acid DHA Double Bound Index DBI 
2,4 DiNitroPhenylhydrazine DNP 8-oxo-desoxiGuanosine 8-oxo-dG 
Double Strand Break  DSB Dihomo-γ-Linolenic Acid DGLA 
DocosoPentaenoic Acid DPA   
    
Elongases ELOVL Endoplasmic Reticulum ER 
EicosaPentaenoic Acids EPA Electron Transport Chain ETC 
Excitatory AminoAcid Transporter-2 EAAT2 Epoxy-EicosaTrienoic acids ETT 
Enzyme-Linked ImmunoSorbent 
Assay 
ELISA Extracellular-signal-Regulated 
Kinases 
ERK1/2 
    
Fatty Acid FA Fatty Acid Binding Protein FABP 
∆5 Fatty Acid Desaturase FADS1 Fatty Acid Transport Protein FATP 
∆6 Fatty Acid Desaturase FADS2 FrontoTemporal Dementia FTP 
FUsed in Sarcoma FUS   
    
γ-AminoButiric Acid GABA Gas Chromatography GC 
GLutamete Transporter-1 GLT1  Glutamic SemiAldehyde GSA 
GlyceroPhosphoLipids  GPL Glutamate Glut 
Glial Fibrilary Acidic Protein GFAP   
    
Hepatic Nuclear Factor 4 α / γ HNF-4α  / γ High Density Lipoprotein HDL 
4-HydroxyNonEnal 4-HNE 4-Hydroxy-2-HexEnal HHE 
Histone γ2AX γ-2HAX HydroxyEicosaTetraEnoic acid HETE 
Hepatocellular carcinoma G2 HepG2 Human  dermal Microvascular  HMEC-1 
  Endothelial Cells-1 
    
IsoProstane IsoP Inositol 1,4-diPhosphate IP2 
InterLeukin IL Inositol 1,4,5-triPhosphate IP3 
independent Phospholipase A2 iPLA2 InmunoHistochemistry IHQ 
    
Linoleic Acid LA Low Density Lipoprotein LDL 
Long-Chain-PUFA LCPUFA LeucoTrienes LT 
LipoXines LX Lipoxigenase 1 / 2 LOX1,LOX2 
Liver X Receptor α LXR α Liquid Chomatography Mass 
Spectrometry 
LCMS 
    
    
20 
Neuro2A N2A Neuroblastoma×SpinalCord 34 NSC-34 
N-Methyl-D-Aspartate NMDA NeuroProtectin D-1  NPD1 
Nuclear Factor Kappa-light-chain-
enhancer of activated B cells 
NFκB NonSteroidal Anti-Inflammatory 
Drug 
NSIAD 
    
Membrane Contact Sites  MCS MalonDiAldehyde MDA 
MalonDiAldehyde Lysine MDAL Mitogen Activated Protein Kinase MAPK 
mamalial Target Of Rapamicyn mTOR Motor Neuron MN 
Mitochondria-Associated Membrane MAM Macrophage mediators in  Maresin 
mitochondrial DNA mtDNA Resolving Inflammation  
    
Organotypic  OT   
    
Patale Activated Factor PAF Phosphatidil-Cholines PC 
PhosphoLipid PL Phosphatidil-Ethanolamines  PE 
ProstaGlandines PG Prostacyclines PGI 
Phosphatidil-Iinositols  PI PhosphoLipase B, C, D PLB, PLC, PLD 
Protein Kinase B PKB, AKT Phosphatidil-Serines  PS 
PeRoxidability Index PRI Protein Kinase C PKC 
Phosphatidyl-Inositol-4,5- PI3K PolyUnsaturated Fatty Acid PUFA 
bisphosphate 3-Kinase    
    
Reactive Lipid Species RLS Reactive Nitrogen Species RNS 
Reactive Oxygen Species ROS RiboNucleid Acid RNA 
Resolvin D, E RvD, RvE Retinoid X Receptor α RXR α 
    
Copper Zinc SuperOxide Dismutase SOD Sterol Carrier Protein SCP 
Sterol Regulatory Element-Binding 
Protein  
SREBP Copper Zinc SuperOxide 
Dismutase Glynine93Alanine 
SODG93A 
SphyngoMyelin SM Syntaxin-3 STX3 
secreted Phospholipase A2 sPLA2 Soluble N-ethylmaleimide-  
S-(2-succinyl)cysteine 2SC sensitive factor-Attachment protein 
REceptor 
SNARE 
    
1,2,3-TriAcylGlycerol TAG Tumor Necrosis Factor - α TNF-α 
ThreoHydroxyAspartate THA Tumor Growth Factor-β TGF-β 
TransActive Response Binding 
Protein-43 
TDP-43 ThromboXane TX 
    
Uncoupling Protein 3, 4 UCP3, 4 Unfolding Protein Response UPR 
VeryLongchainFA VLFA UBiQuiliN-2 UBQN2 
    
Western Blot WB Wild Type WT 
    
    
 
 
  
List of Tables 
 
 
  Page 
Table 1.  Melting point of different FA.............................................. 26 
Table 2. PUFA-related processes.................................................... 30 
Table 3. PUFAs interactions among nuclear receptors................. 34 
Table 4. Omega 3 and 6 essential FA dietary requirements.......... 52 
   
 
 
 
 
 
 
List of Figures 
 
  Page 
Figure 1.  FA structure......................................................................... 25 
Figure 2.  FA melting points................................................................ 26 
Figure 3. Glycerophospolipids structure.......................................... 28 
Figure 4. Membrane representation.................................................. 29 
Figure 5. PUFAs cellular signalling................................................... 32 
Figure 6. PUFAs actions..................................................................... 36 
Figure 7. FA delivery across the membrane.................................... 41 
Figure 8. FA intermembrane transportation..................................... 42 
Figure 9. FA de novo synthesis......................................................... 45 
Figure 10. Desaturases structure........................................................ 46 
Figure 11. Phospholipases cleavage sites......................................... 47 
Figure 12. Deacylation-reacylation cycle............................................ 49 
Figure 13. FA and antioxidants intake along human evolution........ 53 
Figure 14. Blood-brain barrier scheme............................................... 56 
Figure 15. Inflammation partners in CNS........................................... 63 
Figure 16. Inflammatory-stimulated PUFAs derivatives.................... 65 
Figure 17. ETC depiction and physiology.......................................... 74 
Figure 18. Representative oxidative products structure scheme.... 76 
Figure 19. Genes founded implied in ALS/FTD development........... 80 
Figure 20. ALS phatophisiology partners scheme............................ 84 
  
 
 
 
 
 
 
 
 
22 
 
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
 
 
 
24 
 
 
25 
1.A PUFA Physiology 
 
1.A1 PUFA structure and relevance in phospholipids 
 
Polyunsaturated fatty acids (PUFA) belong to the lipid family. They are fatty acids (FA) having 
at least two or more carbon-carbon double bonds. But let’s start from the beginning with a brief 
introduction of what a FA is, how many diverse forms there are and how this would have an 
influence in the different biological outcomes (for a review of the topic see (Tvrzicka et al. 
2011). 
 
Structurally, FA are composed of a carboxylic (organic acid) group at one end and a variable 
length aliphatic carbon chain on the other, seeded with none (saturated), one (monounsaturated) 
or multiple (polyunsaturated) carbon-carbon double bonds. The carbon atom on the acid group 
is chemically an electrophilic centre (electron deficient area) and therefore susceptible of being 
attacked by nucleophilic species (electron rich area). Hence, this carbon is termed alpha and the 
last one on the chain is named omega (see Figure 1). This nomenclature is often used in 
biomedicine and nutrition being referred as omega-x or n-x, meaning a double bond located on 
the xth carbon–carbon bond, counting from the terminal methyl carbon (as said before, 
designated as n or ω) along the carbonyl chain towards the carboxylic region. For instance, 
linoleic acid (common nomenclature, LA) is a C18:2 fatty acid (meaning eighteen carbons and 
two carbon-carbon double bonds), belonging to the n-6 family (or omega-6, ω-6, specifying the 
position of the latest double bond). This point of view of the nomenclature is useful for 
nutritional purposes since the same family members, ω-6 or ω-3, share related biosynthetic 
pathways, and even similar outcomes. 
 
Other classifications of FA are based on the length of the chain, being short (up to six carbons), 
medium (ranging between six and twelve), long (from thirteen to twenty-one) and very long 
(more than twenty two) FA, and/or the optical activity of those species (relying on the 3D 
structure). Stereospecifically, each particular double bond could be either cis, if the structural 
configuration on which adjacent hydrogen atoms are on the same side of the double bond (and 
therefore “bulky” sides are closeby) or trans, when the two hydrogen atoms are bound on 
opposite sides of the double bond.  
 
 
 
Figure 1. FA structure. 3D 
representation of different FA 
structures and its classification, 
according to the number of double 
bounds. It can be clearly seen that the 
number of unsaturations bend the 
aliphatic chain rendering each FA to 
specific steric impedances. Symbols α 
and Ω represented the first and the 
last carbon atom of the aliphatic chain 
respectively. 
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These variable situations (e.g. chain length, number of double bonds and/or stereospecifity of 
those) physically affect to the properties of different FA. This variability of the sterical 
incapacitances and packing difficulties at low scale are reflected, at macromolecular level, in 
terms of melting point temperature, fluidity and/or viscosity variations, as other 
hemorheological parameters. For instance, longer chains (increased number of carbon) are 
related to lower melting temperature. Double bonds also favour lower melting points and 
increased fluidity. Finally, cis configuration is another factor that caused melting point decrease, 
compared with the same FA in trans configuration. This data is summarized and presented in 
Table 1 and Figure 2. 
 
Fatty Acids Melting Points 
Saturated T (ºC) Unsaturated (cis) T (ºC) 
Butiric (C4:0) -6 Myristoleic (C14:1 ω-5) -4 
Caproic (C6:0) -3 Palmitoleic (C16:1n ω-7) 1 
Caprilic (C8:0) 17 Oleic (C18:1 ω-9) 13 
Capric (C10:0) 32 Gadoleic (C20:1 ω-11) 23 
Lauric (C12:0) 44 Unsaturated (trans)  
Miristic (C14:0) 54 Elaidic (C18:1 ω-9) 46 
Palmitic (C16:0) 63 Vaccenic (C18:1 ω-7) 40 
Estearic (C18:0) 69 Linoelaidic (C18:2 ω-6) 28 
Araquidic (C20:0) 77 Polyunsaturated  
Behenic (C22:0) 80 Linoleic (C18:2 ω-6)  -5 
Lignoceric (C24:0)  84 α-Linolenic (C18:3 ω-3)  -11 
Cerotic (C26:0)  88 Araquidonic (C20:4 ω-6)  -50 
  Docosohexaenoic (C22:6 ω-3) -44 
 
   
 
Table 1. Melting point of different FA. Celsius degrees. 
 
 
 
 
 
Figure 2. FA melting points. Graph representation of melting point temperatures of various FA 
in relation with the number of double bounds (left panel) or the number of carbon in the aliphatic 
chain (right panel). Data obtained from (Nelson DL, Cox 2005) and (Knothe and Dunn 2009). 
 
As previously shown, structural differentiation confers a wide capacity for fine tuning 
modulation. This is biologically relevant since, within cells, free FA are often rapidly converted 
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into more complex forms, including phospholipids (PL), plasmalogens, triglycerides (TAG) and 
derivatives of those. We will later dig deeper into PL metabolism, biosynthesis and maintenance 
but just as an introduction for now, PL are major constituents of any membrane bilayer within a 
cell, also with sterols, sphingolipids and proteins. All those biomolecules are held together by 
coulombic, Van der Walls and hydrogen bonding forces. Regular composition of PL consists in 
diglyceride (two fatty acid chains covalently bonded to a glycerol molecule through ester 
linkages) and a phosphate group and a simple organic molecule (commonly choline) attached to 
it. This particular composition of glycerophospholipids (GPL), with one polar head (phosphate) 
and a non-polar (or low polar) chains allows an amphipathic behaviour in aqueous solution, 
since they possess one hydrophobic side (aliphatic chain tail) but also, a hydrophilic head on the 
molecule (phosphate group, represented as a red dot in Figure 3, next page). This organisation 
in aqueous solution is the key chemical PL property for being perfect candidates for, in general, 
cell organellae membrane scaffold.  
 
Different GPL “families” are studied based on the structure of the polar group, finding 
phosphatidilcholines (PC), phosphatidilethanolamines (PE), phosphatidilinositols (PI), 
phosphatidilserines (PS) and cardiolipins (CL). Each family comprises numerous molecular 
species that keep the same head group but changed acyl chain; some relevant forms are showed 
in Figure 3. Synthesis location of those families differs, since CL and majority of PE are 
synthesized in mitochondria whereas other PL families are mostly generated in the endoplasmic 
reticulum (ER). This is also relevant for FA (discussed later in chapters 1.B2 and 1.C2) and 
plasmalogen synthesis, since many steps are started in peroxisomes to be finished at ER and/or 
mitochondria implying that a good communication between those organelles and a correct 
inner-cell trafficking is crucial for an optimal lipid balance. 
 
Arousing from particular FA properties mention above, but also with increasing complexity by 
playing among combinations of different polar groups and/or residues, viscosity, curvature, 
permeability, elastic compressibility and fluidity of such membranes could therefore be 
successfully modified solely (but not only) by mixing specific amounts of particular FA 
incorporated to GPL. 
 
1.A1.1.- Glycerophospholipids 
 
 Structurally, while the hydrocarbon chain at the sn-2 position is usually ester-linked to the 
glycerol moiety, the one in the sn-1 position can be linked via an ester, ether or a vinylether 
bond. Length of the alkyl chain typically varies from 14 to 24 carbons and, for the most relevant 
GPLs, the number of double bonds ranges from 0 to 6. Usually, alkyl chain in the sn-1 position 
is saturated or monounsaturated, while that in the sn-2 position is often polyunsaturated but 
again, the degree of unstauration would change wedge form of the acyl chains making it more 
or less bulky. Even more, since membrane bilayers (outer leaflet cell membrane, Golgi, ER, 
peroxisomes and/or mitochondria) are sprinkled with numerous proteins, interaction with those 
in specific regions (eg lipid rafts) would affect its association (itself but whiting other proteins 
too) and obviously its functional outcome (reviewed in (Stillwell and Wassall 2003) and 
(Nelson DL, Cox 2005)). 
 
Due to the large number of different alkyl chain combinations, each GPL “family” consist of 
numerous structurally different molecular species, thus eukaryotic cells can contain hundreds of 
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different GPLs. It is important to note that approximately 5% of the genome on these cells is 
related to synthesis and maintenance of those molecules (Catalá 2012). Even though the 
meaning of such diversity is not fully understood, it is presumably related to the multiple 
functions of GPLs and their numerous ways for interacting within surrounding biomolecules, 
especially those with signalling purposes. 
 
 
 
 
 
Figure 3. 
Glycerophospolipids 
structure. Representation of 
various GPLs. In the scheme, 
the red circle represents the 
polar head, which also 
corresponds to the Z 
substituents commonly found. 
Aliphatic chains could be 
saturated or unsaturated (red 
line) and are represented by 
the R1 and R2 substituents in 
the lower-letf panel. 
 
GPL location within a specific membrane is asymmetric, differing from the inner leaflet to the 
outer bilayer in the majority of membranes. For instance, inner leaflet in eukaryotic cell 
membranes is rich in PE, PS, and PI whereas the outer is enriched with choline containing 
species, PC and SM. In fact, a widely used test for cell viability (early apoptosis) is based in the 
location change of PS and its interaction with AnexinV (Boas, Forman, and Beutler 1998). This 
membrane asymmetry is present in the ER, peroxisomes and mitochondria too and is actually a 
basic tenet for its correct performance. So, asymmetry maintenance, by translocases, flippases 
or phospholipases action (which will be discussed later in section 1.B1 and 1.B3) is tightly 
regulated. 
 
Since Singer and Nicolson firstly described Mosaic Fluid model (Singer and Nicolson 1972) 
some revisions complete the picture to show a more complex and comprehensive scheme 
(Catalá 2012; Somerharju, Virtanen and Cheng 1999). In general, membrane surface can be 
subdivided into lipid-rafts containing motives and non-lipid-rafts ones. But, what is a lipid-ratf? 
Lipid rafts are micro domains enriched in sphingolipids and cholesterol (CHO) with an average 
diameter of about 50nm. Their formation occurs transiently (they are highly dynamic, but 
ordered) within inner and/or outer leaflet of membranes. They concentrate selected proteins 
serving therefore as platforms or scaffolds where selected cellular processes can occur more 
easily, ranging from cell signalling, pathogen entry, cell adhesion, motility and protein sorting 
and trafficking (reviewed in (Simons and Vaz 2004)). Lipid rafts are consequently so-called 
“liquid-ordered” phases, meanwhile, non-rafts membrane phases are “liquid-disordered” ones. 
 
Studies from Atkinson and Harroum (Atkinson et al. 2010) hypothesized that, in addition to 
higher SM and CHO enrichment in lipid rafts, the liquid disordered ones had higher PUFAs 
concentrations (may be due to sterical impedances related to double bonds). Furthermore, when 
compared with lipid rafts, disordered areas had much higher levels of the main membrane 
resident antioxidant, the E vitamin (tocopherol). On the other side, CHO enriched phases (liquid 
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ordered) were more rigid and it is believed that oxygen diffusion events were reduced on those 
areas (Dumas et al. 1997; Subczynski, Hyde and Kusumi 1991). So, in general terms, at liquid 
ordered phases there was lower quantity of tocopherol and lower oxygen diffusion, hence, 
components were correctly localized, i.e. where more pexoxidation events can occur. Altogether 
this data suggest that specific and controlled positioning of all membrane constituents, GPL, 
SM, CHO, proteins and antioxidants, is crucial for a correct membrane function. 
Figure 4. Membrane representation. Components of a membrane showing lipid raft domains 
and their characteristics (Higher CHO, SM and proteins enrichment), whereas non raft domains 
had higher levels of tochopherol (but also more oxidised PUFA). Not to scale. 
 
In chapter 1.B3 we will dig deeper on membrane modification mechanisms by deacylation and 
reacylation processes and in the next section and 1.C2 we will say a few words about lipid 
signalling events. Just mention here that both are very active processes and thus FA 
biochemistry not only comprises the so cold “free” FA buy also GPL, TAG and much more 
complex derivatives (i.e. lipoxins, eicosanoids, docosanoids or plasmalogens; discussed in 
section 1.C1.2) whose powerful functions are still under debate. 
 
 
 
1.A2 PUFA major functions 
 
PUFAs have been related to interfere and/or regulate a huge variety of functions in very 
different organisms (i.e. birds, worms, humans). In general, functions could be clustered in a 
number of physiological roles, as: i) energy substrates; ii) structural and functional components 
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of cell membranes and, finally, iii) signalling purposes, themselves, and/or as precursors for 
lipid mediators, components affecting signal transduction pathways and gene transcription. 
Therefore, among others pathophysiological events, PUFAs have been linked to:  
 
PUFA -related Processes 
               Process         References 
Learning and memory (Hashimoto et al. 2006) 
Neurotransmitter release (Aïd et al. 2003) 
Autocrine and paracrine communication (Nicolas G Bazan 2008; Kitson et al. 2013) 
Physiquiathric and mood disorders (Freeman et al. 2006; McNamara et al. 2013) 
Immunity and inflammation (Calder n.d.; Serhan et al. 2004) 
Membrane ion channels, enzymes and 
receptors (Eckert et al. 2011; Gawrisch et al., 2008.; Im 2012) 
Adhesion molecules (Yates et al. 2011) 
Apoptosis (Akbar et al. 2005) 
Neurogenesis and neurite growth (Calderon and Kim 2004; Innis 2007) 
Pro/antioxidative potentiation (Nicolas G Bazan 2005; J.-M. Lee and Johnson 2004; Yavin, Brand, and Green 2002) 
 
   
  
 
 
Table2. PUFA-related processes. List of processes and references in which PUFAs had 
relevant functions. 
 
1.A2.1.- Energy substrates 
 
Dietary FAs, in the form of TAG, are the primary source of the body’s energy representing (in a 
balanced diet) 25-35% of the total energy intake in humans. Compared with proteins and 
carbohydrates, FAs have about twice as much energy value and their storage in adipose tissue 
needs less amount of water. The estimated energy value of long and very long chain FAs is 
about 38 kJ/g, and for those medium chain FAs approximately 29 kJ/g. While short chain FAs 
represent a local energy source for enterocytes and colonocytes, the others must be delivered 
(discussed in section 1.B1.1), generally in esterified forms or albumin-complexed. Also 
important, FAs take part in the process of transferring and depositing crucial lipid soluble 
molecules (such as vitamins A, D, E and K) and are precursors of lipid mediators. 
 
Unfortunately, as fat intake has increased within recent years in western-type environments 
(reviewed in (Simopoulos 2011)), the percentage of FA in the energy intake could represent 
nowadays up to 40-45% of the total, depending on food sources and habitual consumption. 
Hence, the evolutionary positive role of FA as a energy storage for further necessities, 
altogether with the sedentary lifestyle of western population and their increased fat consumption 
turned nowadays fat into the focus of non-communicable diseases. Especially since 
epidemiological studies pointed that visceral adiposity (possibly emerged from fat intake 
unbalance) was a risk factor to developed metabolic syndrome (Björntorp 1993). Therefore, to 
conceal this major threat of western civilization, nutritional recommendations have been 
established about total fat and particular fat types, including essential FA and ω-3 PUFA 
(discussed in chapter 1.B4). 
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1.A2.2.- Structural membrane actions 
 
As stated in the previous chapter, FAs, in the form of GPL, are the structural components of all 
cell membranes. Their profile have a profound influence in the biophysical properties of those 
membranes and, thus, the activity of membrane associated proteins (i.e. enzymes, ion channels, 
receptors and transporters) (Nelson DL, Cox MM. 2005). As indicated above, the tuning 
capacity of specific molecules (CHO and/or specific proteins) or the degree of unsaturation of 
FA present in GPL to promote higher or lower membrane fluidity should be considered 
(Chapkin et al. 2008; Stulnig et al. 2001). Finally, a very remarkable function of fats as 
insulators is found in many living organism, especially relevant, for instance, in marine 
mammals. 
 
 
1.A2.3.- Signalling purposes 
 
A) FA itself as second messengers 
 
From preliminary studies by Berridge in 1984 (Berridge 1984), the hydrophilic inositol 1,4,5-
triphosphate (IP3) and the lipophilic 1,2-diacylglycerol (DAG) are considered second 
messengers. Both are generated from the membrane lipid phosphatidylinositol 4,5-bisphosphate  
(IP2) by the action of a phospholipase C (PLC, for a review on its regulation see (Bunney and 
Katan 2011)). Mechanistically, IP3 interacts with an intracellular IP3 receptor and leads to the 
mobilization of Ca+2 from intracellular stores (ER and/or mitochondria), whereas DAG directly 
activates protein kinase C (PKC) and thereby initiates important down-stream signal 
transduction cascades (Nelson DL, Cox MM. 2005). Other phospholipases (discussed in section 
1.B3.1) would also release some FA and derivatives, which had relevant signal transduction 
activities. For instance, phosphatidic acid (PA, excised by phospholipase D, PLD), is rapidly 
converter to DAG (with the aforementioned consequences). But, in parallel, this substance is 
necessary for appropriate mTOR (mamalial target of rapamicyn, a key protein representing a 
relevant survival cascade) signalling too (Fang et al. 2001). Through phospholipase A (PLA) 
action, docosahexaenoic acid (DHA, C22:6ω-3) or arachidonic acid (AA, C20:4ω-6) could be 
also released from the membranes and interact with multiple nuclear transcription factors 
(discussed below) and/or could be non-enzymatically oxidised too and those new lipid species 
(e.g. HETE, NPD1, 8-iso-PGF2α, among others) may interact with specific cellular receptors for 
achieving another different outcome. 
 
From the complex lipid signalling overview seen before, which is in fact much more coiled, it 
seems clear that there is not a single mechanism for FA regulation of gene transcription. The 
classical point of view implied a specific FA to enter the cell in order achieve its regulation, but 
nowadays is well accepted that this could be overcome through membrane receptors (e.g. G-
proteins coupled, reviewed in (Kostenis 2004)) which not only turn active by non-estified FA, 
but also very complex derivatives. It is therefore depending upon the cell-specific context, the 
target genes or the overall status of the cell, that FAs could take very different routes to alter 
transcription (Duplus and Forest 2002).  
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B) FAs as precursors of lipid mediators 
 
Through the action of multiple enzymes, but through non-enzymatic oxidation too, FAs are 
converted into relevant signalling lipid species, such as eicosanoids (i.e. LT, PG, prostacyclines 
-PGI- and tromboxanes-TX), isoprostanes, endocannabinoids, docosanoids (maresins, 
docosatrienes, neuroprotectins, neuroprostanes), resolvins (D and E series) and sphingolipid 
derivatives (e.g. ceramide, sphingosine 1-phosphate, sphingosylphosphorylcholine). All those 
species compose an enormously wide family which exerts a myriad of different outcomes in 
multiple locations across the body, but which could be separated, in a very simplistic view, into 
pro or anti-inflammatory ones, and will be discussed in chapter 1.C. 
Figure 5. PUFAs cellular signalling. Cellular signalling response to FA and its derivatives 
could be achieved in multiple ways: (1) DAG direct action on protein kinase C (PKC) will trigger 
kinase pathways. (2) Free FA, cleaved form membrane by cPLA2 (which is sensible to Ca+2 
concentrations), would interact with different transcription factors (discussed below) and 
translocate to nucleus where they activate specific pathways. (3) PA (which cloud be released 
by phospholipase D- PLD, action under extracellular receptor stimulation) is necessary for the 
correct mTOR signalling. (4) Ca+2 release could be trigger by specific IP3 (whose accretion 
could be PLC-dependent, through extracellular G-protein receptor stimulation) receptors 
present in ER and start signalling events. (5) Specific membrane receptors (e.g. TXA2R and/or 
G-protein-coupled receptors, but also PG-dependent ones, among others) could themselves 
initiate an appropriate signalling cascade. Although, upon stimulation (e.g. PLC), they may 
influence PKC behaviour too, present in the surroundings, and ultimately affect cellular 
responses (e.g. nuclear factor kappa-light-chain-enhancer of activated B cells –NFκB-or 
mitogen-asctivated protein kinase -MAPK- cascades). (6) Finally, another possibility for free FA 
is to undergo further processing to achieve specific lipid products (through action of 
cycloxygenases-COX-, lipoxygenases-LOX- and/or cytochrome P450-CYP450) which 
potentially enhance paracrine and/or autocrine signalling. (cPLA2, Ca+2-dependent 
phospholipase A2; LPC, lysophosphatidil-choline;PA, phosphatidic acid; PC, phosphatidil 
choline; TXA2, tromboxane A2; COX2, cycloxygenase 2; CHO, Cholesterol; LPPs, 
lysophosphatidic acid phosphatase). 
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C) Palmitoylation 
 
Recently, a new form of post-translational modification involving FA attachment was found, the 
palmitoylation. This modification consists in the introduction of the palmitate lipid in the 
cysteine residues of a specific protein (a recent revision on the topic could be found (Blaskovic 
et al. 2014)). Another cellular lipidations such as myristoylation and prenylation, can also occur, 
opening a new field in signalling regulation, but due to its chemical properties (specially its 
reversivility), palmitoylation seems the most relevant. Lots of proteins have been shown to be 
palmitolated, therefore, multiple mechanisms of cellular metabolism are affected (e.g. 
signalling, ion transport across membranes, protein folding and degradation, synaptic plasticity, 
endocytosis, exit from the ER, transcription, bacterial and viral infection, among others; 
reviewed in (Nadolski and Linder 2007 and Planey and Zacharias 2009)). The obvious 
consequence of this modification is clear, to upgrade protein lipofilicity and help in any-
membrane attachment, which ultimately results in a variation of its regular location. This was 
proposed to affect, for instance, synaptic plasticity (Conibear and Davis 2010) and Ras (proto-
oncogene) regulation (Rocks et al. 2005). Among the identified 23 DHHC (core Asp-His-His-
Cys motif which is essential for transferase activity, in vitro and in vivo (Huang et al. 2009)) 
mammalian palmitoyl-acyl-transferases, there was found several neuronal-specific, which 
exhibit a particularly marked substrate specificity, pointing that this post-translational 
modification is tightly regulated. However, due to the multiple mechanisms potentially affected, 
palmitoylation is still a wide open field for research. 
 
 
 
D) FA direct interaction with transcription factors 
 
Transcription factors are protein structures that bind to specific DNA sequences, usually close 
to the target genes, in order to control (commonly, by enhancement or repression at the 
promoter area) the flow of genetic information from DNA to messenger RNA. This specific 
DNA interaction is the defining feature of any transcription factor, that is, they must contain one 
or more DNA-binding domains. On the contrary, other molecular species, such as coactivators, 
chromatin remodelers, histone acetylases-deacetylases or methylases, which alter genetic flux 
too, lack those specific domains. FAs, specially long chain ones (C20-C22) but also medium 
and some lipid derivatives (e.g. epoxyeicosatrienoic acids, ETT (Liu et al. 2005)) could act as 
ligands of these cellular triggers. Hence, they could modulate gene transcription which, 
ultimately, influences cell signalling and fate (Chapkin et al. 2008). Two general mechanisms 
characterize FA control over transcription factors: one implies direct binding to the protein 
structure (see below) whereas the other refers to the greater stability and/or abundance of a 
specific transcription factor, but a direct binding is unlikely.  
 
 
Therefore, among some others, non-esterified long chain unsaturated FA (C20-22) and some of 
their metabolites have been identified as effective ligands of nuclear receptors and/or 
transcription factors like:  
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PUFA Interactions Among Nuclear Receptors 
Nuclear Receptor / Transcription Factor References 
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n
 PPAR -α,-β/δ, -γ1 and -γ2 (Xu et al., 1999) reviewed in ( Berger et al., 2002) 
LXR α (Ou et al., 2001) 
RXR α (Lengqvist et al. 2004; de Urquiza et al. 2000) 
HNF4α and HNF4γ (Dhe-Paganon et al. 2002; Wisely et al. 2002) 
In
di
re
ct
 SREBP (Xu et al. 1999) 
 ChREBP (Dentin et al. 2005) 
NFκB (Camandola et al. 1996) 
 
 
Table 3. PUFAs interactions among nuclear receptors. List of references and interactions 
founded between nuclear receptors/transcripcion factors and PUFAs and their derivatives. 
 
We will discuss now some details of the aforementioned transcription factors: 
 
1.-Peroxisome-proliferator activator receptor (PPARs) are members of the steroid 
hormone nuclear receptor superfamily and play important roles in lipid metabolism and 
homeostasis, generally through an induction of FA degradation (increasing peroxisomal and 
mitochondrial oxidation, reviewed elsewhere). Three subtypes of PPARs have been 
characterized in humans, PPAR-α, -γ, and -δ (the latter also known as PPAR-β; γ generates 
three isoforms) whose mechanism of action implies homo and/or heterodimerization (the latter, 
more frequently) with the 9-cis-retinoic acid receptor (RXR) and binding to PPAR-responsive 
elements in the promoter region of various target genes, ultimately regulating their transcription. 
Their DNA and protein sequences are highly conserved among them, especially upon the DNA 
binding domain, meanwhile the ligand binding pocket possess a wider variation to achieve their 
specific selectivity (Xu et al. 1999). There have been found homologous proteins in many 
different species, including all metazoan phyla, pointing out the relevance of their physiological 
functions across evolution (reviewed in (Escriva, Delaunay and Laudet 2000)). 
 
In rodents, as well in humans, PPAR-α is highly expressed in the liver, skeletal muscle, heart, 
and kidney meanwhile PPAR-γ is predominantly found in white and brown adipose tissue, 
colon, endothelial and vascular smooth muscle cells and, to a lesser extent, in immune cells and 
liver. Finally, PPAR-δ is ubiquitously expressed, but its action is especially relevant in skeletal 
muscle. In the central nervous system (CNS), expression for all isoforms was found, but δ is the 
predominant (Basu-Modak et al. 1999). Thanks to knock out, inducible, deletion and silencing 
studies upon the family members performed in rodents over the past years, a complex time-
dependent cell-specific distribution was found, in CNS too (reviewed in (Keller et al. 2000)). 
Whereas PPAR-α and γ are expressed at very low levels, predominantly in astrocytes and 
microglia respectively, PPARδ has been found in neurons of numerous brain areas as well as in 
immature oligodendrocytes, revealing a key feature helping a correct axon myelination (Peters 
et al. 2000). Interestingly, recent studies (Ciana et al. 2007) had demonstrated a differential 
male-to-female induction of PPAR, at least for the liver, which could be on the basis of the 
different lipid handling by each of the two sexes. 
 
Regarding its activation, several FA and natural occurring derivatives (e.g. eicosanoids, PG, 
HETES) interact with PPARs (Krey et al. 1997), besides lots of synthetic agonist had been 
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proved to do so (reviewed in (Fruchart 2013; Derosa and Maffioli 2012; Bernardo and 
Minghetti 2006 and Bhurruth-Alcor et al. 2010) with particular preferences between the 
different isoforms. Synthetic thiazolidinediones (e.g. pioglitazone and rosiglitazone, already 
approved treatments for type-II diabetes) are preferred substrates for PPAR-γ induction, 
whereas fibrates do so to PPAR-α or thia-fatty acids (synthetic sulphur-containing FA with 
plasma lipid lowering effects) could have an effect on all of them (Bhurruth-Alcor et al. 2010).  
 
2.- Liver-X-Receptor (LXRs) are crucial nuclear receptors for lipid homeostasis (for a 
review in this topic see (Jakobsson et al. 2012; Repa and Mangelsdorf 2002)). In vitro LXR 
interaction with FA (serving as direct antagonists) has been proved for some of the PUFA 
family (Ou et al. 2001), but surprisingly not for the unsaturated stearic acid (C18:0). In response 
to oxysterols (derivatives of CHO), the two LXR isoformrs (α and β, with a 77% amino acids 
homology) formed heterodimers with retinoid X receptor to be fully activated and induces the 
expression of genes required for the reverse CHO transport. This fact explains the extensive 
research aimed to develop synthetic agonist to help in dyslipidemia treatments, in general, and 
more specifically in metabolic syndrome and related cardiovascular disarrangements, being 
statins of special relevance (for a review on the statins and their relevance in CNS see (A 
Farooqui et al. 2007). LXR activation induces genes for de novo lipogenesis in liver in two 
separate pathways: i) transcriptional induction of SREBP1c (Repa et al. 2000); ii) by up-
regulation of ChREBP expression (Cha and Repa 2007). LXR-mediated increases in both 
ChREBP and SREBP-1c will raise expression of lipogenic enzymes to enhance fatty acid 
synthesis from glycolytic end-products, being therefore considered a master hepatic lipogenic 
factor. 
 
3.-Sterol regulatory element-binding proteins (SREBPs) comprise another transcription 
factor family. Composed of three members (named 1a, 1c and 2 respectively), they are activated 
(by cleavage from ER-Golgi and nuclear membranes) when low levels of cellular CHO are 
present. In order to enhance CHO and FA biosynthesis, they bind specific DNA regions (10 bp 
length, named sterol regulatory element) located in promoter regions of various genes (for a 
review on the SREBP topic see (Xiao and Song 2013)). SREBP-2 is relatively selective for 
CHO biosynthesis enhancement, meanwhile SREBP-1c activates the FA pathway (e.g. promote 
expression of the fatty acid synthase) and SREBP-1a remains in between, with a mild activation 
of both. Two genes encode their protein sequences, asides the latter had different splicing to 
raise the two isoforms (Brown and Goldstein 1997). In relation with SREBP-1c, PUFA cause an 
activation, whereas, surprisingly, saturated or monounsaturated FA suppressed the induction of 
lipogenic genes by inhibiting its expression (reducing mRNA stability) and processing 
(Nakamura et al. 2004). 
 
4.- Carbohydrate-response element-binding protein (ChREBP) heterodimerizes with 
Max-like protein X and bind to the carbohydrate response element regions of the DNA when a 
substantial decreaseof AMP/ATP ratio is present. Recently, it has been reported that ChREBP 
has two isoforms, ChREBP-α and ChREBP-β, and that they are located mainly in the cytosol 
and nucleus, respectively (Herman et al. 2012). Moreover, ChREBP is susceptible of being 
phosphorylated by various stimuli (e.g. protein kinase A, adenosine-monophosphate kinase), 
and therefore blocked in the cytosol, inhibiting the control over genes related to glycolysis, 
lipogenesis, and gluconeogenesis (e.g. liver type pyruvate kinase, fatty acid synthase and 
glucose-6-phosphatase catalytic subunit, respectively). Thus, the main function of ChREBP is to 
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regulate metabolic gene expression to convert excess carbohydrate into triglyceride, rather than 
glycogen. But this protein could repress PPAR-α, hypoxia inducible factor-1b and sirtuin-1 
(among other transcription factors, for a review see (Iizuka 2013)) activities too, having a 
greater gene expression interference. 
 
5.-Nuclear factor kappa-light-chain-enhancer of activated B-cells (NFκB) pathway 
represents a key factor in cell survival. It had been implicated in a myriad of diverse situations, 
from the immune response to infection (the origin of its discovery) to cancer, as well as 
inflammatory and autoimmune diseases or synaptic plasticity and memory events (for a review 
see (Gilmore 2006)). Early studies about PUFA action on the pathway, showed a differential 
role for ω-3 and ω-6 fatty acids (Camandola et al. 1996) and it has been proved that some of 
PUFA derivatives affect it too (Ho et al. 2008; Sánchez-Galán et al. 2009). Remarkably, apart 
from the direct influence of PUFA and its derivatives in the signalling cascade, NFκB pathway 
is affected by PKC action. Hence, several members of the pathway are phosphorylated or helped 
to be stabilised (e.g. IKKα/β, RelA, among others) by most of the PKC isoforms studied (but 
with particular cell/tissue or pathology variations), providing another frame for PUFA’s 
influence on cell fate. 
 
Figure 6. PUFAs actions. Apart from their specific membrane functions, under PLA2 activity, 
PUFA are released from the membrane and could initiate various cascades and/or directly 
interact with response elements to enhance different cellular mechanisms. Importantly, PUFAs 
could also serve as substrates for the synthesis of multiple signalling molecules. 
 
1A2.4.-Cell Survival 
 
Akbar and co-workers (Akbar et al. 2005) linked DHA to crucial signalling cascades, PI3K-
AKT/mTOR. As a consequence, it has been proved that cell survival is altered by various 
kinases pathways, susceptible to be PUFA and PUFA-derivative sensitive. For instance, the 
phosphoinositide 3-kinase (PI3K) and the MAPK pathways are activated in injured neurons 
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(Henshall et al. 2002) as well as in tumours (reviewed in (Bertucci and Mitchell 2013)). PUFA 
and their anti-inflammatory derivatives could alleviate PI3K mediated cell death, at least in 
yeast models (Couplan et al. 2009) or in lipopolysaccharide-induced microglial inflammatory 
response (Xu et al. 2013), but could also result in increased mortality in cancer cell-lines (Toit-
Kohn, Louw and Engelbrecht 2009). Furthermore, in activated microglia, PI3K inhibition 
enhanced prostanoids production, and expression of COX-2 could be regulated by PI3K as a 
response to neuroinflammation (de Oliveira et al. 2012). Interestingly, a synthetic derivative of 
PGF2α, latanoprost, is able to promote retinal ganglion cell survival and neurite outgrowth 
through a PGF receptor-mediated modulation of the PI3K pathway (Zheng et al. 2011). 
Therefore, MAPK pathways are involved in neuroinflammation in many ways, including the 
enhancement of IL-6 synthesis in sensory neurons (St-Jacques and Ma 2011) and the regulation 
of IL-1-mediated COX-2 expression (Moolwaney and Igwe 2005) and those pathways could be 
affected by different lipid derivatives in a feedback loop. 
 
Concluding: DHA and AA, two different motorways. 
 
DHA and AA are chosen as paradigmatic examples from the two main eukaryotic fatty acid 
families, ω-3 and ω-6 respectively. They are “endproducts” themselves since their unique 
characteristics confer them special functions. Besides, they are crucial because they represent 
main precursors of a broad range of paracrine substances acting in a wide type of schemes, with 
different outcomes. In terms of inflammation, it is generally well accepted that both families 
symbolize two different actions in response to an insult (with the exception of AA-derived 
lipoxins). This is, AA and ω-6 derivatives initially predisposes to inflammation whereas DHA, 
EPA and ω-3 derivatives alleviate and, up to an extent, try to solve the urgency. 
 
For one simple molecule, DHA, to have an effect in so many presumably unrelated processes, it 
should function in a fundamental level, common to most cells. On the other hand, ω-3 
docosapentaenoic acid (DPA) is a DHA precursor and membranes enriched in this FA posse 
very subtle membrane fluidity alterations respect to those with DHA. Furthermore, ω -3 DPA is 
only two protons diferent, requires less energy (and reduced complexity) to be synthesized and 
it is more resistant to peroxidation than DHA. Why this molecule is tenaciously conserved 
through evolution (especially concerning its visual and cognitive virtues) is discussed in an 
interesting publication (Crawford et al. 2013). 
 
It is been proved that ω-3, as well as ω-6 FA, are involved in: i) hormone production; ii) 
formation of potent lipid peroxidation products (which could be detrimental, but signalling 
useful too, reviewed in section 1.C2.3) ; iii) direct effectors on specific enzyme activity or as 
indirect effectors through transcription events and/or iv) membrane structure and function 
alterations (reviewed in (Stillwell and Wassall 2003)). All those general modes of action are not 
mutually exclusive, rendering ω-3 and ω-6 FA pleiotropic effects.   
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1.B1 PUFA systemic and cellular delivery 
 
1.B1.1.- Systemic delivery 
 
Along digestion, phospholipase A2 (discussed later in section 1B3.1), inespecific esterases and 
lipases, and bile acids are secreted, initially at the stomach and through small intestine. Most of 
those enzymes are originated in the pancreas and emulsified fats breakdown into free FA, mono 
and diglycerides and cholesterol-esters to form mixed micellaes. They are composed by bile 
acids, CHO (dietary, and bile-secreted too), the aforementioned break fats, PL and dietary 
liposoluble vitamins (A, D, E and K). This process takes place mostly in the upper part of the 
small intestine, and along it, increased amounts of lipolisis products enrich micellae 
composition. Those enzymes digregate lipids at neutral pH and the lipid enrichment of micellae 
renders then “soluble” and easily absorbed by enterocytes at microvelssels, in a passive manner. 
But this uptake could be also helped by specific proteins, such as CHO capturing proteins (i.e. 
Niemann Pick C1 like 1), ATP-binding cassette transporters or microvelssel membrane-FABP 
(fatty acid binding protein) (Berne and Levy 2000). ER of enterocytes resterifies FA and 
monoglicerids to obtain triglycerids (major chylomicron component, up to 77%), PL (up to 9%) 
and Cholesterol-esters (3%) to form, combined with apoliproteins (synthesized in the rough-ER 
and mainly composed by apoliprotein B, ≈100 KDa, 1%), the chylomicrons. These substances, 
conformed by a lipid core but protein coated, could range from 0.08 to 0.6 micrometers and are 
secreted to lymphatic system, bypasing portal vein transportation and liver, to arrive wherever 
they are needed along the lymph and finally re-entering into the blood stream at the thorax. This 
is the common transportation for long FA, but it’s not the case for those short and medium chain 
lengths FA. Due to their higher aqueous solubility they avoid reacylation, chylomicron forming 
and secretion, being ready for use through blood stream from enterocyte, thus, entering directly 
to the liver by portal circulation.  
 
Passing across adipose tissue and skeletal muscle capillaries, plasma chylomicorns are cleared. 
This could take around one to two hours after ingestion; meanwhile those substances could 
reach up to 2% of the plasma, conferring it turbidity and a yellow colour. Lipoprotein-lipase is 
responsible for this clearance, acting at capillar endothelium level. These enzymes hydrolysed 
triglycerids and PL at chylomicrons to form glycerol and free FA which immediately diffuses 
through membranes. Those FA are readily re-esterified to be stored for further requirements. 
Hence, the liver plays key roles: i) decomposing FA to obtain energy; ii) synthesising 
triglycerides from carbohydrates; iii) synthesising other lipid compounds from FA, specially 
CHO and PL. Meanwhile, adipose tissue: i) stores triglycerides forming fat; ii) is a major 
endocrine organ, synthezising or assisting in the synthesis of important hormones as 
adiponectin, TNFα, IL-6, leptin, resistin among many others; iii) regulates free FA levels; iv) 
the brown type one generates heat by uncoupling mitocondrial respiratory chain. Both tissues 
are therefore central organs controlling dietary fats and its further release when required. 
 
Moreover, free FA transportation occurs, representing 5% of total lipids in plasma after 
chylomicron clearance. Nevertheless, it is not usually related with digestion processes, instead it 
is more commonly linked to energy expenditure recovery. There are at least two signals which 
cooperate to evoke FA delivery to form storage depots. One is the α-glicerophosphate decay in 
tissues with high energy demand and/or secondly, hormone-sensitive lipase activation. 
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However, free FA in plasma is scarce, regularly only 0.45 g in the whole circulatory system. 
Surprisingly, this low relative amount is enough, since its turnover is especially high. Half-life 
of a plasmatic FA is around 2-3 minutes, and when depleted, new FA is desorbed from storage 
depots. The flexible amounts of FA transported in plasma helped by albumin are also 
remarkable. Starvation or diseases such as type-I diabetes deplete carbohydrates and, under such 
conditions, FA/albumin ratio could peak to 30/1, when is normally around 3/1. 
 
In fact, the majority of lipid delivery along the body is lipoprotein linked. Apart from 
chylomicrons, there are four types of lipoproteins, which could be classified attending its 
density after centrifugal distribution (expressing a ratio between triglycerides and proteins 
presented on them): i) very low density, containing high amounts of triglycerides, but moderate 
PL and CHO; ii) medium density, which are in fact very low density ones but half depleted of 
triglycerides (therefore raising its PL and CHO percentage); iii) low density, already 
triglycerides depleted, with very high amounts of CHO, but moderate PL quantity and  iv) high 
density ones, where protein composition rises to 50%. 
 
These are some important points related to lipid transport from dietary sources to the whole 
body through the circulatory system, but, what happens with lipids crossing cell membranes or 
the inner trafficking whiting the cell? These issues will be discussed below.  
 
1.B1.2.- Regulation across cell membranes 
 
The physical properties mentioned before claimed for very low FA solubility in aqueous 
solutions. For decades, there had been controversy on whether FA transportation across 
membranes occurs eventually by chance (by simple passive diffusion events) or facilitated by 
proteins. Nowadays the general idea is that both issues could happen, but for optimization, 
protein-mediated transport is more common.  
 
Flip-flop and diffusion events take place naturally. Hamilton and co-workers (Kamp and 
Hamilton 2006; Kamp and Hamilton 1992; Hamilton 2007) demonstrate not only that proteins 
are not completely necessary for fatty acids to go across cytosolic membrane but also that they 
are not required for releasing those fatty acids into cytosol. Further, they demonstrated that 
extracellular membrane crossing could be much easier for fatty acids than for glucose, water or 
small non-electrolytes. 
 
But driving forces for free diffusion are based on concentration and gradient generation, so it 
would be impossible to meet the requirements when high metabolic tissues demand it fast (e.g. 
muscle upon contraction). Thus, from a physiological point of view, it would be interesting to 
have a better control of FA trafficking to: i) ensure FA uptake when low levels are present 
inside cytosol; ii) avoid FA export when low levels are present outside the cell and uptake when 
inner quantities are sufficient (the latter may not take place because of gradient loss); iii) 
potentially select a particular FA type (specific enrichment) and finally iv) allow those rapid 
adjustments when metabolic fluctuations occurs. A scheme representing FA membrane 
trafficking is pictured next page in Figure 7. 
 
So, in order to optimise transportation to and across biomembranes, FA and some of their 
derivatives, are helped by proteins. For instance, albumin levels in plasma and interstitial spaces 
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could range from 300 to 600µM and such an “unspecific” protein may help to “dissolve” 100 to 
400µM (extreme cases up to 1,5mM) fatty acids (Richieri, Anel and Kleinfeld 1993). Finally, 
taking into account particularities found in the CNS (energetic demands, highly complex cell 
types, brain blood barrier intersection) its FA transportation and metabolism will be discussed 
later on section 1.B5. 
Figure 7. FA delivery across the membrane. Current scheme of FA transport mechanisms to 
intersect cell membranes. Since the exact mechanism of transmembrane translocation of FA is 
still unresolved, Figure 7 shows the most likely ones: (1) In view of their hydrophobic nature, 
Albumin-desorbed FA could cross the membrane by simple diffusion. (2) Alternatively, CD36 
(88kDa; also referred as fatty acid translocase), alone or together with the peripheral membrane 
protein FABPpm (plasma membrane-associated fatty acid-binding protein; 43kDa) accepts FA 
at the cell surface to increase their local concentration and thus increase the number of FA 
diffusion events. (3) It is possible that FA membrane crossing is actively achieved through CD36 
too. Once at the inner side of the membrane, FA are bound by cytoplasmic fatty acid binding 
protein (FABPc) before entering metabolic or signalling pathways and transformed into Acyl-
CoAs. (4) Additionally, a minority of FA are thought to be transported by fatty acid transport 
proteins (FATP1) and rapidly activated by plasma membrane acyl-CoA synthetase (ACS1) to 
form acyl-CoA esters. (5) Very-long- chain fatty acids are preferentially transported by FATPs 
and, by action of their synthetase activity, directly converted into very-long-chain acyl-CoA 
esters. 
 
1.B1.3.- FA inner trafficking 
 
Different membranes in a single cell had clearly shown different lipid distribution. For instance, 
plasmatic membrane exhibits a transverse lipid composition asymmetry with high amounts of 
sterol and sphingolipids, whereas ER displays symmetrical distribution and contains low level 
of both species (Voelker 1991). Migration into and between organelles could be a difficult task 
because most lipid species lack any intrinsic motif that mediates their intracellular distribution 
like proteins do. However, some sort of connectivity between ER, Golgi, mitochondria and 
peroxisomes has to operate to interconnect FA fate. As commented previously, interplay 
between those organelles is necessary to achieve specific amounts of a required lipid for 
metabolic purposes or, if is not delivered, need to be synthesized. This internal connectivity 
could be, essentially, vesicular or non-vesicular mediated. It has been demonstrated that both 
systems occur but the latter is more likely to be restricted to membrane contact sites (MCS, 
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discussed in next section), where ER and virtually all the organelles “touch” each other 
(reviewed in (Holthuis and Levine 2005)).  
 
Non vesicular spontaneous interconnection in between one of the mentioned areas and/or with 
the cytoplasmatic membrane could exist as i) total free desorption, stochastically diffusion 
across the cytosol and absorption to the target membrane or, on the contrary, ii) being helped by 
specific proteins (lipid transport proteins, LTP). Both processes have no net energy expenditure, 
but proteins can greatly facilitate (desorption and diffusion across aqueous cytoplasm are 
believed to be the more difficult steps) and more likely regulate final destination (reviewed in 
(Helmkamp 1986) and (Lev 2010; Lev 2012)). Finally, other possibility for FA exchange in 
between membranes includes collision, which could be “activated” when a substantial part of 
the lipid extends from the bilayer surface. 
 
LTP are nowadays being extensively studied. From this research became clear that monomeric 
exchange (a single lipid specie intermembrane interchanged) proceeds even when vesicular 
pathways are blocked due to genetic manipulation or chemicals. For instance, a well-studied 
case is the delivery of ceramides (synthesized in the ER) to the trans-Golgi (Hanada et al. 2003) 
or the PI delivery form the ER to both the Golgi and the plasma membrane (Whatmore et al. 
1999). Both routes are highly conserved throughout evolution and are both LTP mediated. 
Thanks to crystallographyseveral LTPs structures were elucidated (with and without their 
natural ligands). In general, their tunnel-shape determined lipid selectivity and more 
surprisingly, some of the elucidated structures had a “lid” to close the tunnel which, in turn, is 
opened through a conformation change when LTP is bound to a membrane. LTP targeting for a 
specific membrane is not clear yet, but studies in the past years pointed that Trp residues present 
at membrane binding sites helped in the correct positioning, but in a non-specific manner 
(Phillips et al. 2006). 
Figure 8. FA intermembrane transportation. There are four main mechanisms for non-
vesicular lipid transport: (1) spontaneous transfer; (2) transbilayer LTP-mediated; (3) lateral 
diffusion and (4) flip-flop (which could be spontaneous or protein-helped, by flippases). The last 
two are not commonly involved on lipid layer exchange (only when membranes are connected 
through bridges), but also occurs naturally and remodelate lipid bilayers. 
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All in all LTP non vesicular transport represents a precisely, non-energy wasting and elegant 
way to translocate lipid species between two membranes probably much more efficiently than 
spontaneous processes, but further research is needed to clarify different aspects like membrane 
target specificity, its regulatory mechanism and cytoskeleton relationships, among others. 
 
1.B1.4.- Lipid transport at membrane contact sites 
 
Membrane contact sites (MCS) are defined as regions where two membranes are closely 
apposed but the membranes do not fuse and thus each organelle maintain its identity. MCS have 
been described for ER with mitochondria, Golgi, peroxisomes, endosomes, lysosomes and lipid 
droplets, as well as the plasma membrane (for a review see (Elbaz and Schuldiner 2011 and 
Rowland and Voeltz 2012)). The most studied ones are those between the ER and mitochondria. 
In fact, there is a fraction of the ER which can be isolated, that is attached to mitochondria 
(named the mitochondria-associated membrane, MAM) and this fraction is enriched in enzymes 
that are involved in lipid synthesis. Hence, for some lipid species (e.g. PC, PE or DHA, 
discussed later), synthesis started in the ER but mitochondria is required for several steps of the 
process. 
 
ER-mitochondria MCS can have different structural features. Some contact sites are discrete, 
whereas others are more extensive, circumscribing almost completely around the mitochondrial 
membrane. Contact sites appear to be stable structures because the two organelles stay tethered 
to each other even as they move along the cytoskeleton, pointing out the relevance of this 
linkage. Spectacular live cell imaging videos show that the two organelles can traffic in a 
coordinated fashion without any noticeable disruption in their contact (Friedman et al. 2010). 
Lipid transport at the MCS could also occur as protein mediated or spontaneously. Again, when 
transport is LTP mediated, is more likely to be better regulated, hence more efficient. An 
example of this process is, for instance, the production of PE form PS in mammalian cells. PS is 
scarce in the mitochondria (2-3% of total membrane PL), but among other diverse functions, is 
required for the mitochondrial resident enzyme PS-decarboxylase. PS formation is ATP 
consuming and occurs through the exchange of a serine residue with either the choline moiety 
of PC or the ethnolamine moiety of PE. This process is catalysed by two enzymes, PS-synthase 
1 (for both substrates) and 2 (specific for PE) which are  mainly resident in the ER (specially at 
MAM, remarkable in hepatocytes) but could be found in the Golgi too (Daum and Vance 1997). 
Furthermore, most of the PE synthesized in mammalian cells comes from the decarboxylation 
of PS at the inner mitochondrial space (although two alternative mechanism of synthesis exists). 
Hence, the transport of PS from the ER to the mitochondria and PE back from the mitochondria 
to the ER is a remarkable example of bidirectional non-vesicular lipid transport mechanism at 
the MCS and how those regulate lipid biosynthesis and distribution. 
 
 
 
1.B2 PUFA biosynthetic pathways: desaturase and elongase 
 
De novo FA biosynthesis involved different enzymes (i.e. desaturases, elongases) distributed in 
various organelles across the cell (i.e. microsomes, ER, mitochondria, peroxisomes). For its 
obtention a coordinated cascade of processes (i.e. elongation, desaturation and β-oxidation) 
takes place in those precise locations. Because we lack the ∆12 and ∆15 desaturases present in 
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plants, mammals cannot synthesize all sort of PUFAs we need from the ω-3 and the ω-6 series. 
Hence, some FA must be dietary provided and consequently named “essential FA”. We will 
focus in the two most relevant PUFAs as examples from both series, DHA (ω-3) and AA (ω-6), 
here we will discuss how these FA are formed arising from their dietary sources, that is, the 
C18:2ω-3 (alpha-linolenic acid, ALA) and the C18:3ω-6 (LA). 
 
1.B2.1.-DHA synthesis 
 
Stated long time ago by Dr Sprecher (Sprecher 1981), DHA synthesis has been recently 
revisited in non-mammalian species, for which certain ∆4 desaturase activity was proposed (Qiu 
2003). Nevertheless, the canonical eukaryotic route for DHA synthesis, starting from its main 
precursor, ALA, involves a ∆6 desaturation step, performed by specific FADS2 (52KDa), 
followed by an elongation step, executed by a PUFA selective elongase, ELOVL5, to form 
C20:4ω-3. This reaction, in which malonyl-CoA is the two carbon donor and NADPH the 
reducing agent, takes place at the microsomes (ER) and involves four separate reactions: 
condensation (β-ketoacyl CoA synthase), reduction (β-ketoacyl CoA reductase), dehydratation 
(β-hydroxyacyl CoA dehydrase) and reduction once again (trans-2, 3-enoyl-CoA reductase). 
 
The initial condensation step is the rate limiting factor and takes place at the cytosolic surface of 
the ER membrane. Chain length of the end-product is determined by a serine residue of the 
elongase at the luminal surface (Denic and Weissman 2007). It is therefore believed that end-
product specificity is driven by a distinct chain length rather than by a number of repeated two-
carbon additions. 
 
After these two steps, another desaturation phase is required (∆5, FADS1) followed by to 
consecutive elongation steps (ELOVL2 and 5) to form C22:5ω-3 and another ELOVL2 
elongase cycle to achieve C24:5ω-3. ∆5 and ∆6 desaturases share up to a 75% sequence 
similarity in humans (for a review on those enzymes and their relation to FA abundance see 
(Lattka et al. 2010)). They introduce a double bound at position 5 (being substrates C20:3 and 
20:4 for the in the ω-3 and ω-6 series respectively) or 6 (being substrates C18:3 and C18:2 for 
the in the ω-3 and ω-6 series respectively) of the acyl chain. Finally, FADS2 action desaturates 
once more to produce C24:6ω-3. The last step takes place in the peroxisomes and includes a β-
oxidation to successfully synthesize DHA. A scheme of the described mechanism is pictured in 
Figure 9 in the next page. 
 
FADS2 mRNA expression occurs principally in adrenal glands, but high amounts were found in 
the liver, brain and cerebellum too (Leonard et al. 2000). Interestingly, the level in foetal liver 
and brain was 6-fold greater than that found in the adult pointing to an early synthetic necessity. 
The same pattern of expression was observed for human FADS1, but with lower general levels, 
and again, the level in foetal tissues was several times higher than in adults. This may be related 
to their chromosomic location, since they share close positions in chromosome 11q12. Also 
remarkable, human ∆5 shares approximately 60% of their proteic sequence with mouse and rat 
∆6. Nevertheless it is not clear whether these genes evolved through duplication, but since both 
desaturases were found to have been developed from a single protein in zebrafish, it seems clear 
that both had a common origin (Hastings et al. 2001). However, recently polymorphism 
findings showed an important role for these variations on the regulation of FA metabolism 
(reviewed in (Glaser, Heinrich and Koletzko 2010)). Similarities in the protein sequence are 
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reflected at structural levels, since both desaturases contain a cytochrome b5-like domain, as 
well as three conserved histidine-rich domains (HXXHH histidine-box motif) (Cho et al. 1999a) 
as other membrane-bound desaturases usually do. A schematic representation of the structural 
and actual membrane attachment is shown in the next page, Figure 10. Finally, as soon as 
FADS1 and FADS2 were cloned (Cho et al. 1999b), researches could verify that dietary PUFAs 
downregulated their expression (at least in the liver). Besides, enzyme expression is influenced 
if essential FA is present on the diet. Therefore, increased expression is achieved upon 
consumption of FA rich on essential FA (e.g. corn oil). On the contrary, ingestion of food poor 
in those (e.g. butter), decreases their levels. Furthermore, hepatic activity of both desaturases 
was suppressed by fasting and induced by re-feeding carbohydrate and when agonist of PPAR 
(fenofibrate) is used, its expression also increases. However, this seems restricted to the liver. 
CNS played in “another league” and dietary changes have to be sustained across time to achieve 
a substantial change on their lipid profile or expression pattern of lipid-regulatory genes 
(Igarashi et al. 2007a; Hofacer et al. 2011 and Kitson et al. 2012).  
Figure 9. FA de novo synthesis. The scheme here represented the most common mechanism 
for representative PUFAs synthesis from their essential FA precursors, separated into the two 
vias (ω-3 and ω-6). Note that necessary enzymes are shared for both vias. Most of the 
synthesis is achieved in the ER, but for final steps mitochondrial translocation is required.  
 
In mammals, seven ELOVL have been found, being 1, 3, 6 and 7 specific for saturated or 
monounsaturated FA and 2, 4 and 5 for PUFA ones. The expression pattern along the body 
differs, since 1, 5 and 6 are ubiquosly expressed (with high levels in liver, testis, adrenal glands 
and white adipose tissue) meanwhile 2, 3, 4 and 7 has a tissue specific distribution. Although 
the physiological consequences of such specificity are not clear yet, it is believed to respond to 
tissue-specific demand of long-chain-PUFA (LCPUFA). Therefore, whereas ELOVL 1, 4 and 7 
may act as enzymes controlling the synthesis of LCPUFA as membrane components for optimal 
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membrane function, the ELOVL 3 and 6 are believed to take part in a more complex system 
controlling cellular and whole body lipid homeostasis (Guillou et al. 2010). For instance, 
ELOVL3 expression is under control of glucorticoids, norepinephine and the three isoforms of 
PPAR. In contrast, ELOVL1 (often named “housekeeping” elongase) liver expression is not 
regulated by PPARα, liver X receptor or SREBP-1c (sterol response element binding protein-
1c) and not even subjected to nutritionally induced changes (Wang et al. 2006) meanwhile 
ELOVL7 is highly expressed in the kidney, pancreas, adrenal gland and prostate, where was 
found to be linked to cancer development in the latter (Tamura et al. 2009). 
 
Finally, EPA and DHA have been proposed to have a complete different biosynthetic pathway 
for some marine eukaryotic and prokaryote microbes (Metz et al. 2001). Those species take 
advantage of a specialised poliketide synthase enzyme to form them and are very interesting as 
biotechnology tools for massive, cheap and clean FA production. 
 
 
Figure 10. Desaturases 
structure. Schematic 
amino acid sequences of 
membrane-bound fatty acid 
desaturases from plants, 
animals and other 
organisms. All of them had 
three strongly conserved 
histidine-rich sequences 
(blue boxes) with the 
general motifs HXXXH, 
HXXHH and HXXHH. 
These boxes are required 
for enzyme activity and are separated by membrane-spanning domains that must provide the 
correct orientation for the active sequences. Many enzymes, including the mammalian FADS1 
and FADS2, contain a cytochrome b5-like N-terminal extension (brown box). Electrons acquired 
from NADH cytochrome b5 reductase are transferred to cytochrome b5 and then to the active 
site of the desaturase where the redox reaction proceeds through two iron atoms (green circles) 
that are stabilized by conserved histidine boxes interaction.  
 
1.B2.2.- AA synthesis 
 
Similarly, AA de novo synthesis was established long time ago (Sprecher 1981). It shares with 
DHA most of its enzymes, pathways and locations, being therefore “competitors”. But, since 
AA only possess 2 more carbon atoms and 2 more double bond than its precursor, LA, 
elongation and desaturation steps comprises one and two steps, respectively. Thus, it starts with 
a ∆6 desaturation followed by elongation (ELOVL5) and finally a ∆5 desaturation again to form 
AA. All of these steps take place at the microsomes, in the ER. Nevertheless, AA synthesis is 
part of a longer process which leads to achieve 22:5ω-6 DPA, in a very similar way than it is 
done for DHA, hence including delivery to mitochondria to perform a β-oxidation step. This 
FA, DPA, is interesting since its accumulation in tissues (especially CNS) takes place when 
insufficient amounts of DHA and its ω-3 precursors are present in the diet, serving therefore as 
a marker for inadequate ω-3 intake.  
 
Although it is now clear that FADS1, FADS2, ELOVL2 and ELOVL5 are involved in the 
metabolism of essential ω-3 and ω-6 FA, it is uncertain whether they play key roles (if any) in 
the synthesis of “non-essential” PUFAS (those of the ω-7 or ω-9), even when early works 
47 
(Mead 1958) pointed out the possibility of sharing the same pathways and enzymes. Further 
research is required to shed some light on this minoritary FA since, for instance, mead acid 
(C20:3ω-9) is known to be synthesized in animals fed with a PUFA deficient diet and is in fact 
used as a relevant indicator of such deficiency when accumulated.  
 
Finally, it is important to remark the complex machinery involved in de novo synthesis of FA. 
As explained in this and previous chapter, not only specific enzymes and substrates are required 
for precise biosynthesis of the desired lipid specie, but also optimal interconnection with 
different organelles and their orchestrated timing.  
 
 
 
1.B3 PUFA Reacylase and phospholipase systems 
 
Delivery after ingestion, maintenance inside a specific PL, inner trafficking and de novo 
synthesis are part of a general mechanism for FA balance. Membrane structure modification by 
reacylase and phopholipase systems are both crucial to regulate and help to maintain correct 
levels of specific lipid species and to face both, physiological and pathophysiological 
conditions.  
 
1.B3.1.- Phospholipase system 
 
A phospholipase is an enzyme that hydrolyzes PLs into FAs and other lipidic substances. There 
are four major classes, termed A, B, C and D, distinguished by the cleaveage reaction location 
which they catalyze and therefore, the products obtained. Phospholipase A (PLA) comprises a 
superfamily of enzymes whose members cleave the sn-1 acyl chain (PLA1) or the sn-2 acyl 
chain (PLA2), releasing a FA. Phospholipase B cleaves both sn-1 and sn-2 acyl chains and is 
also known as a lysophospholipase. Phospholipase C cleaves before the phosphate, releasing 
DAG and a phosphate-containing head group (commonly, IP3) which results in intracellular 
Ca+2 increase. Therefore, this enzyme plays a central role in signal transduction, releasing 
secondary messengers such as those aforementioned in chapter 1.A2 (Figure 5), which are 
related to multiple events directly, but to even many more indirectly (for an excellent review in 
PLC see (Kadamur and Ross 2013)). Finally, phospholipase D cleaves after the phosphate, 
releasing phosphatidic acid and an alcohol. Both types C and D are considered 
phosphodiesterases. 
 
 
 
 
 
 
 
Figure 11. Phospholipases cleavage sites. Cleavage sites 
for each phopolipase family. Note that an enzyme that 
displays both PLA1 and PLA2 activities is called 
Phospholipase B. 
 
PLA2 is the more extensively studied family of phospholipases since both products, FA 
(specially AA, DHA and EPA) and lysophospholipid, represent first steps in generating 
important second messengers (whose formation is discussed in section 1.C1.2). It is especially 
relevant in inflammation and immune responses, besides sleep regulation, pain perception or 
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GPL-hydroperoxides detoxification and clearance associations. In fact, like other 
phospholipases (due to space limitation we will only focus on PLA2), functions and implications 
related to them raised from the particular products that they generate on upon its activity and 
which serve as substrates for further synthesis of multiple bioactive lipidic compounds. PLA2 
superfamily is composed by several unrelated protein families with common enzymatic activity 
(for a review related to CNS, see (Sun et al. 2004)). In the classification based upon the Ca+2 
requirement for their activity, they can be divided into three categories: i) secretory PLA2 
(sPLA2) that require millimolar concentrations of Ca+2; ii) the cytosolic PLA2 (cPLA2) that 
require micromolar concentrations of Ca+2; and iii) the Ca+2 independent PLA2 (iPLA2). 
Regarding its location, sPLA2 are stored in cytosolic granules or synthesized upon stimulation 
and then secreted extracellularly whereas cPLA2 and iPLA2 are intracellular enzymes. cPLA2 
are located in the cytosol and translocated into the membrane, while iPLA2 are located both in 
the cytosolic and in the membrane fractions. Other members of the PLA2 family are the 
lipoprotein-associated PLA2 (lp-PLA2), also known as platelet activating phospholipase and the 
recently discovered lysosomal phospholipase. 
 
sPLA2 are structurally characterised by their (relative) low molecular weight (14kDa average), 
histidine and Ca+2 requirements in the active site and six conserved disulfide bonds along the 
sequence. Their functions are diverse, since more than ten subfamilies have been found in 
different species (Burke and Dennis 2009) but some of the more remarkable are involved in the 
pathophysiology of inflammatory diseases, and have long been considered “inflammatory 
enzymes” (Yedgar, Lichtenberg and Schnitzer 2000). Nevertheless, some sPLA2 isoforms have 
been reported to have a protective, anti-inflammatory potential too (Murakami et al. 2011) and 
an unambigual role in antimicrobial function and PLs digestion in the stomach (Eerola et al. 
2006). For a more extensive study of sPLA2 see (Lambeau and Gelb 2008 and Murakami and 
Lambeau 2013). Mammalian sPLA2s do not show a distinct preference for particular fatty acids, 
whereas there is some specificity for certain head groups of the PL substrate: generally sPLA2s 
show a high activity with anionic PL but some PLA2 subfamilies also hydrolyze 
phosphatidylcholine (PC) vesicles (Singer et al. 2002). To date, the direct relevance of sPLA2 in 
the eicosanoid production remains unclear, but it is true that those enzymes mediated AA 
release (which can be in an auto or paracrine manner) and accumulation would activate a variety 
of prostaglandin synthases, lipoxygenases and cytochrome P450 proteins which ultimately raise 
eicosanoids production. 
 
Lysophopholipids (the other subproduct) can be converted into lyso-phosphatidic acid or 
acetylated to form platelet activated factor (PAF), a well-known specie that plays key roles in 
different pathophysiological events (Murakami and Lambeau 2013) and which mediates a 
feedback loop by the activation of another PLA family member, lp-PLA2. 
 
On the other hand, cPLA2 (which are classified in six sub families) had longer protein sequences 
(refelected by 65 to105 kDa ranging weight; for a general classification on the PLA family see 
(Schaloske and Dennis 2006)) and Ca+2 loading is required for a complete functionality (not in 
the case of γ isoform). Surprisingly, this load is not required for catalysis, but rather for 
intracellular membrane translocation of the enzyme. Those enzymes have remarkable different 
specificity for the FA present in the PL sn-2 position. Therefore, cPLA2α has specificity for the 
AA in this position, whereas cPLA2δ is specific for LA-containing PL. In contrast, β and γ 
isoforms have very little FA discrimination and ε and ζ isoforms hydrolyze both, AA and LA 
(for a profound review on cPLA topic see (Ghosh et al. 2006 and Schaloske et al. 2006)). 
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The iPLA2s are Ca+2-independent enzymes and, like the cPLA2s, utilize a serine residue for 
catalysis. The group consist of six enzymes and the most extensively studied one is the iPLA2β 
which includes several splice variants which may exert an inhibitory response (Larsson, 
Claesson and Kennedy 1998). A structural feature of iPLA2 is the presence of several ankyrin 
(structural anchors) repetitions which may be responsible for protein–protein interaction 
between monomers. Functionally, these enzymes are not specific with regard to the fatty acid 
being released but it seems that ATP helps to stabilize the protein (Lio and Dennis 1998). Main 
functions of this family are related with membrane homeostasis maintenance through its 
remodelling (reviewed in (Akiba and Sato 2004)). In addition, they play a role in processes 
connected with the metabolism of reactive oxygen species, at least in macrophages (Martínez 
and Moreno 2001) and astrocytes (Jianfeng Xu et al. 2003). They have been implicated in 
membrane transformation during apoptosis (Wissing et al. 1997) resulting in AA release and 
increasing caspase 3 activation, which could end up with the enzyme cleavage itself (Atsumi et 
al. 1998). Later on in we will discuss about the susceptibility of PUFAs to be oxidized if they 
are not effectively protected, so together with observations mentioned before, suggest that ROS 
could serve as a factor for regulating iPLA2 activity, although the exact mechanism remains to 
be elucidated.  
 
1.B3.2.- Reacylase system 
 
The deacylation-reacylation cycle maintains a balance between free and esterified FA, resulting 
in normal membrane integrity and function, including optimal activity of membrane-bound 
enzymes, receptors and ion channels involved in normal signal-transduction processes. Using 
acyl-CoAs as donors, GPLs are formed by de novo pathway (Kennedy pathway (Kennedy and 
Weiss 1956)) and modified by a remodelling pathway (Lands' cycle (Lands 1958)) to generate 
membrane asymmetry and multiple lipid species (for an excellent review on GPL homeostasis 
see (Hermansson, Hokynar and Somerharju 2011)).  
 
In neuronal tissues, four major enzyme families are responsible for membrane deacylation-
reacylation cycle: acyl-CoAsyntetase (ACS), acyl-CoAhydrolase (ACH), acyl-
CoAlysophospholipid acyltransferase (ACL) and phospholipaseA2. The picture below shows a 
representation of the overall process. 
 
 
 
 
 
 
 
 
 
 
Figure 12. Deacylation-reacylation cycle. (1) PLA2; (2) Lysophoslipase; (3) Acyl-CoA 
synthetase; (4) Acyl-CoA hydrolase; (5) Acyl-CoA lysophospholipid acyltransferase; (6) 
Cycloxigenases, lipoxigenases. CoASH is a cofactor required for the activation of a determined 
acyl group.  
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A) ACS 
 
ACS converts free FA into acyl-CoA esters. Essentially, all cellular metabolic pathways in 
which FAs participate firstly require their activation into CoA derivatives (for a profound 
review see (Watkins 1997)), with a notable exception, pathways for conversion of PUFAs, AA 
and DHA to bioactive eicosanoids and docosanoids, respectively. Nowadays, 26 ACSs are 
encoded by the human and mouse genomes, and could be classified according to its FA 
specificity, being short (2 to 4 carbons), medium (4 to 12), long (12 to 20; the more studied 
ones, reviewed in (Watkins 2008)), bubblegum (14 to 24, whose name aroused form Drosophila 
mutant "bubblegum”) and very long-chain, (18 to 26) synthetases. Another classification take 
into account its location within a cell, being therefore, cytosolic, microsomal (ER-resident), 
mitochondrial or peroxisomal (Watkins and Ellis 2012). The ACS reaction is ATP-dependent 
(Groot, Scholte and Hülsmann 1976), and in some cases Mg2+ is also required for a complete 
activation (Farooqui, Horrocks and Farooqui 2000). These enzymes are regularly membrane-
bound and act on non-polar hydrophobic substrates. Their products (acyl-CoAs) are water-
soluble and very powerful detergents. ACS function is especially relevant for the synthesis of 
unsaturated long chain acyl-CoA, since long term presence of free FA could result on its 
oxidation, with generation of potentially toxic (but also signalling) peroxides and 
hydroperoxides. 
 
 
B) ACH 
 
ACHs represent a group of enzymes that cleave acyl-CoAs into fatty acids and coenzyme A 
(CoA-SH). ACH relevance is therefore related to control levels of those species, because they 
participate in a large number of reactions, including lipid synthesis and oxidation, energy 
metabolism and potential regulation of a variety of signalling pathways (for a review see 
(Kirkby et al. 2010)). Although those enzymes have been less investigated than ACS, ACHs 
were localised in the cytosol, mitochondria, peroxisomes and ER. Within these compartments, 
they are distributed in a wide range of mammalian tissues, being detected in brain, liver, kidney, 
heart, lung, steroidogenic and brown adipose tissues, where they exert important functions, 
especially in the brain where its hydrolyzing activity is much higher than in any other organ in 
the body. Thirteen mammalian ACH genes are divided into two types, which differ according to 
the structural organization of the catalytic domains: type I enzymes contain an α/β-hydrolase 
domain and type II enzymes comprise one or two “hot dog-like” thioesterase domains (Han and 
Cohen 2012). Human orthologs are located within a very narrow region of chromosome 14 as a 
gene cluster (Hunt et al. 1999). Their activity is regulated by substrate for some of the family 
members, causing an inhibition, but they seem not to be affected by of non-esterified FA 
accumulation. Some of the family members have been shown to be under PPARs (Hunt et al. 
1999), SREBP (especially long-chain, brain resident ACH (Takagi et al. 2005)) or HNF4α 
(Dongol et al. 2007) control. Finally, also noteworthy, a knock out animal model of ACOT7 
(Ellis, Wong and Wolfgang 2013) was found to exhert hyperactive neural response when fasting 
and some kind of neurodegeneration, reflected by locomotor defects and increased GFAP 
inmunoreactivity in older animals, pointing its relevance in neuroprotection. 
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C) ACL 
 
ACLs acylates (insertion of an acyl group) the sn-1 and/or the sn-2 positions of a given 
lysophopholipid. Because there are many species of GPL differing in the phosphoryl head 
groups, the fatty acids in chain lengths and degrees of saturation, many ACLs should exist and 
participate in both, de novo synthesis and remodelling. High selectivity for the activated FA 
(therefore, acyl-CoAs) desaturation degree and length is present in a particular enzyme. In 
general,there is higer prevalence for saturated (or monounsaturated) acyl-CoAs insertion in the 
sn-1 position of a given GPL, meanwhile, in the sn-2 position acyl-CoAs is more likely 
polyunsaturated. Combined actions of that enzyme family and the PLA2 family would finally 
produce the great variety of GPL. ACL activities are widely distributed in various cells and 
tissues, and are tightly bound to microsomal and plasma membranes (for a review on ACL topic 
see (Shindou et al. 2009)). 
 
All in all, membrane remodelling is a tightly regulated mechanism. In “resting” cells, one can 
assume that reacylation dominates, and hence, the bulk of cellular FA is found in the esterified 
form. But, upon stimulation (which could be caused by a myriad of factors), transient dominant 
reaction is the PLA2-mediated deacylation, which results in dramatic releases of free FA 
(specially signalling relevant AA and DHA) that is now available for exerting its particular 
function (e.g. eicosanoid or docosanoid synthesis). However, activation conditions only last for 
a while (basics of any signalling event) and reacylation dominates again until replenishment of 
the intracellular pools of a particular FA is achieved. 
 
 
 
1.B4 Essential FA dietary requirements 
 
Essential FAs are required for a normal cell function and serve as a substrate/scaffold for further 
FA synthesis, if a specific need or depletion occurs. So, international organizations, nutritionists 
and medical doctors published some dietary recommendations for general healthy subjects (in 
different status; i.e. pregnancy, development, aging), but also for disease and to prevent them. 
 
In a typical western society, adult intake ranges 1-2 g/day of ALA, meanwhile LCPUFAs is 
somewhere around 150-300mg/day (Lauritzen et al. 2001). In Spain, ω-3 FA consumption is 
approximately 380 mg/day (340 and 40 mg/day of DHA and EPA respectively (data obtained 
from Ministry of Agriculture, 2005)), the majority (67%) due to blue fish (tuna, sardine or 
salmon) consumption. Spanish dietary essential FA (ALA and LA) intake range between 0.4 
and 3.4 g/day for ALA and 4 to 29 g/day for LA (with average values of 1,2 and 12 g/day for 
ALA and LA respectively (Sala-Vila et al. 2011)).  
 
Omega 3 index (sum of DHA and EPA FA percentage in erythrocytes, extensively used in 
cardiovascular research) is remarkably high in Spanish population in comparison with other 
western countries (e.g. 7,1% in Spain vs 4,9% in USA-excluded Alaska Inuit population for 
whom reaches up to 20%). However, is lower than what is estimated for the highest marine 
product consumers worldwide (e.g. Iceland, Norway, Korea or Japan). Tables in the next page 
represent average values for FA daily intake recommended for healthy subjects (USA Institute 
of Medicine in 2002 (Trumbo et al. 2002)). 
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Omega 3 and 6 Essential FA Daily Dietary Requirements 
Vital Stage Age(years) Ω-6 (LA) Ω-3 (ALA) 
Male Female Male Female 
Babies 0-12 months 4,4* 4,4* 0,5* 0,5* 
Childs 1-3 7 7 0,7 0,7 
Childs 4-8 10 10 0,9 0,9 
Childs 9-13 12 10 1,2 1 
Teenagers 14-18 16 11 1,6 1,1 
Adults 19-50 17 12 1,6 1,1 
Elderly ≥ 51 14 11 1,6 1,1 
Pregnancy Any age - 13 - 1,4 
Breastfeeding Any age - 13 - 1,3 
 
 
* Breast milk from a healthy woman (at least following above mentioned recommendations) provides 
enough ω-6 and ω-3 PUFAs. Data represented daily consumption in grams. 
 
Table 4. Omega 3 and 6 essential FA dietary requirements. 
 
 
More recently, WHO (World Health Organisation) has established a daily ingestion for healthy 
adults (included non-pregnant or non-breast feeding females) of around 0,250 g/ of EPA+DHA 
summation. This recommendation does not specify individual dosage for those FA, due to the 
lack of scientific relevant evidence. However, they suggest a maximum value (2 g/day), 
possibly due to lipid peroxidation and cytokine production affectance (“Fats and Fatty Acids in 
Human Nutrition. Report of an Expert Consultation.” 2010). In this line, Mozaffarian and 
collaborators (Mozaffarian and Rimm 2006) showed, thanks to a risk-benefit study, that more 
than 500 mg/day of DHA+EPA intake has no net effect in diminishing cardiovascular risk. On 
the other hand, in 2009 EFSA (European Food Safety Authority, (European Food Safety 
Authority 2009)) proposed the same quantity for long ω-3 PUFAs as the labelling reference 
intake, but they suggest ALA (2g/day) and 10g/day for the ω-6 PUFA LA consumption too. 
Even so, differences in dietary recommendations reflect different nutritional purposes, since 
some advices are proposed to correct clinically evident deficiency in a given population, 
meanwhile other are based on cardiovascular and/or neurodevelopment health. 
 
However, controversy arises, since some international organizations suggest avoiding intensive 
fish intake (especially bigger ones like tuna, emperor or big sharks) during pregnancy, 
breastfeeding and early childhood due to high risk of contaminants potentially present on them 
(toxic heavy metals and related species, particularly methyl mercury) (Mozaffarian and Rimm 
2006). Anyway, this could be avoided by tiny blue fish ingestion (e.g. sardine or mackerel, 
since large and long-lived animals could accumulate those toxins) or by biotechnology-
produced algae. The picture below is just to have an idea how nutritional status, regarding FA, 
vitamins E and C has evolved along humanity.  
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Figure 13. FA and antioxidants 
intake along human evolution. 
Hypothetical scheme of fat and 
fatty acid (ω-3, ω-6, trans and 
total) intakes (as % of calories 
from fat) and intake of vitamins E 
and C (mg/day) along human 
evolution Copied from 
(Simopoulos, Leaf and Salem 
1999). 
 
 
1.B4.1.-ω-3 defiency 
 
Taking into account western society ω-3 FA consumption plus limited endogenous synthesis 
(currently under debate for CNS tissues), deficiency could arise both, on disease or by 
nutritional unbalance. However, this is hard to prove because i) there are no clear specific 
recognized symptoms for such deficiency; ii) ω-3 and ω-6 interdependency and 
interconnectivity could, up to an extent, mask such unbalance. However, impaired growth, 
reproductive disturbances and skin lesion are mostly related to ω-6 deficiency (Kremmyda et al. 
2011). On the other hand, dysopsia and abnormal electroretinogram could point a specific ω-3 
unbalance. Even so, the most noticeable marker for ω-3 deficiency is the accumulation of ω-6 
long chain PUFAs, particularly ω-6 DPA (22:5ω-6) (Neuringer et al. 1986) and ω-6 adrenic acid 
(22:4 ω-6). The opposite (ω-6 deficiency), is not normally reflected by a PUFA ω-3 accretion. 
Finally, a concomitant deficiency (ω-3 and ω-6) would raise mead acid (C20:3ω-9). In general, 
even if ω-3 deficiency is hard to find, based on their potential positive outcome, some dietary 
recommendations regarding optimalω-3 status are offered in different conditions. 
 
Finally but also remarkable, it is the fact that an unbalance in the ω-3/ω-6 dietary intake could 
enhance different signalling pathways, and therefore modulate responses to various stimuli, as 
recently demonstrated in terms of learning and memory processes (Hajjar et al. 2012) or 
inflammation (Liu et al. 2013). 
 
1.B4.2.-Pregnancy and development 
 
Since Lamptey and co-workers showed in 1976 that ω-3 deficient rats had decreased learning 
abilities (Lamptey and Walker 1976), lots of different test had also pointed out behavioural, 
olfactory or visual disarrangements in rats, mice or rhesus monkeys under such deficiency. 
Anyway, it is difficult to extrapolate those results to human infants and, in fact, some authors 
suggest that several of the differences encountered in early development stages are faded out 
along lifetime (Agostoni et al. 1997). In any case, most (80%) of the brain DHA accrues in the 
human foetus from week 26 until term (Sabel et al. 2009). The presence of LCPUFA-specific 
placental FABP (Fatty acid binding protein) as well as increased accretion of intrauterine DHA 
could determine why maternal DHA depots seem depleted after pregnancy (Lauritzen et al. 
2001). Therefore, it is strongly recommended for preterm infants to be fed with DHA 
54 
supplements to improve their cognitive (Agostoni et al. 1997) and visual (Carlson et al. 1996) 
conditions, whether healthy termed ones should do, is still controversial.  
 
1.B4.3.-Cardiovascular diseases 
 
From long time ago (1965 by Sir Austin Bradford), outstanding evidences showed lower 
cardiovascular risk when high ω-3 index exist in vivo. Potential mechanisms for this reduced 
risk included anti-inflammatory, anti-thrombotic, antihypertensive, hypo-triglyceridemic and 
antiarrhythmic properties found in ω-3 FA rich diets, particularly in long chain ones. However, 
some recent meta-analyses studies of randomized trials pointed out low significance related to 
prevention (Rizos et al. 2012, Chowdhury et al. 2012 and Chowdhury et al. 2014), seeming that 
when damage is done, ω-3 PUFAs are beneficial to reduce its outcome but it fails preventing it 
when a balance diet is already present in a healthy individual. In any case, government health 
institutions still recommend two fish pieces per week in a balanced diet aimed to increase 
cardiovascular protection. 
 
1.B4.4.- Neurodegenerative diseases 
 
Studies on ω-3 function and levels in neurodegenerative diseases have been extensively 
performed, particularly in Alzheimer, Parkinson and some dementias (for reviews see, (Calon 
2011; Sydenham, Dangour and Lim 2012; Saugstad 2006). In contrast to cardiovascular 
disarrangements, ω-3 supplementation seems to offer a preventive neuroprotection, especially in 
Alzheimer and mood disorders where adequate ω-3 correlates with a better cognitive function 
retention and better behaviour (Calon 2011). 
 
Regarding amyotrophic lateral sclerosis (ALS), there is a recent paper that shows a deleterious 
effect in EPA supplementation diet in a wide used model of disease, copper zinc superoxide 
dismutase (with a glynine/alanine substitution in the 93 amino acid, SODG93A) overexpersion 
(Yip et al. 2013). Authors related this dimished survival to increased oxidative stress and 
accretion of 4-hydroxy-2-hexenal (HHE) in activated microglia. Other studies with valpronic 
acid (a FA acting as histone deacetylase inhibitor that showed antioxidative and antiapoptotic 
properties and reduced glutamate (Glut) toxicity in preclinical studies) failed to prolong lifespan 
in both, animal model (Crochemore et al. 2009) and patients (Piepers et al. 2009). Interestingly, 
the combination of a high intake of PUFAs and vitamin E has been related with a 50–60% 
decreased risk of developing ALS, and these nutrients appear to act synergistically (Veldink et 
al. 2007). Similarly, a very recent publication (Fitzgerald et al. 2014) epidemiologist focused 
also in the possible relation of dietary consumption of ω-3 FA and the risk of ALS development 
or a better outcome after diagnosis and, for both issues, higher levels of dietary ω-3 correlated 
with reduced ALS development probability, and also importantly, once diagnosed those patients 
had better progression. All in all, those researches suggest a possible prevention and better 
outcome after ω-3 PUFAs consumption for various neurodegenerative diseases, and may even 
be better if those levels are increased concomitant with substantial autoxidative protection. 
 
1.B4.5.- Sex dimorphism 
 
Data in Table 4 showed different FA necessities along a lifetime for male and female 
individuals. This is completely reasonable, and is believed to be linked to differential 
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peroxisomal β–oxidation rate and/or hormone synthesis and processing for both sexes. In fact, 
this could rely on the very different adipose tissue organization (reviewed in (White and 
Tchoukalova 2014 and Stevens et al. 2010)). Studies form professor Burdge group (Bakewell, 
Burdge and Calder 2006 and Childs et al. 2008) pointed that, in general, female have greater 
DHA synthesis from its precursors (possibly by stimulation at the transcriptional level) and 
circulatory (plasma) levels than male. From works studying women using oral contraceptives 
(Magnusardottir et al. 2009) or hormone-replacement therapy (Giltay et al. 2004b) and a study 
of sex-hormone treatment in trans-sexual subjects (Giltay et al. 2004a) was clear that hormone 
function had very relevant consequences in PUFA handling.  
 
Also important, in response to dietary manipulation, ω-3 metabolism seems to be affected by 
gender, since desaturases ∆5 and ∆6 changed its activity and expression (Extier et al. 2010) 
(upregulated in female liver in response to ω-3 replenishment diet) as well as PUFA-related 
synthetic machinery, having increased ∆4 desaturation index (DHA/ω-3DPA ratio) for females 
too (Alessandri et al. 2012). Importantly, again CNS PUFA-synthetic enzymatic machinery was 
more difficult to be affected, and no differences were found regarding sexual dimorphism 
(Extier et al. 2010). Furthermore, the opposite occurs; FA synthesis is dependent on the 
hormone production, at least in neuroblastome cell line (Alessandri et al. 2008) or an elegant 
animal model of ovarictomized females treated with different dosage of 17-β estradiol 
(Alessandri et al. 2011) unveiling sex a as relevant factor regarding PUFA metabolism. 
 
 
 
1.B5 PUFA and Central Nervous System  
 
 
1.B5.1.- Delivery across brain blood barrier  
 
As stated before, FA are important substrates for energy supply but also relevant as buildings 
block for membrane synthesis and signalling mediators (discussed in the next section). This is 
especially relevant in such a complex “orchestator” apparatus as the CNS, which is the second 
lipid accretion tissue (after adipose) whose PUFAs accounts up to 20% of dry weight (Owada 
2008). In fact, there is an entire evolutionary theory which points out the relevance of shore 
based diets, particularly rich in DHA, trying to explain hominid encephalization burst (Cunnane 
et al. 2007). So, taking into account that particular insulation issues that apply for CNS and in 
situ synthesis which may not be sufficient (DeMar et al. 2006), we will discuss here how FA are 
transported to and passed through brain-blood barrier to overcome PUFA needs at CNS.  
 
Blood-brain barrier (BBB) is the cellular structure that keeps CNS sectioned from the rest of the 
whole body and maintains cerebrospinal fluid (CSF) and blood separated. It occurs along all 
capillaries adjacent to CNS and could represent up to 12 m2 surface in an adult human (Abbott 
et al. 2010). It consists of tight junctions (zipper-like) and high-density cells restricting passage 
around the capillaries and do not exist in regular circulatory system. Those endothelial cells, 
pericytes and astrocytes restrict the diffusion of microscopic particulae and large or hydrophilic 
molecules into the CSF, while allow diffusion of small hydrophobic molecules (O2, CO2, 
hormones, etc). Therefore, for crossing BBB, different epithelial walls and even cell types must 
be intersected. A schematic representation of BBB is shown below. 
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After a postprandial peak, plasma levels of triglycerides in healthy subjects are maintained 
stable. They are mainly distributed as sterificated lipids complexed with lipoproteins but there is 
a controversy on whether unesterificaded PUFAs are sufficient or not to maintain CNS lipid 
levels, in order to achieve their well-known neuroplasticity capacities (Purdon, Arai and 
Rapoport 1997). More than twenty years ago it was demonstrated that lipoprotein receptors are 
expressed at brain capillaries (Méresse et al. 1989) and that they show modulator capabilities 
related to PLs transfer, at least in those isolated brain capillaries. Nowadays it is believed that 
only unesterified forms are selectively incorporated (Rapoport, Chang and Spector 2001). Thus, 
it is demonstrated that dietary intake of PUFAS influence plasma derived levels, and that those 
indirectly influence brain PUFA metabolism, so BBB is unambiguously overcome by dietary 
fatty acids. 
 
Figure 14. Blood-brain barrier scheme. Cell types encountered in the BBB and their 
relationships (CSF, cerebro-spinal fluid). Not to scale 
 
It is believed that up to 3-5% of AA and 2-8% of DHA is daily replaced form rat brain GPL by 
the unesterified PUFAs presented in plasma (Rapoport, Chang and Spector 2001). The actual 
quantity in humans is estimated to be 0,3% for AA, but higher amounts are believed to be 
achieved by de novo synthesis through elongation and desaturation processes of their precursors 
or by deacylation and reacylation processes (see chapter 1.B2 and 1.B3, respectively). Dietary 
supplementation of human subjects with DHA (but also for AA) undoubtedly boost plasma 
levels of non esterificated DHA, remarkably with no net increase of serum lipoproteins, 
(Conquer and Holub 1998) but how this increase is affecting brain levels (whether its synthesis 
form ALA is significant) or which forms (stereoisomers specificity, preferential bioavailability, 
etc) are more prone to be uptake by the brain remains unclear. 
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Using DHA as a paradigmatic PUFA example, current models for delivering FA into the brain 
via plasma include passive diffusion of non-esterified DHA through the BBB (Spector 2001) 
and/or uptake by HDL or LDL containing DHA lipids via specific lipoprotein receptors on the 
luminal membrane of endothelial cells (Balazs et al. 2004). The first possibility, is supported by 
the of endothelial lipase that was found in brain capillary endothelial cells (Sovic et al. 2005) 
which was regulated (negatively, both protein and mRNA levels) when PPARα and γ agonists 
were applied. Surprisingly, those lipases possess a remarkable specificity for DHA positioning 
within the PL (Chen and Subbaiah 2007). Also remarkable is the preferential cleavage of ALA 
over LA by ∆6 desaturase present in endothelium (Cunnane et al. 1994) and how its evolution 
over a lifetime changed opposed to liver resident ones, Endothelium type FADS2 activity is 
enhanced during development and scarce in adults, contributing to brain-development-related 
DHA necessities.  
 
Another possibility is that a sophisticated selective carrier mechanism exists for the 
transportation of ω-3 FA into the brain (Beisiegel and Spector 2001), including a BBB transport 
system that is highly selective for PUFAs esterified into PL such as DHA lysoPC (Bernoud et 
al. 1999). In fact, a recent study has demonstrated that lipoprotein particles can cross the BBB, 
at least in Drosophila (Brankatschk and Eaton 2010), suggesting that the lipoproteins could act 
as transporters of therapeutic lipid molecules across the BBB for the treatment of brain 
disorders.  
 
Finally, in a recent published paper (Chen and Subbaiah 2013), Chen and collaborators 
proposed that DHA stereoespecificity in a given PL (being at sn-1 or sn-2 positions) may 
determine its destination. They claim for the DHA in sn-1 position at the PC to be more 
“protected” against the reacylase/deacylase cycle and therefore have more possibilities to be 
released at the BBB and, ultimately, uptake. 
 
 
1.B5.2.- In situ synthesis  
 
 
For a long time, neurons were believed to lack the ability to synthesize DHA from its ω-3 FA 
precursors (Igarashi DeMar et al. 2007b). In fact it wasn´t until recent studies (Kaduce et al. 
2008) that PUFAs in situ synthesis was solely attributed to astrocyte action (Kaduce et al. 2008; 
Moore et al. 1991) rather than to a neuronal origin. In any case, this synthesis is believed to be 
scarce, so dietary DHA supplements in the forms of PL or/and TAG were (and still are) usually 
recommended in order to promote brain health across lifetime, but specially during early 
development (Guesnet and Alessandri 2011) and elderly. 
 
For optimal in situ synthesis, adequate amounts of precursors are needed, but also large batteries 
of different enzymes are required (commented in chapter 1.B2). Nevertheless, studies from Dr 
Rapoport’s group (DeMar et al. 2005; DeMar et al. 2006) reveals that the contribution of in situ 
synthesis for both AA and DHA to brain PL is indeed very little. In those works, both with a 
non-deficient diet for the FA family studied, they estimated de novo synthesis represent less 
than 1% for both AA and DHA. The majority of unesterified precursors that cross the BBB 
undergo through β-oxidation (59% LA and 67% ALA, respectively) or acylation processes 
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(11% of LA, 12%ALA, respectively) rendering de novo synthesis residual and pointing out that 
delivery of final products (the required FA itself on its multiple forms; e.g. PC, PS, lysoPL, etc) 
but not its precursors must be the mechanism that avoids PUFAs depletion in the brain. In fact, 
a recently published review (Rapoport, Ramadan and Basselin 2011) using in vivo radiolabeled 
[1-14C]DHA intravenously perfusion (for both rats and humans) they pointed out that the 
incorporation rate of DHA to brain equals its rate of metabolic consumption suggesting that if 
an increase need is required, in situ synthesis could be insufficient. 
 
All in all, those data pointed out how complex regulatory machinery operate for FA delivery at 
the BBB and that FA destination after crossing differs enormously between them, further 
research is needed to clarify whether in physiological conditions, lipoproteins or phospholipases 
at the BBB are key factors to meet CNS FA delivery and requirements (it seems so) or, in the 
contrary, in situ synthesis (regardless neuronal or astrocytic origins) is sufficient. How this weak 
equilibrium is disrupted in disease and potential therapeutics regarding delivery and upgrading 
local synthesis are also major points to be elucidated.  
 
 
1.B5.3.- Neurotransmitting  
 
 
Vesicle formation, delivery to synapsis, exocytosis and substrate clearance represented essential 
compulsory processes for a correct neurotransmission. Synaptic proteins could be enhanced in 
order to optimize neurondialog, the basic tenet of the CNS. However, numerous events could 
interfere these chemical information interchange (e.g. oxidative stress, cytoesqueleton 
deregulation, membrane deareagments, among others) causing detrimental or 
missunderstanding connectivity and could even lead to denervation and ultimately, neuron 
death. In this sense endocannabinoid system demonstrated (Berghuis et al. 2007) to be very 
relevant for axon guidance and synaptogenesis. Further, astrocytic support fuction (commented 
in the next chapter) is also crucial in this delicate system. ω-3, but also ω-6 PUFA could 
enhance synaptic membrane expansion (Darios and Davletov 2006) with an increased 
expression of syntaxyn 3 (STX3, a protein involved in vesicle formation and exocitosis in 
synapsis) and seems clear the PUFA influence in the SNARE (soluble N-ethylmaleimide-
sensitive factor-attachment protein receptor) protein complex formation and stability (García-
Martínez et al. 2013 and Lang, Halemani and Rammner 2008; for an excellent revision on the 
FA-SNARE regulation see (Davletov, Connell and Darios 2007)). In fact, the SNARE proteins 
complex are believed to provide the required specificity for vesicle docking and sorting as well 
as they represent the minimal basic machinery required for membrane fusion (Weber et al. 
1998). Finally, since membranes must adopt different curvatures during fusion, the commented 
membrane structural actions of PUFA are also crucial to complete exocytosis, as showed by 
cone-shaped lipids when they may favour the appropriate membrane geometry (reviewed in 
(Chernomordik and Kozlov 2003). 
 
In this sense, deacylation-reacylation machinery was relevant, since, in cultured neurons 
(Marszalek et al. 2005), overexpression of ACS6 promoted an increased DHA-CoA 
accumulation (respect to oleic acid or AA) and, ultimately, neurite outgrowth (previously found 
for ACS2 too (Marszalek et al. 2004)). Interestingly, silencing its expression (by RNA 
interference) resulted in a decreased neurite outgrowth of various neuronal cell lines (Kim et al. 
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2009) and futher, dAcsl (ACS4 orthologue in drosophila) was found essential for correct axonal 
targeting and normal synaptic vesicle formation (Liu et al. 2011). 
 
Also importantly, expression and function of Glut receptors (e.g. the glial excitatory amino-acid 
transporter 2, EAAT2, which is specially relevant since its excitoxicity involvement in the ALS 
pathogenesis and will be commented in section 1.D2.3), could be influenced by AA (Zerangue 
et al. 1995), causing a reduced Glut recovery. This mechanism seems to be triggered by AA 
itself, but whether PLAs play a role by influencing local membrane release is still controversial 
in this model. However, this opened the door for a more coiled synaptic-membrane-structural 
PUFA action. Therefore, all in all, PUFA action and regulation on the continuous synaptic 
remodeling represents important points for a correct neurotransmission and, possibly more 
important, promising therapeutic intervention in various diseases.  
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1.C PUFA Pathophysiology 
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1.C1 Inflammation induction and resolving phase 
 
1.C1.1.- Inflammation partners 
 
Since inflammation could play a key role in neurodegenaration, and particularly in ALS 
(reviewed in (Evans et al. 2013)), the importance of this phenomena should be discussed. 
Neuroinflammation refers to the rapid reaction on the CNS, through activation of the resident 
immune cells, in response to infections, trauma, toxins and ischemia, among others (Frank-
Cannon et al. 2009). It is a complex combinatory mechanism of acute and chronic responses in 
which all CNS population (neurons, astrocytes and microglia) and infiltrating leukocytes take 
part. Innate immune response in CNS is responsible for microglia activation resulting in release 
of pro-inflammatory cytokines (Interleukins-IL-1β, -IL-6- and TNFα- among other), 
chemokynes (e.g. prostaglandin E2, PGE2) and nitric oxide (and other oxidative derived species 
such as superoxide and peroxinitrite), but also rescue anti-inflammatory signals (IL-4, IL-10, 
nerve growth factor-NGF-, BDNF, insulin-like growth factor-1, glia derived neurotrophic 
factor-GDNF-, leukemia inhibitory factor-LIF-, ciliary neurotrophic factor-CNF-, among 
others); for a review see (David and Kroner 2011). (Consilvio Vincent and Feldman, 2004) 
 
Autoinflammation is a relative new concept (McDermott et al. 1999). It was proposed as an 
emerging family of clinical disorders which were characterized by seemingly unprovoked 
inflammation episodes without high number of neither autoantibodies nor T-lymphocytes 
activation. From this point, various diseases were related to developed the “autoinflammatory” 
imprint (recently reviewed in (Standing, Omoyinmi and Brogan, 2013)), like in the case of some 
granulomatous diseases, as chronic granulomatous synovitis with uveitis and cranial neuropathy 
(Blau syndrome) and Crohn’s disease, among others. Interestingly, both diseases have shown a 
disregulation in the NF-κB activation, but, as other autoinflammatory diseases, aetiology 
seemed more complex than initially (genetically) though. Also importantly, some multiple 
sclerosis patients showed complications compatible with autoinflammation episodes (Kümpfel 
et al. 2007) and, more recently, a significant host predisposition (Kastner, Aksentijevich and 
Goldbach-Mansky 2010) is proposed to open the “classical” definition to a broader one. 
 
Focusing in neuroinflammation-related cell types, astrocytes play crucial roles supporting 
neuron activity, both under physiological conditions and disease. This cell type, with an 
ectodermal origin, could grow, in specific brain regions, up to ten times more numerous than 
neurons in the CNS, although in the whole brain, neuronal (counted as NeuN positive cells) and 
nonneuronal cells have almost equal number (Azevedo et al. 2009). Since they envelop synaptic 
terminals, astrocytes clear most of the synaptic neurotransmitters (Glut, γ-Aminobutyric acid -
GABA- and glycine, among many others). They provide throphic factors (e.g. brain derived 
neurotrophic factor, BDNF, and tumor necrosis factor-α -TNFα), energy (lactate and FA among 
others) and precursors (e.g. adenosine, purines) for neuron optimal function. Astrocytes are not 
immune cells per se, but can, in specific conditions, contribute to the immune response 
(reviewed in (Philips and Robberecht 2011)). Evidences of astrocyte regulated intracellular Ca+2 
concentration rise/fall accompanied firing synapses support the idea that astrocyte excitability is 
important not only for astrocyte-astrocyte crosstalk but also for astrocyte-neuron ones. 
Altogether, those findings gave rise to the “tripartite synapse theory” (Araque et al. 1999), in 
which not only pre and post-synaptic neurons are important for optimal synaptic function, but 
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also astrocyte population surrounding them. Ca+2 balance is also noteworthy related to ALS, 
since it is known to be deregulated and plays a key role on pathophysiology of the disease 
linking ER and mitochondria (recently reviewed in (Prell et al. 2013)). Finally, astrocytes are 
also responsible for glucose and FA uptake from the blood across BBB and therefore they 
regulate CNS energy flow (which is an important issue in ALS (Dupuis and Oudart 2004)). 
 
Microglia are the resident macrophages of the CNS and have two main distinct roles: first, they 
help astrocyte population to support neurons in a concerted mechanism and the second is related 
to its immunological role, which could be cytotoxic-linked. They derive from primitive myeloid 
progenitors and, resembling to them, recent studies classify microglia according to its role as 
neuroprotective or detrimental for CNS (Henkel and Beers 2009) being M1 related to the latter 
and M2 to the former. Hence, their inflammatory outcome is believed to be based in both, by 
intrinsic factors and by microglia-neuron-astrocyte cross-talk. When activated, microglia 
undergoes morphological changes to an amoeboid shape and proliferates. They also migrate 
toward injured areas; release various powerful soluble factors and phagocyte foreign substances 
or unwanted self debris. 
 
Like microglia, astrocytes also exhibit double edge sword behaviour. However, under 
neuroinflammation, shift from proinflammatory towards anti-inflammatory processes is poorly 
understood until date. When activated, they result in astrogliosis, usually identified by glial 
fibrilary acidic protein (GFAP) and aldehyde dehydrogenase-1 family-member-1 expression, 
concomitant with and cell body hypertrophy, and which could lead to pro-inflammatory 
cytokines release (mostly like microglia ones, but also producing neurotranmiters like Glut) 
and/or anti-inflammatory ones (transforming growth factor-β, IL-6, Interferon-γ, among others) 
(a complete review in astrocyte function could be found at (Sofroniew and Vinters 2010). 
Finally, other players in the inflammatory game are T cells, which could infiltrate CNS and 
modulate its outcome (regarding ALS those are a relevant papers (Chiu et al. 2008; Beers et al. 
2008)) and oligodendrocyte and perycyte population, whose action regarding 
neuroinflammation is poorly understood yet.  
 
It is important here to bear in mind that inflammation is a physiological response to an insult 
and, in general, acute neuroinflammation is a protective mechanism trying to “fix the problem” 
up to a extent, whereas chronic inflammatory status produces long-lasting and self-perpetuating 
mediators that remain after the insult, hence being more often related with the detrimental 
outcome (Glass et al. 2010). This is a plausible explanation why those cell populations could 
both, help to diminish or to exacerbate inflammatory damage, depending on how profound the 
aggression is. 
 
Also noteworthy is the difference between anti-inflammatory and resolving actions of a specific 
molecule. Resolution is a relatively recent term (Serhan et al. 2007) and is defined, in contrast to 
anti-inflammatory species, by its action not only serving as agonist for inflammation responses 
(e.g. lowering lymphocyte infiltration and/or diminishing adhesion-molecule synthesis) but also 
by promoting active processes to achieve homeostasis/catabasis-return from disease (e.g. 
promoting uptake and clearance of apoptotic cells, stimulating expression of antimicrobial 
defense mechanism). Anyway, in general terms for all cases, first steps after an insult involved 
generation of proinflammatory mediators (classically, leukotrienes-LT- and prostaglandins-PG, 
mostly AA-derived) to be substituted afterwards by PGE2 and PGD2 which gradually induced 
anti-inflammatory and pro-resolution key enzymes (by LOX upregulation) which, in turn, 
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generate lipoxins, resolvins and protectins (Levy et al. 2001) for helping resolution. This new 
lipid profile is termed “lipid mediator switch” and is crucial for inflammation resolution. In fact 
recent studies (Schwab et al. 2007) have shown that COX-2 inhibition (classically pro-
inflammatory, but signalling helpful) results in a delayed cleaning, and, therefore, slower 
recovery. 
 
Broadly speaking in CNS, the mechanism could start by TNFα and Ilβ release by microglia and 
astrocyte followed by its binding to their specific receptors and upregulation of gene 
transcription via NFκB pathway (Blais and Rivest 2001). Among them, AA signalling cascade 
genes. Hence cPLA2 and sPLA2 in one side, and cyclooxygenases, lipoxygenases and 
thromboxane synthases (COX, LOX and TXS respectively, discussed below) release and 
modify AA to form powerful lipid species (generally termed eicosanoids for its 20 carbon 
content: LT, PG, prostacyclines -PGI-  and tromboxanes -TX-  in general). And, on the other 
hand, phospholipases (specially plasmalogen-selective phospholipase A2 -PlsEtn-PLA2) could 
also release DHA (and/or EPA) activating docosanoid synthesis which could, in turn, counteract 
those outcomes, since most of their derivatives (maresins, neuroprotectins, neuroprostanes) and 
closely related EPA-derived eicosanoids and dihomo-gamma-linolenic acid (DGLA) derived 
ones (less prominent) exhert anti-inflammatory properties. Below, there is a scheme of the 
aforementioned process and the cell types involved, and in the next chapter we will say some 
words about the synthesis of those derivatives, generally termed oxolipids. 
 
Figure 15. Inflammation 
partners in CNS. 
Inflammatory-derived 
and neurovascular 
changes in amyotrophic 
lateral sclerosis. VCAM-1 
Vascular Cell Adhesion 
protein 1; ICAM-1 
InterCellular Adhesion 
Molecule-1; GM-CSF 
Granulocyte-Macrophage 
Colony Stimulating Factor; 
BDNF Brain-Derived 
Neurotrophic Factor; CD200 
Cluster of Differentiation 
200; VEGF Vascular 
Endothelial Growth Factor; 
IGF-1 Insulin Growth 
Factor-1, IFN-γ Interferon-γ; 
bFGF basic Fibroblast 
Growth Factor. Copied 
from (Evans et al. 2013). 
 
 
1.C1.2.- Oxidative-derived inflammatory-relevant lipid species 
 
In common with other lipid mediators, all these lipid species are not stored in any cellular 
compartment, meaning they are quickly synthesized upon demand and therefore rely on the 
abundance of its precursors as well as the enzymes responsible for their synthesis (for an 
excellent review on oxolipids synthesis in CSN see (Phillis, Horrocks and Farooqui 2006). 
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Therefore, for some of them, the limiting factor is their relative abundance of the precursor, 
since they share, and therefore compete for the same enzymatic machinery with many other 
mediators.  
 
A) Cyclooxygenases 
 
COX-1 and COX-2, confined chromosomes nine and one respectively, catalysed the limitant 
step in the synthesis of PG, PGI and TX (collectively termed prostanoids). Those heme-
containing bifunctional enzymes posses two catalytic centers. They are 65% homologous and, 
among FA, their preferred substrate is AA (other substrates include cannabinoids (Kozak, et al. 
2001) and lipo-amino acids (Prusakiewicz et al. 2002)). However, their activities differ, since 
COX-1 is constitutively expressed in most tissues and produces derivatives that generally serve 
a housekeeping function, whereas COX-2 (constitutively expressed in the kidney, stomach, and 
CNS) was initially characterized as an inducible enzyme whose expression is enhanced in 
response to inflammatory stimuli, cytokines and transcription factors (e.g. IL-1β, TNFα, LPS, 
PAF, TGF-β, NF-κB) (O’Banion 1999). Under pathological conditions COX-2 expression was 
observed increased (respect to COX-1) in neurons and astrocyte, whereas in microglia, the latter 
is more often expressed (Consilvio, Vincent and Feldman 2004), although this cell type 
“selectivity” is not well understood. Nevertheless, COX-2 action was also reported to increase 
under excitotoxic (kainic acid) conditions in neurons (Adams et al. 1996) as well as in 
astrocytes (Sandhya and Farooqui 1998) and can be suppressed by Glut antagonists (e.g. MK-
801, dexamethasone) implying that COX-2 regulation is dependent on synapse activity. 
Importantly, astrocyte and neuronal activation are sometimes non-simultaneous. Thus, neurons 
are more often rapidly induced and silenced, whereas astrocytes could sustained its induction for 
a longer period (Sandhya et al. 1998). These timing differences are crucial since it is know that 
the same PG could operate different responses (even opposed) depending upon the target cells 
and, of course, different PG could evoke opposed responses on the same cell. 
 
Nomenclature of prostanoids aroused due to their structure, which is nowadays extremely wide, 
but originally resembled that of prostanoic acid. Subindex numbering of those molecules refers 
to the number of unsaturation along the aliphatic chains residues and the letter is related to the 
type, unsaturation degree and substituent present in the ring (Herrera E. 1993). During the 
conversion of substrates (we use AA as a representative) to oxolipids, there are two sequential 
steps. First, a pure cyclooxygenase phase operates where an O2 molecule is added to form 
PGG2; secondly, peroxidase action of the enzyme converts it to PGH2, involving free radical 
release. This PG is subsequently metabolised by tissue-specific synthases to yield a variety of 
products (e.g. PGE2, PGD2, PGF2a PGI2, TXA2, 15d-PGJ2) which could be modified to generate 
a greater array of specific PG, with very different outcomes.  
 
Finally, regarding COX substrate preferences, some differences have been reported. Although 
AA is the preferred substrate for COX-1 and COX-2, other fatty acids can be oxygenated by 
both isoforms with varying efficiencies (Wada et al. 2007), having COX-2 more extensive array 
of substrates compared with COX-1, presumably because of a ≈20% larger active site 
(Kurumbail et al. 1996). However, oxygenated products are scarce when DHA is the substrate 
(12%, versus 30% of EPA, respect to AA) and in fact, until recently DHA was not considered a 
valid substrate 
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Figure 16. Inflammatory-stimulated PUFAs derivatives. Schematic representation of relevant 
lipid derivatives raised in inflammatory processes, depicted by FA family (ω-3 vs. ω-6) and 
responsible enzymes. In red, inhibitors, in blue, DHA derived and in black AA and EPA derived 
substances. NSIAD, Non-steroidal anti-inflammatory drug. 
 
 
 
 
n-6 PUFAs (AA)
n-3 PUFAs (DHA, EPA)
Acetylated-
COX-2
Prostagladines
CYP450
Epoxygenases
Cycloxigenases
COX-1        COX-2
PGG2
Lipoxygenases
5-LOX      12-LOX    15-LOX
Leucotrienes
Lipoxines
Protectines
5-HpETE
15-epi-LXA4
PGH2
PGD2 PGE2 PGF2αPGI2
Prostacyclines
TXA2
Tromboxanes
12-HpETES
15-HpETE
15-HETE
12-HETE
5-HETE
LXA4 , LXB4LTA4
LTB4
LTC4
LTD4
LTE4
PGJ2
PGG2
Prostagladines
3-series PGs and
3-series TXs
Resolvines E/D
RvD1, RvD6RvE1, RvE2
17S-HpDHA
Leucotrienes
5-series LTs
(LTB5, LTE5)
PGE2 receptor
antagonist
NSIADs COX-2
inhibitors
Acetylated-
COX-2
CYP450
Epoxygenases
Cycloxigenases
COX-2
Lipoxygenases
5-LOX       15-LOX    12 LOX
5-HpETE
Resolvines D
RvD1
RvD6
NPD1 
Resolvines E
RvE1, RvE2
∆12PGJ2
15d-PGJ2
15R-HETE
8-isoPGF2α
free radical oxidation
5,6-EET
8,9-EET
11,12-EET
14,15-EET
5-,-15-HETE
16-,-20-HETE
DHET
5-LOX
peroxidation
HNE
HETE
MDA
HXA3TXB2
LXA4
12-LOX
Hepoxilines
14S-HpDHA
Maresines
MaR1 
pe
rox
ida
tion
66 
B) Lipoxygenases 
 
Lipoxygenases (LOXs) constitute a heterogeneous family of lipid peroxidizing enzymes capable 
of oxygenating PUFAs containing cis, cis 1-4 pentadiene structures to their corresponding 
hydroperoxy derivatives. Lipoxygenase proteins have a single polypeptide chain (molecular 
mass ≈75–80 kDa) with an N-terminal β-barrel domain and a larger catalytic domain containing 
a single atom of non-heme iron critical for its optimal function (Brash 1999). Since 1974 
(Hamberg and Samuelsson 1974), when the formation of 12-hydroxyeicosa-5,8,10,14-tetraenoic 
acid (12-HETE) was described as being formed by exogenous AA addition to trombocytes, it 
was proved that those enzymesflamilies were found in both, superior animals and plants. In 
mammals, LOXs could be classified according to their positional specificity of AA oxygenation 
into 5-, 8-, 12-, and 15-LOXs or attending its positional specificity of arachidonate oxygenation 
into S and R isoforms (Meruvu et al. 2005). In recent years, LOX biochemistry and its 
regulation had gained increaseing attention due to its intimate relation with inflammation-
resolution processes and, especially in allergic responses. Hence, intensive research has been 
done, mainly in 5, 12 and 15-LOX  
 
The 5-LOX is a Ca+2-dependent membrane-binding which is translocated to the nuclear 
membrane and whose fully activation also requires a helper protein, known as 5-LOX-activating 
protein (FLAP) (Peters-Golden and Brock 2003). This location close to the nucleus, and the 
high probability of ROS leak on their catalysis could influence redox tone and thereby 
modulate, for example, the activity of oxidant-sensitive transcription factors such as NF-κB 
(Bonizzi et al., 1999). the Ca+2 dependence of this enzyme is also noteworthy, since this ion is 
largely known to be deregulated in various neurodegenative processes (reviewed in (Calì, 
Ottolini and Brini 2013 and Prell et al. 2013)). 5-LOX is the key enzyme for the LT (the name 
comes from its discovery being generated from “leuko”cytes and conserved 3 carbon-carbon 
double-bond, “trienes”) synthesis (Funk et al. 2002) and catalyzes the oxygenation of AA to 
form 5-HEPETE, and finally the epoxide intermediate LTA4. This LT can be later hydrolyzed 
by LTA4 hydrolase to leukotriene B4 (LTB4). Another possibility renders LTA4 to be 
conjugated with glutathione by leukotriene C4 synthase to yield LTC4 (other possibility of 
LTA4 is to serve as substrate of 12-LOX to form LXA4). Then, LTC4 can be converted by γ-
glutamyl transpeptidase to LTD4. In turn, LTD4 could be also converted to LTE4 by 
dipeptidases. Those derivatives (LTC4, LTD4, LTE4), are termed cysteinyl LT and are mainly 
produced by eosinophils, basophils, and macrophages cells. LTD4 and LTE4 are secreted (not 
having an intracellular function to date) and the three of them are relevant in allergic responses 
as slow-reacting substances of anaphylaxis (Austen et al. 2009).  
 
Finally, using a DHA derivative, 17-hydroperoxy-docosahexaenoic (17-(R,S)-HPDA) acid, 5-
LOX also catalyzes its conversion into resolvines one and two (RvD1, RvD2, discussed below). 
Interestingly, this synthesis could be also aspirin triggered, and when is under such conditions, 
predominant lipid specie posses R configuration (Hong et al. 2003). These potent species have 
been proved to reduce neutrophil recruitment and infiltration as well as functioning as pain 
reduction agents in mice (Hong et al. 2003; Spite et al. 2009) possibly serving as new 
“antinflammatory therapy”. 
 
Two types of 15-LOX have been characterized in humans: reticulocyte-type (15-LOX-1) and 
epidermal-type (15-LOX-2). This enzymes displayed differential substrate specifity, LA is the 
preferred substrate for 15-LOX-1 whereas AA is the preferential election for 15-LOX-2. Thus, 
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LA is metabolized to 13S-hydroperoxyoctadeca- (9Z, 11E)-dienoic acid, which is later reduced 
to 13S-hydroxyoctadeca-(9Z,11E)-dienoic acid (13-HODE). On the other hand, 15-LOX-
2oxygenates AA to form 15(S)-HPETE, which is reduced to 15(S)-HETE (Mahipal et al., 
2007). One important action of 15-LOX-1 is related with the synthesis of Neuroprotectin D1 
(NPD1) (Calandria et al. 2009) since its action upon DHA generates 17-(S)-HPDHA as an 
intermediate, which after epoxidation and hydrolysis reaction generated NPD1. It was 
demonstrated that this lipid specie protects against oxidative stress-induced cell death and to 
exert pro-resolution signals, in retinal pigment epithelial cells. In the brain, NPD1 was related to 
attenuated protein misfolding responses (Calandria et al. 2012) which are specially relevant in 
Alzheimer disease (Lim et al. 2005; Zhao et al. 2011) but also in ALS (Ilieva et al. 2007; 
Walker and Atkin 2011) since it is largely known an alteration in unfolding protein response 
(UPR) of the ER involved in its pathogenia (recently reviewed in (Matus et al. 2013; Prell et al. 
2013). 
 
Three types of 12-LOX have been described and they catalyze the stereo-specific oxygenation 
of AA to yield 12(S)- hydroperoxyeicosatetraenoic acid (HPETE, a well known thromboxane 
suppressor by inhibition of platelet cyclooxygenase (Brüne and Ullrich 1991)) and 12(S)-
hydroxyeicosatetraenoic acid (HETE). Both 12 and 15-HETE have been linked with 
hypertension (González-Núñez et al. 2001), endothelial pathology (Anning et al. 2005) and even 
renal function (reviewed in (Hao and Breyer 2007)). 12-HPETE is also a substrate for the 
synthesis of HXA3 mediated by hepoxilin synthases (even when this could also be obtained by 
the CYP450-mediated catalysis, reviewed in (Nigam and Zafiriou 2005)). Lots of functions 
have been related to be hepoxilin modulated, most of the research has been done in neutrophils 
(Nigam and Zafirio 2005) but they were also related to hyperpolarization in rat hippocampal 
slices (Carlen et al. 1994). 
 
C) Acetyl-salicylic acid-stimulated ω-6 anti-inflammatory mediators: 
Lipoxins 
 
Lipoxins are generated in humans from AA via LOX enzymes and comprise 2 distinct 
regioisomers, lipoxin (LX)A4 and LXB4. They were among the first lipid mediators recognized 
to have both antiinflammatory and proresolving actions (Serhan et al. 2008) by stimulating 
monocytes and macrophages to perform phagocytosis without releasing cytokines or 
chemokines. Classically, their biosynthesis proceeds via 15-LOX and 5-LOX mediated 
conversion of AA during cell-cell interactions (e.g. epithelial-leukocyte, leukocyte-leukocyte) 
or, in the contrary, 12-LOX mediated in the vasculature during platelet-leukocyte interactions 
and their actions proceed via activation of specific receptors (found in murine and human CNS 
brain atlas; http://human.brain-map.org; http://mousespinal.brain-map.org/  imageseries/ 
detail/100028215.html). However, an intriguing novel lipoxin route involving COX-2 and 5-
LOX under the presence of aspirin was discovered, the 15-epi-LXA4 (Clària and Serhan 1995). 
Its biosynthesis was recently proposed to be alternatively initiated by CYP450 enzymes and this 
pathway may underlie its generation in the absence of aspirin. For a review on lipoxin synthesis 
and resolving functions see (Ryan and Godson 2010). Since in one hand, aspirin was proved to 
acetylate both COXs (Loll, Picot and Garavito 1995) (more recently CYP450 too) causing its 
inhibition by active site alteration and, on the other, DHA and EPA are known to be substrates 
for acetylated COX, this opened a new route for more aspirin triggered lipoxins, which, in fact 
have been found (EPA derived resolvines, RvE1 and DHA-derived 17R-
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hydroxydocosahexaenoic acid, among others, discussed below) with novel powerful resolution 
properties.  
 
D) ω-3 Pro-resolution mediators: Resolvins, Protectins and Maresins 
 
Resolvins represent a novel potent lipid mediator family in vivo arising from ω-3 FA at final 
stages of acute inflammation. Those local, short-lived lipids species exerted their function, 
together with protectins and the previously described lipoxins, on recently discovered 
membrane receptors (Krishnamoorthy et al., 2010) but, interestingly, do not activate PPAR (all 
isoforms) or RXR factors (at least in HEK-293 cells). As pointed before, resolution is an active 
process and resolvins are termed so since, i) they are produced during cell-cell interactions 
occurring in the resolution phase of acute inflammatory response; ii) they “stop” further 
neutrophil entry to sites of inflammation, and iii) reduce proinflammatory exudates 
(Bannenberg et al. 2005). All those lipid mediators, generally termed docosatrienes (twenty-two 
carbons, 3xC-C double bounds), were found thanks to a complex bioinformatics approach and 
its in vivo relevance was confirmed by LC-MS/MS. Depending on the ω-3 source (EPA or 
DHA), Resolvins are classified as E and D series. On the other hand, Protectins and Maresins 
were described as DHA hydroxyl derivates (for a review (Ariel and Serhan 2007;Spite and 
Serhan 2010)); the latter discovered in macrophages (Macrophage mediators in resolving 
inflammation (Serhan et al. 2009) and the former found in inmmune cells and/or neural tissues 
(Mukherjee et al. 2004). In the past years (for a recent rewiew see (Serhan, Dalli and Colas 
2014)) research was focused in structural and biosinthesis elucidation of those potent mediators, 
trying to clarify whether this substances could be responsible for the “inflammatiory switch”.  
 
E) Isoprostanes 
 
Isoprostanes are lipid species emerging from nonenzymatic free-radical oxidation of PUFAs, 
sometimes (but not always) when they are esterified in biomembranes. Those compounds are 
named prostanes since, when firstly described (70’s decade (Porter and Funk 1975)), its 
structure had a cyclopentane (prostane) ring. However, nowadays compound family has grown a 
lot and many different structures could be found (for profound review on isoprostanes 
generation and function see (Milne et al. 2011)). In fact, there is controversy just on its 
nomenclature (Mueller 2010), in simple, IUPAC proposed C20 derivatives (mainly AA source, 
but also EPA ones) are termed isoprostanes (IsoP), C22 derived ones (often DHA derived) 
neuroprostanes (NeuroP, firstly described by Roberts in 1989 (Roberts et al. 1998)) and C18 
(could araise from α and/or γ linolenic acids) Phytoprostanes -founded in plants too. A sub 
classification of those species was needed and F2, E2, D2, A2, J2-IsoP (AA derived with a closed 
cyclopentane ring but also open structures like E2- and D2-IsoK; EPA derived, F3-IsoP; DHA 
derived, F4-IsoP) and NeuroP were subdivided according to where oxygenation takes place, 
arising 5, 8, 11, 12 and 15 series (this is the case for the simplest AA-derived IsoP; the more 
double bonds the more possibilities). The myriad of different structures arises since initial 
stochastically-radical-oxidation takes place close to a high number of double bounds (along 
those FA) and those reactions could terminate in a great variety of options. However, there are 
some C-C double bounds more likely prone (based on their hydrogen pK) and/or exposed 
(depending on structural configuration or their degree of concealment) to oxidation, and, also 
importantly, some of those “unspecific” products were in fact substrates for further synthetic 
processes. For instance, in the AA-derived IsoP generation, series 5 and 15 are predominant, but 
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the 12 and 8 series (minority) could serve for dioxolanes (another IsoP type, with two 5-vertex-
ring) synthesis and therefore, reduced its accretion (Yin, Morrow and Porter 2004). For a more 
detailed study of EPA derived IsoP see (Yin, Brooks, Gao and Porter 2007). 
 
IsoP, and some of the related family members, are considered a new class of biomarkers for 
oxidative stress measurements (Roberts and Morrow 2000) and are especially relevant among 
lipid peroxidation ones. Besides the major lipid oxidation products (HNE and MDA (Spickett 
2013), IsoP fullfills the requirements to be a good marker: They are (i) frequently accumulated 
up to detectable quantities in biological fluids and tissues, allowing the definition of a normal 
range; (ii) stable compounds; (iii) their formation increases dramatically in vivo, in a number of 
models of oxidant injury; (v) their formation is modulated by antioxidant status.  
 
Nevertheless, IsoP family have been proved to affect very different aspects of cell fate, from 
actions on vascular system (where F2-IsoP are specially relevant (Hou et al. 2004)), muscle 
contraction, nociception or cell proliferation. Those actions, are believed to take place through 
“specific” membrane receptors, since some have been shown to bind to classical prostanoid (for 
PG) membrane receptors (for instance TX receptor is known to bind F2-IsoP), although most 
IsoP are “orphan” receptors to date.  
 
 
 
1.C2 Lipid peroxidation: Friend or foe? 
 
1.C2.1.-Chemistry of oxidative stress 
 
Oxidative stress is a term used to explain a situation when, an unbalance in between 
physiological oxidative production and antioxidant defence counteract (enzymatic and non 
enzymatic too) and/or reparatory systems is present. In principle, this situation could be 
therefore achieved when antioxidant defence and/or repairing systems fail to detoxify 
physiological noxious by-products or, on the other hand, when regular occurring oxidation is no 
longer under strict control, hence, promoting damage to cell molecules constituents (proteins, 
sugars, lipids and nucleic acids). This, among others, is the basic tenet of several 
pathophysiological states, such as neurodegeneration (reviewed in (Barber and Shaw 2010)), 
cancer or aging (Harman 1956). Although any biomolucule is susceptible to receive this 
modofication, proteins, due to its high overall abundance, are more probably affected by 
oxidative processes and are therefore believed to account (as final acceptors) for the majority 
reactive species generated (50%–75%) (Davies, Fu and Wang 1999). However, damage to 
DNA, often measured by the accretion of 8-oxo-deoxiguanosine (8-oxo-dG) as well as proteic 
systems designed to detect (double strand break -DSB-, e.g. phosphorylation of histone γH2AX 
(Rogakou et al. 1998)) and respond to DNA-oxidative damage are relevant mechanisms, 
especially in the “germ” cells, since any DNA mutation could be therefore inherited. 
 
From an evolutionary point of view, oxidative biochemistry (phosphorylation), which in 
superior eukaryotes is mainly taken part in mitochondria or chloroplasts, turned out to be a very 
satisfactory mechanism. Ancient archeas, bacteria and cyanobacteria started oxygen production, 
as an undesirable metabolic by-product, around 3400 million year ago. Approximately 1000 
million years later, Earth atmosphere reflected the “work” done. This event was known as “the 
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oxygen burst”, which ultimately caused one of the first massive extinctions (almost complete) 
of obligated anaerobiotic organisms, but on the other side helped to promote a massive 
biodiversity. In any case, from this oxygenated atmosphere, and helped by aforementioned 
organellas (whose eukaryotic evolution was elegantly explained by the Russian biologist 
Konstantin Mereschkowsky in the endosymbiotic theory (Mereschkowsky 1910), organisms 
evolved to live in an oxygenated ambient, taking enormous benefits, specially, in terms of 
energy production. 
 
However, there are hundreds (possibly thousands, since extremophiles research is a an 
enormously growing field) of organisms which obtain energy without oxygen being the final 
electron acceptor, through multiple ways, from methane or acetate to sulphur or even halogens 
or uranium (Methanothrixthermophila, Sulfolobus genus, Geobacteraceae, Geobacter-
metallireducens respectively, reviewed in (Schäfer, Engelhard and Müller 1999)). In any case, 
those organisms also grapple with side effects of oxidative reactions and represent an interesting 
research field, because those different options to optimize energy sources give rise to various 
approaches in terms of antioxidant capacity design. Either way, eukaryotic anaerobic cell 
respiration, consisting in glycolysis, produces 2 ATP per unit of glucose consumed. On the 
contrary, aerobic respiration (composed by glycolysis, plus Krebs cycle and oxidative 
phosphorylation) could produce up to 36 ATP per glucose. All in all, aerobic respiration in 
eukaryotes is roughly 18 times more efficient than anaerobic. Furthermore, efficiency of the 
process for energy extraction from nutrients is believed to be about 40%. The remaining 60% is 
converted in heat, which is useful for poikylothermic organisms, but could become an issue to 
deal with for homoeothermic ones. 
 
Nevertheless those energetic benefits pay a bill, which is the production of undesired oxidative 
species. But let’s start from the beginning, what is and oxidant? What is a free radical? Or 
where do they come from? Chemically, redox reactions represent a group of natural occurring 
reactions which involve electron transference between two species. So oxidant processes have 
to be understood as a pair of coupled reactions, reduction of one counterpart with the oxidation 
of the other. Under this situation, oxidant is the specie which “receives” those electrons, being 
itself therefore reduced on its oxidation state. On the contrary, a reducing agent will decrease its 
oxidation state (because it is electron donor) causing the oxidation of the pair. Hence, is 
important to bear in mind that any specie is oxidant or reducing depending on the counterpart 
which is confronted. Nonetheless, in biological systems, those conditions are in an homeostatic 
range, so the oxidant behaviour of a given substance is normally “permanent”. 
 
Among oxidants, free radicals are one of the most powerful agents. In a simple definition, a free 
radical is any atom (e.g oxygen, nitrogen, sulphur) or group of atoms (e.g. •O−2 superoxide 
anion, HO• hydroxyl radical) or molecular species (e.g. ascorbate radical, lipid radical, LO• or 
LO2•) capable of independent existence (commonly extremely short due to its high instability) 
that contains at least one or more unpaired valence electrons (the ones in the more exterior atom 
shell) or a open outer shell configuration (Halliwell B, Gutteridge JMC 2000). In biology, due 
to its relevance, free radicals are also known as reactive oxygen species (ROS), reactive 
nitrogen species (RNS) (Halliwell B, Gutteridge JMC 2000). and more recently, reactive lipid 
species (RLS), although, in nature, all sort of radicals can be found. 
 
In eukaryotic biota, those radical species are mainly generated along the electron transport chain 
(ETC) in mitochondria and chloroplasts. Mitochondrial ETC comprises very sophisticated and 
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complicated proteic systems which could be “divided” in five complexes (each composed by 
multiple subunits, but interestingly not all encoded in the mitochondrial DNA, mtDNA) and 
electron donors-transporters (e.g. Ubiquinone, Coenzyme Q). All of them are cristae resident, 
thus, embedded in the inner mitochondrial membrane. ETC bioenergetics, composition and 
physiology will be discussed below, just say here that they orchestrate a controlled transfer of 
energy from the substrate (e.g. pyruvate, malate, succinate) to molecular oxygen (the final 
acceptor) forming, along this process, the corresponding reduced equivalents (e.g. NADPH+, 
FADH2) and generating an intermembrane electrochemical gradient (∆Ψ) which ultimately 
results in ATP production (trough ATP synthase) and/or heat (uncoupling proteins, UCP). 
 
Hence, mitochondrial ETC complex I and III have been blamed for main ROS production long 
time ago (Turrens and Boveris 1980). However, there is still controversy on which of them are 
“the more responsible”. Nowadays, it is believed that CI ROS production could be counteracted 
more efficiently by mitocondrial antioxidant defence, but due to its location and functionality, 
affects mtDNA more significantly (reviewed in (Stefanatos and Sanz 2011)). On the other hand 
CIII ROS are more prone to affect extra-mitochondrial molecules (Chen et al. 2003), and 
possibly related with signalling events to control this excess. 
 
However, during millions of years, those processes where refined to avoid undesired leaks in 
the system, which could generate the mentioned radicals and/or oxidant species with those 
harmful consequences. Pointed long time ago (Richter 1997), taking into account this 
evolutionary process and its statistically-stochastically-linked physiological leak, organisms 
evolved to understand and react when situations turned dangerous. There are sensitive 
mechanisms which detect the unbalance and operate towards solving it. This fact changed the 
classical harmful focus into, up to an extent, benign signalling. So nowadays, ROS, RNS and 
RLS are known to have double edge-sword behaviour. Nobody is saying that general 
indiscriminate damage to neither nucleotides nor proteins is beneficial, but, along million of 
years, is reasonable to think that organisms developed a wide array of mechanisms in order to 
ascertain their status and therefore orchestrate a reasonable response, among them oxidative 
signalling (for a review see (Martindale and Holbrook 2002)). In fact antioxidant 
supplementation, aimed to minimize radical production, is nowadays controversial (Bjelakovic 
et al. 2013 and Dolara et al. 2012). Some studies have shown that antioxidant supplementation 
could have no effect in health subjects with a balanced diet and a reasonable active lifestyle 
(Taghiyar et al. 2013) or even, in turn, exacerbate oxidative damage (Schnorr et al. 2011 and 
Bjelakovic and Gluud 2007). This may be explained, since if dietary intake is exceeded, local 
synthesis and detoxifying mechanisms would render “unnecessary” and the body would reach 
another homeostatic situation, potentially harmful if this dietary supplements failed to be at the 
right time and location.  
 
This relates to a relative new concept, mitohormonesis (Tapia 2006), which, in brief, refers to 
the already mentioned minimal oxidative damage needed to achieve a balanced status of the 
organism's natural response to the oxidant compounds. This was partially validated by finding 
an increased life expectancy in C elegans (Schulz et al. 2007). However, it seems pretty clear 
that those antioxidant-dietary supplements are beneficial when an altered diet or pathology is 
present (Kim, Kim and Choue 2013 and Miyamae et al. 2013) and there is no discussion on the 
positive role of radical production for pathogen control, like physiologically produced oxidant 
derivatives by myeloperoxidase action in neutrophiles, Nitric Oxide signalling or NRF2 
translocation, among other beneficial properties. 
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1.C2.2.- Mitochondrial physiology 
 
We will present here a brief description of mitochondrial bioenergetics and components trying 
to shed some light on its physiology. As stated before, ETC could be subdivided into five 
complexes (complex I, CI; II, CII; III, CIII; IV, CIV or cytochrome-c oxidase and V, CV, or 
ATP synthase) each one composed of multiple subunits and mobile electron shuttles - 
ubiquinone (Coenzyme Q, CoQ), a lipidic quinone and cytochrome c (Cyt c), a heme-containing 
peptide -. A representation is shown in page 74, Figure 17. 
 
mtDNA encodes several, but not all, subunits of the ETC. Apart from 2 ribosomal and 22 
transfer RNAs, mammalian mtDNA encodes only 13 proteins (7 from CI, 1 from CIII, 3 from 
CIV, and 2 from CV) (Mitochondrial Oxidative Phosphorylation 2012). Also remarkable, for a 
correct mitochondrial functionality, this organelle needs from, approximately, 1000 (Elstner et 
al. 2009) nuclear-coded cytosol-synthesed proteins, delivered through two classical “pathways”, 
but with increasing novel partners (both issues recently reviewed in (Schmidt, Pfanner and 
Meisinger 2010)).The vast majority of mitochondrial proteins (taking into account mtDNA 
encoded and nuclear encoded ones) shows a prokaryotic origin, as reflected by the findings of 
orthologous phylogenetically related ones. However, a large number of proteins were 
incorporated during the evolution of eukaryotic cells, with increased complexity, probably for 
optimising regulation since those cells had also higher networking and their functioning proceed 
more specifically. Thus, actual eukaryotic mitochondrial proteome represents a mosaic of 
ancestral components and components emerged though evolution to adapt their new 
functionality, for which no orthologous are found in prokaryotes.  
 
In mammalian mitochondria, CI catalyzes the oxidation of reduced NADH by CoQ. This 
complex is the largest in the ETC system, consisting of ≈45 subunits in mammals. 
Ultrastructural studies of purified CI revealed an “L” shaped object, consisting of two arms, a 
hydrophilic “peripheral arm” protruding into the matrix, and a hydrophobic “membrane” arm, 
embedded in the mitochondrial inner membrane (Efremov, Baradaran and Sazanov 2010). This 
two arms harbour the  three functional modules: i) the dehydrogenase site, responsible for the 
oxidation of NADH to NAD+; ii) the Q module, in the hinge region between the two arms, 
contains the CoQ reduction site; ii) the P module, which is responsible for proton translocation. 
Various human diseases have been linked to mutated or malfunction of CI (reviewed in 
(Fassone and Rahman 2012)), most of them with an early clinical manifestation. Interestingly in 
a recent paper (Ghiasi et al. 2012) researchers find a reduced complex I activity concomitant to 
an increase in ADP content, in ALS patients’ circulating lymphocytes. Finally another SOD1 
mutation linked to ALS was found to alter C I activity and ATP production (in animal model 
(Coussee et al. 2011) suggesting a CI involvement in the ALS pathogenic mechanism. 
 
CII is a succinate dehydrogenase which represented the only membrane-bound member of the 
tricarboxylic acid (TCA) cycle. This enzyme catalyzes the oxidation and dehydration of 
succinate to fumarate coupling this reaction to the reduction of ubiquinone to ubiquinol. CII is 
the smallest among the ETC complexes, consisting of four subunits and three Fe–S centers and 
having a FAD (Flavin-adenin-dinucleotide)-binding domain. The crystal structure consists of a 
hydrophilic head protruding into the matrix, a hydrophobic tail embedded in the inner 
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membrane and a short segment projecting into the intermembrane space (Sun et al. 2005). 
Interestingly, mRNA expression levels of both, FAD and succinate dehydrogenase complex 
subunits were found decreased in ALS patients (Lin et al. 2009). 
 
Finally, CIV (which is believed to represent a rate limiting step of the ETC (Pacelli et al. 2011)) 
is the unique responsible of final electron acceptor of oxygen, but unlikely responsible of ROS 
production (Yu et al. 2011), and represents the only mitochondrial complex that has been found 
to have different isoforms on 5 of the 10 nuclear-encoded proteins. The existence of tissue and 
developmental specific forms is believed to occur to provide a platform for tissue-specific cell 
signalling and for a better adaptation to tissue/age demands too (Hüttemann et al 2008). In line 
with this, this complex was found to undergone accelerated evolution in primates (Uddin et al. 
2008 and Grossman et al. 2004) respect to the other complexes. CIV is the only complex to be 
ATP/ADP-binding-regulated, also probably due to an increased adaptation of its activity to the 
particular energy demand. This complex also developed a special Ca+2 sensitivity. Apart from a 
direct effect (mamalial Cyt c have a Ca+2 binding site (Kirichenko et al. 2005), high extra-
mitochondrial Ca+2 levels promote CIV dephosphorylation (Hopper et al. 2006) and this could 
lead to a mitochondrial hyperpolarization and increased ROS production.  
 
Also remarkable, very relevant due to its function in transduction events leading to apoptosis, is 
the role of Cyt c (recently reviewed in (Wu and Bratton 2013)). This intrinsic pathway for self-
controlled cellular death is conserved from worms to humans and represents one of the most 
likely forms of suicide in a specific cell when deleterious effect of various stimuli can no longer 
be confronted. Interestingly a significant Cyt c deletion was found in CNS of SOD1G93A 
mouse at endpoint (120 days but not in early stages (Kirkinezos et al. 2005)), linked to an 
increased MDA accretion suggesting an involvement of this ETC element in ALS development 
too.  
 
For evaluation of relative contributions of mitochondrial complexes to oxygen consumption, 
several mitochondrial specific inhibitors and substrates could be added sequentially in an 
experiment, as routinely performed in our laboratory (López-Erauskin et al. 2013). Therefore, 
one can depict each-complex oxygen consumption in permeabilized samples, as well as the 
overall contribution in intact tissue or isolated mitochondria. This is a valuable and helpful tool 
for specific detection of the question, when the overall process (respiration) is believed to be 
altered.  
 
 
1.C2.3.- Lipid peroxidation events 
 
Let’s focus now on lipids, particularly PUFAs, and their potentially harmful oxidative 
amplification. Particular composition of mitochondrial membrane lipids was extensively studied 
along the 90’s at the laboratory of Dr Shalme and Dr Kligenberg (Schlame et al. 1991) and 
more recently revisited thanks to lipidomic analyses (Kiebish, Han and Seyfried 2009). Both 
studies showed big local differences from mitochondria of different sources. There are adaptive 
variations depending on the tissue, which is up to an extent reasonable, but even for the same 
tissue differences were found (e.g. fast or slow stretch muscle (Stefanyk et al. 2010)), or the 
synaptic location (e.g. pre or postsynaptic (Kiebish, Han and Seyfried 2009)) and of course, 
pointed long  time ago, related to  temperature where the  specie is adapted to  (Dey et al. 1993). 
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Figure 17. ETC depiction and 
physiology. From left to right CI 
(NADH dehydrogenase) generates 
reduced equivalents of Ubiquinone 
(QH2) and pumps protons from the 
NADH generated in the TCA cycle 
(tri carboxylic acid) into the 
intermembrane space. The CII 
(succinate dehydrogenase activity) 
also generates Ubiquinone, while 
consuming FADH2. CIII complete 
the Ubiquinol (Q) cycle (helped by 
the cytochrome bc1) as well as 
transmit electrons to CytC 
(cytochrome c) and releases 
protons to the intermembrane. All 
those complexes generate free 
radicals as by products which, for CI 
and CII, are in part counteracted by 
the mitochondrial antioxidant 
defence machinery (catalase, 
manganese superoxide dismutase, 
glutathione, glutathione peroxidase, 
and glutathione reductase; MnSOD, 
GSH, GPX, and GRase 
respectively). Complex IV 
(cytochrome c oxidase) reduced 
oxygen to water and sends protons 
to the intermembrane space. The 
electrochemical gradient (∆Ψ) 
generated by the pumped protons is 
used by CV to couple its entrance 
(protons) back to the mitochondrial 
matrix to ATP generation. Other 
possibility, helped by the uncoupling 
proteins (UCPs), is to “waste” the 
electrochemical gradient formed 
along the ETC to generate heat. 
Radical generated in CIII affects 
more easily extramitocondrial 
species and, under specific harmful 
conditions, Cyt c could be launched 
out from the mitochondria triggering 
the intrinsic apoptotic pathway. Inhibitors are shown in red, substrates in green and products in black. Electron flux is represented by green arrows and proton flux by blue arrows. Not to scale. 
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Surprisingly, temperature could in fact regulate the rate of incorporation of FA into those 
mitochondrial PLs, at least in in vitro astrocyte cultures (Tocher and Sargent 1990). However, 
broadly speaking, one can assume that mitochondrial membranes are principally enriched in PE, 
PC, CHO and CL, representing, approximately 26%, 27%, 21% and 7% of lipids, respectively. 
 
Among them, mitochondrial CHO levels are funded the lowest founded in any membrane 
(probably to minimize sterical impedances and reduce cholesteryl oxidation) and CL is the only 
mitochondrial-specific one. Remarkable, CL dysplayed an extremely precise acyl composition 
for a given particular specie and/or tissue and its accretion could rise to represent up to 25% of 
total GPL in the inner mitochondrial membrane. CL contains normally only one or two types of 
sterified FA (i.e. LA and 18:1 are the most frequently found in humans, raising up to 80% of the 
CL FA (Schlame et al. 2005)). Although CL composition has a strong difficulty to be dietary 
modified, could be changed up to an extent specially in highly metabolic tissues (e.g. liver, heart 
(Stavrovskaya et al. 2013)). This strong uniformity in the FA pattern, also reflected by the 
identical tretaenoyls found in majority of CL, had stereochemical implications (e.g. symmetry) 
that very likely affect the physico-chemical molecular properties: i) symmetry will increase 
molecular entropy since increases the freedom of rotational and vibrational motion and thus 
may affect interactions between CL and other components of the mitochondrial membrane as 
well as the physical state of the membrane itself; ii) symmetric CL may freely adopt the optimal 
binding conformation with respect to the central carbon atom (in contrast to the asymmetric one 
which could be more sterically constrained); iii) chiral properties of the central carbon atom 
may affect the capacity of CL to act as a local proton buffer (Kates, Syz, Gosser, & Haines, 
1993), which is believed to represent a key factor on its biological function. 
 
Also noteworthy is the incorporation of different FA into other GPL. As a component of them, 
DHA mainly takes the sn-2 position, especially in PS, PE and PC; while AA is also 
incorporated into the sn-2 position, but the majority in PI and PC. Different from DHA and AA 
ALA, LA and EPA have lower incorporation rate into the membrane GPL and lower 
resterification rates when consumed (Zhang et al. 2011). 
 
From the previously commented location of the mitochondrial ETC complexes and carriers, 
embedded in the membrane, and their composition, it seems clear that those lipid species are 
potentially targets of the mitochondrial ROS and RNS, thus converting themselves in RLS. 
Particularly, unsaturated FAs, due to their double bounds (bis-allyllic hydrogen are much more 
prone to be abstracted by radicals), are more susceptible to be oxidised. Importantly, if this 
oxidation occurs via radical chemistry, consequences are potentially more harmful, since 
breakdown of those double bounds would generate higher amounts on new radicals, and 
therefore amplify damage. However, two interesting issues emerged here since, as stated before, 
i) a minimal damage is believed to be necessary to establish a balance point where a drastic 
increase could be sensed and up to an extent, orchestrate an ordered response, and ii) multiple 
signalling events raised related to coordinated (e.g. LOX and COX mediated) oxidation of 
PUFAs. Also noteworthy, in the already discussed mechanism, in case of increased 
peroxidation, esterified FA exchange from the GPL membranes could be performed by PLA 
and acyltrensferaese and possibly account for sufficient turnover. 
 
Furthermore, it is plausible to speculate with a potential antioxidant role of PUFAs, 
understanding it as previously commented prevalence to be a preferred oxidation substrate, in 
order to “protect” other biological species. From this point of view, the high vulnerability to 
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peroxidation of free PUFAs in CNS (where there is a lack of intense antioxidant defences) and 
its close-to-damage mitochondrial location, coupled with their relative abundance in those CNS 
tissues could point that PUFAs might play a passive protective role of nucleotides, hence 
limiting their oxidation, fact already demonstrated, at least in vitro (Kim et al. 2010). 
Figure 18. Representative oxidative products structure scheme. ROS formed in the 
mitochondria could interact with different lipid structures to form multiple lipidic propagators. 
These species are characterized by the presence of highly reactive carbonyl groups 
(remarkable for those α/β unsaturated), hence potentially increasing and spreading the oxidative 
damage. Those propagators could form stable adducts with different biological substances, 
especially with protein residues and those substances could be used to ascertain the oxidative 
status of a given sample as they fulfil the previously commented requirements to be a 
successful oxidative damage marker. Further, according to the source of the oxidative damage, 
we could account for lipoxidation (MDA-Lys, HNE-Lys), glicoxidation (CML, CEL), DNA (8-oxo-
dG) or mitochondrial (2SC) damage or metal catalysed carbonylation (GSA, AASA or DNP 
adducts) as oxidative-affected pathways.  
 
Finally, for a better support of this concept, the formation of some lipoxidation (and also 
nitrosilated FA) products were demonstrated to be reversible (Batthyany et al. 2006), specially 
through GSH function. Also relevant, some enzimatically-synthesized lipid species could be 
also generated through a non-enzymatically pathway (Morrow et al. 1990). Hence, those facts 
open the possibility for higher regulation of enzymatic functioning and/or signalling in relation 
to oxidised PUFAs and their derivatives. 
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In any case, lipid oxidation (GPL, but also free FA and PUFAs) occurs physiologically 
and specific products are usually found. Furthermore, from lipidic intermediates, highly reactive 
aldehydes could be generated, and also relevant, some PG could undergo dehydratation and 
oxidative modifications which would also interact with other cellular components. All those 
species could be sometimes crosslinked (the most frequently are covalently bounded) with 
virtually all sort of protein residues (but especially to cysteine, histidine and lysine groups via 
Michael addition (Requena et al. 1997; Uchida and Stadtman 1992)). Since they form stable 
adducts with them, this substances could be very useful as biomarkers of oxidative status/stress 
(for a profound review on the lipoxidation adducts formation see (Domingues et al. 2013) and 
regarding PL oxidation see (Reis and Spickett 2012). 4-hydroxy-alkenals (especially nonenal, 4-
HNE, and hexenal, HHE), malondialdeyde (MDA) and 2-propenal (acrolein) protein adducts are 
the most commonly studied oxidative-produced lipidic derivatives (and also more often 
accumulated in biological samples) and meet the commented features to be considered valuable 
oxidative stress markers. Furthermore, unespecific carbonylated products (insercion of C=O 
duble bound) are often accumulated and commonly detected through 2,4 dinitrophenylhydrazine 
(DNP) incubation and WB. Anyway, multiple methodological approaches (e.g. WB, ELISA, 
HPLC, GC/MS, LC/MS/MS) compose a more or less accurate and reliable satate-of-art in a 
specific situation. However, origin of the damage (e.g. glucidic, purely lipidic or metal catalysed 
protein-protein), even when is sometimes difficult to interpret (e.g. MDA is generated as by-
product of TX and PG synthesis too) gives relevant information helping to better represent the 
whole situation and possibly pointing to a metabolic pathway which could be more affected or 
susceptible. In addition, as commented before, when a specific accretion of those molecules 
occurs, could be either due to i) failure of the detoxification system; ii) for an increased 
indiscriminate damage and/or iii) an specific signalling purpose.  
 
All in all, those data reinforce the complex machinery operating in the physiology of lipids 
related to the oxidative status in a specific situation. Moreover, when pathology overcomes, this 
tightly cross linked net had multiple ways to try to resolve the situation. Finally, in order to 
reduce damage to the minimum, this homeostatic mechanism could lead to a lipid profile 
adjustment. How dietary lipid could influence this outcome is an interesting question and is one 
the focus of this work. 
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1.D Amyotrophic Lateral Sclerosis 
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1.D1 ALS Introduction 
 
The amyotrophic lateral sclerosis (OMIM #105400) is an adult onset neurodegerative disease, 
characterised by selective loss of both upper (comprising the cortex and the corticospinal tract) 
and lower motor neurons (MN) arising from the brainstem nuclei and ventral roots of the spinal 
cord. This devastating disease was initially described by Charcot in 1869 and represented the 
most common MN disorder with a prevalence of 2-3 per 100,000 people. ALS is, in reality, a 
member of heterogeneous disorders covering different forms of heritance, age and location for 
initial onset and different markers and proteins are involved to be deregulated. Initially, this 
illness was classified to be sporadic (when a familial linked heritage is missing or 
etiopathogenesis remains unclear) or familial (genetically linked, representing up to 15%), but 
whereas is generally acknowledged that the clinical presentations of sporadic and familial ALS 
are indistinguishable, there are subtle differences in pathology (Ajroud-Driss and Siddique 
2014). 
 
The first relevant research finding was established more than 20 years ago when Rosen and 
colleagues demonstrated (Rosen 1993) that mutations in copper/zinc superoxide dismutase 
(SOD) were a primary cause for ALS, which led to development of mouse models (Gurney et 
al. 1994) of the familial form. Since then, more than 100 different heterozygous mutations in 
SOD have been found (reviewed in (Gaudette, Hirano and Siddique 2000)) in patients with ALS 
(representing approximately 15-20% of the familial forms), and, for many of them, an animal 
model was developed. Also noteworthy, along the past years, multiple enzymes were 
demonstrated to be mutated and/or deregulated up to an extent, showing a more broad spectra 
than was initially thought (an excellent review on the genetics behind the pathophysiology of 
ELA could be found in (Al-Chalabi et al. 2012 and Ajroud-Driss and Siddique 2014)). In figure 
20 there is a picture of the yearly progression of genetic/protein involvement in the pathology. 
 
Another breakthrough point was recently found thanks to geneticists, when an intronic 
expansion of a hexanucleotide (GGGGCC) repeats in the chromosome 9 open reading frame 72 
(C9ORF72) gene was demonstrated (DeJesus-Hernandez et al. 2011 and Renton et al. 2011) to 
represent the major cause (35%) of familial form of ALS, and very importantly, frontotemporal 
dementia (FTD) too. Although, surprisingly, the ALS penetrance in people carrying this 
repetition varies enormously along lifetime (Majounie et al. 2012), raising from almost zero (for 
young individuals, below 34 years) to 50% at 58 years and finally almost complete for those 
individuals who reached 80 years old. This suggests that this characteristic predisposition to 
suffer the disease required extra unknown-yet events to be finally developed. In between these 
two discoveries, more than 19 different proteins were related to participate in ALS 
development, with different particular features. Hence, mutated and/or misslocalized or 
phosphorylated forms of TDP-43 (TransActive Response DNA Binding Protein-43 kDa, 
TARDBP), FUS (FUsed in Sacroma protein) and UBQNL2 (Ubiquilin-2, Ubiquitin-like 
protein) were described for various phenotypes, from purely “typical” ALS to FTD. Further, 
disease-associated gene variants (e.g. encoding elongator protein-3 (Simpson et al. 2009), 
inositol 1,4,5-trisphosphate receptor 2 (van Es et al. 2007), dipeptidyl-peptidase 6 (van Es et al. 
2009)) were also described suggesting that ALS is not a simple disease implying only one or 
two groups of related proteins, monogenic mutations or so. Instead, it comprises several distinct 
hallmarks, which make more difficult to establish a precise coiling the data interpretation of 
those treatments when they fail.  
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Figure 19. Genes founded implied in ALS/FTD development. Copied from (Al-Chalabi et al. 
2012). NEFH, NEuroFilament Heavy polypeptide; ATX2, ATaXin-2; SIGMAR1 SIGMAR1 gene variant; 
DCTN1, DynaCTiN heavy subunit-1; PSEN1, PreSENilin-1; PGRN ProGRaNulin; VCP, Valosin Containing 
Protein. 
 
Epidemiological studies showed a little increased disease prevalence in European ancestry 
(Cronin, Hardiman and Traynor 2007; Zaldivar et al. 2009), in contrast, for instance, to Latin 
American, native American or ethnically mixed populations. Dealing with gender dimorphism, 
a higher incidence in men, respect to women (even this difference is faded out in the elderly, 
reviewed in (McCombe and Henderson 2010)) is known. This sexual dimorphism was relevant 
since some specific differences in disease progression are also found. Some of them were 
reproduced in murine models of the disease (Suzuki et al. 2007) and were modified by estrogens 
therapy (Choi et al. 2008). From those epidemiologic studies, many different situations had 
been shown to affect illness development. Environmental risk factors (recently reviewed in 
(Trojsi, Monsurrò and Tedeschi 2013)), veterans of the Army (Gulf war (Cox et al. 2009)), 
grass-field sportsman players (Beghi 2013), western-Asian populations (Kaji et al. 2012; Lee 
2011), exposure to pesticides (Furby et al. 2010) and some occupancies (McGuire et al. 1997; 
Park et al. 2005) were among many other cited that play a role in the incidence or development 
of this disease.  
 
 
1.D2 Mechanism involved 
 
As pointed previously, many different tissular and cellular events are related to ALS 
development. These can be clustered as: i) mitochondrial-Ca+2-ER deregulation; ii) energetic 
unbalance; iii) non-cell-autonomous inflammation/excitotoxicity; iv) proteinopathy; v) heavy 
metals and toxic/ environmental agents exposure; etc. Here, we will discuss briefly about them. 
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1.D2.1.-Mitochondrial-Calcium-ER dysfunction 
 
Regarding ALS and mitochondria, relevant amount of research has been done (nice reviews 
were recently published (Cozzolino et al. 2013; Tan, Pasinelli and Trotti 2014)). Very closely-
related to mitochondrial function, decreased Ca+2 buffer capacity was extensively described 
both in patients and animal models (Guatteo et al. 2007; Siklós et al. 1996). Miss-localization of 
mutated SOD (usually found in the cytosol, but also in nucleus, ER and intermembrane space in 
disease models) have been also described in animal models, linked to anti-apoctotic Bcl-2 in the 
mitochondria (Pasinelli et al. 2004) as well as aberrant mitochondrial swollen and vacuolization, 
both in animals and human patients (Bendotti et al. 2001; Mattiazzi et al. 2002; Siklós et al. 
1996). Using the SODG93A murine model, decreased mitochondrial respiration was also found 
(Mattiazzi et al. 2002) in animals under clinical stages, but whether preclinical ones are affected 
is still under debate. Further, regarding oxidative damage, an impairment of Cyt c was found 
and reduced respiration complexes linked to an increased MDA accretion (also in preclinical 
animals) in isolated forebrain mitochondria of this mouse model (Kirkinezos et al. 2005). Of 
note, it should be reminded that mitochondrial respiration is very sensitive to lipid peroxidation 
(Echtay et al. 2003) and links with the “energetic unbalance theory”, which will be discussed 
later in this section. 
 
Anyway, in these early works, increased carbonylation and lipid hydroperoxdes were also found 
for brain and spinal cords of older animals, however, the methodology used could be criticised 
This increased oxidative damage, even whether to be cause or consequence is controversial yet, 
was initially found as augmented carbonylation in spinal cord (Shaw et al. 1995) and motor 
cortex (Ferrante et al. 1997) of patients. Higher glyco- and lipoxidative products (Shibata et al. 
2001) were found in all CNS population in the spinal cord, as well as damage to DNA was 
verified, as pointed the accretion of 8-oxodG (as previously commented, extensively-studied as 
oxidative biomarker of DNA damage) (Ferrante et al. 1997). The latter was also found increased 
in CSF of patients (Ihara et al. 2005), concomitant with an increased 4-HNE too (Smith et al. 
1998). Regarding oxidative-derived IsoP, increased 15-F2t-IsoP levels were found in CSF from 
patients suffering Alzheimer, but not in those ALS patients, respect to the control ones (Montine 
et al. 1999). However, in a later study (Mitsumoto et al. 2008), significant accretion of urinary 
8-oxodG and 15-F2t-IsoP, (both ELISA measured) was demonstrated, but interestingly none of 
those levels were correlated with an increased plasma carbonyl content (DNP measured) nor a 
better clinical outcome. However, one should take into account that increased excreted levels of 
IsoP or 8-oxodG could have two sides. One can assume that there is a raised production of those 
species, but is also reasonable to think in a better clearance of those substances in these 
individuals. So, whenever is possible, a more reliable measure of such species, aimed to express 
an increased oxidative damage, should be done in situ. In any case, collectively, all those 
outstanding findings pointed towards oxidative stress as a relevant factor in the ALS pathogeny. 
 
Some of those human hallmarks were recapitulated in the wide variety of transgenic animal 
models (e.g. TDP-43, SODG93A, FUS, in mouse, rat, drosophila and zebrafish species, among 
others), tissular (lumbar slice organotipic culture) and cellular models developed. Taking into 
account their limitations, organotypic (OT) culture model stands out, since it conserves cell to 
cell interactions. This is relevant since not only one cell type but a concert of them (e.g. MNs, 
astrocytes, microglia, interneurons and muscular junctions) are involved in the degeneration. 
Also interesting, but just for the opposite, MN primary cultures may clarify what specific MN 
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signature would help to better confront different stimuli, aimed to reproduce the different ALS 
features. 
 
As pointed before, in ALS there is an unbalance in the Ca+2 homeostasis (reviewed in 
(Grosskreutz, Van Den Bosch and Keller 2010)). MNs are known to be vulnerable to membrane 
depolarization and increased intracellular calcium concentration (Arakawa et al., 2002). Hence, 
higher levels of such ion increased their susceptibility to undergo cell death (Gou-Fabregas et al. 
2009; Kaiser et al. 2006), but, even when some specific responsible enzymes (e.g. protein 
phosphatases, endonucleases, or proteases) are known, the exact mechanism is not fully 
understood yet. We (Ilieva et al. 2007) and many others (recently reviewed in (Prell et al. 2013 
and Roussel et al. 2013) had pointed to deregulated ER, UPR stress and Ca+2 unbalance as key 
partners on pathophysiology of ALS, linking ER and mitochondria. These two cellular locations 
are the main ones responsible for Ca+2 regulation and a combined reduction of calcium 
buffering capacity and a high number of Ca+2-permeable α-amino-3-hydroxy-5-methylisoxazole 
proprionic acid (AMPA) receptors in several animals models and in patients was demonstrated 
(reviwed in (Kwak et al. 2010)). 
 
The relative importance of vesicular transport in cellular and sub-cellular lipid homeostasis and 
sorting remains unclear. As previously commented, it is a key mechanism required for a correct 
neurotransmission. But it is also believed to be an important connexion route from trans-Golgi 
and plasma membrane, helping to maintain especially high levels of SM and PS on that 
membrane. However no direct evidence of such transportation has been proved for 
mitochondrial or peroxisomes-ER connection even when for mitochondrial and peroxisomes 
exists (Schumann and Subramani 2008). Furthermore, fragmented Golgi apparatus was already 
described for preclinical classical mouse model (Gonatas, Stieber and Gonatas 2006) and 
patients (Stieber et al. 1998). Vesicular transport requires intact cytoesqueleton organization and 
functionality. It is also energy dependent (opposed to LTP mechanism) and comprises a very 
complex mechanism involved in different processes, ranging from lipid droplet formation 
(Jacquier et al. 2011) to autophagy (reviewed in (Knævelsrud and Simonsen 2012), which has 
been linked to various neurodenerative diseases (Salminen et al. 2013; Shen et al. 2013), 
including ALS (Zhang et al. 2013; Zhang et al. 2014). In fact, the finding of a relatively new 
familial form (named ALS8) of this disease related with mutations (P56S and T46I) in the gene 
encoding an ER-resident vesicle-associated membrane protein (Nishimura et al. 2004 and 
Kanekura et al. 2006) opened a new possible terapeutic route. This protein is related to 
regulation of vesicle trafficking (Rocha et al. 2009) but also plays a critical role in the UPR and, 
its malfunction, results in increased MN vulnerability to ER stress (Prosser et al. 2008). 
Interestingly, defects in this protein does not lead to morphological defects at the neuromuscular 
junction nor to muscle denervation in mice (and zebrafish, Kabashi et al. 2013), and only leads 
to a mild, late-onset motor impairments. However, in flies, this mutation caused a marked ER 
stress, with an accumulation of ubiquitinated proteins in brain neurons (Moustaqim-Barrette et 
al. 2014) and, furthermore, a misslocalization of oxyterol and ceramide binding proteins, 
suggesting an integral mechanism of sterol and SM metabolism malfunction.  
 
Finally, we discuss some issues regarding pro-survival signalling. Some years ago it was 
demonstrated that NFκB inhibition leads to neuron protection from the Glut-mediated injury (at 
least in cultured cells (Pizzi et al. 2005)), a mechanism already involved in phatophysiology of 
ALS. In the SODG93A mouse model, it was demonstrated (Prell et al. 2014) that microglial 
activation of the NF-κB pathway accounts for the MN loss, both in vitro and in vivo. 
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Furthermore, Julien and collaborators (Swarup et al. 2011) shown that synthetic inhibition of 
NF-κB in another mouse model of ALS (TDP-43) reduced denervation in the neuromuscular 
junction and TDP-43 silencing (by siRNA transfection in microglial cells) increased neuron 
survival whereas, the contrary, TDP-43 up-regulation, resulted in increased microglia-mediated 
neurotoxicity in primary cultures. Also importantly, a relation between inflammatory signalling, 
TNF-α mediated, and NFκB was shown in other model of ALS, the threohydroxyaspartate 
(THA) excitotoxicity (developed by Rothstein (Rothstein et al. 1993) and commented in the 
next section) on OT spinal cord slice cultures (Tolosa et al. 2011). In this work, researches 
showed increasing production of COX-2 concomitant with MN loss along the culture as well as 
drastic decay of them when co cultures were performed with TNF-α. Furthermore they 
demonstrate down-regulation of the main astrocitic Glut transporter (GLT-1, ortologous to 
EAAT2) in the combined excitotoxic and TNF-α treatment. Altogether, this data reinforces the 
link of various prominent pathogenic mechanisms of ALS, excitotoxicity, neuroinflammation 
and prosurvival siganalling, at least for some models.  
 
Also noteworthy, results from our group refer to an altered phospho-ERK1/2 signalling upon 
TDP-43-mediated toxicity in cell lines under different stress stimuli, spinal cord OT culture as 
well as human patients (Ayala et al. 2011). This is relevant since implication of PI3K pathway 
was demonstrated some years ago (Wagey et al. 1998) and more recently confirmed for humans 
and animal models (Dewil et al. 2007). Patients were reported to have increased spinal cords 
protein levels and activity of PI3K respect to controls, but no changes in activity nor expression 
in ERK1/2 was found in this early work. Interestingly, those two pro-survival pathways (PI3K-
AKT and ERK1/2) were recently proved to be enhanced by palmitic acid (in muscle cell line, 
but surprisingly, both pathways at the same time (Pu et al. 2011)) and DHA (in neuron cell line, 
activates AKT but not upstream PI3K (Akbar et al. 2005)). In another recent paper (Peviani et 
al. 2014) researchers showed that activation of AKT3 (one of the three isomers of protein kinase 
B/AKT pathway) increased survival of MNs both in in vitro co-cultured (astrocyte and MNs) 
and in vivo “fast” SODG93A model although in previous paper, the same group found no 
substantial changes in AKT pathway in this murine model of ALS (Peviani et al. 2007). 
Unfortunately, this MN preservation does not ameliorate disease progression of the animals 
(although only females were studied in both papers). On the other hand, DHA pretreatment was 
observed to significantly increase neuronal survival by promoting ERK-related survival 
pathways, at least in Alzheimer disease models (Florent-Béchard and Koziel 2007). However, 
further research is needed and, to our knowledge, no deep examination have been developed 
regarding PUFA’s action alleviating excitotoxicity, reducing oxidative spread and/or 
counteracting inflammatory ALS components even when compiling evidences pointed an 
specific altered lipid status in patients tissues (Ilieva et al. 2007). 
 
1.D2.2.- Energetic unbalance: ALS hypermetabolism 
 
Once a patient is diagnosed, their body mass index, better than dyslipidemia (Paganoni et al. 
2011), is predictor of its outcome, with worst prognosis for lower body mass individuals 
(Greenwood 2013). Hence, dietary interventions focusing in a correct energetic status have been 
shown to be beneficial in animal models (e.g. high fat diet (Dupuis et al. 2004), L-carnitine 
(Kira et al. 2006) and caprylic-TAG (Zhao et al. 2012), among others) as well in humans (Dorst, 
Cypionka and Ludolph 2013; Wills et al. 2014 and Beghi et al. 2013) (for a review on this topic 
see (Dupuis et al. 2011)). Not surprisingly,  on  the  contrary,  caloric  restriction  in  SODG93A 
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Figure 20.-ALS phatophisiology partners 
scheme.(A) Mitochondrial dysfunction 
increased ROS production, which could 
reduce astrocyte EAAT2 Glut buffering 
capacity, leading to excitotoxycity, as well 
as damage to DNA.Further, CytC could be 
launched from mitochondria, altogheter 
with mutated SOD1 blocking Bcl-2 
prosurvival signalling would seriously 
comprise cell viability. (B) Altered RNA 
processing was demostrated in patients. 
TDP-43 aggregates and mislocalized could 
be found (with degenerated mitochondria 
too) vacuolized and/or inside proteasome 
(D) when the UPR is exhausted. Those 
facts altered normal ER fuction. Other 
proteins were found accumulated inside 
proteasome (i.e.valosin-containing protein 
(VCP), optineurin (OPTN)). (C) Ca+2 
metabolismin MN is different than in regular 
neurons. They possess high number of 
membrane Ca+2 permeable AMPA 
receptors concomitant with lower 
cytoplasmic Ca+2 binding proteins, 
rendering them to be very sensitive to Ca+2 overload. Furthermore, Glut binding to AMPA receptors, promote increased Ca+2 entrances. Those situations, 
together with IP3 signaling (which could be triggered by PLC activation), could result in Ca+2 desorption from ER depots and, ultimately, its uptake by 
mitochondria, comprising this organelle too. Mitochondrial (i.e. entrance through the Ca2+ uniporter; release through the Na+/Ca2+ exchanger) and ER (Ca+2 
intake is mediated by the sarco-endoplasmic reticulum calcium ATPases -i.e. through ER Ca+2 uniporter- Ca+2 depletion could occur through IP3 dependent 
channels) Ca+2 trafficking is represented. Ca+2 is required for cPLA2 activity. High plasmatic Ca+2 content could result in higher plasma membrane FA 
desorption, potentially causing enhanced lipoxidative products formation. Altogether, this claimed for a key role for this ion along ALS pathophysiology. (E) 
Mutated SOD1 altered cytoskeleton structure (some neurofilaments) and blunted axonal transport too. This would alter neurotransmission (less number of 
synaptic vesicles or altered configuration). (F) Fewer, smaller and sometimes vacuolated mitochondria were found in patients synapses. (G) Muscle 
denervation (whether a cause or a consequence) leads to neuron degeneration and apoptosis. (H) ROS generated by mitochondrial malfunction could also 
activate microglia and initiate a pro-inflammatory lipid derivatives cascade, possibly resulting in a feedback loop by astroglial activation (with lees pro-surviving 
factor release, e.g. BDNF, IGF, VEGF and enhancing inflammatory intermediates).A similar mechanisms may operate in non MN cells. Not to scale 
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animal model have been shown detrimental (Patel et al. 2010) but some interesting issues also 
aroused. Oxidative carbonylation of proteins in skeletal muscle (measured by WB) was reduced 
in caloric restricted animals compared with ad libitun ones (both sexes), but lipoxydation 
(MDA, spectrophotometrically measured) was increased, showing complex crosslinked 
oxidative responses to diet. Furthermore, both types of superoxide dismutase (mitochondrial and 
cytoplasmic) and TNF-α were drastically raised as a result of caloric restriction, again in both 
sexes, but only restricted females raised their uncoupling protein 3 levels, possibly trying to 
reduce de oxidative production. However, the same group had previously reported (Hamadeh 
and Tarnopolsky 2006) that only females were protected against detrimental effects of short-
term mild caloric restriction (60%, from postnatal days 40 to 55) in the same mice strain. 
 
The previously commented preclinical outcomes in animal’s models (e.g. increased oxidative 
damage, lower mitochondrial capacity, reduced Ca+2 buffering) as well as premature weight loss 
(seven days after birth, unpublished observations), altogether with some clues for 
hypermetabolic status (probably due to skeletal muscle origin), both in animal models 
(Capitanio et al. 2012) and patients (Vaisman et al. 2009 and Funalot et al. 2009) suggest that 
early events are very relevant in the pathogenesis, which, ultimately, reflect the MN loss, and 
finally leading to motion and behavioural consequences. Those features could also point to a 
mitochondrial deregulation possibly linking those two pathogenic mechanisms. In any case, the 
pharmacological studies focused in hypermetabolism “reduction” through thyroid hormone 
regulation failed to improve survival, with no gender differences found (Li et al. 2012). 
Research focussed in dietary optimization for energetic balance could be beneficial in terms of a 
better handling of disease, once diagnosed. In this sense, transplantation with adipose-tissue 
derived human stem cell to a SODG93A mouse model showed alleviation (Kim et al. 2013) of 
clinical onset and prolonged life span concomitant with increased levels of neurotrophic factors. 
 
Since the anti-inflammatory implication of PPARγ agonists, and the well documented 
participation of inflammatory processes underlying the pathogenesis of ALS, promising 
research has shown an alleviated response, not only in survival, but also disease progression 
(better MN and muscular preservation) in the SODG93A murine model under pioglitazone 
supplementation (Schütz et al. 2005). Unfortunately, translation to humans revealed no effect on 
survival (Dupuis et al. 2012). Anyway, despite this disappointing result, research on this field, 
aimed to a better lipid status control and signalling is still promising, and more efforts should be 
done since PPAR expression and regulation have been recently studied regarding its influence 
upon natural occurring neuronal stem cells (reviewed in (Cimini and Cerù 2008)). Thus, even 
when physiological localization of those neuronal stems cell seems is far from mainly affected 
disease location, they represented another potential therapeutic field of action. In fact, another 
recent publication (Benedusi et al. 2012), demonstrates, in females of the SODG93A mouse 
model, that there is an activation of PPARγ (nuclear localization) in MNs concomitant with 
clinical symptoms and this activation is produced (at least in vitro) by lipid peroxidative 
subproduct 4-HNE, as mentioned, present in CSF of ALS patients too. 
 
Of note, statin treatment, aimed to control CHO status by reducing LXR action, had shown 
contradictory results, increasing confusion to clinicians. General statin function is the 
mevalonate synthesis blockade, therefore resulting in reduced CHO and their derivatives. 
(24(S)-hydroxycholesterol) concentration. But interestingly, the later is produced in large 
amounts in CNS and is the principal endogenous LXR agonist therein. Furthermore, side effects 
of statins have been proved in some individuals, including muscle toxicity, such as myopathy 
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(Sathasivam and Lecky 2008). Initially, no harmful effects had been published (diminished 
survival) linking ALS and statins usage (Edwards, Star and Kiuru 2007; Drory et al. 2008; 
Colman et al. 2008). However later studies suggest a gender specific variation (Nefussy et al. 
2011) and a recent review (Beltowski 2010) also revealed that statins may increase the risk of 
ALS by inducing LXR-dependent perturbations of cholesterol/phytosterol metabolism in the 
CNS. 
 
Regarding FA delivery, in a very recent paper developed with a TDP-43 knock-in mouse model 
(Stribl et al. 2014) researchers showed impaired lipid metabolism as reflected by 
donwregulation of the CD36 protein expression in old animal brains. Also remarkable, the 
transcriptome analisis of those mice (brain and muscle tissues) showed a disregulation of many 
mithocondrial-related genes and electron microscopy images confirmed impaired morphology 
in motor cortex and hippocampus, although this cristae morphology disruption was not observed 
in spinal cords. In this line, lipid-raft domains in ALS, were recently described in the 
SODG93A mouse model (Zhai et al. 2009) comparing the specific lipid-raft-resident protein 
changes. This study identified 154 proteins. Among them, 41 had quantitative statistical 
differences. Also important, they found proteins uniquely expressed in SODG93A (17; 29% 
related to cytoesqueletal regulation, 24% microglia/inflammation, 17% vesicular transport, 
respectivelly), and, on the contrary, only few expressed in the WT animals (9 proteins). 
Importantly, a majority of the identified proteins were found donwregulated in the SODG93A 
animals. Hence, among them vesicular transport, neurotransmitter synthesis and release 
represented approximately 20%, but also metabolism (19%), cytoesqueletal regulation (15%) 
and microglial activation/inflammation (9%) where represented, all of them major threats in 
pathophysiolgy of this devasting disease. 
 
Finally, a link between fat storage location and functional and survival alleviation in patients 
was recently observed (Lindauer et al. 2013) suggesting that not only having enough energy 
depots is relevant but also where those are located. All in all, is therefore believed that optimal 
energetic equilibrium along lifetime could help to maintain a better status, with upgraded 
responses, hopefully ultimately alleviating pathology and extending survival. 
 
1.D2.3.-Non cell autonomous inflammation/excitotoxicity 
 
Non-cell-autonomous toxicity, meaning, MN damage derived from other cell types (e.g. 
astrocytes, microglia, muscle cells, among others) than MN solely was elegantly demonstrated 
by Clement and colleagues (Clement et al. 2003) by creating a chimeric mice. It had been 
anyway speculated before, since protein mutations, already recognized to evoque a fALS-like 
disease, were ubiquitously expressed along the body and among different cell types. 
Experiments developed by Lino and collaborators (Lino, Schneider and Caroni 2002) and 
Pramatrova (Pramatarova et al. 2001), where mutant SOD expression was restricted to 
motorneuron or astrocytes (Gong et al. 2000) failed to cause specific neuron degeneration nor 
death. Therefore, from those early works, deleterious mutations were shown to act in a non-cell 
automomous specificity. Subsequent molecular biology developments, such as Cre/Lox 
cassettes to selectively turn on and off specific genes in interesed locations and for a limited 
time, confirmed that MN neighbourhood really matters. Hence, all CNS population, microglia 
(Corcia et al. 2012), astrocyte (Rothstein et al. 1995), oligodendroglia (Kang et al. 2013) and 
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even perycyte (Winkler et al. 2013) as well as neuromuscular junctions (Shindo et al. 1995) of 
patients were shown to be affected, up to an extent, along disease progression. 
 
Therefore, shortly after the discovery of SOD1 mutations, a defective Glut transporter protein 
EAAT2 (Rothstein et al. 1995) was found in spinal cord and cortex glia from sALS patients. 
Thus, this provided one of the first lines of evidence that indicate a possible role of Glut-
mediated excitotoxicity in this disease (recently reviewed in (Philips and Rothstein 2014)). 
Further, the same group rapidly established the previously commented excitoxity tissular model 
(Rothstein et al. 1993), useful thanks to its preservation of cell-to-cell interactions. In this model 
of explanted lumbar region spinal cords, the addition of THA blockades Glut reuptake, leading 
to MNs loss in 30 days. In this widely used model, as previously commented, we demonstrated 
a relation between TDP-43 phophorylation and ERK1/2 signalling and, up to our knowledge, 
we were among the first to show a decreased O2 consumption under THA treatment, which, up 
to an extent, could be rescued by antioxidant treatment (the second paper of this thesis). 
 
Anyway, Glut neurotransmission also involves other receptors. Furthermore, Riluzole©, the 
unique approved drug for ALS treatment, directly interacts with GABA and glycinere ceptors 
(Mantz et al. 1994 and Umemiya and Berger 1995, respectivelly) in addition to its 
antiglutamatergic action. Of note, both substrates (GABA and glycine) represented the major 
ionotropic inhibitory neurotransmistters in MNs. In any case, and leaving apart all metabotropic 
Glut receptors (for further immersion see (Caraci et al. 2012)), MNs express all three types of 
ionotropic Glut receptors too, AMPA, N-methyl-D-aspartate (NMDA) and kainate receptors, 
with different expression patterns and interactions among them (for a profound review see 
(Rekling et al. 2000)). Other excitatory molecules may play a role and, from the tripartite 
synapse theory, not only MNs but astrocyte and surrounding cells support a correct 
neurotransmission (Araque et al. 1999). Alltogether with differential expression of some of 
synaptic enzymes found in patients, and sometimes recapitulated in models, there are compiling 
evidences conforming a wider picture of neutotranmission malfunction and excitotoxic 
involvement in ALS. 
 
We previously commented the powerful machinery acting in membrane remodelling (e.g. 
PLAs, ACS and SNARE actions, among others), thus it is worthy describing how these weak 
equilibriums could be modified by PUFAs’ actions in the synaptic cleft. Extensive research has 
been done in Alzheimer disease and PLAs (for a review see (Schaeffer et al. 2010)) and in 
Parkinson too, where a mutation in PLA2 (group VI) was recently found to produce an early-
onset rare form (Shi et al. 2011). However, ALS research in this field is still poor, even when 
higher expression and activation (phosphorylated) of cPLA2 (110kDa) was found in motor 
neurons, astrocytes and activated microglia of patients (Noriyuki Shibata et al. 2010) as well as 
lumbar sections of the SODG93A and the SODG85R mouse models (Kiaei et al. 2005). In a 
model of spinal cord injury, (Liu et al. 2006) downregulation of cPLA2, already described to be 
present in all along spinal cord motor neurons (Ong, Horrocks and Farooqui 1999) was 
demonstrated to be beneficial in terms of reduced inflammatory cytokine production, lower 
lipoxidative damage and neuronal loss. Moreover, PLA2 injection after injury induced a massive 
demyelination, a fact that is counteracted by administration of an inhibitor. Altogether, this 
could open a potentially interesting terapeutic point of action, but precaution should be taken, 
since chronically inactivation of both PLAs (cPLA2 and iPLA2) was demonstrated to be 
detrimental, at least in cultured hippocampal neurons (Forlenza et al. 2007). Definite proof for 
this membrane remodelling therapeutic potential comes from a recent work (Staats et al. 2013). 
89 
They firstly found a microsatellite polymorphism marker for association with sALS, which was 
related to phospholipase C delta 1 (PLCδ1). Hence they focus the study in the SODG93A 
mouse model, finding increased gene expression of plcd1 in spinal cords and further confirmed 
by WB in end-stage animal. Crossing PLCδ1-/- animal and mutated SOD significantly increased 
survival, with alleviated nuclear shrinkage, without changes in glial activation, nor aggregation 
or MNs number at end stage, compared to ALS mice expressing PLCδ1. Possible mechanism 
behind those findings imply the commented function in second messenger action of PLC, this 
is, the hydrolysation of IP2 to form DAG and IP3.which may create a feedback loop by the 
increased Ca+2 release through IP3 specific receptors in ER, resulting in increased excitoxicity. 
 
Finally, as pointed before, inflammation’s implication is clear, since early involvement and 
release of various cytokines and chemokynes was found in patients (for a list in CSF see 
(Tateishi et al. 2010)). Hence, the modulation of its duration and intensity represent a potential 
beneficial treatment. In this sense, the influence of potent lipid mediators have been found to be 
relevant in Alzheimer’s disease (recently reviewed (Bazan 2013)) and, interestingly, also in 
ALS (Liu et al. 2012) although to date this is the unique paper we found regarding those 
mentioned potent lipid intermediates and ALS. In this work, ResolvinD1 minimizes 
macrophage phagocytosis in ALS patients in vitro as well as promotes a reduced transcription 
of inflammatory cytokines and chemokines, revealing an interesting therapeutic approach to be 
applied in early detection.  
 
Furthermore, recent studies (Abraki et al. 2013) demonstrate an important cross-talk in response 
to different stimuli for achieving an orchestrate pro/anti-inflammatory response, since both 
PPAR-γ stimulation via 15d-PGJ2, product of COX-2 action (found increased in spinal cord of 
ALS patients (Kondo et al. 2002)), and the inhibition of the latter enzyme could lead to similar 
standards of neuroprotecion though the activation of nuclear factor E2-related factor 2 signalling 
pathway, decreasing NF-κB and reducing pro-apoptotic Bax/Bcl-2 ratio. And, for instance, 
PGE2 suppression was demonstrated to increase motor function and lifespan in SOD1 mutant 
mice in mechanism implying a ROS reduction (Shin et al. 2012). Other example of inter-
cellular dialogue in response to inflammation using stem cells to generate motor neurons and 
cocultered them with mutated (SODG93A) glia, demonstrate its sensitization towards PGD2, 
since its inhibition partially rescues motor neuron loss (Di Giorgio et al. 2008). Finally, other 
examples to stress the relevance of this interconnectivity emerged from the finding of NF-κB 
immunoreactivity depletion from neuronal nucleus in spinal cord of patients, concomitant to an 
increased accretion in microglia (Sako et al. 2012). This might render neurons more vulnerable 
as well as prone microglia to inflammation-related processes.  
 
Globally, all this multiple factors interfering between each other render ALS to have many 
faces. This may be among the most difficult point to be confronted. Hence, like most biological 
systems, unravel the complexity and interconnectivity of processes involved to finally rise ALS-
like phenotype, challenge us and gives encourage force to keep researching. In any case, due to 
intrinsic ramification, a definite cure would probably emerge from cutting off several of 
different aspects rather than focusing in a single frame of the scene. In this sense, based on the 
multifactorial functions in FA metabolism, there are plenty of possibilities to be explored trying 
to alleviate disease sintomatology. 
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2. Hypothesis 
 
 
As commented in the introductory section, PUFA physiology is very important for global 
homeostasis. Numerous biologically relevant processes have been shown to be dependent on 
PUFA or its derivatives, and/or their actions are fundamental for a healthy condition. 
 
On the other hand, CNS is particularly exquisite in terms of FA handling, further, special 
requirements of this tissue (e.g. high energetic demands, low antioxidant capacity, particular 
vascular and immune systems, extremely high cellular specificity, among others) points to a 
critical regulation of lipid metabolism for optimal functioning. 
 
Finally, both ALS patients and models have shown mitochondrial, ER and Ca 2+ malfunction in 
numerous cell types in the CNS linked to a hypermetabolism status, also in the muscular tissue. 
Furthermore, relevant inflammatory parameters as well as oxidative status (closely impinged by 
PUFA status) are raised along the disease progression in multiple locations. 
 
Knowing the potential role of PUFA in all those processes and the sexual differences found in 
both, ALS and PUFA metabolism, altogether, we therefore hypothesized that PUFA and/or 
their derivatives could alter oxidative status and responses to it in biological samples. 
Therefore they might play a role in the modulation and spread of oxidative damage and 
inflammation in various models of ALS disease and, further, those outcomes could be 
dietary modified in animal models. 
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3. Objectives 
 
 
In order to validate the above mentioned hypothesis, we propose the following objectives: 
 
GOAL 1.- To determine the potential of phenolic antioxidants as 
modulators of oxidative stress in a wide variety of biomolecules and their 
biological significance. 
 
• AIM 1.1-To establish, by using immunological methods, a suitable methodology 
to ascertain the degree of protection which different phenolic antioxidants could 
offer to representative biomolecules (LDL, BSA, Human plasma) against 
various oxidative stress conditions.  
• AIM 1.2.-To describe the effects of different phenolic antioxidants in the 
oxidative modification of proteins and lipids in human LDL under the Cu+2 
oxidative system. 
• AIM 1.3.-To establish the biological relevance (measured by cell viability test in 
two different cell lines-HMEC-1 and HepG2) of the antioxidant potential of 
various phenolic antioxidants against the noxious effect of in vitro oxidized LDL 
or oxidative stress inducers in human plasma.  
• AIM 1.4.-To evaluate the biological relevance of an ex vivo oxidative system 
operated in both, a diet-induced hypercolesterolemic hamsters feed with a 
polyphenol extract and human plasma oxidized with Fe-Asc and protected with 
luteolin.  
 
GOAL 2.- To describe the relevance of DHA and TDP-43 related processes 
in sALS and different ALS models. 
 
• AIM 2.1-To describe DHA related enzymatic machinery (FADS1/2, ACAA1/2, 
ACOX1, SCP2) in sALS samples and different ALS models. 
• AIM 2.2-To characterize DHA-related proteins (drebrin and syntaxin-3), its 
synthesis and the responsible enzymatic machinery in sALS samples and its in 
vivo and in vitro relation under stress conditions (TDP-43 and oxidative stress). 
• AIM 2.3-To establish the relevance of FA precursors in OT model of ALS in 
terms of cell survival, fatty acid and lipidomic signatures and mitochondrial 
functionality (O2 consumption) and lipid-phase antioxidants influence. 
 
GOAL 3.- To define and describe the possible beneficial outcome of a 
nutritional intervention, regarding lipid unsatutration degree, in a mouse 
model of ALS. 
 
• AIM 3.1.-To determine the effects of a dietary intervention (consisting in 
different lipid unsaturation degrees) on behavior, clinical phenotype and survival 
in a mouse model of ALS. 
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• AIM 3.2.-To test the biochemical effectiveness of the above-mentioned dietary 
intervention by measuring lipid profiles in different tissues, as well as surrogates 
of PUFA abundance (sintaxyn) and unfolding protein response elements 
(Ubiquitin). 
• AIM 3.3.-To measure dietary interference in terms of protein oxidative 
modifications and its possible relationship with tissular lipid profile changes in 
above mentioned model. 
• AIM 3.4.-To establish the potential relationship of nuclear damage response 
and protein damage crosstalk in such dietary intervention.   
 
GOAL 4.- To clarify, in the same mouse model, the relationship between 
oxidative damage and mitochondrial dysfunction along the disease, with 
particular relevance on sexual dimorphism found. 
 
• AIM 4.1.-To define a novel method for evaluation of mitochondrial function, 
based on O2 consumption, in fresh slices of mice’s spinal cord. 
• AIM 4.2.-To evaluate, through the aforementioned methodology, the effect on 
the O2 consumption of the SODG93A overexpression mouse model, dissected 
into the different mitochondrial complexes.  
• AIM 4.3.-To determine the relationship between general vs. mitochondrial-
specific protein oxidative damage measurements and the mitochondrial 
dysfunction in both genders of commented mouse model, in various points 
along disease progression. 
• AIM 4.4.-To investigate whether estrogens treatment may recapitulate the 
modulated mitochondrial functionality in an in vitro cell line (N2A) model of ALS. 
 
In order to answer all those questions, the main objectives were depicted into different research 
works, and fortunately were successfully written (but not all of them already published) to 
compose the Thesis core: 
 
Paper one. Title: “Plant-derived Phenolics Inhibit the Accrual of Structurally Characterised 
Protein and Lipid Oxidative Modifications”. 
 
Paper two. Title: “Interplay between TDP-43 and docosohexaenoic acid-related processes in 
amyotrophic lateral sclerosis”.  
 
Paper three. Title: “Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications 
of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner”. 
 
Paper four. Title: “Gender specific differences in spinal cord mitochondrial function and 
oxidative damage markers in a mouse model of ALS in early stages of disease”. 
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Plant-Derived Phenolics Inhibit the Accrual of
Structurally Characterised Protein and Lipid Oxidative
Modifications
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Abstract
Epidemiological data suggest that plant-derived phenolics beneficial effects include an inhibition of LDL oxidation. After
applying a screening method based on 2,4-dinitrophenyl hydrazine- protein carbonyl reaction to 21 different plant-derived
phenolic acids, we selected the most antioxidant ones. Their effect was assessed in 5 different oxidation systems, as well as
in other model proteins. Mass-spectrometry was then used, evidencing a heterogeneous effect on the accumulation of the
structurally characterized protein carbonyl glutamic and aminoadipic semialdehydes as well as for malondialdehyde-lysine
in LDL apoprotein. After TOF based lipidomics, we identified the most abundant differential lipids in Cu++-incubated LDL as
1-palmitoyllysophosphatidylcholine and 1-stearoyl-sn-glycero-3-phosphocholine. Most of selected phenolic compounds
prevented the accumulation of those phospholipids and the cellular impairment induced by oxidized LDL. Finally, to
validate these effects in vivo, we evaluated the effect of the intake of a phenolic-enriched extract in plasma protein and lipid
modifications in a well-established model of atherosclerosis (diet-induced hypercholesterolemia in hamsters). This showed
that a dietary supplement with a phenolic-enriched extract diminished plasma protein oxidative and lipid damage. Globally,
these data show structural basis of antioxidant properties of plant-derived phenolic acids in protein oxidation that may be
relevant for the health-promoting effects of its dietary intake.
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Introduction
The oxidative stress hypothesis of atherosclerosis is based on the
fact that free radical-derived damage participates in atherogenesis
pathophysiology by means of LDL modification, among other
mechanisms [1–3]. Supporting this hypothesis, LDL modified by
oxidation (oxLDL) has been detected in atherosclerotic lesions [4–
6] and oxLDL exhibits various proatherogenic activities in vitro
[3,7].
It is important to emphasize that oxLDL represents a
heterogeneous population of modified forms of LDL that differ
greatly in their chemical composition and biological properties.
The conversion of native LDL into highly modified LDL via
oxidative processes can occur by two major mechanisms: In the
first case, the events start with the complete loss of LDL’s
endogenous antioxidants (i.e., a-tocopherol, ubiquinol-10), fol-
lowed by the conversion of a majority of the polyunsaturated fatty
acids (PUFA) into their corresponding hydroperoxides. Then,
these primary lipid oxidation products are fragmented into
secondary lipid oxidation products, such as malonyldialdehyde
or 4-hydroxynonenal, which can react with the Ng-amino group
of lysine residues from LDL apoprotein (Apo B-100). Conse-
quently, the particle’s electrophoretic mobility increases and the
lipoprotein becomes ‘‘high uptake’’ [8]. Additionally, in the
subendothelial space, oxLDL may exert a ‘‘Trojan horse effect’’,
e.g. allowing the diffusion of those lipid mediators modifying
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endothelial and vascular smooth muscle cells. The second case is
characterized by the immediate and preferential oxidation of
amino acid residues from Apo B-100 in the absence of substantial
consumption of lipid soluble antioxidants and/or occurrence of
lipid peroxidation [9]. Nevertheless, apoprotein oxidative modifi-
cations have been not studied as extensively as lipid-phase ones.
The beneficial effects of Mediterranean diet concerning
cardiovascular diseases are well known. Most of them are
associated with olive oil and wine consumption [10,11], nutrients
with a high content of phenolic acids. With regard to the influence
of diet on atherosclerosis, the ingestion of fruits and vegetables
(phenolic-rich vegetal sources) is related to a lesser development of
atheroma plaque [12,13]. This effect is mainly attributed with
their protective effects against LDL oxidation [14–17]. Despite a
great deal of research having been devoted to the prevention of
lipid peroxidation in LDL by antioxidants, including phenolic
acids [18–21], few studies have reported the prevention of protein
oxidation in LDL by exogenous antioxidants. Apo B-100
modifications, e.g., the binding of lipid peroxidation products or
direct oxidation of amino acid side-chain residues, are thought to
finally result in the formation of new epitopes that are specifically
recognized by scavenger receptors [22–25], but the potential
preventive effect of nutritional compounds on apoprotein oxida-
tive modifications have not been studied so extensively.
To fill those gaps, the antioxidant effect of 21 different vegetal-
derived phenolic compounds (mainly founded in olive oil and
grape-derived products) in the oxidation of apolipoprotein of
human LDL was assessed in this study. For that purpose, the
quantification of carbonyl groups (detected by Western-Blot) was
carried out in LDL-model systems. The antioxidant behaviour of
the more active phenols was then further characterized by
measuring the protection of the lipidome changes induced by
Cu++, the accumulation of specific oxidation and lipid peroxida-
tion markers in LDL apoproteins. The preventive role on the loss
of cell viability induced by Cu++-treated LDL was tested using
these phenolic compounds. Finally, in order to test whether those
or related phenolic compounds would have similar effects in vivo in
an atherosclerosis model, carbonyl content of plasma proteins and
lipid oxidation markers were analysed in hypercholesterolemic
hamsters fed with a phenolic- enriched diet.
Methods
Reference Compounds
a-Tocopherol was purchased from Sigma-Aldrich Chemical Co
(St. Louis, MA, USA). Phenolic standards from the following
sources were used without further purification: 2-(3,4-dihydrox-
yphenyl)-4,5-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-
6-methyl-oxan-2-yl)oxymethyl]oxan-2-yl]oxy-chromen-7-one (ru-
tin), 49,5,7-tihydroxyflavone (apigenin), apigenin 7-O-glucoside,
39,49,5,7-tetrahydroxyflavone (luteolin), luteolin 7-O-glucoside,
trans-4-hydroxycinnamic acid (p-coumaric acid), 2-(3,4-dihydrox-
yphenyl) ethyl alcohol (OH-tyrosol) (3,4-DHPEA), 2-(4-hydroxy-
phenyl) ethyl alcohol (tyrosol) (p-HPEA), oleuropein, verbascoside
and vanillin from Extrasynthese (Genay, France); 3,4-dihydrox-
ycinnamic acid (caffeic acid), ferulic acid, and 3,4,5-trihydrox-
ybenzoic acid (gallic acid) from Fluka Co. (Buchs, Switzerland);
Pinoresinol from Arbonova Sales (Turku, Finland). Phenolic
enriched grape seed extract was obtained as previously described
[26].
Isolation of Phenolic Compounds by Semipreparative
HPLC
Secoiridoid derivatives 4-(acetoxyethyl)-1,2-dihydroxybenzene
(3,4-DHPEA-AC), 4-hexenoic acid, 4-formyl-3-(2-oxoethyl)-2-(3,4
dihydroxyphenyl) ethyl ester (3,4-DHPEA-EDA), methylated form
of the oleuropein aglycone (ME 3,4-DHPEA-EA) and 4-hexenoic
acid, 4-formyl-3-(2-oxoethyl) 2-(4-hydroxyphenyl) ethyl ester (p-
HPEA-EDA) were isolated from virgin olive oil phenolic extract by
semi-preparative HPLC method according to the method of
Artajo et al. [27]. Stock solutions of commercial standards and
phenolic compounds isolated from virgin olive oil were dissolved in
methanol/H2O (80:20 v/v) and stored at 240uC before the
evaluation of their antioxidant activity. The chemical structures of
the phenols included in the study are shown in Figure S1.
Hypercholesterolemic hamsters and human plasma
Twelve male Gold Syrian hamster weighing 127.5566.75 g
were randomly assigned to two groups (n = 6 for each group) with
approximately equal mean group body weights. They were caged
and maintained in a 12:12 (light:dark) cycle at 2262uC and
50610% relative humidity with free access to both food and
water. Food intake and body weight were controlled every week.
The control group ate an atherogenic diet [28] in which the
cholesterol content had been set at 5% and which was
supplemented with 15% of lard, and the experimental group ate
this atherogenic diet supplemented with a 0.2% of phenolic-
enriched vegetal extract (Table 1). The diets were maintained
during 12 weeks and the animals were deprived of food for 15 h.
Hamsters were anesthetized and then sacrificed by heart puncture
and plasma and serum were collected and stored at 220uC until
analysis. For metabolomic analyses, the method of Wikoff et al was
used [29]. The plasma triglycerides, cholesterol, HDL, LDL, and
alkaline phosphatase content were quantified by enzymatic
Table 1. Control and supplemented diet composition.
Component Control (g) Supplemented (g)
Casein 200 200
L-Cysteine 3 3
Corn starch 362 362
Sugar 140 140
Corn oil 0 0
Cellulose 50 48
Minerals 35 35
Lard 150 150
Vitamins 10 10
Cholesterol 50 50
Polyphenol extract 0 2
Total weight 1000 1000
Energy (Kcal/g diet) 4.62 4.62
Carbohydrates (g/Kg) 502 502
% Energy 43.5 43.5
Proteins (g/Kg) 203 203
% Energy 17.6 17.6
Lipids 200 200
% Energy 39 39
The control diet is an atherogenic diet.
doi:10.1371/journal.pone.0043308.t001
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colorimetric reactions using commercial kits (Spinreact, Girona,
Spain).
Human plasma was obtained from 6 different, healthy male
donors after an overnight fast (mean age: 2563) by standard
venepuncture and centrifugation using EDTA coated Vacutainer
tubes. Both plasma obtention and animal experiments were
supervised and approved by the Experimental and Ethics
Committee of the University of Lleida.
Protein oxidation screening method: Protein oxidation
and Western blot analysis
Aliquots of phenolic acid compounds dissolved in methanol
were transferred to Eppendorf tubes and desiccated under a
nitrogen current at room temperature. The dried phenols were
redissolved to a final concentration of 5 mM with PBS (except
when indicated) containing dissolved protein. Then, protein
(700 mg/ml) was oxidized by exposure to different prooxidants.
We used i) CuSO4 (5 mmol/l free Cu
++); ii) Hemin:H2O2
(30 mmol/l: 5 mmol/l); iii) H2O2 (5 mmol/l); iv) Ascorbate:Fe
3+
(1.5 mmol/l: 8 mmol/l); v) ultraviolet radiation (l 254 nm) and v)
myeloperoxidase (MPO) (0.77 U/mL and H2O2 100 mmol/l) in
phosphate buffered media at 37uC for 3 hours, according
published procedures [30]. All samples were used immediately
or stored at 280uC for further analysis.
To assess the extent of protein oxidation, 2,4-dinitrophenylhy-
drazine (DNP)-reactive carbonyls were measured by Western Blot
as previously described [31] (See Methods S1 to further
information).
Measurement of glutamic (GSA) and aminoadipic (AASA)
semialdehydes and malondialdehyde lysine (MDAL)
The concentration of chemically characterized markers of
protein oxidative modification GSA, AASA, and MDAL, in LDL
apoproteins was evaluated by gas chromatography/mass spec-
trometry (GC/MS) as previously described [31] (See Methods S1
to further information).
Lipidome analyses
Lipid composition was assessed by both fatty acid analysis (see
Methods S1 to further information) and time of flight mass
spectrometry (TOF)-based lipid molecular species analyses. In
both cases the total lipids from LDL were extracted with
chloroform:methanol (2:1, v/v) in the presence of 0.01% butylated
hydroxytoluene as previously described [31].
For TOF-based lipid molecular species analyses, lipid extracts
(from LDL) or methanolic extracts (from hamster’s plasma) were
submitted to mass-spectrometry using a LC ESI-QTOF MS/MS
6520 (Agilent Technologies, Barcelona, Spain), coupled to a
capillary LC module using an untargeted approach as described
[29] (see Methods S1 to further information). In order to offer a
relative quantification of 1-palmitoyl-2-(5-oxovaleryl)-sn-glycero-3-
phosphocholine (POVPC) and 1-palmitoyl-2-glutaryl-sn-glycero-3-
phosphocholine (PGPC), bioactive lipids present in oxLDL mass
profiles [32] were integrated for an m/z of 594.3 for POVPC and
610.2 for PGPC with a D of 0.01 Da.
FRAP assay
The ferric reducing antioxidant power of the samples was
estimated according to the procedure previously described [33,34].
Briefly, FRAP reagent, was mixed with distilled water and either of
sample or appropriate reagent blank. The readings at 30 min were
selected for calculation of FRAP values. Reduction power activities
were as mmol of Trolox equivalents, per gram of dry matter.
Cell viability
Both HMEC (kindly providen by Anne Negre-Salvayre,
INSERM, Toulouse [35] and HepG2 viability were measured
with the MTT-based Cell Toxicity Colorimetric Assay Kit (Sigma-
Aldrich, St.Louis, MA, USA) according to the manufacturer’s
instructions after oxLDL tert-butylhydroperoxide (t-BOOH) as
described [36,37]. The results were expressed as the percentage of
viability versus cells exposed to non-oxidized LDL or untreated
with t-BOOH. Further details are described in the Methods S1
section.
Statistical analyses
All statistics were analysed using the SPSS software (SPSS Inc.,
Chicago, IL, USA). Differences between the groups were analysed
by the Student’s T tests or ANOVA (with post-hoc analyses for
detecting differences between specific pairs), after assessment of
normal distribution of variables by the Kolmogorov-Smirnoff test.
Correlations between variables were evaluated by the Pearson
statistic and plotted with the Metaboanalyst software [38] The
0.05 level was selected as the point of minimal statistical
significance in every comparison.
Results
Effect of individual phenolic compounds on LDL
oxidation. LDL oxidation by different methods induces
accumulation of carbonyl in LDL apoproteins: differential
inhibitory potential of phenolic compounds
The antioxidant capacity was quantified after Western Blot of
DNP reactive carbonyls in LDL apoproteins (Figure 1A) being the
value corresponding to oxLDL considered 0% of antioxidant
capacity. The anti-DNP immunoreactivities which are lower than
that found in oxLDL were interpreted as anti-oxidant activity and
that which are higher as prooxidant activities. The different
phenols were tested at three concentrations (5, 50 and 100 mM)
(Figure 1B), using a-tocopherol as a reference. Apoprotein
oxidation was significantly inhibited by the majority of the phenols
tested. The OH-tyrosol showed the maximal efficiency even at
5 mM, higher than the efficiency of a-tocopherol. Luteolin
(flavonoid), pinoresinol (lignan), gallic and caffeic acids showed a
good efficiency which was concentration-dependent. These
phenols reduced the Cu++ inducted oxidation by between 60
and 80%. The secoiridoid derivatives (3,4-DHPEA-EDA and p-
HPEA-EDA) showed a slight activity, similarly to a-tocopherol.
Other phenols, such as verbascoside, vanillin, 3,4-DHPEA-AC
and the methylated form of the oleuropein aglycone (ME 3,4-
DHPEA-EA) showed lower antioxidant activity with oxidation
inhibition values below 20%. The prooxidant effect shown by
some phenols, such as oleuropein, tyrosol and apigenin in its
aglycone and glucosidic forms should also be noted.
As Figure 1B shows, different phenolic compounds exhibit
differential effects in a dose dependent fashion, in the apoprotein
moiety of human LDL. According to this first screening, the more
active phenols selected were: OH-tyrosol (OH-tyrosol), 3,4-
DHPEA-EDA (3,4-DHPEA) as secoiridoid derivative; pinoresinol
(Pin) as a lignane; luteolin (Lut) as a flavonoid; and gallic (Gallic)
acids as a phenolic acid.
In order to extend those findings from Cu++ to other oxidation
systems, we measured the effects of phenolics in different systems
ranging from ultraviolet radiation to enzymatic paradigm
(Figure 1C, D, E, F and G). Of those, only UVA, Fe+3-Asc and
H2O2 increased carbonyl content more than 50% in LDL
(Figure 1D, E and F). In those systems, all phenols analysed had
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a strong antioxidant action, with the exception of Fe+3-Asc, where
only luteolin (and 3,4-DHPEA and pinorresinol to a minor extent)
had a significant effect. Of note, pathogenically relevant systems
such as MPO+H2O2 do not offer a significant increase in carbonyl
staining (Figure 1G). Most importantly, all selected phenolic
compounds are able to significantly inhibit the accrual of carbonyl
modification after MPO+H2O2 incubation, being pinoresinol the
most active.
In order to extent those results to other proteic systems, BSA
and human plasma were oxidized using Hemin-H2O2, UVA and
Fe3+-Asc. These results (Figure S2) do not allow to distinguish any
individual phenol as a general antioxidant, i.e. its effect being
independent of the protein and oxidation-system used. Generally,
BSA is less oxidizable than LDL in same conditions, and only
pinoresinol and luteolin diminish significantly protein oxidation in
specific systems (Figure S2B and S2C). In contrast, human plasma
is more oxidizable than BSA (under UVA and Fe+3-Asc). Under
Fe3+-Asc, again pinoresinol and luteolin stand out as significant
inhibitors of protein oxidation in plasma (Figure S2E and S2F). Of
note, several polyphenols (notably gallic acid) exhibited prooxidant
actions under these conditions (Figure S2B and S2D).
Cu++ incubation induces accumulation of metal-
catalyzed oxidation (MCO), lipoxidation markers in LDL
apoproteins and changes in LDL lipidome: differential
inhibitory potential of phenolic acid compounds
Taking into account that DNP reactive carbonyls could arise
from either lipid peroxidative damage or the direct modification of
aminoacid residues by MCO [39] specific probes for each of those
oxidative modifications were measured by using GC/MS. The
results show that Cu++ incubation led to significant increases in the
MCO markers GSA, AASA and an even greater increase in the
lipoxidation marker MDAL (Figure 2A, B and C). OH-tyrosol and
the lignane were the most effective compounds for inhibiting GSA
accumulation. Luteolin also prevented its accumulation in Cu++-
treated LDL. Neither gallic acid, nor 3,4-DHPEA-EDA were
effective (Figure 2A). A similar pattern was observed for AASA
accumulation, but in this case, gallic acid was significant inhibitors
of its formation (Figure 2B). Finally, OH-tyrosol and pinoresinol
were potent antioxidants in considering MDAL accumulation,
while 3,4-DHPEA-EDA, and specially luteolin (with no significant
effect), were among the lowest in this sense (Figure 2C). To
reinforce the importance of the lipid composition in relation with
the lipoxidative modifications of proteins, a significant correlation
was observed (r2 = 0.91; p,0.0001) between PI and MDAL
formation (Figure 2D).
Carbonyl modification of apoproteins can arise from lipid
peroxidation. In such a case, the LDL fatty acid composition
exhibits PUFA consumption. To test this, the fatty acid
composition of LDL was analysed after Cu++-induced oxidation,
demonstrating significant losses in PI and PUFA content (Table 2).
For this reason we examined the potential for prevention of this
phenomenon. OH-tyrosol, and the lignane were among the most
potent compounds, almost preventing the effect of Cu++. Gallic
acid was less potent, and luteolin and 3,4-DHPEA-EDA had
almost no effect on the oxidative modification of LDL
After TOF-based analyses of oxLDL, palmitoyllysophosphati-
dylcholine (PLPC), 1-stearoyl-sn-glycero-3-phosphocholine
(SGPC) and 1-oleoylglycerophosphocholine (OGPC) comprised
more than 90% of the differentially present lipids in Cu++-treated
LDL (Figure 2E). Similarly to the fatty acid analyses, luteolin and
gallic acid exhibit the lowest capacity for preventing the build-up
of PLPC, while the other compounds prevented the accumulation
of this compound almost completely. Luteolin was the only
compound unable to inhibit the formation of SGPC (Figure 2F
and 2G).
Taking into account that 1-palmitoyl-2-(5-oxovaleryl)-sn-gly-
cero-3-phosphocholine (POVPC) and 1-palmitoyl-2-glutaryl-sn-
glycero-3-phosphocholine (PGPC) have been identified as biolog-
ical effectors of oxLDL [32], the presence of those compounds was
ensured. As expected, their level increased in Cu++-treated samples
(12 and 4-fold over untreated samples, respectively). Luteolin and
gallic acid prevented the accumulation PLPC to a lower extent
when compared with the other compounds (Figure 2F).
Biological relevance of plant-derived phenolics
antioxidant effects: Loss of cell viability induced by Cu++-
treated LDL and in vivo evidences of protein and lipid
antioxidant activity
To further reinforce the biological relevance of the antioxidant
potential of those compounds and the methodology described here
for its identification, we examined the cytotoxic potential of Cu++
incubated LDL in an endothelial cell culture model. For this
purpose, the endothelial cell line HMEC-1 was treated with Cu++-
treated LDL and 18 h later, the viability of the cultures was
assessed with the MTT assay. The results demonstrate that oxLDL
led to a loss of 60% of viability and OH-tyrosol prevented partially
those effects (Figure 3A), inducing only a 10% of viability loss.
Unexpectedly, luteolin, a compound with a low antioxidant
potential, based on lipidome changes, showed a significant
preventive effect on the oxLDL induced loss of viability.
To ascertain whether this was due to a specific cellular effect
(e.g. by modulation of antioxidant cellular responses in endothelial
cells), we examined the potential influence of those compounds in
tert-BOOH-mediated cell death in a HepG2 cell line, an unrelated
cell line. Those analyses demonstrate that luteolin, OH-tyrosol and
3,4-DHPEA-EDA were the only compounds able to prevent
significantly the loss of viability secondary to treatment with tert-
BOOH (Figure 3B).
The correlation of cell viability with antioxidant capacity
reinforced the pathogenic importance of LDL apoprotein oxida-
tive modification, as that GSA amount showed the most significant
correlation with the loss of viability induced by oxLDL (Figure 3C).
Figure 1. Plant-derived phenolic acids inhibit protein oxidation in isolated human LDL to varying degrees. A. Representative Western
Blot of the screening phase for LDL apoprotein protection in oxLDL. Data are presented for 3,4-DHPEA-AC, apigenin, rutin, p-cumaric acid and
apigenin-7-O-glucoside at 100 mM. Veh:Vehicle, * indicates Apo B-100 molecular weight and arrow indicates protein fragmentation induced by
oxidation. B: Effect of plant-derived phenolic acids in protein carbonylation in Cu++-incubated LDL. All phenols were tested at three concentrations
(5 mM, 50 mM and 100 mM). LDL and Cu++ incubated LDL were used as control of native and oxidized LDL. The antioxidant capacity of each phenol at
different concentrations is expressed as percentual values, considering that the immunoreactivity of Cu++-incubated LDL is considered 0% of
antioxidant capacity - positive values reveal decreased carbonyl formation and negative values reveal increased protein carbonylation-. LDL
Apoprotein oxidation was also prevented to various extents in oxidation induced with Hemin:H2O2 (C), Ultraviolet radiation (254 nm) (D),
Fe3+:Ascorbate (E), H2O2 (F) and MPO: H2O2 (G) as indicated in the Methods and Materials section. In the case of C-G, phenols were tested at 5 mM. In
these, carbonyl contents are expressed as percentual values, considering that the immunoreactivity of LDL incubated without oxidant (Ctl) as 100%
of carbonyl content. *p,0,05 and ** p,0,01 by ANOVA respect to oxidant-incubated LDL. Data shown are mean6S.D., (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.g001
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Protein antioxidant activity of phenolic acids should be
bioavailable. For this reason we analysed the plasma proteins
from a hypercholesterolemic model (Golden Syrian Hamsters
under hypercholesterolemic diet, showing an increase around
125% in cholesterol levels respect animals under standard chow)
under a diet enriched in vegetable-derived phenols. The polyphe-
nol supplementation did not induce any signs of toxicity nor
changes in alkaline phosphatase, indicating that it was well
tolerated. Despite an effect in LDL cholesterolemia was noted, no
significant differences were evidenced in other values analysed
(Table S1). Nevertheless, the results (Figure 3D) demonstrate that
phenolic-enriched diet significantly diminishes steady state levels of
circulating protein carbonyls. Furthermore, their intake reduces
oxidability of proteins ex vivo under Fe3+-Asc system, both in
hypercholesterolemic hamsters (Figure 3E) and in human plasma
with exogenously added luteolin at 5 mM (Figure 3F). Noteworthy,
compounds with masses compatible with oxidized phospholipids
as PLPC, OGPC and PGPC were detected in the methanolic
extract of hamster plasma (Figure S3, S4, S5). The levels of those
metabolites were diminished in animals under phenolic-enriched
diet (Figure 3G, H and I). Reinforcing the importance of specificity
of oxidative damage measurements, FRAP assay of plasma
demonstrated that polyphenol-enriched diet did not change
antioxidant capacity (Figure 3J), although it changed significantly
profiles of metabolic parameters by hierarchical clustering
(Figure 3K).
Discussion
The present work demonstrates the antioxidant properties of
selected plant-derived phenols (mainly found in olive oil and
grape-derived products) in protein oxidation both in vivo and in
vitro, and the existence of some heterogeneity in the mechanisms.
We offer a novel approach for analysing and screening the
antioxidant properties of natural products over LDL modification,
especially in its protein components. After a screening phase, five
different compounds were selected for further analysis. We have
demonstrated for the first time, the effect of those nutritional
compounds on the accrual of structurally characterized markers of
both protein (GSA, AASA and MDAL) and lipid peroxidation
(POVPC, PGPC) in oxLDL. The pathogenic importance of LDL
protein oxidation is shown by the fact that it was the only factor
that correlated with oxLDL-induced cell death. To extend the
validity to an in vivo setting, we have shown that phenolic intake in
a hypercholesterolemic context diminishes protein carbonyl
content in plasma as well as the concentration of lipid peroxidation
markers.
Figure 2. Cu++-incubated LDL show significant increases in the amounts of mass-spectrometry characterized protein and lipid
oxidation markers, whose formation is inhibited by selected plant-derived phenolic acids. A–C show GC/MS analyses of GSA and AASA
(markers of metal-catalyzed oxidation), and MDAL, originated from lipoxidation. Values shown are % changes of mean6 S.E.M. over values from non-
oxidized LDL (GSA: 5945661 mmol/mol lysine; AASA: 1128620 mmol/mol lysine; and MDAL: 177623 mmol/mol lysine); *p,0,05; ** p,0,01 and ***
p,0,001 respect to Cu++ incubated LDL. D: protein lipoxidative damage shows a quadratic relationship with peroxidizability index (PI)
(r2 = 0,911;p,0,0001; model:[MDAL] = 1,03*[PI]2-151,26*[PI]+5698) E: Pie plot showing distribution of differential (Student’s T test p,0.001) lipid
species between control and Cu++-incubated LDL, after TOF-based lipidome analyses. F: Effect of plant-derived phenolic acids in the accumulation of
PLPC induced by Cu++-incubation. G: Effect of plant-derived phenolic acids in the accumulation of SGPC induced by Cu++-incubation. H: Effect of
plant-derived phenolic acids in the accumulation of POVPC induced by Cu++-incubation. I: Effect of plant-derived phenolic acids in the accumulation
of PGPC induced by Cu++-incubation. Values shown are mean 6 S.E.M. over values from Cu++-incubated LDL, *** p,0,001 (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.g002
Table 2. Effect of Cu++ and phenolic acids in LDL fatty acid composition.
Ctl Cu++ OH-Tyrosol Lut Gall 3,4-DHPEA Pin
16:0 21,1160,59* 24,7860,78 23,3960,84 26,5560,91 24,2560,65 24,7760,8 23,3260,10
16:1n-7 3,0660,28* 3,2760,55 3,0060,66* 3,3360,26 3,2560,87 3,1060,7 3,2660,15
18:0 11,5560,16 11,0860,93 8,9060,30* 11,6360,35 10,0860,41 11,4160,0 9,3660,46*
18:1n-9 22,7760,97** 26,3860,26 24,9160,27 25,3760,06 25,2460,93 25,7460,0 24,6160,69
18:2n-6 28,8460,50** 24,9760,21 30,3960,33** 23,1160,81 28,0260,8** 26,0960,9* 29,7860,13**
20:3n-6 1,5960,47* 0,9860,07 1,3960,85* 0,8860,02 1,1860,14* 1,0160,1 1,2460,22*
20:4n-6 6,0560,96** 3,0860,70 4,6260,19* 2,6760,25 3,7760,14* 3,3260,6 4,2960,65*
ACL 17,7460,9 17,560,7 17,660,2 17,560,1 17,560,8 17,560,7 17,660,1
SFA 34,4161,2* 38,160,3 33,860,0* 40,260,6* 36,160,4 37,960,8 34,660,3*
UFA 65,5962,2* 61,861,7 66,261,0* 59,760,4 63,860,6 62,062,2 65,461,2*
MUFA 26,0760,7* 30,360,5 28,060,2* 28,860,8 28,760,1 29,060,2 28,060,2*
PUFA 39,5260,8** 31,560,2 38,260,1** 30,860,6 35,160,6* 33,060,0 37,460,2*
PUFAn-3 1,6760,02* 0,960,08 1,260,1 0,860,1 1,060,5 1,060,7 1,360,1
PUFAn-6 37,8561,2* 30,560,4 36,960,9* 30,0560,1 34,160,1* 31,960,3 36,160,1*
DBI 124,5863,2** 104,660,6 119,060,6** 103,260,0 111,660,8* 106,660,5 117,360,7**
PI 69,2662,3** 49,160,1 60,660,1** 50,460,2 54,660,9* 51,160,1 59,860,6*
Values: mean6S.E. ACL, average chain length; SFA, saturated fatty acids; UFA, unsaturated fatty acids; PUFA n-6/n-3, polyunsaturated fatty acids n-6 or n-3 series; MUFA,
monounsaturated fatty acids; DBI, double bond index; PI, peroxidizability index,
*p,0,05 and ** p,0,01 respect to values in Cu++ incubated LDL by ANOVA post-hoc analyses (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.t002
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In order to establish whether structural features determine the
effect on the resistance of LDL to Cu++-induced oxidation, the
chemical structures of the phenolic compounds should be
considered (Figure S1). Important differences in the protection
of the apoprotein oxidation were observed in this study, similar to
those observed by other authors using the lag time of LDL as
marker oxidation [40,41]. The differences between those phenols
are attributable to their chemical structure, e.g. OH-tyrosol
possesses a 3,4-dihydroxy structure linked to an aromatic ring that
confers the moiety with a higher proton dislocation, facilitating a
higher scavenging activity than observed with tyrosol, which only
has a hydroxyl group linked to an aromatic ring (Figure S1). The
protective effect of the OH-tyrosol structure has biological
relevance as OH-tyrosol and tyrosol are the more simple phenols
detected in plasma and LDL after the ingestion of virgin olive oil
and red wine [42,43]. It should be noted that OH-tyrosol, with the
highest potential for inhibition of MDAL, has been previously
described as a potent inducer of cellular antioxidant responses,
both in oxLDL-induced and in tert-BOOH-induced cell stress
[36,44].
The antioxidant capacity shown by oleuropein and its
secoiridoid derivatives was quite different. The aglicon derivative
of oleuropein (3,4-DHPEA-EDA) and the ligstroside derivative (p-
HPEA-EDA) showed a positive result as antioxidants, mainly at
the maximum concentration tested. These compounds exhibit a
high selectivity for lipid-related changes since they mainly
prevented Cu++ induced changes in lipidome and MDAL in
LDL. Although no previous results were available on lipid or
protein antioxidant properties, 3,4-DHPEA-EDA is a compound
of special interest because of its presence as one of the major
phenolic antioxidant compounds in virgin olive oil. Moreover, it is
an important source of OH-tyrosol in plasma. In contrast with
these data, a similar phenolic structure, the 3,4-DHPEA-AC
showed no significant antioxidant activity in this system. This may
be attributed to the potential proton dislocation due to double
bonds in the elenolic structure in 3,4-DHPEA-EDA. Reinforcing
the importance of conjugation, oleuropein, or glucose-conjugated
elenolic acid, showed the more remarkable prooxidant activity of
all phenols included in the study in agreement with its previous
reported pro-oxidant activities [45,46]. Most interestingly, as
oleuropein is considered a proapoptotic agent with potential use as
an anti-tumoral agent [47,48], it may be suggested that those
protein prooxidant properties could be involved in the beneficial
effects of oleuropein.
Flavonoids such as rutin, flavones (apigenin and luteolin), and
their glucosides (apigenin-7-O-glucoside and luteolin-7-O-gluco-
side) can scavenge reactive oxygen radicals, by donating a
hydrogen atom or electron [49,50]. Their radical scavenging
activity seems to be substantially dependent on three structural
groups: (i) the orto-dihydroxyl structure (catechol structure) in the B
ring, which is the obvious radical target site, (ii) the 2,3 double
bond in conjunction with 4-oxo function, which is responsible for
electron delocalization, and (iii) the additional presence of both the
3- and the 5-OH groups for maximal radical scavenging potential
and the strongest radical absorption. Our data suggest the
importance of the ortho-dihydroxyl structure in the prevention of
protein modification, as luteolin and rutin -both containing this
structure- act as more effective antioxidants than apigenin, a very
similar molecule. Comparing the antioxidant activity in the
copper-induced LDL oxidation of the luteolin and luteolin-7-O-
glucoside, the antioxidant capacity of both structures was similar.
Despite the described preventive effects of those flavonoids in the
diminution of the lag-phase of LDL induced by Cu++ and other
oxidants [51,52] no data were available on their role as inhibitors
of protein oxidation markers. In fact, luteolin can be classified as
an agent with more potential for preventing direct oxidation (i.e.
GSA and AASA accumulation) than for preventing lipid
peroxidation, as it shows a lower power for protecting against
Cu++-induced lipidome changes in LDL, in agreement with
previous data showing a modest inhibition in the formation of
thiobarbituric acid-reactive substances driven by Cu++ [53]. In
contrast with this relative low in vitro potential, it shows a high
efficiency in both cell systems as it is able to completely block tert-
BOOH-induced changes in cell viability and it shows a high
potential against oxLDL-induced cell death, in agreement with the
reported inhibitory effect of luteolin in oxidized LDL-induced
endothelial monocyte adhesion and/or oxidised LDL uptake [53].
Other major phenols quantified in virgin olive oils and grape-
derived products are lignans, with a 2,3-dibenzylbutane skeleton,
whose concentration is related to the olive cultivar of origin [54].
Although they are important as sources of lignans enterodiol and
enterolactone by colonic flora metabolism, our data reveal that
acetoxypinoresinol and pinoresinol possess antioxidant activity, in
agreement with previous reports, where it was shown that some
vegetable extracts, rich in pinoresinol, were able to inhibit LDL
oxidation [55,56]. Their antioxidant activity could be more closely
related to their chelating properties than scavenging activity, as
they only exhibit a hydroxyl group linked to an aromatic ring.
Figure 3. Plant-derived phenolic acids inhibit both the effects of oxidative stress in endothelial and HepG2 cell culture and protein
oxidation in diet-induced hypercholesterolemia in vivo. A: Effect of plant-derived phenolic acids in cell death in HMEC (endothelial cell line)
induced by Cu++-incubated LDL; ** p,0,01 and *** p,0,001 respect to cell death induced by Cu++ incubated LDL (n = 6 for each data point). Values
shown are mean6 S.E.M. over values from samples treated with control LDL B: Effect of plant-derived phenolic acids in HepG2 capacity to withstand
t-BOOH induced cell death; *** p,0,001 respect to cell death induced by t-BOOH (n = 6 for each data point). Values shown are % changes of mean6
S.E. over values from control samples. C: Endothelial cell death induced by Cu++-incubated LDL is strongly correlated with GSA content (r =20.734;
p,0,016 by the Pearson correlation test). To validate this in vivo, proteins from hypercholesterolemic hamsters were analyzed for carbonyl content
(D). Both plasma from hypercholesterolemic hamsters with a dietary supplement of phenolic acid-enriched vegetal extract (E) and pooled human
plasma (F) were oxidized with Fe3+-Asc as indicated in the Methods and Material section. Aliquots were taken at indicated time points and processed
for determination of carbonyl content. G: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound compatible with PLPC
in plasma from hypercholesterolemic hamsters. H: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound compatible
with OGPC in plasma from hypercholesterolemic hamsters. I: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound
compatible with PGPC in plasma from hypercholesterolemic hamsters. J: Effect of phenolic acids-enriched diet intake in FRAP activity of plasma. K:
Heat-map showing that phenolic acids-enriched diet induces a significant hierarchical clustering of measured parameters, including both oxidative
damage and metabolic (cholesterol, HDL and LDL-cholesterol, triacilglyceride and alkaline phosphatase activities), revealing an important biological
effect. The carbonyl content is expressed as a percentual value, considering that the immunoreactivity of plasma from hypercholesterolemic hamsters
individuals (Controls in D) or protein incubated without oxidant (Ctl) (in E) as 100% of carbonyl content. ** p,0,01 by Student’s T test respect to
untreated animals (E,G,H,I,J) or oxidant-incubated human plasma (F). Data shown are mean6S.E.M., (n = 4 for each data point). For clustering
analyses, values of samples were log transformed and hierarchical clustering was performed using Pearson correlation coefficient as distance measure
and the Ward’s clustering algorithm. Colors in K express intensity/abundance with red colors showing high levels and blue colors lower levels.
doi:10.1371/journal.pone.0043308.g003
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Globally, acetoxypinoresinol and pinoresinol exhibit similar
potencies in the inhibition of direct protein oxidation and lipid
peroxidative damage, as well as in the prevention of lipidome
changes induced by Cu++.
With regard to the phenolic acid group (ferulic, cumaric, caffeic
and gallic acids) (Figure S1), all the phenols showed antioxidant
capacity at 50 and 100 mM. Ferulic and p-cumaric acids showed a
slight prooxidant activity at 5 mM, that may be attributed to H2O2
in vitro production from phenolic compounds [57,58]. According to
their mechanism of action, the phenolic acids may be classified as
free radical terminators interfering with lipid oxidation by rapid
donation of a hydrogen atom to peroxy radicals. Their antioxidant
activity is related to the molecule containing at least two
neighbouring phenolic hydroxyl groups; three such groups are
even more desirable facilitating the interference. Results of the
present study showed that the caffeic (with two neighbouring
phenolic hydroxyl groups) and gallic acids (three hydroxyl groups)
shown to have the highest antioxidant capacity. Previous results
have demonstrated the antioxidant capacity of gallic and caffeic
acids on lipid peroxidation [59–61], but only one reported the
effect of gallic acids on protein modification, and that was related
to nitrosative stress [62]. Concerning their cellular effects, gallic
and caffeic acid differed in their effects: while gallic acid was
unable to prevent oxLDL-induced or tBOOH-induced loss of
viability, caffeic acid inhibited the toxic effects of oxLDL (data not
shown). This agrees with the known effect of gallic acid as a
proapoptotic agent [63–65] and the reported protective effect of
caffeic acid in endothelial cell survival after oxLDL treatment [66].
All the phenols studied showed antioxidant capacity in the LDL
model, the OH-tyrosol being the more effective. In general, all the
phenols showed higher antioxidant activity than a-tocopherol,
which could be attributed to the hydrophilic nature of the phenolic
structures. In the biphasic microenvironment constituting core
lipids and water phase, such as biomembranes and plasma
lipoproteins, the location of phenols should be taken into account
for understanding their antioxidant activity. Vitamin E (a-
tocopherol) seems to be located within the membrane lipids or
lipoprotein particles because of its high lipophilicity. However, it is
demonstrated that flavonoid aglycones interact in the polar surface
region of the phospholipids bilayers in membranes [67], offering a
higher protection. This is specially relevant assuming that the
antioxidant profile is completely dependent on the system. As
shown by experiments with BSA and human plasma, phenolic
interaction in protein oxidation is a very complex phenomenon,
which depends on not only of the system used for oxidation, but
also on the protein, the presence of lipids and the several
mechanisms between protein-phenol and free radical source.
In summary, these data show novel antioxidant properties of
plant-derived phenolic acid compounds in LDL oxidation and
demonstrates phenolic activity in protein oxidation in vivo. It is also
demonstrated that in vitro antioxidant measurements could only
partially predict biologic responses to oxidized LDL, thus
reinforcing the importance of a multidisciplinary approach for
the description of oxidative phenomena in atherosclerosis patho-
genesis and its dietary modulation.
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Supplemental Table 1 
 
 
 
Control Polyphenol 
extract 
P (By Student’s T 
test) 
Final weight (g) 118.12±7.6 114.18±8.6 0.062 
Total cholesterol 
(mg/dL) 
455,0 ± 36,39 
 421,9 ± 12,07 0.108 
LDL-Cholesterol 
(mg/dL) 
403,8 ± 50,57 345,9 ± 44,09 0.4 
HDL-Cholesterol 
(mg/dL) 
327,7 ± 17,63 305,4 ± 10,03 0.27 
Triacilglyceride (mg/dL) 225,0 ± 35,95 142,6 ± 9,492 0.051 
Alkaline phosphatase 
(U/L) 
54.07±18.3 47.63±6.6 0.56 
Shown is mean±S.E.M (n=6) 
 
 Figure S1 
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Structures of plant-derived phenolics used in the present study.  
doi:10.1371/journal.pone.0043308.s001 
(DOCX) 
 
 
 Figure S2 
 
 
Representative phenolic acids inhibit protein carbonylation in different oxidative 
systems up to various extents. All phenols were tested at 5 µM. Oxidation of BSA 
(A,B,C) or a human plasma pool (D,E,F) was induced with Hemin:H2O2 (A, D), 
Ultraviolet radiation (λ 254 nm) (B,E), and Fe3+:Ascorbate (C,F) as indicated in the 
Methods and Materials section. Carbonyl contents are expressed as percentual values, 
considering that the immunoreactivity of protein incubated without oxidant (Ctl) as 
100% of carbonyl content. ** p<0,01 by ANOVA respect to oxidant-incubated protein. 
Data shown are mean±S.D., (n = 4 for each data point). 
doi:10.1371/journal.pone.0043308.s002 
(DOCX) 
 
 Figure S3 
Control
Polyphenol extract
A
B C
 
Chromatographic and mass-spectra evidence for the presence of PLPC in 
methanolic extracts of plasma from hypercholesterolemic hamsters. A: Extracted 
ion chromatogram of m/z 496.3398 (magnified in B) showing the peak quantified as 
PLPC (arrow in A). C: Mass spectra of the peak quantified as PLPC (arrowhead 
showing m/z peak with ∆<0.05 Da in comparison to a theoretical mass of C24H50NO7P) 
doi:10.1371/journal.pone.0043308.s003 
(DOCX) 
 
 Figure S4 
Control
Polyphenol extract
A
B C
 
Chromatographic and mass-spectra evidence for the presence of OGPC in 
methanolic extracts of plasma from hypercholesterolemic hamsters. A: Extracted 
ion chromatogram of m/z 522.3554 (magnified in B) showing the peak quantified as 
OGPC (arrow in A). C: Mass spectra of the peak quantified as OGPC (arrowhead 
showing m/z peak with ∆<0.02 Da in comparison to a theoretical mass of C26H52NO7P) 
doi:10.1371/journal.pone.0043308.s004 
(DOCX) 
 
 Figure S5 
610.3692
Control
Polyphenol extract
A
B C
 
Chromatographic and mass-spectra evidence for the presence of PGPC in 
methanolic extracts of plasma from hypercholesterolemic hamsters. A: Extracted 
ion chromatogram of m/z 610.3715 (magnified in B) showing the peak quantified as 
PGPC (arrow in A). C: Mass spectra of the peak quantified as PGPC (arrowhead 
showing m/z peak with ∆<0.01 Da in comparison to theoretical mass of C29H56NO10P) 
doi:10.1371/journal.pone.0043308.s005 
(DOCX) 
 
 SUPPLEMENTAL ONLINE MATERIAL 
Supplemental Methods 
Protein oxidation screening method: Protein oxidation and Western blot analysis.  
Briefly, to 15 µl of sample SDS was added to a final concentration of 6%, and, after boiling for 3 min, 20 
µl of 10 mM DNP in 10% trifluoroacetic acid were added. After 7 min at room temperature, 20 µl of a 
solution containing 2M Tris base, 30% glycerol and 15% β-mercaptoethanol was added for neutralization 
and sample preparation for loading onto 4-20% gradient pre-made SDS-PAGE gels (Invitrogen, 
Barcelona, Spain).  For immunodetection after SDS-PAGE, proteins were transferred using a Mini Trans-
Blot Transfer Cell (BioRad Laboratories, Barcelona, Spain) to PVDF membranes (Immobilon-P 
Millipore, Bedford, MA, USA). Immunodetection was performed using a rabbit anti-DNP antiserum as 
the primary antibody (1:4000, Dako, Carpenteria, CA, USA). Peroxidase-coupled secondary antibodies 
were used from the Tropixchemiluminiscence kit (TropixInc, Bedford, MA, USA). Luminiscence was 
recorded and quantified in Chemidoc equipment (BioRad, Barcelona, Spain), using the Quantity-one 
analysis software (Biorad). The average mode of background subtraction was chosen to quantify. Control 
experiments showed that omission of derivatization step, primary or secondary antibody addition 
produced blots with no detectable signal (data not shown). After developing, the blots were silver-stained 
as described to check the protein load (1). 
Measurement of glutamic (GSA) and aminoadipic (AASA) semialdehydes and malondialdehyde lysine 
(MDAL). 
Samples containing 0.4 mg of protein were extensively delipidated using chloroform:methanol extraction 
(2:1 v/v, 3x) in the presence of 0.01% butylatedhydroxytoluene, and the proteins were precipitated by 
adding 10% of trichloroacetic acid (final concentration) and subsequent centrifugation. The protein 
samples were reduced overnight with 500 mM NaBH4 (final concentration) in 0.2M borate buffer, pH 
9.2, containing 1 drop of hexanol as an anti-foam reagent. The proteins were then reprecipitated by 
adding 1 ml of 20% trichloroacetic acid and then centrifuging this. The following isotopicallylabelled 
internal standards were then added: [2H8]Lysine (d8-Lys; CDN Isotopes); and [2H8]MDAL (d8-MDAL), 
[2H5] 5-hydroxy-2-aminovaleric acid (for GSA quantization) and [2H4]6-hydroxy-2-aminocaproic acid 
(for AASA quantization) as described(1). The samples were hydrolysed at 155º C for 30 min in 1ml of 
6N HCl, and then vacuum dried. The N,O-trifluoroacetyl methyl ester derivatives of the protein 
hydrolysate were prepared as previously described(1). The GC/MS analyses were carried out on a 
Hewlett-Packard model 6890 gas chromatograph equipped with a 30m HP-5MS capillary column (30m x 
0.25mm x 0.25 µm) coupled to a Hewlett-Packard model 5973A mass selective detector (Agilent 
Technologies, Barcelona, Spain). The injection port was maintained at 275º C; the temperature program 
was 5 min at 110º C, then rising by 2º C/min to 150º C, then by 5º C/min to 240º C, then 25º C/min to 
300º C, and finally hold at 300º C for 5 min. Quantification was performed by external standardization 
using standard curves constructed from mixtures of deuterated and non-deuterated standards. The 
analytes were detected by selected ion-monitoring GC/MS. The ions used were: lysine and  d8-lysine, 
m/z 180 and 187, respectively; 5-hydroxy-2-aminovaleric acid and d5-5-hydroxy-2-aminovaleric acid 
(stable derivatives of GSA), m/z 280 and 285, respectively; 6-hydroxy-2-aminocaproic acid and d4-6-
hydroxy-2-aminocaproic acid (stable derivatives of AASA), m/z 294 and 298, respectively; and MDAL 
and d8-MDAL, m/z 474 and 482, respectively. The amounts of products were expressed as the ratio µmol 
GSA, AASA, or MDAL/mol lysine. 
Lipidome analyses. 
Fatty acid profiles 
For fatty acid analyses, the chloroform phase was evaporated under nitrogen, and the fatty acids were 
transesterified by incubation in 2.5 ml of 5% methanolicHCl for 90 min at 75º C. The resulting fatty acid 
methyl esters were extracted by adding 2.5 ml of n-pentane and 1 ml of saturated NaCl solution. The n-
pentane phase was separated, evaporated under nitrogen, redissolved in 75 µl of hexane and 1 µl was used 
for the GC/MS analysis. Separation was performed in a SP2330 capillary column (30m x 0.25mm x 
0.20µm) in a Hewlett Packard 6890 Series II gas chromatograph (Agilent Technologies, Barcelona, 
Spain). A Hewlett Packard 5973A mass spectrometer (Agilent Technologies, Barcelona, Spain) was used 
as the detector in the electron-impact mode. The injection port was maintained at 220º C, and the detector 
at 250º C; the temperature program was 2 min at 100º C, then rising by 10º C/min to 200º C, then 5º 
C/min to 240º C, and finally held at 240º C for 10 min. Identification of fatty acid methyl esters was done 
by comparison with authentic standards and based on mass spectra. Results are expressed as mol %. The 
following indexes were calculated from the fatty acid composition: Saturated Fatty Acids (SFA)= Σ % of 
saturated fatty acids; Unsaturated Fatty Acids (UFA)= Σ % unsaturated fatty acids; Monounsaturated 
Fatty Acids (MUFA)= Σ % of monoenoic fatty acids; Polyunsaturated n-3 Fatty Acids (PUFAn-3)= Σ % 
of polyunsaturated fatty acids n-3 serie; Polyunsaturated n-6 Fatty Acids (PUFAn-6)= Σ % of 
polyunsaturated fatty acids n-6 serie; Average Chain Length (ACL)= [(Σ %Total14 x 14) + …+ (Σ 
%Total n x n)]/100 (n= carbon atom number); Peroxidizability index (PI) = [(Σ mol% Monoenoic x 
0.025) + (Σ mol% Dienoic x 1) + (Σ mol% Trienoic x 2) + (Σ mol% Tetraenoic x 4) + (Σ mol% 
Pentaenoic x 6) + (Σ mol% Hexaenoic x 8)]. 
LC-TOF based lipidome analyses 
Briefly, lipid samples, extracted as above, after drying and reconstitution with mobile phase (see below) 
were injected into a reversed-phase chromatography system, using a  Zorbax C18 column (150 x 0.5 mm  
x 5 µm) at a flow rate of 8 µl/min in a LC system consisting of a capillary pump (Agilent 1200). Buffer A 
was water with 0.1% formic acid, and buffer B was acetonitrile with 0.1% formic acid. The column was 
equilibrated in 5% B and the gradient was 5%--95%B over 50 min. The eluant was directed to an ESI 
source, with a nebulizer gas flow of 15 l/min at 300º C with a capillary voltage of 3500 V operating in 
positive mode, with a dual spray for reference mass (m/z 121.05087 and m/z 922.0098). The instrument 
was calibrated immediately prior to the test. For the data analysis with the Agilent MassHunter Profiling 
software, five repeated injections of each extract sample were measured by the same LC/MS method. The 
acquired MS data were extracted by the Molecular Feature Extractor in the Agilent MassHunter 
Qualitative software. In this process, the identified ions were clustered to “Molecular features” 
comprising different isotopic distribution and adducts from the same molecule. The obtained files were 
grouped according to the samples into two respective groups (control samples vs Cu++ treated samples or 
control hypercholesterolemic hamsters vshypercholesterolemic phenolic-enriched vegetal extract 
supplemented hamsters) and loaded into the Agilent MassHunter Profiling software. For the differential 
analysis of both groups the features of each group were compared using Student’s T Test. The resulting 
masses were searched for in the Lipid Maps Databases (http://www.lipidmaps.org/tools/index.html), and 
among 73 differential molecular features found, 17 were significantly increased (p<0.01) over values 
found in control incubations of LDL (being the remaining 56 diminished).  Among those, the three most 
abundant had masses compatible with 1-palmitoyllysophosphatidylcholine –PLPC- (measured mass: 
495.3328, theoretical mass: 495.3325), 1-stearoyl-sn-glycero-3-phosphocholine –SGPC- (measured mass: 
523.364, theoretical mass: 523.3638) and 1-oleoylglycerophosphocholine –OGPC- (measured mass: 
521.3476, theoretical mass: 521.3481). 
Cell viability 
HMEC cell line (endothelial cell), kindly donated by Dr. A. Negre-Salvayre (INSERM, Toulouse, 
France) were cultured in 100mm plates with high glucose DMEM containing 10% FBS until they were 
70-80% confluent. Afterwards, the cells were harvested, counted and seeded in 96-well microplates 
(25,000 cells/well) with the same culture medium, leaving a strip of wells free of cells to be used as a 
blank. The cells were immediately centrifuged at 1000 rpm for 4 min, without stop brake, in order to 
obtain a fast and homogeneous attachment to the bottom of the wells. After 6 h, the cell culture medium 
was removed and serum-free DMEM was added to the cells. One hour later, the culture medium was 
removed again and 100 µl of serum-free DMEM containing non-oxidized LDL, oxLDL, oxLDL in the 
presence of phenolic acids or the vehicles alone, was added to each well. The final concentration of LDL 
in all conditions was 200 µg/ml. Eighteen hours later, the culture medium was removed and 100 µl of 
PBS was added to each well in order to avoid possible interferences, immediately before determining 
viability. The effect of phenolic compounds on the cellular capacity to withstand tert-butylhydroperoxide 
(t-BOOH) challenge was measured. The HepG2 cells were serum starved (0.5% FCS) in the presence of 
selected phenolics (5 µM) for 8 h. The cells were then challenged with 200 µM t-BOOH as peroxide 
donor, and 2 h later, cell viability was estimated with the 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) test, according manufacturer instructions. 
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 UNCOVERING
A NOVEL PATHWAY POTENCIALLY THERAPEUTIC TARGET FOR THE STUDY
OF !,3 PATHOGENESIS OF !,3 PATHOGENESIS
2ESERVED FOR 0UBLICATION &OOTNOTES
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&IG  %NZYMES FOR $(! SYNTHETIC PATHWAYS ARE
INmUENCED BY S!,3 IN A CLOSE RELATIONSHIP WITH 4$0
 AGGREGATION &!$3 IMMUNOREACTIVITY IS DISTORTED
IN MOTOR NEURONS FROM S!,3 SAMPLES AS SHOWN BY
!	 WITHREDUCED &!$3 IMMUNOREACTIVITY IN CERTAIN
CELLS ARROWHEAD	 WHILE PRESERVED IN OTHERS ARROW	 )
MAGNIlCATION X	 4HIS IS ACCOMPANIED BY ABNORMAL
AGGREGATION OF &!$3 IN A FEW MOTORNEURONS WITH
REDUCED &!$3 IMMUNOREACTIVITY )))6 MAGNIlCATION
X	#ONFOCAL IMAGING IN " SHOWS THAT IN COMPARI
SON WITH MOTOR NEURONS FROM HEALTHY INDIVIDUALS )	
MOTOR NEURONS IN S!,3 WITH 4$0 AGGREGATES SHOW
REDUCED !#!! CONTENT ))6)	 4HE SAME PHENOMENA
IS PRESENT FOR &!$3 #	 AND !#/8 $	 SHOWING
REDUCED !#/8 EXPRESSION IN S!,3 MOTOR NEURONS WITH
4$0 INCLUSIONS ARROW IN $	 !S INDICATED BY TRANS
FECTION EXPERIMENTS #4& FRAGMENTS OF 4$0 ARE
ABLE TO REPRODUCE THE LOSS OF &!$3 %	 2IGHT PANEL
IN % SHOWS THE IMMUNOREACTIVITY QUANTIlCATION WITH
BARS REPRESENTING THE MEANSs3%- OF IMMUNOmU
ORESCENCE VALUES FOR DIFFERENT TRANSFECTIONS N
DIFFERENT EXPERIMENTS	 

 )NDICATES P WITH REF
ERENCE TO VALUES OF '&0744$0 AFTER ONE WAY
!./6! TEST 0ARAFlN SECTIONS SLIGHTLY COUNTERSTAINED
WITH HAEMATOXYLIN "AR IN !   ˩M
&IG  4$0 AGGREGATION AND S!,3 ARE RELATED TO DECREASED CONTENT OF THE $(!DEPENDENT PROTEIN DREBRIN IN NEURONS !	 SHOWS THAT TRANSFECTION
WITH AGGREGATION PRONE 4$0 #4& LEADS TO DECREASED AMOUNTS OF THE $(! DEPENDENT PROTEIN DREBRIN BUT NOT SYNTAXIN 4HIS IS CELLSPECIlC AS SHOWN BY
COEXISTENCE OF 4$0 AGGREGATES AND DREBRIN DEPLETION IN CONFOCAL MICROSCOPY "	 .OTE THE DIFFERENT ABUNDANCE OF DREBRIN IN CELLS TRANSFECTED WITH 744$0
 ARROWHEAD IN UPPER PANEL	 AND THAT IN A CELL SHOWING #4&4$0 AGGREGATES ARROWHEAD IN LOWER PANEL	 4HIS COULD EXPLAIN CHANGES PRESENT IN SAMPLES
FROM HUMAN SPINAL CORD AND BRAIN CORTEX REVEALING THAT S!,3 IS ASSOCIATED TO SPECIlC CHANGES IN THE CONTENT THE $(! DEPENDENT SYNAPTIC PROTEINS DREBRIN IN
SPINAL CORD #	 THOUGH IMMUNOmUORESCENCE ANALYSES SHOW THAT MOTOR NEURONS IN S!,3 SAMPLES CONSERVE DREBRIN LEVELS $	 EVEN WITH 04$0 AGGREGATES )N
LINE WITH MAINTAINED $(! LEVELS BRAIN CORTEX LYSATES DO NOT SHOW CHANGES IN DREBRIN NOR IN SYNTAXIN LEVELS ,OWER PANELS IN !# AND % SHOW THE DENSITOMETRIC
ANALYSES OF THE ABOVE WESTERNBLOTS .UMBERS IN THE LEFT OF BLOTS SHOW THE APPROXIMATE MOLECULAR WEIGHT "ARS IN !# AND % REPRESENT THE MEANSs3%- BEING

P WITH REFERENCE TO VALUES OF '&0744$0 !	 SPINAL CORD #	 OR BRAIN CORTEX %	 FROM CONTROL INDIVIDUALS AFTER !./6! !	 OR 3TUDENTಬS T TEST #%	
#FTJEFT FYDJUPUPYJDJUZ JU TIBMM CF SFNJOEFE UIBU NPTU T"-4
QBUJFOUT FYIJCJU 5BS%/" CJOEJOH QSPUFJO 	5%1
 BHHSFHBUFT
(FOF EFMFUJPO PG UBSECQ FODPEJOH 5%1 MFBET UP B QIFOPUZQF
DPOTJTUJOHXJUI BMUFSFE MJQJE IPNFPTUBTJT 	FH EJTUPSUFE GBU TUPSBHF
BOE NFNCSBOF USBGGJDLJOH NFDIBOJTNT
	
 5IJT TVHHFTU UIBU
QFSIBQT %)" TZOUIFUJD NBDIJOFSZ DBO CF JOGMVFODFE CZ 5%1
QBUIPHFOJD FWFOUT
5P GJMM UIFTF HBQT XF IBWF TUVEJFE UIF FO[ZNFT SFTQPOTJCMF
GPS %)"TZOUIFTJT BT XFMM BT UIF QPUFOUJBM MPTT PG ESFCSJO BOE
TZOUBYJO  BTTPDJBUFE UP UIF "-4MJOLFE %)" MPTT 8F DPSSFMBUFE
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&IG  #HRONIC EXCITOTOXICITY INCREASES THE CONCENTRATION OF $(! AND BIOLOGICALLY RELATED COMPOUNDS IMPINGING SELECTIVE CHANGES IN THE LIPIDOME WITH
DEPLETION OF ˶ PRECURSORS AND MITOCHONDRIADERIVED OXIDATIVE STRESS !	6ARIATIONS IN FATTY ACID COMPOSITION SHOWN BY FOLDCHANGE	 INDUCED BY CHRONIC
EXCITOTOXICITY IN SPINAL CORD REVEAL THAT THE CONCENTRATIONS OF THE $(! PRECURSOR DOCOSAPENTAENOIC ACID #N		 AND ,.! #N		 ARE
SEVERELY DECREASED UNDER THESE CONDITIONS ˶ DEPLETION IS PATHOGENICALLY RELEVANT AS SHOWN BY THE FACT THAT LOSS IN MOTOR NEURON NUMBER INDUCED BY CHRONIC
EXCITOTOXICITY IS PREVENTED BY LINENSEED FATTY ACIDS ,3&!	 INCUBATION"	 # SHOWS REPRESENTATIVE MICROGRAPHS WITH THE EFFECT OF ,3&! AND lSH FATTY ACIDS F&!	 IN
THE NUMBER OF NEUROlLAMENT POSITIVE 3-) IMMUNOREACTIVE	 CELLS IN VENTRAL HORNS OF SPINAL CORD ORGANOTYPIC CULTURES IDENTIlED AS MOTOR NEURONS ARROWS	
$	 ,IPIDOME ANALYSES AFTER CHRONIC EXCITOTOXICITY REVEAL RELATIVELY MINOR CHANGES AS SHOWN BY HEATMAP OF LIPIDS IN POSITIVE LEFT	 AND NEGATIVE RIGHT	 IONIZATION
MODES ,OWER PANELS SHOW TRIDIMENSIONAL 0RINCIPAL #OMPONENT !NALYSES OF THESE IONIZED LIPIDS BLUE SPHERES ARE CONTROL SPECIMENS WHILE RED SPHERES ARE 4(!
TREATED CULTURES	 %	 #ONSISTING WITH INCREASED $(! AVAILABILITY ONE OF ITS ENZYMATIC PRODUCTS RESOLVIN $ SHOWS A TENDENCY FOR INCREASED CONCENTRATIONS IN
CULTURES UNDER EXCITOTOXICITY &	 ,EVELS OF THE LIPID PEROXIDATION MARKER ISOPROSTANE ISO0'&˞ ARE INCREASED BY CHRONIC EXCITOTOXICITY AND DIRECTLY CORRELATED
'	 TO THE RESOLVIN $ AMOUNT YX P 2SQ	 (	 )N LINE WITH THIS HIGHRESOLUTION RESPIROMETRY SUGGESTS THE POTENTIAL IMPLICATION OF LIPID
PEROXIDATION AFECTING MITOCHONDRIAL FUNCTION IN THE MOTOR NEURON LOSS INDUCED BY CHRONIC EXCITOTOXICITY AS ˞TOCOPHEROL TREATMENT DURING  DAYS ˞TOC 
˩-	 IS ABLE TO PREVENT THIS FUNCTION LOSS WHICH CAN BE ATTRIBUTED TO COMPLEX ) ACTIVITY &URTHER )	 INDICATES THAT OXIDATIVE STRESS CAN BE PATHOPHYSIOLOGICALLY
RELEVANT AS LOSS OF MOTOR NEURON INDUCED BY EXCITOTOXICITY IS PREVENTED BY ADDITION OF $(! COMBINED WITH ˞TOCOPHEROL ˞TOC$(!  ˩- BOTH	 ದBUT NOT
$(! ALONE DATA NOT SHOWN	 IS ABLE TO PREVENT MOTOR NEURON LOSS ASSOCIATED WITH CHRONIC EXCITOTOXICITY "ARS IN !"# ( AND ) REPRESENT THE MEANSs3%-
N SLICESCONDITION	 BEING 
P 

P AND 


 P WITH REFERENCE TO #TL VALUES BY 3TUDENTಬS T TEST !%&)	 ONEWAY !./6! ")	 AND
TWOWAY !./6! #	 )N # A AND B SUPERINDEXES INDICATE SIGNIlCANT DIFFERENCES BETWEEN THE FATTY ACIDS USED P	 "ARS IN # ARE ˩M LONG
UIFTF GJOEJOHT XJUI 5%1 BHHSFHBUFT JO TQJOBM DPSE TBNQMFT
GSPN T"-4 QBUJFOUT 	JF XIFSF NPUPS OFVSPO EFBUI JT BMNPTU
DPNQMFUF
 8F IBWF BMTP VTFE UIF DISPOJD FYDJUPYJDJUZ NPEFM BU B
TUBHF QSFDFFEJOH NPUPS OFVSPO EFBUI *O UIJT TZTUFN XF TUVEJFE
UIF DIBOHFT PG MJQJEPNJD QSPGJMF BOE UIF GBUUZ BDJE DPNQPTJUJPO UP
FWBMVBUF DIBOHFT JO %)" BWBJMBCJMJUZ *O UIJT MJOF XF FTUBCMJTIFE
UIBU PYJEBUJWF TUSFTT JT BCMF UPNPEVMBUF%)" TZOUIFTJT BOE%)"
MJOLFE QSPUFJOT 'JOBMMZ UP TIFE MJHIU VQPO B QPUFOUJBM OPWFM
UIFSBQFVUJD QBUIXBZ XF IBWF TUVEJFE JG UIF BEEJUJPO PG ˞MJOPMFOJD
BDJE 	"-"
 BOEPS %)" DPNCJOFE XJUI TFWFSBM BOUJPYJEBOUT JT
BCMF UP JOUFSBDU XJUI EJWFSTF GBUUZ BDJET SFTDVJOH NPUPS OFVSPO
MJLF DFMMT GSPN PYJEBUJWF TUSFTT JOEVDFE DFMM EFBUI BOE NPUPS
OFVSPOT GSPN DFMM EFBUI JO DISPOJD FYDJUPUPYJDJUZ
2ESULTS
T"-4 JT BTTPDJBUFE XJUI TQJOBM DPSE TQFDJGJD DIBOHFT JO FO[ZNFT
GPS %)" TZOUIFTJT BTTPDJBUFE JO B DFMMTQFDJGJD GBTIJPO UP 5%1
BHHSFHBUFT
*O B QSFWJPVT XPSL XF IBWF TIPXO UIBU T"-4 JT BTTPDJBUFE
XJUI DIBOHFT JO GBUUZ BDJE DPNQPTJUJPO 	
 XF EFUFDUFE EF
DSFBTFE %)" DPOUFOU JO TQJOBM DPSE BOE JODSFBTFE MFWFMT JO CSBJO
DPSUFY %)" TZOUIFTJT JT EFQFOEFOU PO UIF TP DBMMFE 4QSFDIFSಬT
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&IG  /XIDATIVE STRESS ENHANCES $(! SYNTHESIS ASSOCIATED TO 4$0 PATHOLOGICAL EVENTS AND DREBRIN LOSS AND ITS NEUROPROTECTIVE ROLE IS ENHANCED BY
EXOGENOUS ANTIOXIDANTS !	 2EPRESENTATIVE WESTERNBLOT SHOWING THAT (/ INCUBATION OF .! CELLS ALSO CHANGES THE EXPRESION OF &!$3 AND 3#0 "	
2EPRESENTATIVE CHROMATOGRAM FOR D LABELLED $(! AS EVIDENCED BY COMPATIBLE MASS SPECTRA OF THE .( ADDUCT IN THE INSET	 SHOWING THAT LEVELS ARE HIGHER
IN (/ TREATED CELLS GREEN TRACE	 IN COMPARISON WITH CONTROL CELLS BLUE TRACE	 /MISSION OF D LABELLED !,! RESULTED IN INDETECTABLE SIGNAL OF D LABELLED
$(! #	 )N LINE WITH THESE CHANGES CAPACITY FOR CONVERSION OF D LABELLED !,! TO D$(! IS SLIGHTLY INCREASED 4HIS INCREASED $(! SYNTHESIS CAN BE A RESPONSE
TO AN (/DRIVEN 4$0 PHOSPHORYLATION AND AGGREGATION WHICH PRECEEDES DREBRIN LOSS AS SHOWN BY WESTERN BLOT $	 AND IMMUNOCYTOCHEMICAL ANALYSES
%	 DEMONSTRATING LOSS OF DREBRIN IN THOSE CELLS WITH 4$0 AGGREGATES ARROWHEADS IN %	 )NTERACTOMIC ANALYSES DEMONSTRATE THAT DREBRIN IS MAINLY LINKED TO
4$0 BY COEXPRESSION WITH (,!$2! (,!$2" AND 82. AS LINKING NODES %	 )N CONTRAST TO ORGANOTYPIC SPINAL CORD CULTURES (/INDUCED LOSS OF .3#
VIABILITY IS NOT PREVENTED BY ˞TOCOPHEROL ˞TOC  ˩-	 BUT BY THE PHENOLIC COMPOUNDS DERIVED FROM VIRGIN OLIVE OIL P(0%!%$!  ˩-	 AND HYDROXYTYROSOL
 ˩-	 IN A FATTYACID SPECIlC FASHION ,OWER PANELS IN ! AND $ SHOW THE DENSITOMETRIC ANALYSES OF THE ABOVE WESTERNBLOTS .UMBERS IN THE LEFT OF BLOTS SHOW
THE APPROXIMATE MOLECULAR WEIGHT "ARS IN ! # $ AND & ARE THE MEANSs3%-  EXPERIMENTS	 BEING 
P 

P 


 P AND 



 P BY
3TUDENTಬS T TEST !#	 OR ONEWAY !./6! $ AND &	 WITH REFERENCE TO #TL
TIVOU XIJDI DPPSEJOBUFT B TFSJFT PG FMPOHBUJPO BOE EFTBUVSBUJPO
TUFQT JODMVEJOH B DPPSEJOBUFE BDUJPO PG FOEPQMBTNJD SFUJDVMVN
BOE QFSPYJTPNBM GVODUJPOT 	
 *OUFSFTUJOHMZ '"%4 FYQSFTTJPO
JO UJTTVF XBT BGGFDUFE CZ T"-4 XJUI TPNF DFMMT TIPXJOH QSFTFSWFE
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&IG  $(!SYNTHETIC ENZYMES ARE ALTERED IN BRAIN
CORTEX AND SPINAL CORD FROM S!,3 PATIENTS )N LINE WITH
$(! SYNTHESIS BEING REACTIVE AS A RESPONSE TO STRESS
REPRESENTATIVE WESTERN BLOT ANALYSES OF ENZYMES FOR
05&! SYNTHESIS IN HUMAN SPINAL CORD !	 AND BRAIN
CORTEX "	 LYSATES DEMONSTRATE SPECIlCAL INCREASES IN
!#!! BOTH FOR SPINAL CORD AND BRAIN CORTEX	 !#!!
AND &!$3 THAT COULD EXPLAIN COMPOSITIONAL CHANGES
IN FATTY ACIDS PREVIOUSLY REPORTED IN S!,3 ,OWER PAN
ELS IN ! AND " SHOW THE DENSITOMETRIC ANALYSES OF
THE ABOVE WESTERNBLOTS .UMBERS IN THE LEFT OF BLOTS
SHOW THE APPROXIMATE MOLECULAR WEIGHT "ARS IN !
AND " REPRESENT THE MEANSs3%- BEING 
P OR


P WITH REFERENCE TO VALUES OF SPINAL CORD
!	 OR BRAIN CORTEX "	 FROM CONTROL INDIVIDUALS AFTER
3TUDENTಬS T TEST
JNNVOPSFBDUJWJUZ BOE PUIFST XJUI NBSLFE EFQMFUJPO PG UIJT FO
[ZNF 	'JHVSF "
 1IPTQIP5%1 BHHSFHBUJPO JT B IBMMNBSL
GPS NPUPS OFVSPO EFNJTF JO T"-4 8F GPVOE UIBU DZUPTPMJD 5%1
 BHHSFHBUFT BSF BTTPDJBUFE XJUI DIBOHFT 	HFOFSBMMZ EFDSFBTFE
FYQSFTTJPO
 PG %)" TZOUIFUJD FO[ZNFT TVDI BT "$"" 	'JHVSF
#
 '"%4 	'JHVSF $
 BOE "$09 	'JHVSF %
 'VSUIFSNPSF
JO WJUSP FYQFSJNFOUT TIPXFE UIBU UIF FYQSFTTJPO PG UIF BHHSFHBUJPO
QSPOF 5%1 DBSCPYZUFSNJOBM GSBHNFOUT	$5'
	
 MFBET UP B
TJHOJGJDBOUMZ EJNJOJTIFE FYQSFTTJPO PG '"%4 	Q "/07"
CFUXFFO HSPVQT 'JHVSF &
 TQFDJBMMZ FWJEFOU JO UIPTF GSBHNFOUT
XJUI IJHIFS UFOEFODZ UP BHHSFHBUF TVDI BT $5'  UIPVHIU
JU XBT BMTP QSFTFOU JO UIF PUIFS $5' 	EBUB OPU TIPXO

5%1 BHHSFHBUJPO EFDSFBTFT UIF FYQSFTTJPO PG UIF %)"
EFQFOEFOU TZOBQUJD QSPUFJO ESFCSJO XIPTF MFWFMT BSF MPX JO TQJOBM
DPSE GSPN T"-4 QBUJFOUT
%)" JT GVODUJPOBMMZ MJOLFE UP TZOBQUJD QSPUFJOT TVDI BT
ESFCSJO BOE TZOUBYJO BT UIF FYQSFTTJPO PG UIPTF QSPUFJOT JT
EJSFDUMZ SFMBUFE UP %)" DPODFOUSBUJPO 	 
 *O MJOF XJUI 5%1
 BHHSFHBUJPO QPUFOUJBMMZ JOUFSGFSSJOH XJUI %)" BWBJMBCJMJUZ
PWFSFYQSFTTJPO PG BHHSFHBUJPO QSPOF 5%1 $5' 	TIPXO GPS
$5' 
 JOEVDFT B TJHOJGJDBOU EFDSFBTF JO ESFCSJO FYQSFTTJPO
	Q
 CVU OPU JO TZOUBYJO 	'JHVSF " BOE #
 3FJOGPSDJOH
UIF WBMJEJUZ PG UIFTF JO WJUSP BQQSPBDIFT XFTUFSOCMPU BOBMZTFT
DPOGJSNFE EFDSFBTFE DPOUFOUT PG ESFCSJO JO TQJOBM DPSE GSPN
T"-4 QBUJFOUT XIJMF CSBJO DPSUFY EJE OPU TIPX UIFTF DIBOHFT
	'JHVSF $ BOE &
 JO MJOF XJUI IJHIFS %)" DPOUFOU JO UIJT MBUFS
MPDBUJPO *OUFSFTUJOHMZ UIJT JT OPU MJOLFE UP EJSFDU MPTT PG ESFCSJO
JO NPUPS OFVSPOT TJODF UIPTF TIPXJOH 5%1 BHHSFHBUFT EP
OPU BQQFBS UP IBWF EFDSFBTFE ESFCSJO FYQSFTTJPO 	'JHVSF %

5IJT XPVME BHSFF XJUI PUIFS DFMMT 	OPO NPUPS OFVSPOT
 IBWJOH
EFDSFBTFE ESFCSJO MFWFMT 5IVT XIJMF TJOHMF DFMM UZQF DFMM DVM
UVSF EFNPOTUSBUFE UIBU 5%1 BHHSFHBUJPO JT MJOLFE UP ESFCSJO
EFQMFUJPO JO WJWP NFBTVSFNFOUT TVHHFTU UIBU PUIFS DFMMT DPVME
IFMQ NPUPS OFVSPOT UP NBJOUBJO IPNFPTUBUJD ESFCSJO BNPVOUT
TUSFTTJOH UIF JNQPSUBODF PG JOUFSDFMMVMBS SFMBUJPOTIJQT JO TQJOBM
DPSE
$ISPOJD FYDJUPUPYJDJUZ MFBET UP DIBOHFT JO XIPMF MJQJEPNF BOE
GBUUZ BDJE QSPGJMFT JO MVNCBS TQJOBM DPSE DPNQBUJCMF XJUI JODSFBTFE
%)" TZOUIFTJT BTTPDJBUFE UP NJUPDIPOESJBM EZTGVODUJPO BOE MJQJE
QFSPYJEBUJPO
$ISPOJD FYDJUPUPYJDJUZ JO MVNCBS TQJOBM DPSE TMJDFT JT DPO
TJEFSFE B NPEFM PG TMPX OFVSPUPYJDJUZ XJUI TJNJMBS GFBUVSFT BT
T"-4 QBUIPHFOFTJT 	
 4JODF XF XBOUFE UP FWBMVBUF JO B UJTTVF
QBSBEJHN 	JF XJUI DBQBDJUZ UP SFQSPEVDF JOUFSDFMMVMBS SFMBUJPO
TIJQT
 UIF QPUFOUJBM JOWPMWFNFOU PG %)" DIBOHFT JO NPUPS OFV
SPO EFNJTF XF FWBMVBUFE TPNF PG UIF BCPWF NFOUJPOFE QBSBNF
UFST %SFCSJO EJTUSJCVUJPO CVU OPU HMPCBM DPOUFOU ದJO DPOUSBTU XJUI
T"-4 XBT TJHOJGJDBOUMZ BMUFSFE JO DISPOJD FYDJUPUPYJDJUZ 	4VQ
QMFNFOUBM 'JHVSF 
 'VSUIFSNPSF JODSFBTFE TZOUBYJO MFWFMT
TVHHFTUFE JODSFBTFE %)" MFWFMT B GBDU UIBU XBT DPOGJSNFE CZ
GBUUZ BDJE DPNQPTJUJPOBM BOBMZTFT 	'JHVSF "
 XJUI B TFMFDUJWF
EFDSFBTF PG UIF %)" QSFDVSTPS %1" GSPN ˶ GBNJMZ 	XJUIPVU
WBSJBUJPOT JO UIF FRVJWBMFOU PG UIF˶ GBNJMZ
 &TUJNBUJPO PG EFTBU
VSBTF BDUJWJUJFT TIPXFE UIBU %)" TZOUIFTJT JT UIF NPTU TFOTJUJWF
QBUIXBZ PG GBUUZ BDJE TZOUIFTJT VOEFS UIJT DISPOJD FYDJUPUPYJDJUZ
NPEFM 	4VQQMFNFOUBM 'JHVSF 
 5IFSFGPSF DISPOJD FYDJUPUPYJDJUZ
DPVME MFBE UP B EFQMFUJPO PG %)" ˶ QSFDVSTPST 5P FWBMVBUF
XIFUIFS DISPOJD FYDJUPUPYJDJUZ DPVME MFBE UP B EFQMFUJPO PG %)"
˶ QSFDVSTPST XF FYBNJOFE XIFUIFS FYPHFOPVTMZ ˶ QSFDVSTPST
	MJOFOTFFE GBUUZ BDJET -4'"
 DPVME FOIBODF NPUPS OFVSPO TVS
WJWBM JO UIJT NPEFM JO DPNQBSJTPO XJUI GJOBM QSPEVDUT 	BEEFE
BT GJTI GBUUZ BDJET G'"
 5IF SFTVMUT TIPX UIBU UIF QSFTFODF PG
-4'" FOIBODFE NPUPS OFVSPO TVSWJWBM BOE FYQSFTTJPO PG NPUPS
OFVSPO OFVSPGJMBNFOU NBSLFST JO WFOUSBM IPSO PG UIF TQJOBM DPSE
PSHBOPUZQJD DVMUVSFT JO DPNQBSJTPO XJUI G'" 	'JHVSF # BOE $

5P BTDFSUBJO JG UIFTF DIBOHFT BGGFDUFE B QBSUJDVMBS MJQJE TQFDJF
UIF FGGFDUT PG DISPOJD FYDJUPUPYJDJUZ PO UIF MJQJEPNJD QSPGJMF PG
MVNCBS TQJOBM DPSE PSHBOPUZQJD DVMUVSF XFSF TUVEJFE 5IF EF
UFDUFE DIBOHFT 	'JHVSF %
 NBJOMZ JODMVEFE EFDSFBTFE DPOUFOUT
PG TQFDJGJD MJQJET CFMPOHJOH UP QIPTQIBUJEZMFUIBOPMBNJOF BOE
QIPTQIBUJEZMTFSJOF GBNJMJFT 	4VQQMFNFOUBM 5BCMF 
 -FWFMT PG
TQFDJGJD DFSBNJEFT BOE PUIFS RVBOUJUBUJWFMZ NJOPS MJQJET XFSF
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BMTP EPXOSFHVMBUFE /FWFSUIFMFTT UIF HMPCBM QSPGJMF EJE OPU
TIPX B IJHI OVNCFS PG EJGGFSFOUJBUJOH NPMFDVMFT 	 EJGGFSFOUJBM
NPMFDVMFT CFUXFFO DPOUSPM BOE 5)"USFBUFE TBNQMFT JO B UPUBM
PG  NPMFDVMBS GFBUVSFT FH MFTT UIBO  PG UPUBM MJQJET

4JODF %)" JT B QSFDVSTPS PG UIF SFTPMWJO GBNJMZ PG OFVSPQSP
UFDUJWF NPMFDVMFT XF FWBMVBUFE XIFUIFS JODSFBTFE %)" XPVME
TVTUBJO JODSFBTFE SFTPMWJO DPODFOUSBUJPO 5IF SFTVMUT TIPX UIBU
MFWFMT PG B MJQJE TQFDJF XJUI NBTT DPNQBUJCMF XJUI UIF OFVSP
QSPUFDUJWF %)"EFSJWFE SFTPMWJO % XFSF JODSFBTFE JO DISPOJD
FYDJUPUPYJDJUZ USFBUNFOU XJUI 5)"	'JHVSF &
 5IJT DPVME TVHHFTU
UIBU JODSFBTFE %)" TZOUIFTJT JO DISPOJD FYDJUPUPYJDJUZ DPVME CF
QBSU PG B OFVSPQSPUFDUPS BEBQUJWF NFDIBOJTN )PXFWFS JO UIJT
NPEFM 16'" DPOUFOU JODSFBTFE DPVME BMTP JODSFBTF MJQJE QFSPY
JEJ[BCJMJUZ CFDBVTF EPVCMF CPOET JO BMJQIBUJD DIBJO DPOGFST IJHI
TVTDFQUJCJMJUZ UP QFSPYJEBUJPO $POGJSNJOH UIJT UIF DPODFOUSBUJPO
PG UIF MJQJE QFSPYJEBUJPO JOUFSNFEJBUF JTPQSPTUBOF JTP1('˞
XBT JODSFBTFE JO DISPOJD FYDJUPUPYJD DPOEJUJPOT 	'JHVSF '
 BOE
JU DPSSFMBUFE TJHOJGJDBOUMZ XJUI SFTPMWJO % MFWFMT 	'JHVSF (

0UIFS MJQJE QFSPYJEBUJPO QSPEVDUT JOEJDBUFE JO UIF &YQFSJNFOUBM
.FUIPET TFDUJPO EJE OPU JODSFBTF PS XFSF EFUFDUFE 	EBUB OPU
TIPXO
 TVHHFTUJOH TQFDJGJDJUZ PG UIPTF PYJEBUJWF DIBOHFT
(JWFO UIJT JODSFBTFE MJQJE QFSPYJEBUJPO XF TFBSDIFE GPS QP
UFOUJBM DBVTFT PG JU 5IF SFTVMUT 	'JHVSF )
 EFNPOTUSBUF UIBU
DISPOJD FYDJUPUPYJDJUZ MFBET UP B TJHOJGJDBOU MPTT PG PYZHFO DPO
TVNQUJPO 	DB 
 5IJT JT DBVTFE CZ B TFMFDUJWF MPTT JO NJUP
DIPOESJBM DPNQMFY * BDUJWJUZ 	'JHVSF )
 BT UIFZ XFSF DPNQMFUFMMZ
BCSPHBUFE CZ SPUFOPOF 5IVT QPUFOUJBM QSPUFDUJWF FGGFDUT PG %)"
DPVME CF MJNJUFE CZ QPUFOUJBMMZ FOIBODFE GSFF SBEJDBM QSPEVDUJPO
DPNQSPNJTJOH UIF BWBJMBCJMJUZ PG MJQPQIJMJD BOUJPYJEBOUT 5IFSF
GPSF XF UFTUFE JG B MJQPQIJMJD BOUJPYJEBOU%)"DPNCJOBUJPO DPVME
QSFWFOU NPUPS OFVSPO MPTT JOEVDFE CZ DISPOJD FYDJUPUPYJDJUZ 5IF
SFTVMUT EFNPOTUSBUFE UIBU B %)"˞UPDPQIFSPM DPNCJOBUJPO 	CVU
OPU%)"BMPOF ದEBUB OPU TIPXO
 QSFWFOUT DISPOJD FYDJUPUPYJDJUZ
JOEVDFE MPTT PG NPUPS OFVSPOT 	'JHVSF *

"MM JO BMM UIFTF SFTVMUT TVHHFTU UIBU TQJOBM DPSE SFTQPOTFT
UP DISPOJD FYDJUPUPYJDJUZ DPNQSJTF JODSFBTFE %)" DPOUFOU TVT
UBJOFE CZ BO FOIBODFE EFTBUVSBTF FYQSFTTJPO MFBEJOH UP JODSFBTFT
JO %)" EFSJWFE OFVSPQSPUFDUJWF GBDUPST MJOLFE UP MPTT PG ESFCSJO
BNPVOU BOE EJTUSJCVUJPO BT XFMM BT UP TQFDJGJD JODSFBTFT JO MJQPY
JEBUJPO MJLFMMZ GVFMMFE CZ B DPNQMFY * SFMBUFE NJUPDIPOESJBM EZT
GVODUJPO
%)" TZOUIFTJT BU B DFMMVMBS MFWFM JT VQSFHVMBUFE CZ PYJEBUJWF TUSFTT
BOE JUT OFVSPQSPUFDUJWF SPMF JT FOIBODFE CZ FYPHFOPVT BOUJPYJEBOUT
5IF BCPWF NFOUJPOFE SFTVMUT BSF DPNQBUJCMF XJUI %)" TZO
UIFTJT CFJOH VQSFHVMBUFE BT B SFTQPOTF UP PYJEBUJWF TUSFTT JOEVDFE
CZ B DISPOJD FYDJUPUPYJDJUZEFSJWFE NJUPDIPOESJBM EFDBZ 5P UFTU
UIJT XF FWBMVBUFE XIFUIFS %)" TZOUIFTJT BOE ESFCSJO FYQSFT
TJPO XFSF JOGMVFODFE CZ )0 B TJHOBM EFSJWFE GSPN DPNQMFY *
EZTGVODUJPO 	
)0 JODVCBUJPO JODSFBTFE TJHOJGJDBOUMZ MFWFMT PG
'"%4 	JO BDDPSEBODF UP UIF BCPWF EFTDSJCFE DIBOHFT JO TQJOBM
DPSE "-4 TBNQMFT
 BOE 4$1 	'JHVSF "
 4ZOUIFTJT PG %)"
XBT FWBMVBUFE CZ NFUBCPMJD GMVY FYQFSJNFOUT CZ NFBTVSJOH UIF
DPOWFSTJPO GSPN FYPHFOPVTMZ BEEFE E"-" UP E%)" 	'JHVSF
#
 5IF SFTVMUT TVHHFTU UIBU UIFSF JT BO BMNPTU TJHOJGJDBOU UFO
EFODZ GPS JODSFBTFE %)" TZOUIFTJT 	'JHVSF $
 5IJT FOIBODFE
%)" QSPEVDUJPO DPVME CF B SFTQPOTF UP DPNQSPNJTFE %)"
BWBJMBCJMJUZ
5P EFNPOTUSBUF UIJT XF FWJEFODFE BO FBSMZ 5%1 QIPTQIP
SZMBUJPO BGUFS )0 DIBMMFOHF QSFDFFEJOH ESFCSJO MPTT JO /"
DFMMT 	'JHVSF % BOE &
 (MPCBMMZ BGUFS JOUFSBDUPNJD BOBMZTFT
GFX OPEFT TFQBSBUF 5%1 GSPN ESFCSJO DPOGJSNJOH UIF GFBTJ
CJMJUZ PG UIF QSPQPTFE IZQPUIFTJT 	'JHVSF '

5P FYUFOE UIFTF GJOEJOHT UP PUIFS DFMMVMBS TZTUFNT XF TUVE
JFE UIF FGGFDUT PG FYPHFOPVTMZ BEEFE %)" PS PUIFS GBUUZ BDJET
JO UIF MPTT PG WJBCJMJUZ JO UIF NPUPS OFVSPO MJLF MJOF /4$
$FMM EFBUI JOEVDFE CZ )0 XBT QSFWFOUFE TJHOJGJDBOUMZ CZ UIF
VTF PG Q)1&"&%" BOE IZESPYZUZSPTPM 	OBUVSBM IZESPQIJMJD
BOUJPYJEBOUT PG IZESPQIJMJD OBUVSF QSFTFOU JO WJSHJO PMJWF PJM
 JO
UIF QSFTFODF PG %)" BOE -4'" JO DPOUSBTU XJUI ˞UPDPQIFSPM
	'JHVSF (

"-4 MFBET UP TJHOJGJDBUJWF DIBOHFT JO UIF MFWFMT PG FO[ZNFT GPS
%)" TZOUIFTJT JO TQJOBM DPSE BOE CSBJO DPSUFY
5IFTF SFTVMUT QPJOUFE PVU UIBU JODSFBTFE FYQSFTTJPO PG TFWFSBM
FO[ZNFT GPS %)" TZOUIFTJT DBO CF B SFTQPOTF UP PYJEBUJWF TUSFTT
#BTFE PO QSFWJPVT GJOEJOHT PG PYJEBUJWF EBNBHF JO "-4 TBNQMFT
XF BOBMZ[FE UIF UJTTVMBS DPODFOUSBUJPO PG FO[ZNFT SFTQPOTJCMF GPS
%)" TZOUIFTJT 5IF SFTVMUT 	'JHVSF "
 TIPXFE UIBU JO TQJOBM
DPSE UIF FO[ZNFT SFMBUFE UP ˟PYJEBUJPO BDFUZM $P" BDZMUSBOT
GFSBTF  BOE  	"$"" BOE "$""
 BT XFMM BT UIPTF SFMBUFE UP
FBSMZ TUFQT PG EFTBUVSBUJPO '"%4 XFSF BMM JODSFBTFE JO TQJOBM
DPSET GSPN T"-4 TBNQMFT QFSIBQT BT B DPNQFOTBUJPO GPS NPUPS
OFVSPO EZTGVODUJPO PG '"%4	'JHVSF "
 *O DPOUSBTU 4$1
MFWFMT XFSF EFDSFBTFE *O CSBJO DPSUFY TJHOJGJDBOU JODSFBTFT XFSF
POMZ TFFO GPS "$"" 	'JHVSF #
 5IJT JODSFBTF DPVME QSPWJEF
UIF CJPDIFNJDBM CBTJT GPS JODSFBTFE BNPVOUT PG %)" QSFTFOU JO
CSBJO DPSUFY	

(MPCBMMZ UIFTF SFTVMUT TVHHFTU UIBU JO T"-4 OFVSPOBM SF
TQPOTFT UP PYJEBUJWF DIBMMFOHF DPNQSJTF JODSFBTFE FYQSFTTJPO PG
%)" TZOUIFTJT FO[ZNFT QSFDFFEFE CZ 5%1 EZTGVODUJPO BOE
ESFCSJO MPTT 'VSUIFSNPSF UIFZ BMTP TIPX UIBU NPUPS OFVSPO
TVSWJWBM JT EFQFOEFOU PO UIF JOUFSBDUJPO PG CPUINPUPS OFVSPO BOE
TVSSPVOEJOH DFMMT XJUI GBUUZ BDJE TPVSDFT XJUI QSFGFSFODF PG %)"
BOE JUT QSFDVSTPST BOE UIBU QIFOPMJD BOUJPYJEBOUT DPVME FOIBODF
UIFTF CFOFGJDJBM QSPQFSUJFT
$ISCUSSION
5IF SFTVMUT QSFTFOUFE IFSF FWJEFODF BO JNQPSUBOU SPMF PG UIF
JOUFSBDUJPO CFUXFFO 16'" TZOUIFTJT 5%1 BOUJPYJEBOUT BOE
NPUPS OFVSPO EJTFBTF 5IVT EFTQJUF JODSFBTFE NBDIJOFSZ GPS
%)" TZOUIFTJT JO TQJOBM DPSE BQQBSFOUMZ JU JT OPU BCMF UP GVMMZ
TVQQMZ JODSFBTJOH OFFET PG UIJT JNQPSUBOU 16'" 	CBTFE PO EBUB JO
ESFCSJO
 JO T"-4 TBNQMFT 5IF SFTVMUJOH JODSFBTFE 16'" BNPVOU
	OPO%)"
 DPVME TFSWF BT B TVCTUSBUF UP MJQJE QFSPYJEBUJPO 	VO
EFS TUSFTT DPOEJUJPOT
 *O UIJT TFOTF EBUB GSPN PVS PXO HSPVQ
BOE PUIFST TIPX JODSFBTFE MJQJE QFSPYJEBUJPO JO TFWFSBM OFVSPEF
HFOFSBUJWF EJTFBTFT JODMVEJOH "M[IFJNFSಬT EJTFBTF 1BSLJOTPOಬT
EJTFBTF $SFVU[GFME+BDPCT EJTFBTF 1JDLಬT EJTFBTF BOE "-4 	

*O UIJT XPSL JU JT EFNPOTUSBUFE UIBU UIF PSHBOPUZQJD TQJOBM DPSE
DVMUVSF XIFO BGGFDUFE CZ DISPOJD FYDJUPUPYJDJUZ JOEVDFE CZ UIF
HMVUBNBUF VQUBLF JOIJCJUPS 5)" TIPXT JODSFBTFE %)" DPODFO
USBUJPOT BOE SFEVDFE BSBDIJEPOJD BDJE MFWFMT DPODVSSFOU UP NPUPS
OFVSPO MPTT 'VSUIFS XF TIPX UIBU OFVSPOBM DFMM MJOFT SFTQPOE
UP PYJEBUJWF TUSFTT CZ JODSFBTJOH %)" TZOUIFTJT B GBDU UIBU XJMM
CF GPDVT PG GVUVSF TUVEJFT 5IJT SFTVMU NBZ CF JOUFSQSFUBUFE BT B
HFOFSBM SFTQPOTF UP OFVSPO JOTVMU BT %)" JT QSFDVSTPS PG UIF
QPUFOU SFTPMWJOT BOE OFVSPQSPUFDUJOT JNQMJDBUFE JO UIF EFGFODF
UPXBSET JOGMBNNBUJPO BOE PYJEBUJWF EBNBHF 	
 1SFTFOU EBUB
TIPX UIBU 5%1 QIPTQIPSZMBUJPO B DPOTFRVFODF PG PYJEBUJWF
TUSFTT QSFDFFET ESFCSJO MPTT BOE PWFSFYQSFTTJPO PG %)" TZO
UIFUJD FO[ZNFT *U JT LOPXO UIBU ESFCSJO TIPXT BO JOWFSTF SFMB
UJPOTIJQ XJUI PYJEBUJWF EBNBHF 	
 'VSUIFS ESFCSJO JOUFSBDUJOH
QSPUFJOT TVDI BT )PNFS BSF BMUFSFE CZ PYJEBUJWF TUSFTT UIFSFCZ
QPUFOUJBMMZ DPNQSPNJTJOH ESFCSJO GVODUJPO 	
 0UIFS EBUB TIPX
UIBU ESFCSJO JT QIPTQIPSZMBUFE CZ $EL	
 5IPVHIU PUIFS LJ
OBTFT NBZ CF RVBOUJUBUJWFMMZ NPSF JNQPSUBOU JO 5%1 QIPTQIP
SZMBUJPO 	
 $EL DPMPDBMJ[FT XJUI 5%1 JO HSBOVMPWBDVPMBS
EFHFOFSBUJPO 	
 TVHHFTUJOH UIBU QFSIBQT PYJEBUJWFTUSFTT ESJWFO
$EL BDUJWBUJPO 	
 DPVME JNQBDU CPUI JO ESFCSJO BOE 5%1
GVODUJPOT *O GBDU UIF NPTU TFOTJUJWF FO[ZNF UP PYJEBUJWF TUSFTT
JO /" DFMMT 4$1 JT UIF POF UIBU TIPXT TJHOJGJDBOU EFDSFBTFT
JO TQJOBM DPSE 5IJT TVHHFTUT UIBU QFSPYJTPNBM GVODUJPO NBZ CF
JNQBJSFE JO T"-4 BT QSFWJPVTMZ JOEJDBUFE JO USBOTHFOJD NPEFMT
	
 5IF QFSPYJTPNF"-4 DPOOFDUJPO JT BMTP TVHHFTUFE CZ UIF
QPTTJUJWF FGGFDUT PG TPNF ESVHT JO UIF QFSPYJTPNBM QSPMJGFSBUPS
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Submission PDF
BHPOJTU SFDFQUPS GBNJMZ 	 
 JO UIFTF NPEFMT UIPVHI UIFTF BSF
DIBMMFOHFE CZ OFHBUJWF SFTVMUT JO DMJOJDBM USJBMT 	

*O NBNNBMT UIF TZOUIFTJT PG %)" JT B DPNQMFY QBUIXBZ
EFQFOEJOH BNPOH PUIFS PO UIF MFWFMT PG UIF ˶ MJOPMFOJD BDJE
QSFDVSTPS JUT DPOWFSTJPO UP FJDPTBQFOUBFOPJD BDJE 	&1"
 	˶

UISPVHI FMPOHBTFT BOE EFTBUVSBTFT -BUFS PO &1"	˶
 JT FMPO
HBUFE UXJDF MFBEJOH UP UIF ˶  BOE WJB QFSPYJTPNBM ˟
PYJEBUJPO UP %)"	
 5IF FWBMVBUJPO PG FMPOHBTF BOE EFTBUVSBTF
SBUJPT FWFO BDDPVOUJOH UIFN POMZ BT FTUJNBUJWF JOEFYFT TVHHFTUT
UIBU FBSMJFS TUFQT GSPN "-" UP &1" 	˶
 BSF EJNJOJTIFE JO
UIF FYDJUPUPYJD NPEFM 5IF CFTU IZQPUIFTJT FYQMBJOJOH UIF MPX
MFWFMT PG MJOPMFOJD BDJE BOE &1" 	˶
 BSF UIF NBSLFE JODSFBTF
PG FO[ZNFT PG UIF MBUFS TUFQT 	UIPTF JOWPMWJOH FMPOHBUJPO BOE CFUB
PYJEBUJPO
 XIJDI DPJODJEF XJUI JODSFBTFE '"%4 BOE "$""
FYQSFTTJPO JO "-4 TBNQMFT 5IJT QIFOPNFOPO NBZ FYQMBJO UIF
QSPUFDUJWF SPMF PG -DBSOJUJOF 	
 JO "-4 NPEFMT 5IVT CFTJEFT
NJUPDIPOESJBM ˟PYJEBUJPO -DBSOJUJOF JT B DPGBDUPS OFFEFE GPS
QFSPYJTPNBM ˟PYJEBUJPO 	
 "MM JO BMM PVS SFTVMUT EFNPOTUSBUJOH
UIBU CPUI FO[ZNFT JO QFSPYJTPNBM BOE NJUPDIPOESJBM ˟PYJEBUJPO
	"$"" BOE "$""
 BSF JODSFBTFE JO TBNQMFT GSPN "-4 QB
UJFOUT EJTDMPTF B OPWFM QBUIPHFOJD QBUIXBZ 'VSUIFSNPSF UIF
GBDU UIBU NJUPDIPOESJBM 	"$""
 GPSN JT BGGFDUFE JT JO MJOF PG
QSFWJPVTMZ SFQPSUFE 	
BOE QSFTFOU GJOEJOHT TIPXJOH NJUPDIPO
ESJBM JNQBJSNFOU JO "-4 /PUFXPSUIZ UIF GBDU UIBU TFWFSBM TUFQT
PG 16'" TZOUIFTJT EFQFOE PO FO[ZNFT MPDBUFE JO FOEPQMBTNJD
SFUJDVMVN BOE NJUPDIPOESJB BOE UIF GJOEJOHT SFQPSUFE 	QSFTFOU
XPSL BOE	

 TIPXJOH UIBU UIPTF PSHBOFMMFT BSF BGGFDUFE JO "-4
BSF OPU DBTVBM GJOEJOHT 5IFTF EBUB TVQQPSU UIF IZQPUIFTJT UIBU
FOEPQMBTNJD SFUJDVMVN BOE NJUPDIPOESJBM EJTUVSCBODFT QSFTFOU
JO "-4 DPVME BMTP JNQJOHF 16'" TZOUIFTFT JO OFSWPVT UJTTVF
*O UIJT TFOTF JU IBT CFFO TVHHFTUFE UIBU JO OFVSPOT Ⴄ EF
TBUVSBUJPO 	NBJOMZ QFSGPSNFE CZ GBET
 NBZ CF UIF SBUFMJNJUJOH
TUFQ GPS DPOWFSTJPO GSPN "-" UP %)"	
 %FTQJUF JU IBT CFFO
JNQMJDBUFE JO UIF QBUIPHFOFTJT PG TFWFSBM QTZDIJBUSJD EJTFBTFT	

 OP QSFWJPVT MJOL CFUXFFO '"%4 BOE NPUPS OFVSPO EJTFBTF
XBT QSFTFOU *OUFSFTUJOHMZ JO WJUSP USFBUNFOU PG IJQQPDBNQBM DFMMT
XJUI CSBJO EFSJWFE HSPXUI GBDUPS 	B QSPUFDUJWF BHFOU JO TFWFSBM
"-4NPEFMT SFWJFXFE JO	

 JT BCMF UP JODSFBTF GBET FYQSFTTJPO
	
 .PTU JNQPSUBOUMZ EBUB QSFTFOUFE IFSF TVHHFTU B IJUIFSUP
VOSFQPSUFE SFMBUJPOTIJQ CFUXFFO 16'" TZOUIFTJT BOE "-4 BHBJO
QPJOUJOH UP GBET BT B OPWFM QMBZFS JO UIF QBUIPHFOFTJT 0VS EBUB
EFNPOTUSBUJOH TQFDJGJD JODSFBTFT JO UIJT EFTBUVSBUJPO LFZ FO[ZNF
	CPUI JO WJUSP BOE JO WJWP
 EJTDMPTF B OPWFM UBSHFU PG UIJT EJTFBTF
WBMJEBUJOH UIF VTFGVMOFTT PG PSHBOPUZQJD TQJOBM DPSE DVMUVSF BT B
UPPM GPS QBUIPHFOJD FYQMPSBUJPO PG "-4 NPMFDVMBS NFDIBOJTNT
%FDSFBTFE JOEFYFT PG ˶ GBNJMZ NBZ CF FYQMBJOFE CZ B MJNJU
JO DPNNPO EFTBUVSBTF DPGBDUPST PS B TFMFDUJWF CBMBODF UPXBSET
˶ TZOUIFTJT *U JT LOPXO UIBU JO TQJOBM DPSE JOKVSZ NPEFMT XIJMF
˶ GBUUZ BDJET 	"-" BOE %)"
 IBWF QSPUFDUJOH SPMFT UISPVHI
BOUJPYJEBOU BOE BOUJJOGMBNNBUPSZ BDUJWJUJFT ˶ "" BDUT JO SF
WFSTF XBZ XPSTFOJOH UIF PVUDPNF	
 'VSUIFS "" EPXOSFHV
MBUF HMVUBNBUF USBOTQPSUFST JO WJUSP	
 TP EFDSFBTFE ˶ GBNJMZ
TZOUIFTJTNBZ CF B DPNQFOTBUJWF SFTQPOTF $PODFSOJOH UIF TPVSDF
PG JODSFBTFE %)" JO PSHBOPUZQJD DVMUVSF EFTQJUF JU IBT CFFO
SFDFOUMZ TIPXO UIBU IJQQPDBNQBM OFVSPOT JO WJUSP DPVME QSPEVDF
%)" GSPN "-"	
 JU NBZ CF B NJOPS TPVSDF XIFO DPNQBSFE
UP DJSDVMBUJOH %)" QSPEVDFE CZ MJWFS PS UIF USBOTGFSFODF GSPN
HMJBM DFMMT *O UIJT TFOTF JO WJUSP EBUB TIPXFE UIBU BTUSPDZUFT IBWF B
MBSHFS DBQBDJUZ GPS QSPEVDJOH %)" BOE "" GSPN UIFJS QSFDVSTPST
	 
UIBO OFVSPOT %BUB TIPXO IFSF FWJEFODF UIBU JTPMBUFE
NPUPS OFVSPOMJLF DFMMT CFIBWF TMJHIU EJGGFSFOU DPNQBSFE XJUI
XIPMF PSHBOPUZQJD TMJDFT TVHHFTU UIBU HMJBMOFVSPO JOUFSBDUJPO JO
GBUUZ BDJE NFUBCPMJTN DPVME QMBZ B TJHOJGJDBOU SPMF JO "-4 MJQJE
EFBSSBOHFNFOUT
5IF JODSFBTFE TVSWJWBM PG NPUPS OFVSPOT JO TQJOBM DPSE TMJDFT
PGGFSFE CZ -4'" JO GSPOU PG QVSF %)" BOE G'" TVHHFTU UIBU
UIF JOUSPEVDUJPO PG QSFDVSTPST SBUIFS UIBO UIF GJOBM GPSN PG
16'" DPVME CF BO JOUFSFTUJOH UIFSBQFVUJD UPPM *O UIJT MJOF
SFDFOU EBUB TUSFTTFT UIF JNQPSUBOU OFVSPQIZTJPMPHJDBM EJGGFSFODFT
CFUXFFO %)" BOE "-"	
 0VS EBUB TIPXJOH UIBU ESFCSJO
XBT B DPNNPO UBSHFU JO T"-4 BOE JO DISPOJD FYDJUPUPYJDJUZ
SFJOGPSDF UIF JNQPSUBODF PG %)"EFQFOEFOU QSPDFTTFT JO UIF
QBUIPHFOFTJT PG T"-4 *O UIJT TFOTF JU IBT CFFO EFTDSJCFE UIBU
UIF MBDL PG GVODUJPO PG 5%1 JNQMJDBUFE JO T"-4 JOEVDFT
DIBOHFT JO B TQFDJGJD NJDSP3/" 	MFUC
 MFBEJOH UP JNQBJSFE
TZOUBYJO FYQSFTTJPO	
 1SFTFOU GJOEJOHT SFQPSUJOH DFMMT XJUI
5%1 BHHSFHBUJPOT TIPX BMTP BCOPSNBM '"%4 JNNVOPTUBJO
JOH TVQQPSU UIF OPUJPO PG B QBUIPHFOJDBMMZ SFMFWBOU JOUFSQMBZ
CFUXFFO 5%1 BOE %)"SFMBUFE QSPDFTTFT SFJOGPSDFE CZ GJOE
JOHT XJUI OFVSPOBM DFMM MJOFT XIFSF 5%1 QBUIPMPHJDBM FWFOUT
	JODSFBTFE QIPTQIPSZMBUJPO BOE DZUPTPMJD BHHSFHBUJPO JOEVDFE CZ
)0
 QSFDFFE DIBOHFT JO 16'" TZOUIFTJT BOE ESFCSJO EFQMFUJPO
1SFWJPVT EBUB IBWF TIPXO UIBU MJQJE QFSPYJEBUJPO EFSJWFE 
EFPYZˡ	
QSPTUBHMBOEJO +	
 JT BCMF UP SFQSPEVDF 5%1
QBUIPMPHJDBM GJOEJOHT	
 CVU OP SFMBUJPOTIJQ CFUXFFO 5%1
BOE GBUUZ BDJE TZOUIFTJT IBT CFFO QSFWJPVTMZ SFQPSUFE 0O UIF
PUIFS IBOE "-" TIBSFT CJPMPHJDBM UBSHFUT XJUI SJMV[PMF POF PG
UIF GFX BDDFQUFE USFBUNFOUT GPS FYDJUPUPYJDJUZ 	SFWJFXFE JO 	


*U JT LOPXO UIBU "-" BOE SJMV[PMF BDU PO UIF 1 EPNBJO PG UIF ,
DIBOOFM GBNJMJZ 53&,53"",	
 BOE UIBU UIJT DPNNPO BDUJPO
DPVME FYQMBJO SFEVDUJPO PG DZUPQBUIPMPHJDBM USFBUT PG OFVSPOBM
EFNJTF JO GPDBM JTDIFNJBNPEFMT *U JT BMTP LOPXO UIBU "-" JT BCMF
UP QSFWFOU OFVSPOBM DFMM EFBUI #BY FYQSFTTJPO BOE JOUFSFTUJOHMZ
JODSFBTFE DIBQFSPOF QSPUFDUJPO FYDMVTJWFMZ JO NPUPS OFVSPOT JO
BO JTDIFNJB NPEFM PG UIF TQJOBM DPSE QSFWFOUJOH OFDSPTJT BOE
BQPQUPTJT BEEJOH FWJEFODF UP UIF QSFWJPVTMZ EFTDSJCFE OFVSPQSP
UFDUJWF BDUJPO PG "-"	 

*U DBO OPU CF OFHMFDUFE UIBU QFSIBQT %)" JO DPOUSBTU UP
-4'"  JT PYJEJ[FE JO DISPOJD FYDJUPUPYJDJUZ DPOEJUJPOT DPOUSJCVU
JOH UP MPTT PG WJBCJMJUZ 5IF QSPUFDUJWF SPMF PG ˞UPDPQIFSPM BOE JUT
JOGMVFODF JO NJUPDIPOESJBM GVODUJPO TVQQPSUT UIJT IZQPUIFTJT *U
IBT CFFO QSFWJPVTMZ EFNPOTUSBUFE UIBU %)" QSFWFOUT OFVSPOBM
DFMM EFBUI CZ EFDSFBTJOH SFTQPOTFT UP SFBDUJWF PYZHFO TQFDJFT
JODSFBTJOH BOUJBQPQUPUJD QSPUFJO FYQSFTTJPO BOE NBJOUBJOJOH NJ
UPDIPOESJBM JOUFHSJUZ BOE GVODUJPO	
 5IFTF SFTVMUT HP JO MJOF
XJUI PVS EBUB BCPVU JODSFBTFE FYQSFTTJPO PG "*' JO PVS TBNQMFT
	EBUB OPU TIPXO
 0O UIF PUIFS IBOE %)" IBT CFFO VTFE XJUI
QSPNJTJOH PVUDPNFT JO NPEFMT PG TQJOBM DPSE JOKVSZ XIFSF UIF JO
GMBNNBUPSZ DPNQPOFOU JT B DMFBSNFDIBOJTN PG QBUIPHFOFTJT	

%FTQJUF NJUPDIPOESJBM 	EZT
GVODUJPO IBT CFFO QSFWJPVTMZ
JOWPLFE JO "-4 BOE "-4 NPEFMT UIJT JT BNPOH UIF GJSTU EJSFDU
FWJEFODFT PG MPTT PG 0 DPOTVNQUJPO CZ DISPOJD FYDJUPUPYJDJUZ
JO MVNCBS TQJOBM DPSET 1SFWJPVT EBUB SFG TIPXJOH JODSFBTFE
MJQJE QFSPYJEBUJPO JO UIJT NPEFM UPHFUIFS XJUI UIF QSFWFOUJWF
SPMF PG ˞UPDPQIFSPM GVMMZ TVQQPSUT UIF IZQPUIFTJT UIBU DISPOJD
FYDJUPUPYJDJUZ MFBET UISPVHI MPTT PG NJUPDIPOESJBM SFTQJSBUJPO UP
NPUPS OFVSPO EFNJTF 0G OPUF JU TIPVME CF SFNJOEFE UIBU NJ
UPDIPOESJBM SFTQJSBUJPO JT WFSZ TFOTJUJWF UP MJQJE QFSPYJEBUJPO	

5IF QSFTFOUFE SFTVMUT BSF JO MJOF XJUI QSFWJPVT EBUB TVHHFTUJOH
UIBU TVQQMFNFOUBUJPO PG %)" XJUI ˞UPDPQIFSPM NBZ CF OFFEFE
UP DPOTFSWF DFMMVMBS CJPFOFSHFUJDT JOUP IPNFPTUBTJT	
 TQFDJBMMZ
JO OFVSPOBM UJTTVFT /FWFSUIFMFTT UIF MBDL PG QSPUFDUJWF GVODUJPO
PG ˞UPDPQIFSPM UPXBSET PYJEBUJWF TUSFTT JOEVDFE EFNJTF JO UIF
NPUPSOFVSPO MJLF DFMMT EFNPOTUSBUF UIF DPNQMFYJUZ PG DISPOJD
FYDJUPUPYJDJUZ 0CWJPVTMZ JU NBZ CF BSHVFE XIFUIFS )0 SFQSP
EVDFT GFBUVSFT PG DISPOJD FYDJUPUPYJDJUZ UIBU NBZ CF QSFWFOUFE CZ
BOUJPYJEBOU GVODUJPOT 	FH NJUPDIPOESJBM BOUJBQPQPUPUJD 	

 PG
˞UPDPQIFSPM JO UIF PSHBOPUZQJD DVMUVSF 4JNJMBSMZ ˞UPDPQIFSPM
BOUJPYJEBOU QPUFOUJBM JT MPXFS UIBO UIBU PG PUIFS TUSVDUVSBMMZ
SFMBUFE MJQPQIJMJD BOUJPYJEBOUT TVDI BT ˠUPDPQIFSPM PS UIF UP
DPUSJFOPMJD DPNQPVOET 	
 "O TUSBJHIUGPSXBSE JOUFSQSFUBUJPO
NBZ CF UIBU UIF JOUFSQMBZ CFUXFFO HMJB BOE NPUPS OFVSPOT QMBZT
B LFZ SPMF JO UIF QSPUFDUJPO PG ˞UPDPQIFSPM *O UIJT MJOF JU IBT
CFFO QSFWJPVTMZ EFNPOTUSBUFE UIBU CPUI ˞UPDPQIFSPM BOE ˠ
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UPDPQIFSPM JOIJCJU PYJEBUJWF BOE JOGMBNNBUPSZ SFTQPOTFT JO FY
DJUPUPYJDJUZ MFBEJOH UP EJNJOJTIFE PYJEBUJWF EBNBHF JO UIF NPEFM
PG JOUSBDFSFCSPWFOUSJDVMBS JOKFDUJPO PG LBJOBUF JO WJWP XJUI B DMFBS
JOUFSBDUJPO PG HMJBM DFMMT 	
 *OUFSFTUJOHMZ JU IBT CFFO EFTDSJCFE
UIBU QSFTFSWBUJPO PG NJUPDIPOESJBM GVODUJPO CZ ˞UPDPQIFSPM NBZ
FOIBODF HMVUBNBUF USBOTQPSU JO BO FYQFSJNFOUBM TUSPLF NPEFM
	

*U TIPVME CF SFNBSLFE UIBU JO DPOUSBTU UP ˞UPDPQIFSPM PUIFS
BOUJPYJEBOUT TVDI BT IZESPYZUZSPTPM BOE Q)1&"&%" BDU JO B
GBUUZ BDJE EFQFOEFOU GBTIJPO BT QSPUFDUJWF GBDUPST JO UIF )0
JOEVDFE MPTT PG WJBCJMJUZ JO /4$ 5IFTF QIFOPMT QSFTFOU JO
WJSHJO PMJWF PJM QIFOPMJD GSBDUJPO IBWF QMFJPUSPQJD GVODUJPOT 5IFZ
BDU BT BOUJJOGMBNNBUPSZ BOUJPYJEBOUT BOUJQSPMJGFSBUJWF BHFOUT
UISPVHI UIFJS JOUFSBDUJPO XJUI TUJMM QPPSMZ VOLOPXO SFDFQUPST
*OUFSFTUJOHMZ JU IBT CFFO SFDFOUMZ TIPXO UIBU IZESPYZUZSPTPM BDUT
JO WJWP QSFWFOUJOH MJQJE QFSPYJEBUJPO BOE HMVUIBUJPOF EFQMFUJPO
JO CSBJO JOEVDFE CZ UIF OFVSPUPYJD ESVH OJUSPQSPQJPOBUF 	

1SFWJPVT EBUB SFWFBMFE UIBU JO EJGGFSFOU OFVSPOBM DFMM MJOFT IZ
ESPYZUZSPTPM DPOGFST DZUPQSPUFDUJPO JO B NFDIBOJTN SFMBUFE UP
GBUUZ BDJE VQUBLF 	

(MPCBMMZ UIFTF SFTVMUT TIPX UIBU VQSFHVMBUJPO PG %)" MFWFMT
JOJUJBMMZ B DPNQFOTBUPSZ SFTQPOTF DPVME DPOUSJCVUF UP JODSFBTFE
QFSPYJEJ[JBCJMJUZ BOE DPOTFRVFOUMZ UP EBNBHF TQSFBEJOH *U JT BMTP
TIPXO UIBU %)" BOE PUIFS 16'" XIFO BEFRVBUFMZ QSPUFDUFE
GSPN MJQJE QFSPYJEBUJPO CZ PUIFS EJFUBSZ BWBJMBCMF DPNQPVOET 	˞
UPDPQIFSPM PS IZESPQIJMJD BOUJPYJEBOU QPMZQIFOPMT
 DPVME PGGFS
OFVSPQSPUFDUJPO JO DISPOJD FYDJUPUPYJDJUZ 'VSUIFS XPSL JT OFFEFE
UP FWBMVBUF JUT QPUFOUJBM FGGFDU JO WJWP CVU UIF QSFTFOU SFTVMUT NBZ
IFMQ UP EFGJOF UIF QPUFOUJBM PG OFVSPQSPUFDUJWF EJFUT CBTFE PO BEF
RVBUF DPNCJOBUJPOT PG 16'" BOE TFMFDUFE QIFOPMJD BOUJPYJEBOUT
-ATERIALS AND METHODS
0ATIENT SAMPLES
3AMPLES WERE FROM TEN !,3 CASES AND EIGHT CONTROLS SEE SUPPLEMEN
TAL 4ABLE  FOR DEMOGRAPHIC CHARACTERISTICS	 4HE POSTMORTEM DELAY WAS
BETWEEN  AND  H  MIN AND DID NOT DIFFER BETWEEN THE GROUPS 4HE
BRAIN AND SPINAL CORD WERE RAPIDLY REMOVED (ALF OF THE BRAIN AND ALTERNATE
SECTIONS OF THE BRAIN STEM AND SPINAL CORD WERE IMMERSED IN  BUFFERED
FORMALIN FOR FOUR WEEKS AND THEN SELECTED SAMPLES FROM  DIFFERENT AREAS
EMBEDDED AND PARAFlN AND PROCESSED FOR CURRENT DIAGNOSTIC NEUROPATHO
LOGICAL STUDIES OR STORED UNTIL USE 3ELECTED SAMPLES OF THE OTHER HALF OF
THE BRAIN ALTERNATE SECTIONS OF THE BRAIN STEM AND SPINAL CORD WERE RAPIDLY
FROZEN ON DRY ICE KEPT ON INDIVIDUAL TAG PLASTIC BAGS AND STORED AT |# UNTIL
USE !LL SAMPLES WERE OBTAINED FROM THE )NSTITUTE OF .EUROPATHOLOGY BRAIN
BANK A BRANCH OF THE (5")#/)$)"%,, BIOBANK FOLLOWING THE GUIDELINES OF
THE LOCAL ETHICS COMMITTEES %XTENSIVE PATHOLOGICAL STUDIES WERE DONE FOR !,3
DIAGNOSIS AS PREVIOUSLY DESCRIBED  	 3AMPLE OBTENTION AND EXPERIMENTS
HAVE BEEN CARRIED OUT IN ACCORDANCE WITH 4HE #ODE OF %THICS OF THE 7ORLD
-EDICAL !SSOCIATION $ECLARATION OF (ELSINKI	 
2EAGENTS
!LL REAGENTS UNLESS STATED OTHERWISE WERE PURCHASED FROM 3IGMA
!LDRICH #HEMICAL #O DIHYDROXYPHENYL	 ETHYL ALCOHOL HYDROXYTY
ROSOL	 FROM %XTRASYNTHESE 'ENAY &RANCE	 AND FORMYLOXOETHYL	 
HYDROXYPHENYL	 ETHYL ESTER P(0%!%$!	 WAS ISOLATED FROM VIRGIN OLIVE OIL
PHENOLIC EXTRACT BY SEMIPREPARATIVE (0,# METHOD ACCORDING TO THE METHOD
OF !RTAJO ET AL 	 3TOCK SOLUTIONS OF COMMERCIAL STANDARDS AND PHENOLIC
COMPOUNDS ISOLATED FROM VIRGIN OLIVE OIL WERE DISSOLVED IN -E/((/ 
VV	 AND STORED AT | # BEFORE THE INCUBATION #OMMERCIALLY AVAILABLE FATTY
ACID EXTRACTS %COmAX /MEGA R FROM LINENSEED ,3&!	 AND "IOMEGATECH lSHR
FROM lSH F&!	 WERE OBTAINED FROM "43! -ADRID 3PAIN	 "OTH $(! OR
FATTY ACID EXTRACTS WERE USED AT A lNAL CONCENTRATION OF  w- IN CULTURE
MEDIA EITHER ORGANOTYPIC OR CELL CULTURE MEDIA	 &ATTY ACID COMPOSITION FROM
,3&! WAS ˞LINOLENIC ACID  OLEIC ACID  LINOLEIC ACID  STEARIC
ACID  AND PALMITIC ACID  AND FROM F&! WAS EICOSAPENTAENOIC  AND
DOCOSAHEXAENOIC  0EROXIDE INDEX VALUES OF THESE PRODUCTS WERE BELOW
DETECTABLE LIMITS
)MMUNOHISTOCHEMISTRY AND WESTERNBLOT
)MMUNOHISTOCHEMISTRY )&	 AND WESTERN BLOT )"	 ANALYSES WERE PER
FORMED AND QUANTIlED AS PREVIOUSLY DESCRIBED  	 !NTIBODIES USED FOR
EVALUATION OF ENZYMATIC SYSTEM FOR $(! SYNTHESIS BY )" WERE PEROXISOMAL
ACYLCOENZYME ! OXIDASE  !#/8 !BCAM AB 	 !CETYL #O!
ACYLTRANSFERASE  !#!! !BCAM AB 	 !CETYL #O! ACYLTRANS
FERASE  !#!! !BCAM AB 	 &ATTY ACID DESATURASE  &!$3
!BCAM AB 	 &ATTY ACID DESATURASE  &!$3 !BCAM AB )"
	 3TEROL CARRIER PROTEIN  3#0 !BCAM AB  	 0EROXISOMAL
MULTIFUNCTIONAL ENZYME  -&% !BCAM AB 	 AND ACTIN 3IGMA
A 	 FOR NORMALIZATION OF PROTEIN LOAD /THER ANTIBODIES USEDWERE
3-) #OVANCE )NC 0RINCETON .* 53!	 )& AT  DILUTION )" AT 
DILUTION	 DREBRIN !BCAM 0LC #AMBRIDGE 5+ AB )& 	 SYNTAXIN
!BCAM AB )& 	 NEUROlLAMENT !BCAM AB  )& 	 4$0
 !BCAM AB  )& 	 PHOSPHO4$0 #OSMOBIO ,TD #ARLSBAD
#! 53! 4IP 04$0 )&  OR -ILLIPORE 04$0 3ER3ER	 CLONE
$ -!".	 )" 	 AND NEURONAL SPECIlC TUBULIN ANTIBODIES !BCAM
AB )&  )" 	
)MMUNOREACTIVITY IMAGES WERE ANALYZED WITH THE )MAGE * SOFTWARE
&OR AREA DISTRIBUTION OF IMMUNOREACTIVE ANTIDREBRIN PARTICLES IMAGES WERE
BINARY CONVERTED AND ANALYZED WITH THE PARTICLE ANALYSES ALGORITHM OF THE
SOFTWARE HTTPRSBWEBNIHGOVIJ	 IN A DOUBLE BLINDED FASHION $ISTRIBU
TIONAL ANALYSES OF THE PARTICLE AREAS WAS PRODUCED USING THE 0RISM  SOFTWARE
'RAPHPAD 3OFTWARE ,A *OLLA #! 53!	
.EUROA .!	 MOTORNEURON LIKE .3#	 CELL AND SPINAL CORD ORGAN
OTYPIC CULTURE
/XIDATIVE STRESS HAS BEEN RECENTLY RELATED TO 4$0 PATHOLOGY IN !,3
;=  4HUS TO STUDY THE POTENCIAL LINK WITH $(! SYNTHESIS PATHWAY IN THIS
CONDITION .EURO ! .!	 CELLS WERE INCUBATED WITH  w- (/ FOR  H AS
PREVIOUSLY DESCRIBED 	 4$0 PLASMIDS AND #TERMINAL FRAGMENTS WERE
OBTAINED AS INDICATED	 .EURO ! CELLS WERE TRANSIENT TRANSFECTED WITH
THE EMPTY P%'&0# VECTOR '&0	 OR VECTOR EXPRESSING THE WILD TYPE 74	
HUMAN 4$0 C$.! 	 OR #TERMINAL FRAGMENTS  	 
 	 AND  	 USING ,IPOFECTAMINE 2EAGENT )NVITROGEN
	 ACCORDING TO THE MANUFATURERಬS INSTRUCTIONS FOR  HOURS DEPENDING
ON THE EXPERIMENT	 5NDER THESE EXPERIMENTAL CONDITIONS THE EFlCIENCY OF
TRANSFECTION WITH P%'&0# VECTOR WAS CA 
3PINAL CORD CULTURES WERE PREPARED FROM LUMBAR SPINAL CORD OF POSTNATAL
DAY  RAT PUPS AS PREVIOUSLY INDICATED AND MAINTAINED IN CULTURE MEDIA 4EN
DAYS AFTER PLATING TO INDUCE EXCITOTOXICITY THE SLICES WERE INCUBATED WITH
THE GLUTAMATE TRANSPORT INHIBITOR $,THREOHYDROXYASPARTATE 4(!	 3IGMA
3T ,OUIS -/ 53!	 AT  w- INDUCING A SELECTIVE MOTOR NEURON DEATH AFTER
 WEEKS 	 %XPERIMENTS FOR EACH CONDITION N SLICES PER EXPERIMENTAL
GROUP	 WERE REPEATED AT LEAST THREE TIMES !LL ANIMAL EXPERIMENTS WERE
APPROVED BY THE )NSTITUTIONAL !NIMAL #ARE AND %XPERIMENTATION #OMMITTEE
AND FOLLOWED %5 $IRECTIVE %5 FOR ANIMAL EXPERIMENTS
4O ANALYSE THE POTENCIAL NEUROPROTECTIVE ROLE OF ANTIOXIDANTS SUPPLE
MENTATION IN COMBINATION OF $(! IN A CELLULAR STRESS SITUATION ABLE TO
PROMOTE THE !,3 DEVELOPMENT .3# CELLS WERE INCUBATED WITH FATTY ACIDS
AS ABOVE	 AND ANTIOXIDANTS ˞TOCOPHEROL HYDROXYTYROSOL OR P(0%! %$!
AT lNAL CONCENTRATIONS  ˩-  ˩- AND  ˩- RESPECTIVELY	 WERE ADDED
 HOURS BEFORE INCUBATION WITH  ˩- (/ FOR  HOURS #ELL VIABIL
ITY WAS EVALUATED  HOURS AFTER WITH THE $IMETHYLTHIAZOLYL	
DIPHENYLTETRAZOLIUM BROMIDE TEST -44 TEST 3IGMA	 ACCORDING MANUFACTURER
INSTRUCTIONS
,IPID ANALYSES
&ATTY ACID PROlLES WERE ESTABLISHED AFTER WHOLE LIPID TRANSESTERIlCATION
AND GAS CHROMATOGRAPHY ANALYSIS OF METHYL ESTERS PERFORMED AS PREVIOUSLY
DESCRIBED	 4HE FOLLOWING INDEXES WERE CALCULATED FROM THE FATTY ACID
COMPOSITION ˂ RATIO BETWEEN #N	 AND #  CONTENTS
˂ RATIO BETWEEN # N	 AND #  CONTENTS ˂
RATIO BETWEEN # N	 AND # N	  CONTENTS 
%LONGASE FROM RATIO BETWEEN #N	 AND # N	  CONTENTS AND
 %LONGASE FROM RATIO BETWEEN #N	 AND #N
	 AS PREVIOUSLY DESCRIBED	
&OR ,#14/&BASED LIPID MOLECULAR SPECIES ANALYSES LIPID EXTRACTS
WERE SUBJECTED TO MASSSPECTROMETRY USING A (0,#  SERIES COUPLED
TO AN ELECTROSPRAY14/& -3-3  !GILENT 4ECHNOLOGIES "ARCELONA
3PAIN	 USING A REVERSE PHASE COLUMN AND A METHANOLWATER TO 
PROPANOLHEXANEWATER GRADIENT FOLLOWING THE METHOD DESCRIBED IN
	 ,IPID CLASS REPRESENTATIVE INTERNAL STANDARDS WERE ADDED TO THE
SAMPLES AND AFTER ANALYSES IONIZED LIPIDS WERE PROCESSED FOR TARGETED AND
UNTARGETED ANALYSES "RIEmY THE -ASS(UNTER -ASS 0ROlLER 0ROFESSIONAL
3OFTWARE !GILENT 4ECHNOLOGIES "ARCELONA 3PAIN	 WAS USED TO PERFORM A
NONTARGETED LIPIDOMIC ANALYSIS OVER THE EXTRACTED FEATURES /NLY COMMON
FEATURES FOUND IN AT LEAST  OF THE SAMPLES OF THE SAME CONDITION	
WERE TAKEN INTO ACCOUNT TO CORRECT FOR INDIVIDUAL BIAS 0RINCIPAL COMPONENT
ANALYSES 0#!	 WAS OBTAINED USING THIS SOFTWARE 4HE MASSES REPRESENTING
SIGNIlCANT DIFFERENCES BY 3TUDENT 4TEST FOLD CHANGE ุ  P  	 WERE
SEARCHED AGAINST THE -%4,). METLINSCRIPPSEDU	 (-$" WWWHMDBCA	
,)0)$ -!03 WWWLIPIDMAPSORG	 AND +%'' WWWGENOMEJPKEGG	
DATABASES 4ARGETED LIPIDOMIC ANALYSIS WAS PERFORMED USING THE SAME
CHROMATOGRAPHIC AND SPECTROMETRIC METHOD AS UNTARGETED APPROACH
-ASS(UNTER 1UALITATIVE !NALYSIS 3OFTWARE !GILENT 4ECHNOLOGIES "ARCELONA
3PAIN	 WAS EMPLOYED FOR INTEGRATION AND EXTRACTION OF PEAK INTENSITIES OF
THE DIFFERENT LIPIDIC SPECIES 7E LOOKED FOR THE FOLLOWING FREE FATTY ACIDS
DOCOSAHEXAENOIC ACID OLEIC ACID LINOLENIC ACID STEARIC ACID ARACHIDONIC
ACID LAURIC ACID PALMITIC ACID CAPRIC ACID MYRISTIC ACID PALMITOLEIC ACID AND
STEARIDONIC ACID 4HE MZ VALUES USED FOR QUANTIlCATION WERE MZ 
;-(= FOR OLEIC ACID MZ  ;-(= FOR STEARIC ACID MZ 
;-(= FOR PALMITIC ACID MZ  ;-(= FOR MYRISTIC ACID AND MZ
 ;-(= FOR PALMITOLEIC ACID 7E DETECTED NO DIFFERENCES INDUCED
BY CHRONIC EXCITOTOXICITY IN THOSE FATTY ACIDS 4HE FOLLOWING LIPIDS WERE ALSO
SEARCHED HYDROXYDOCOSAHEXAENOIC HYDROXYDOCOSAHEXAENOIC ISO
0'&˞ HYDROXYOCTADECADIENOIC ACID (/$%	 (/$% (/$%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ESTER PALMITOYLARACHIDONOYLGLYCEROPHOSPHOCHOLINE PALMITOYL
LINOLEYLGLYCEROPHOSPHOCHOLINE CHOLESTEROL HYDROXYNONENAL
NITROOLEATE CHOLESTEROL˞˞EPOXIDE CHOLESTEN˟OLONE ˟
HYDROXYCHOLESTEROL RESOLVING $ CHOLESTERYL LINOLEATE HYDROPEROXIDE
CHOLESTERYL LINOLEATE 4HE MZ VALUES USED FOR QUANTIlCATION WERE MZ
 ;-(= FOR ISOPROSTAGLANDIN &˞ AND MZ  FOR RESOLVIN
$ &OR D LABELLED LINOLENIC ACID #($/	 AND D LABELLED $(!
#($/	 THE ಯ&IND BY FORMULAರ !GILENT	 ALGORITHM WAS USED
/XYGEN CONSUMPTION
/XYGEN mUX OF SETS OF  SLICES OF ORGANOTYPIC SPINAL CORD CULTURES WAS
MEASURED AT  r# IN (ANKಬS BALANCED SALT SOLUTION WITH  M- (EPES
P( 	 BY HIGHRESOLUTION RESPIROMETRY USING THE /ROBOROSp /XYGRAPH
K WITH CHAMBER VOLUMES SET AT  M, AND AT A SLOW STIRRING SPEED 
RPM	 IN ORDER TO AVOID TISSUE DISAGGREGATION $AT,AB SOFTWARE /ROBOROS
)NSTRUMENTS )NNSBRUCK !USTRIA	 WAS USED FOR DATA ACQUISITION  S TIME
INTERVALS	 AND ANALYSIS WHICH INCLUDES CALCULATION OF THE TIME DERIVATIVE OF
OXYGEN CONCENTRATION AND CORRECTION FOR INSTRUMENTAL BACKGROUND OXYGEN
mUX 	4HE EXPERIMENTAL REGIME CONSISTED OF ROUTINE RESPIRATION WHICH IS
DElNED AS RESPIRATION IN CELLCULTURE MEDIUM WITHOUT ADDITIONAL SUBSTRATES
OR EFFECTORS AND CALCULATED AS 3TEADYSTATE RESPIRATORY mUX IN THE TIME
INTERVAL BETWEEN  AND  MIN AFTER CLOSING THE CHAMBER )N ORDER TO AVOID
OXYGEN LIMITATIONS ALL THE EXPERIMENTS WERE PERFORMED ABOVE  OXYGEN
SATURATION /XYGEN CONSUMPTION WAS NORMALIZED BY ACTUAL PROTEIN CONTENT
IN THE RESPIROMETER CHAMBERS AND MITOCHONDRIAL INHIBITORS WERE ADDED AS
DESCRIBED 	
$(! SYNTHESIS mUX EXPERIMENTS
&OR EVALUATION OF POTENTIAL $(! SYNTHESIS UNDER CELL STRESS .! CELLS
WERE SEEDED ONTO WELL PLATES AND GROWN IN !DVANCED MINIMUM ESSENTIAL
MEDIA SUPPLEMENTED WITH  FETAL BOVINE SERUM UNTIL  DAY POSTCONmU
ENCE THE POINT AT WHICH FATTY ACID CHANGES ARE MAXIMIZED	 4HEN CELLS
WERE INCUBATED WITH MEDIUM CONTAINING  w- D LABELLED !,! #AYMAN
#HEMICAL #OMPANY 	 FOR  HOURS !FTER THAT THE MEDIUM WAS
REMOVED AND CELLS WERE TREATED WITH (/  w- FOR  HOURS #ELLS WERE
WASHED AND HARVESTED IN 0"3 USING A CELL SCRAPER ,IPID EXTRACTION WAS CARRIED
OUT AS DESCRIBED	 #ELLS WERE PELLETED BY CENTRIFUGATION  G  |# 
MIN	 AND DISSOLVED IN CHLOROFORMMETHANOL  VV	 4HEY WERE INCUBATED
ON ICE FOR  MIN VORTEXED AND CENTRIFUGED  G |#  MIN	 4HE LOWER
ORGANIC PHASE WAS TRANSFERRED TO A NEW GLASS TUBE AND DRIED COMPLETELY
UNDER NITROGEN 24 ,ATER THE FATTY ACID SAPONIlCATION WAS CARRIED OUT BY
INCUBATING LIPID EXTRACTS IN . +/(-ET/(  VV	 FOR  MIN AT  |#
IN A HEATING BLOCK AS INDICATED 	 4HE P( OF THE SOLUTION WAS ACIDIlED
WITH ONEEIGHTH OF THE VOLUME OF FORMIC ACID 4HE FREE FATTY ACIDS WERE THEN
EXTRACTED WITH AN EQUAL VOLUME OF CHLOROFORM AND AFTER DRYING EXTRACTS
WERE RECONSTITUTED IN CHLOROFORM AND STORED AT |# UNTIL READY FOR ,#1
4/& ANALYSIS ,EVELS OF D LABELLED !,! D LABELLED $(! AND OLEIC ACID USED
FOR NORMALIZATION	 WERE QUANTIlED AS INDICATED ABOVE
3TATISTICAL AND BIOINFORMATICAL ANALYSIS
!LL STATISTICS WERE PERFORMED USING THE 3033 SOFTWARE 3033 )NC #HICAGO
), 53!	 $IFFERENCES BETWEEN GROUPS WERE ANALYZED BY THE 3TUDENTgS
T TESTS /NE WAY AND 4WO WAY !./6! ANALYSES WITH POSTHOC ANALY
SES ONCE NORMALITY OF VARIABLES WAS TESTED BY +OLMOGOROV3MIRNOV TEST
4HE  LEVEL WAS SELECTED AS THE POINT OF MINIMAL STATISTICAL SIGNIl
CANCE IN EVERY COMPARISON &OR INTERACTOMIC ANALYSES WE SELECTED AS INPUT
NODES THE GENES TARDBP AND DBNL AND WE USED THE 'ENE-!.)! SOFTWARE
HTTPWWWGENEMANIAORG	
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Supplemental Figure 1 
A) Representative western blot analyses reveal that chronic excitotoxicity leads to increased amount of syntaxin-3, 
but no major changes in drebrin amount, as quantified in the lower panel. B) Confocal microscopy revealed that 
chronic excitotoxicity induced increased syntaxin-3 immunoreactivity (green upper panels) concurrent with 
diminished SMI-32 immunoreactivity (red, upper panels). This was associated to a loss of drebrin 
compartimentalization  (green, lower panels) since in control conditions anti-drebrin immunohistochemistry was 
distributed into several sizes with small granular-like particles (arrow), without apparent relationship with 
neurofilament marker (Nfl, green). C) The number of smaller particles was much lower in THA-treated spinal cord 
slices, compatible with a loss of drebrin compartimentalization. D) Estimation of desaturase and elongase activities 
in these samples suggest important changes in δ9, δ5 and elongase activities, according the ratios between products 
and precursors. Lower panels in A and D show the densitometric analyses of the above western-blots. Numbers in 
the left of blots show the approximate molecular weight. ***p<0,0001 and ****p<0,00001 between Ctl and THA-
treated organotypic cultures (bars show means±S.E.M. for n=11-15 slices in each condition) by Student’s t test.
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Supplemental Table 1 
 
 
Classification (Lipid Maps) Compound Regulation respect Ctl (at least p<0.05 by Student’s T test) 
Glycerophospholipids 
PS(16:0/18:1) down 
PS(17:0/20:4) down 
PS(18:2/18:0)/ 
PS(18:1/18:1) down 
PS(21:0/22:6) down 
PE(36:1)/PENMe2(44:1) down 
PE(41:0) down 
PE(18:2/18:2) down 
PE(38:0)/PENMe2(36:0) down 
PE(38:1) down 
PE(38:2)/PENMe(36:2) down 
PE(36:0) down 
PE(39:0) down 
PE(44:1) down 
PE(44:0) down 
PE(43:0) down 
PE(O-38:5) down 
PENMe(32:0)/PE(33:0) down 
PENMe(16:0/18:1) down 
PENMe(34:0)/PE (36:0) down 
PG(17:0/20:4) down 
PG(18:1/18:1) down 
PI(16:0/18:1) down 
Sphingolipids 
Cer (d18:1/20:0) down 
Cer(d18:1/22:0) down 
Cer(d18:1/24:1) down 
GlcCer (d18:1/25:0) down 
GlcCer(d18:1/26:0) down 
GlcCer(d18:1/20:0) down 
GlcCer(d18:1/22:0) down 
GlcCer(d18:1/24:0) down 
GlcCer( d18:1/18:0) down 
GlcCer( d18:1/24:1) down 
LacCer (d18:1/20:0) down 
LacCer(d18:1/24:0) down 
SM(d18:1/24:0) down 
SM(d18:1/25:0) down 
C18 Sulfatide down 
C20 Sulfatide down 
C22 Sulfatide down 
C24 Sulfatide down 
C22-OH Sulfatide down 
Ganglioside GM3 
(d18:1/24:1) down 
Trihexosylceramide 
(d18:1/26:1) down 
 
 3 
 
 
Supplemental Table 2. Demographic characteristics of patients studied 
Diagnostic Gender Age Post-mortem 
delay 
ALS F 79 2h 10 min 
ALS F 75 4h 
ALS M 57 4h 
ALS M 64 16h 30 min 
ALS F 76 13 h 
ALS M 76 12h 40m 
ALS M 54 4h 50min 
ALS F 59 14h 15m 
ALS M 71 8h 45m 
ALS F 65 4h 10 min 
Control F 75 6h 10 min 
Control M 76 6h 30 min 
Control M 70 2 h 
Control F 82 3h 5 min 
Control M 76 6h 30min 
Control M 75 3h 25min  
Control M 64 8h 35m 
Control M 68 10h 55 min 
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Abstract The implication of lipid peroxidation in neu-
rodegenerative diseases, including amyotrophic lateral
sclerosis (ALS) derive from high abundance of peroxida-
tion-prone polyunsaturated fatty acids in central nervous
system and its relatively low antioxidant content. In the
present work, we evaluated the effect of dietary changes
aimed to modify fatty acid tissular composition in survival,
disease onset, protein, and DNA oxidative modifications in
the hSODG93A transgenic mice, a model of this motor
neuron disease. Both survival and clinical evolution is
dependent on dietary fatty acid unsaturation and gender,
with high unsaturated diet, leading to loss of the disease-
sparing effect of feminine gender. This was associated with
significant increases in protein carbonyl and glycoxidative
modifications as well as non-nuclear 8-oxo-dG, a marker of
mitochondrial DNA oxidation. Comparison of these data
with cH2AX immunostaining, a marker of DNA damage
response, suggests that the highly unsaturated diet-blunted
mitochondrial–nuclear free radical dependent crosstalk,
since increased 8-oxo-dG was not correlated with increased
DNA damage response. Paradoxically, the highly unsatu-
rated diet led to lower peroxidizability but higher anti-
inflammatory indexes. To sum up, our results demonstrate
that high polyunsaturated fatty acid content in diets may
accelerate the disease in this model. Further, these results
reinforce the need for adequately defining gender as a
relevant factor in ALS models, as well as to use structurally
characterized markers for oxidative damage assessment in
neurodegeneration.
Keywords Oxidative stress  Polyunsaturated fatty acid 
DNA repair response  Gender dimorphism  Lipid
peroxidation
Introduction
Amyotrophic lateral sclerosis (ALS, OMIM #105400) is a
neurodegenerative, motor neuron-specific disease that
causes death within 2–5 years after diagnosis. ALS spo-
radic forms account for most of the cases and despite much
effort have been done, their causes remain unclear. How-
ever, familial forms of the disease (fALS) provide a
valuable tool for the development of animal models to gain
insight into disease mechanisms and therapy design,
especially at preclinical stages. A breakthrough point in
this line was the discovery by Rosen (1993), showing that
mutations in Cu/ZnSOD were a primary cause for ALS.
Since then, multiple mutations on Cu/ZnSOD (more than
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100, reviewed in Gaudette et al. 2000) have been identified,
thus leading to develop experimental models of fALS
(Gurney et al. 1994; Oeda et al. 2001). In particular,
transgenic mice bearing multiple copies of one of the
fALS-linked mutations, a glycine for alanine substitution
(G93A), has become the most used model to study the
pathogenesis of ALS. Nevertheless, it is known that even a
single mutation harbours an increasing disease complexity
pointing novel roles of specific genes and proteins as dis-
ease modifiers (reviewed in Al-Chalabi et al. 2012).
Lipids account approximately for 50–60 % of the brain
dry weight, from which polyunsaturated accounts around
the 35 % (Lauritzen et al. 2001) being mostly long-chain
polyunsaturated fatty acids (PUFAs). The majority of such
lipids present in the central nervous system are structural,
belonging to phospolipid bilayers in biomembranes. But
apart from structural conformation in phospholipids and
source of energy, lipids play key roles in different vital
complex processes such as signalling. They act not only as
direct messengers by signalling in paracrine communica-
tion but also in helping to correctly position cellular
receptors (e.g. lipid rafts Simons and Toomre 2000) and
also binding responsive elements to regulate DNA
expression (e.g. PPARs; reviewed in Willson et al. 2000).
They could also modulate reactive oxygen species (ROS)
production and interact with those by generating reactive
lipid species, which can be signalling intermediates (Niki
2012). Globally, PUFAs are essential for correct neuronal
function. These data are behind the beneficial effects of an
adequate intake of the n-3 series PUFAs, especially for
DHA (C22:6, n-3). Accordingly, its deficiency leads to
visual, cognitive and/or behavioural abnormalities in sev-
eral animal models (Niu et al. 2004) as well as in humans
(Deckelbaum and Torrejon 2012). DHA signalling is sup-
posed to act: (1) through structural characteristics in lipid
bilayers; (2) by DNA interaction through PPAR related
genes enhancement (Willson et al. 2000); (3) also through
its role as a source of signalling intermediates, since for
instance, DHA is the metabolic source of docosanoids and
resolvins, contrasted inflammatory resolution mediators
(Serhan 2005); (4) and finally by oxidative signalling, since
DHA oxidative derivatives also interact with PPARs family
transcription factors (Itoh and Yamamoto 2008). Note-
worthy, PUFA structure (n-3 vs n-6 families) is relevant,
since they stimulate different genes (Barcelo´-Coblijn et al.
2003) as they share (and therefore compete) biosynthetic
pathways for fatty acid itself, but also for its derivatives.
This adds further complexity to the interaction of PUFA
with central nervous system function.
Asides from these physiological roles, one potentially
detrimental effect of PUFAs arises from their high
susceptibility to oxidation, which is believed to play a
major role in ALS pathogeny (as hypothesized 20 years
ago; (Bowling et al. 1993). An excess of ROS could
interact with any of the surrounding biomolecules within
the cell, ranging from DNA and proteins to lipids or car-
bohydrates, amplifying ROS damage. Particularly, after
oxidative protein damage, several oxidatively modified
amino acids are generated, which can be used as specific
markers of distinct types of oxidative stress: (1) for direct,
metal-catalysed, carbonylation, glutamic and aminoadipic
semi-aldehydes (GSA and AASA); (2) for glycoxidation,
N
P
-carboxymethyl-lysine (CML) and N
P
-carboxyethyl-
lysine (CEL) and finally, (2) for lipoxidation malondial-
dehyde-lysine (MDAL) (Portero-Otin et al. 2003; Thorpe
and Baynes 2003). Similarly, ROS could modify DNA, by
generating specific residues, such as 8-oxo-deoxyguano-
sine, between other (Weimann et al. 2001). In this line,
dietary factors could modify 8-oxo-dG accrual (Zhu et al.
2000). In addition, it has not been studied whether PUFA
intake could modify 8-oxo-DG accumulation in a neuro-
degeneration model, though positive role for dietary fish oil
and vegetable PUFA was recently demonstrated related to
a reduction of 8-oxo-dG accumulation both in colonic
samples for a model of Crohn disease (Bancroft et al. 2003)
or patients suffering type 2 diabetes (Mu¨llner et al. 2013).
Nonetheless, besides cytotoxic effects, a signalling role for
ROS is known. Recent data show a crosstalk between
mitochondrial-free radical production and nuclear DNA
damage response (DDR), mediated by cH2Ax (Passos et al.
2010), involved in cell and tissue homeostasis.
In the present work, we hypothesized that if extensive
lipid composition and its susceptibility to peroxidation
could be modified, ALS progression could be partially
modulated. In this sense, regarding dietary intervention,
previous works from our group showed that the fatty acid
profiles of several organs, including brain, can be modified
as a result of dietary modification (Pamplona et al. 2004),
leading to significant effects in the concentration of protein
oxidative markers. For this reason, in this study, diets with
different degree of unsaturation were designed to evaluate
their effects in the survival of an ALS model. Several diet-
related outcomes (weight gain and lipid composition) as
well as clinical score, coordination/strength (stride length)
and distinct markers for oxidative damage to proteins along
the disease progression were also measured. We also ana-
lysed the potential effect of PUFAs in the crosstalk
between mitochondrial ROS production (assessed by
8-oxo-dG immunostaining) and DDR in lumbar spinal
cords, in order to ascertain the potential role of lipid per-
oxidation and dietary lipid composition in ALS
pathogenesis.
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Methods
Animals and Diets
A colony of the strain B6SJL-Tg (SOD1-G93A)1Gur/J
(JAX catalogue stock number 002726; from now on
hSODG93A) was purchased at The Jackson Laboratories
(Bar Harbor, MN, USA) and maintained in the B6SJL
background, by male founder crossing with B6SJLF1/J. All
mice were genotyped by using PCR-according procedures
stated by the providers. For tail DNA extraction a kit for
tissue DNA extraction was used (XNAT, Sigma-Aldrich,
Saint Louis, MO, USA). PCR amplification was performed
in a 2740 Termal Cycler v2.08 (Applied Biosystems,
Carlsbad, CA, USA) as follows: Pre-denaturation for 5 min
at 95 C, denaturation for 1 min at 94 C, annealing for
45 s at 50 C, elongation for 4 min at 72 C and finally,
after 35 cycles, elongation for another 7 min at 72 C. The
amplification products were stored at 4 C before gel
loading and electrophoresis, which was done in 1 % aga-
rose gels and stained with Sybr safe (Molecular Probes,
Carlsbad, CA, USA) following manufacture instructions.
Products were electrophoresed for 30 min under constant
100 V and images were taken under (302 or 365 nm) UV
light lamp from Alpha Innotech (Santa Clara, CA, USA)
with a software acquisition Alpha Digidoc RT2 (Santa
Clara, CA, USA).
After genotyping and weaning, animals were placed at
12:12 h dark/light cycle, at 22 ± 2 C temperature,
50 % ± 10 relative humidity, in individual cages, using
the experimental diets (at 21 days). Whenever was possible
by litter size of transgenic animals, gender and litter-mat-
ched animals were randomly distributed across the three
diets. Animals were weighted weekly and daily for those
under stride length analysis.
All diets used for experiments were purchased at Harlan
Tekland (Madison, WI, USA) and stored at 4 C until use.
Diet composition was designed to be isocaloric and
essential fatty acids requirements were completed (Table
S3). We randomly assigned individual mice to either high
unsaturated diet (Harlan reference number TD06154) or
low unsaturated diet (Harlan reference number TD06155),
whose compositions were as previously described (Pamp-
lona et al. 2004). Those diets have extreme differences for
peroxidizability indexes (fivefold), content of n-3 fatty
acids (sixfold), content of arachidonic and docosahexanoic
acids (100-fold) and double-bond indexes (threefold), with
control diet values in-between. Importantly, low unsatu-
rated diet does not lead to essential fatty acid deficiency, as
shown by content of the n-3 and n-6 precursors linolenic
and linoleic acids. Food pellets were weighted (for intake
calculations) and removed weekly. As a control group, 40
animals (20 male, 20 female) were maintained and fed with
a regular rodent chow (AIN-93G, Harlan reference number
TD94045) to ascertain survival homogeneity and standard
growing curves. All experimental procedures were
approved by the Institutional Animal Care Committee of
Institut de Recerca Biome`dica de Lleida and were con-
formed to the Directive 2010/63/EU of the European
Parliament.
Disability Score Assessment
Disability scores for both hind legs were assessed weekly
for each mouse from 60 days of age to end point. The
neurological score (Amyotrophic Lateral Sclerosis Therapy
Development Institute and Jackson Laboratories) employed
a scale where 0 points were given when full extension of
hind legs away from lateral midline when mouse was
suspended by its tail; one point when there was a collapse
of leg extension towards midline or trembling of hind legs
during this tail suspension; two points when toes
curled under at least twice during walking of 12 inch., or
any part of foot was dragging along cage bottom/table;
three points when it was present a rigid paralysis or min-
imal joint movement, foot not being used for forward
motion and four points when mouse was not able to right
itself within 30 s from either side (that was the endpoint of
the measurement). Disease onset was considered the age at
which an animal scored 2 in the above mentioned test.
Observators for score were blinded to both diet and data
analyses.
Stride Length Analysis
Stride length measurement was adopted from previously
reported methods (Chiu et al. 1995). All animals were
trained to walk freely along a U-shaped flat narrow corridor
(5 cm wide, 70 cm long) three times per week before data
collection (average age 70 days). Once trained, hindlimbs
were stained with non-toxic poster children paints and their
tracks were imprinted on paper (labelled with only with
animal number and date) lining the floor of the corridor.
Only continuous runs were measured among recorded and
a minimum of 5–7 strides were measured per animal per
day (three non-consecutive day measures were taken along
week) to obtain daily mean. Since animals tended to walk
faster when released and went slower at the end of the
corridor, those areas were discarded for the stride mea-
sures, which were taken manually and were defined as the
distance between successive right-to-right and left-to-left
footprints. As the disease progresses, the painted footprints
became increasingly smeared on the paper, which corre-
lated with previous results (Chiu et al. 1995). Loss of stride
length was quantified by determining the age at which
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shortening of the stride length was lower than 10 % for two
consecutive measures. Measurement of stride length was
determined in a blinded manner since only number
of the randomized animal and date identified the recorded
tracks.
Analytical Measurements
Animals, after being fasted overnight, were anesthetised
with 2.5 % isoflurane in air and finally sacrificed. Spinal
cords and brain were rapidly excised, frozen in liquid N2
and stored at -80 C until further analyses. Samples were
homogenized on ice in a buffer containing 180 mM KCl,
5 mM MOPS, 2 mM EDTA, 1 mM diethylene-
triaminepentaacetic acid, and 1 lM of freshly prepared
butylated hydroxyl toluene at pH 7.3 using a homogenizer
device (T10 basic UltraTurraX, IKA, Staufen, Germany).
Protein concentrations were measured by the Bradford
method.
Measurement of Protein Oxidative (GSA, AASA),
Glycoxidative (CML, CEL) and Lipoxidative (MDAL)
Modifications
Gas chromatography–mass spectrometry (GC/MS) mea-
surements of GSA, AASA, CEL, CML, and MDAL con-
centrations in total proteins from mice lumbar spinal cord
homogenates were measured as routinely performed in our
laboratory (Pamplona et al. 2005).Samples containing
0.5 mg of protein were delipidated using chloroform/
methanol (2:1, v/v) (see below), and proteins were pre-
cipitated by adding 10 % trichloroacetic acid (final con-
centration) and subsequent centrifugation. Protein samples
were reduced overnight with 500 mM NaBH4 (final con-
centration) in 0.2 M borate buffer, pH 9.2, containing 1
drop of hexanol as an anti-foam reagent. Proteins were then
precipitated by adding 1 ml of 20 % trichloroacetic acid
and subsequent centrifugation. The following isotopically
labelled internal standards were then added: [2H8]lysine
(d8-Lys; CDN Isotopes); [2H4]CML (d4-CML), [2H4]CEL
(d4-CEL), [2H8]MDAL (d8-MDAL), [2H5]5-hydroxy-2-
aminovaleric acid (for GSA quantitation) and [2H4]6-
hydroxy-2-aminocaproic acid (for AASA quantitation).
The samples were hydrolyzed at 155 C for 30 min in 1 ml
of 6 N HCl, and then dried in vacuo. The N,O-trifluoro-
acetyl methyl ester derivatives of the protein hydrolysate
were prepared as previously described (Pamplona et al.
2005). Then, GC/MS analyses were carried out on a Agi-
lent model 6890 gas chromatograph equipped with a 30-m
HP-5MS capillary column (30 m 9 0.25 mm 9 0.25 lm)
coupled to a Agilent model 5973A mass selective detector
(Agilent, Barcelona, Spain). The injection port was
maintained at 275 C; the temperature programme was
5 min at 110 C, then 2 C/min to 150 C, then 5 C/min
to 240 C, then 25 C/min to 300 C, and finally hold at
300 C for 5 min. Quantification was performed by exter-
nal standardization using standard curves constructed from
mixtures of deuterated and non-deuterated standards.
Analytes were detected by selected ion-monitoring GC/
MS. The ions used were: lysine and d8-lysine, m/z 180 and
187, respectively; 5-hydroxy-2-aminovaleric acid and
d5–5-hydroxy-2-aminovaleric acid (stable derivatives of
GSA), m/z 280 and 285, respectively; 6-hydroxy-2-ami-
nocaproic acid and d4–6-hydroxy-2-aminocaproic acid
(stable derivatives of AASA), m/z 294 and 298, respec-
tively; CML and d4-CML, m/z 392 and 396, respectively;
CEL and d4-CEL, m/z 379 and 383, respectively; and
MDAL and d8-MDAL, m/z 474 and 482, respectively. The
amounts of products were expressed as the ratio micro-
molar of GSA, AASA, CML, CEL, or MDAL/mol of
lysine.
Fatty Acid Compositional Analyses
Fatty acid analysis in tissue samples and diets was per-
formed as previously described (Pamplona et al. 2005).
Total lipids from homogenates were extracted with chlo-
roform/methanol (2:1, v/v) (3 times) in the presence of
0.01 % butylated hydroxytoluene. The chloroform phase
was evaporated under nitrogen, and the fatty acids were
transesterified by incubation in 2 ml of 5 % methanolic
HCl for 90 min at 75 C. The resulting fatty acid methyl
esters were extracted by adding 2 ml of n-pentane and 1 ml
of saturated NaCl solution. The n-pentane phase was sep-
arated, evaporated under nitrogen, re-dissolved in 80 ll of
carbon disulphide, and 2 ll was used for GC analysis.
Separation was performed by a DBWAX capillary column
(30 m 9 0.25 mm 9 0.20 lm) in an Agilent GC System
7890A with a Series Injector 7683B and a FID detector
(Agilent Technologies, Barcelona, Spain). The injection
port was maintained at 220 C, and the detector at 250 C;
the temperature programme was 2 min at 100 C, then
10 C/min to 200 C, then 5 C/min to 240 C and finally
hold at 240 C for 10 min. Identification of fatty acid
methyl esters was made by comparison with authentic
standards (Larodan Fine Chemicals, Malmo¨, Sweden).
Results are expressed as mol%.
From particular fatty acids, the following indexes were
calculated as previously described (Pamplona et al. 2005).
Saturated fatty acids (SFA) = R % of saturated fatty acids;
unsaturated fatty acids (UFA) = R % unsaturated fatty
acids; monounsaturated fatty acids (MUFA) = R % of
monoenoic fatty acids; polyunsaturated fatty acids series
n-3 (PUFAn-3) = R % of polyunsaturated fatty acids n-3
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series; polyunsaturated fatty acids series n-6 (PUFAn-
6) = R % of polyunsaturated fatty acids n-6 series; average
chain length (ACL) = [(R % Total 14 9 14) ?  ? (R %
totaln 9 n)]/100 (n = carbon atom number); peroxidiz-
ability index (PI) = [(R mol% monoenoic 9 0.025) ? (R
mol% dienoic 9 1) ? (R mol% trienoic 9 2) ? (R mol%
tetraenoic 9 4) ? (R mol% pentaenoic 9 6) ? (R mol%
hexaenoic 9 8)]; Double-bond index (DBI) = [(R mol%
monoenoic) ? (2 9 R mol% dienoic) ? (3 9 R mol%
trienoic) ? (4 9 R % mol tetraenoic) ? (5 9 R mol%
pentaenoic) ? (6 9 R mol% hexaenoic); Antinflamatory
index (AI) = (20:3n-6) ? (20:5n-3) ? (22:5n-3) ?(22:6n-
3)/(20:4n-6); ratio PUFAs = (PUFAn-3)/(PUFAn-6).
Immunohistochemistry
Selected animals were anaesthetized by intraperitoneal
injection (pentobarbital and ketamine, 20 and 60 mg/kg
respectively on PBS). Animals were therefore exsangui-
nated by perfusion, firstly with saline solution (4 C) and
thereafter with ice cold 0.4 % paraformaldeyde (Sigma-
Aldrich, Saint Louis, MO, USA) solution (freshly prepared
with pH 7.4 phosphate buffer). After tissue collection
(spinal cord) samples were immersed for 24 h in the same
fixative to assure preservation. Samples were thereafter
immersed in 30 % sucrose, (made in pH 7.4 phosphate
buffer) for 48 h to achieve cryopreservation. Tissue was
encased in a cubic recipient (Peel-A-Way Disposable
Embeding Molds-S-22, Polysciences Inc., Warrington, PA,
USA), labelled and embedded in tissue freezing medium
(Triangle Biomedical Sciences Inc., Newcastle, UK) for
easily cutting and better preservation and finally frozen
(-80 C). For immunofluorescence, 16 lm wide sections
of lumbar spinal cord were cut and carefully seeded along
gelatine-coated slide. Selected sections were permeabilized
with 0.4 % Triton 9-100 PBS. After blocking with 5 %
normal horse serum in 0.4 % Triton 9-100 PBS for 2 h at
room temperature (RT), the tissue was incubated for 24 h
at 4 C with the primary antibodies. Next day, the slices
were washed with PBS three times for 10 min at RT. Then,
the slices were incubated for 1 h at RT in darkness with
corresponding secondary antibodies. Sections were finally
counterstained with 4,6-diamidino-2-phenylindole dihy-
drochloride (DAPI, 1 ug/ml) in PBS for 5 min at RT and
mounted on slides with Vectashield (Vector Laboratories,
Burlingame, CA, USA). In selected sections primary anti-
body was omitted to assure labelling specificity. Mounted
slices were examined under a Fluoview 500 Olympus
confocal laser scanning microscope (Olympus, Hamburg,
Germany). For quantification of anti-ubiquitin, anti-syn-
taxin3 and anti-cH2Ax immunoreactivity images were
analysed with the Image J software (http://rsbweb.nih.gov/
ij/).
Statistical Analyses
All statistics were performed using the SPSS software
(SPSS Inc., Chicago, IL, USA) or the Prism software
(GraphPad Software, San Diego, CA, USA). Differences
between groups were analysed by the Student’s T tests or
ANOVA with post hoc analyses, after normality of variable
distribution was ensured by Kolmogorov–Smirnov test.
Correlations between variables were evaluated by the
Pearson’s statistic. The 0.05 level was selected as the point
of minimal statistical significance in every comparison.
Results
Survival and Clinical Evolution of ALS G93A Mice is
Modified by Dietary Fatty Acid Unsaturation
in a Gender-Specific Fashion
When compared with a regular rodent chow, low unsatu-
ration in diet diminishes gender-related influence on med-
ian survival (Fig. 1a and Supplemental Figure 1). Survival
analyses taking diet into account show that under control
diet females survived longer (Fig. 1b), a fact maintained
under low unsaturated diets (Fig. 1c), but not under high
unsaturated diets (Fig. 1d). For males, results (Supple-
mental Figure 1) show that survival was highest in animals
under low unsaturated diets (p \ 0.05 for Log rank test),
while as differences in females were not significant.
Phenotypic analyses for disease onset (as assessed both
by a clinical score and stride length loss) revealed a similar
trend: global analyses show that dietary fats did not affect
disease onset (Fig. 1e). In contrast with survival, where
feminine gender showed an evident protective effect under
control diets, these diets did not show differences in disease
onset (Fig. 1f). In contrast, low unsaturated diet delayed
significantly disease onset in females (Fig. 1g), in contrast
with highly unsaturated diet (Fig. 1h). If performed sepa-
rately, no major differences were evidenced neither in
males nor in females (Supplemental Figure 1). When
evaluating loss of stride length preservation (defined by a
consecutive decay of at least 10 % in stride length), we
found that males under highly unsaturated diet reached this
stage faster than those under low unsaturated or control
ones (Fig. 1i). However, this phenomenon was not present
in females (Fig. 1j). Rather, it appeared that both low and
high unsaturated diets enhanced stride length preservation
significantly in females, in comparison with control diets.
Food intake calculations were similar between dietary
groups and comparable with a control diets with no major
statistical differences along the experiment (data not
shown). Mice gained weight as expected (Fig. 1k, l),
reaching a maximum value at 100 days for males,
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Fig. 1 Dietary fatty acid unsaturation induces a gender-specific
effect in survival in the hSODG93A ALS mice model. a Low
unsaturated fats (see text for description) maintained gender-related
differences in median survival (seen under control conditions), while
high unsaturated diet diminished this gender-induced difference.
b Further, survival and gender-specific analyses demonstrated that
under control (b) or low unsaturated diet (c), females lived longer
than males, in contrast with the high unsaturation diet (d). Similarly,
disease onset, as defined by changes in clinical score in the
‘‘Methods’’ section, was not affected by dietary fat unsaturation, as
shown by global analyses (e). Disease onset in males was not affected
by diets (f), in contrast with females (g) with significant differences
(p \ 0.05 by or that with high unsaturation (h). In line with this,
disease progression proceeded faster in males under high unsaturation
(i), while females were protected against this effect (j). Effects of
dietary unsaturation in weight gain were similar for both genders (k,
l). Males reached a maximum (23.04 ± 0.370 g, n = 22;
21.85 ± 0.559 g, n = 22; 20.83 ± 0.8 g, n = 12 for high, low and
control unsaturation diets, respectively) at 100 days, meanwhile
females did it at 100 days for ones under high unsaturation and
control (18.69 ± 0.327 g, n = 22; 17.9 ± 0.62 g, n = 13) and at
97 days those on low unsaturated diet (18.70 ± 0.270 g, n = 28).
m Confocal microscopy images in lumbar spinal cord demonstrating
increased biological availability of dietary unsaturated fatty acids in
male animals (endpoint: 130 ± 7 days) as suggested by increased
syntaxin-3 immunostaining, quantified in the whiskers plot in the left
panel. In a asterisk indicates statistical differences between males and
females survival by Bonferroni multiple test post hoc analyses after
2-way ANOVA. For b–j significant differences between diets and/or
genders were evaluated by Kaplan–Meier survival statistic
(*p \ 0.05; **p \ 0.001). For k and l * and asignificant differences
by 2-way ANOVA of diet and age effects, respectively, while as
bsignificant increases in weight at 50–80 days in males under high
unsaturated diets by Bonferroni multiple test post hoc analyses after
2-way ANOVA. A total of 30 slices (n = 3 animals per treatment)
were analysed for quantification in m, with differences induced by
diet being evaluated by Student’s T test. Bars in m are 500 lm
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irrespectively of diet; meanwhile, females reached a max-
imum at 100 days for those under high unsaturated and
control diets and at 97 days on low unsaturated one. Males
under high unsaturated diet weighted significantly more
than those of control during preclinical stages (from day 50
to day 75) (Fig. 1k, l).
To confirm fatty acid bioavailability, we measured both
lipid composition and surrogate markers of n-3 availability.
Since the profile of fatty acids in control-fed animals
resemble strongly those present in low unsaturation diets
(Supplemental Table 1 and 2), we focused to differences
between high and low unsaturation fed animals. Thus, lipid
profiles in brain (Table 1) and spinal cord (Tables 2, 3)
revealed that in this latter, the concentration of arachidonic
acid (AA, 22:4n-6), under low unsaturation, was higher
than those found in high unsaturated ones. In contrast, a
major fatty acid (18:0) responsible for approximately 40 %
of the total fatty acids measured was not affected by the
diet.
Similarly, DHA levels were not severely altered. Anti-
inflammatory index (AI) was always higher for animals
under highly unsaturated diet independently of tissue or
gender, including those from control-fed animals
(Tables 1, 2, 3, Supplemental Tables 1 and 2). Double-
bound (DBI) and peroxidizability (PI) indexes both
reflecting susceptibility for lipid peroxidation were found
Table 1 Fatty acid composition
(% of abundance) and derived
indexes for whole brain
homogenate (60 days)
p value reflects statistical
significance between diets by
Student’s T test
Male hSODG93A Female hSODG93A
High unsat Low unsat p value High unsat Low unsat p value
14:0 0.317 ± 0.092 0.542 ± 0.121 0.190 0.260 ± 0.027 0.420 ± 0.123 0.137
16:0 24.47 ± 0.592 16.32 ± 0.273 0.001 24.44 ± 0.239 13.05 ± 0.233 0.001
16:1n-7 0.593 ± 0. 038 0.535 ± 0.099 0.604 0.556 ± 0. 046 0.203 ± 0.114 0.024
18:0 22.67 ± 0.198 24.26 ± 1.177 0.230 23.21 ± 1.413 20.73 ± 1.701 0.352
18:1n-9 21.95 ± 0.848 22.00 ± 0.856 0.967 20.74 ± 0.521 18.82 ± 1.345 0.167
18:2n-6 0.690 ± 0.072 0.725 ± 0.053 0.732 0.621 ± 0.107 0.554 ± 0.077 0.698
18:3n-3 0.089 ± 0.010 0.035 ± 0.019 0.031 0.066 ± 0.085 0.446 ± 0.258 0.077
18:4n-6 0.905 ± 0.325 2.23 ± 0.130 0.009 0.685 ± 0.133 1.944 ± 0.385 0.015
20:0 0.365 ± 0.090 0.555 ± 0.048 0.100 0.330 ± 0.007 0.383 ± 0.008 0.384
20:1 n-9 1.142 ± 0.113 1.516 ± 0.140 0.084 1.203 ± 0.062 1.426 ± 0.520 0.538
20:2n-6 0.430 ± 0.145 0.726 ± 0.134 0.185 0.241 ± 0.015 0.948 ± 0.021 0.092
20:3n-6 0.094 ± 0.012 0.072 ± 0.018 0.175 0.081 ± 0.006 0.590 ± 0.329 0.066
20:4n-6 8.44 ± 0.796 10.09 ± 0.869 0.212 8.219 ± 0.255 8.965 ± 0.153 0.132
20:5n-3 0.276 ± 0.114 0.161 ± 0.073 0.440 0.314 ± 0.008 0.868 ± 0.427 0.103
22:0 1.522 ± 0.293 1.935 ± 0.197 0.289 0.478 ± 0.083 1.472 ± 0.122 0.002
22:4n-6 2.065 ± 0.339 2.976 ± 0.425 0.144 1.557 ± 0.065 2.567 ± 0.025 0.001
22:5n-6 0.365 ± 0.071 0.925 ± 0.186 0.030 0.363 ± 0.011 0.690 ± 0.011 0.001
22:5n-3 0.420 ± 0.018 0.680 ± 0.190 0.222 0.411 ± 0.005 1.177 ± 0.275 0.011
24:0 0.075 ± 0.015 0.152 ± 0.050 0.164 0.039 ± 0.006 0.769 ± 0.073 0.001
22:6n-3 12.741 ± 1.088 12.33 ± 1.807 0.654 15.77 ± 0.530 13.32 ± 0.619 0.039
24:5n-3 0.150 ± 0.049 0.485 ± 0.180 0.125 0.064 ± 0.016 0.928 ± 0.359 0.018
24:6n-3 0.290 ± 0.022 0.430 ± 0.115 0.279 0.325 ± 0.053 0.711 ± 0.175 0.045
SFA 49.46 ± 0.736 43.83 ± 1.402 0.012 48.77 ± 1.210 36.84 ± 1.625 0.004
UFA 50.06 ± 0.736 55.93 ± 1.345 0.013 51.22 ± 1.201 54.15 ± 0.128 0.130
MUFA 23.68 ± 0.760 24.07 ± 1.000 0.779 22.50 ± 0.576 20.45 ± 0.943 0.121
PUFA 26.87 ± 1.344 31.86 ± 2.238 0.105 28.72 ± 0.798 33.20 ± 1.071 0.016
PUFAn-3 13.98 ± 1.086 14.13 ± 1.049 0.917 16.95 ± 0.530 17.44 ± 0.901 0.637
PUFAn-6 13.10 ± 1.421 17.73 ± 1.221 0.045 11.77 ± 0.295 16.75 ± 0.169 0.001
ACL 18.43 ± 0.048 18.68 ± 0.798 0.209 18.46 ± 0.027 17.37 ± 0.247 0.005
DBI 156.97 ± 8.64 176.21 ± 10.10 0.133 168.88 ± 4.67 183.96 ± 2.85 0.105
PI 159.75 ± 11.6 179.91 ± 13.18 0.237 179.27 ± 4.40 192.71 ± 3.33 0.185
R/PUFAs 1.120 ± 0.155 0.795 ± 0.020 0.084 1.440 ± 0.023 1.071 ± 0.043 0.003
AI 163.04 ± 18.5 131.73 ± 9.19 0.192 200.74 ± 2.88 171.38 ± 2.18 0.001
Neuromol Med
123
T
a
b
le
2
F
at
ty
ac
id
co
m
p
o
si
ti
o
n
(%
o
f
ab
u
n
d
an
ce
)
an
d
d
er
iv
ed
in
d
ex
es
in
sp
in
al
co
rd
(l
u
m
b
ar
re
g
io
n
)
fo
r
m
al
e
h
S
O
D
G
9
3
A
6
0
d
ay
s
9
0
d
ay
s
1
2
0
d
ay
s
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
1
4
:0
0
.8
3
0
±
0
.0
8
5
0
.8
2
4
±
0
.0
3
5
0
.9
5
4
0
.1
7
1
±
0
.0
1
4
0
.4
5
4
±
0
.0
6
4
0
.0
0
6
0
.2
0
2
±
0
.0
2
1
0
.6
9
6
±
0
.1
0
0
.0
0
3
1
6
:0
2
1
.4
1
1
±
0
.3
7
3
1
9
.9
3
4
±
0
.4
0
3
0
.0
2
2
2
2
.3
3
±
2
.3
7
2
2
6
.5
7
±
0
.3
9
1
0
.0
8
7
2
2
.6
5
±
1
.1
7
1
2
0
.5
4
±
0
.6
2
4
0
.1
3
0
1
6
:1
n
-7
0
.8
3
8
±
0
.1
2
4
0
.8
4
2
±
0
.0
4
2
0
.9
7
4
0
.5
5
8
±
0
.0
7
6
0
.7
1
5
±
0
.0
4
9
0
.1
1
4
0
.8
0
6
±
0
.1
9
5
1
.0
1
1
±
0
.0
7
5
0
.3
2
1
1
8
:0
1
5
.5
2
8
±
0
.5
0
4
1
6
.1
6
0
±
0
.3
8
8
0
.3
3
5
1
5
.8
6
±
1
.0
5
6
1
6
.5
9
±
1
.6
8
1
0
.7
4
2
1
6
.1
6
9
±
0
.8
8
5
1
5
.6
1
±
0
.6
1
1
0
.6
1
2
1
8
:1
n
-9
3
7
.0
6
5
±
0
.7
0
6
3
5
.9
4
±
0
.4
8
0
0
.2
0
4
3
8
.7
6
±
1
.5
7
2
3
3
.0
3
±
1
.8
6
5
0
.0
5
8
3
8
.6
6
5
±
0
.5
8
1
3
6
.5
7
5
±
0
.4
0
1
0
.0
1
4
1
8
:2
n
-6
1
.5
2
9
±
0
.2
4
4
1
.4
2
9
±
0
.0
9
4
0
.6
9
2
1
.0
0
2
±
0
.3
0
2
0
.9
7
8
±
0
.0
4
0
0
.9
3
1
0
.9
0
3
±
0
.0
3
1
1
.2
9
6
±
0
.1
1
0
.0
1
3
1
8
:3
n
-3
0
.1
9
8
±
0
.0
5
1
0
.1
7
7
±
0
.0
2
7
0
.7
1
2
0
.1
0
1
±
0
.0
1
3
0
.1
6
4
±
0
.0
3
3
0
.1
4
1
0
.1
3
7
±
0
.0
2
8
0
.4
4
9
±
0
.0
6
3
0
.0
0
3
1
8
:4
n
-6
0
.3
9
5
±
0
.0
6
7
0
.4
5
6
±
0
.0
6
1
0
.5
1
9
0
.1
1
0
±
0
.0
5
0
0
.2
0
5
±
0
.0
5
5
0
.2
6
2
0
.1
6
6
±
0
.0
4
6
0
.5
2
1
±
0
.1
0
4
0
.0
1
8
2
0
:0
1
.6
0
8
±
0
.1
0
7
1
.6
9
±
0
.0
9
2
0
.5
6
9
1
.4
6
7
±
0
.0
4
2
1
.5
2
8
±
0
.0
8
2
0
.5
6
4
1
.2
7
3
±
0
.1
2
5
1
.1
9
8
±
0
.0
9
4
0
.6
3
7
2
0
:2
n
-6
0
.6
8
3
±
0
.0
4
1
1
.0
9
2
±
0
.0
7
6
0
.0
0
1
0
.4
4
7
±
0
.0
6
5
0
.7
2
1
±
0
.0
4
5
0
.0
1
0
0
.5
5
7
±
0
.0
3
6
0
.7
2
0
±
0
.1
0
7
0
.2
1
9
2
0
:3
n
-6
2
.0
0
7
±
0
.3
7
1
2
.2
6
9
±
0
.2
1
6
0
.5
4
3
1
.3
4
5
±
0
.1
8
9
1
.1
9
9
±
0
.1
8
0
0
.5
9
8
1
.6
7
1
±
0
.0
9
6
1
.9
6
8
±
0
.2
2
2
0
.2
8
3
2
0
:4
n
-6
4
.3
9
4
±
0
.1
3
9
5
.9
1
7
±
0
.1
2
7
0
.0
0
1
4
.7
3
8
±
0
.2
8
9
5
.2
9
6
±
0
.1
2
6
0
.0
9
8
4
.4
1
9
±
0
.0
5
5
5
.6
3
7
±
0
.3
2
7
0
.0
0
9
2
0
:5
n
-3
0
.2
7
1
±
0
.0
2
1
0
.0
9
4
±
0
.0
1
3
0
.0
0
1
0
.0
4
8
±
0
.0
1
3
0
.0
9
4
±
0
.0
1
4
0
.0
5
7
0
.4
9
3
±
0
.0
6
2
0
.6
2
2
±
0
.1
1
3
0
.3
1
7
2
2
:0
0
.2
6
4
±
0
.0
7
0
0
.1
5
1
±
0
.0
2
3
0
.1
3
2
0
.1
1
4
±
0
.0
1
8
0
.3
8
9
±
0
.0
6
7
0
.0
1
0
0
.3
2
1
±
0
.0
3
4
0
.6
3
5
±
0
.0
5
2
0
.0
0
1
2
2
:4
n
-6
1
.6
1
6
±
0
.1
0
1
2
.2
9
2
±
0
.0
4
2
0
.0
0
1
1
.3
9
5
±
0
.0
8
8
4
2
.2
6
0
±
0
.1
2
6
0
.0
0
1
1
.1
2
6
±
0
.0
5
0
2
.2
3
4
±
0
.0
7
3
0
.0
0
1
2
2
:5
n
-6
0
.4
1
5
±
0
.0
7
5
0
.5
6
9
±
0
.0
4
4
0
.0
9
4
0
.2
4
9
±
0
.0
8
9
0
.2
8
7
±
0
.0
4
1
0
.6
9
4
0
.2
7
3
±
0
.0
3
3
0
.6
9
1
±
0
.1
1
2
0
.0
1
0
2
2
:5
n
-3
0
.5
4
3
±
0
.0
9
7
0
.4
1
2
±
0
.0
6
4
0
.2
7
5
0
.9
9
8
±
0
.1
2
1
0
.2
8
9
±
0
.0
4
2
0
.0
0
1
0
.9
4
8
±
0
.0
6
2
0
.4
8
7
±
0
.0
3
3
0
.0
0
1
2
4
:0
0
.1
1
7
±
0
.0
1
1
0
.2
0
9
±
0
.0
2
6
0
.0
0
7
0
.6
3
0
±
0
.0
1
7
0
.0
5
5
±
0
.0
2
7
0
.0
0
1
0
.1
7
8
±
0
.0
2
4
0
.0
3
9
±
0
.0
1
6
0
.0
0
1
2
2
:6
n
-3
7
.9
3
0
±
0
.4
8
2
6
.9
5
4
±
0
.2
3
3
0
.0
8
3
7
.5
8
7
±
0
.3
5
6
6
.6
2
0
±
0
.2
7
8
0
.0
6
6
6
.3
6
2
±
0
.1
1
7
6
.2
6
9
±
0
.1
7
3
0
.6
8
3
2
4
:5
n
-3
0
.0
5
3
±
0
.0
0
4
0
.0
5
4
±
0
.0
0
4
0
.8
8
7
0
.0
9
5
±
0
.0
4
7
0
.0
9
8
±
0
.0
1
4
0
.9
4
3
0
.1
5
8
±
0
.0
2
7
0
.3
7
7
±
0
.1
0
8
0
.0
5
8
2
4
:6
n
-3
2
.3
0
0
±
0
.1
7
2
2
.5
2
2
±
0
.1
0
1
0
.2
7
5
2
.1
5
1
±
0
.0
6
5
2
.4
4
0
±
0
.1
3
4
0
.1
2
0
2
.5
4
2
±
0
.1
6
0
2
.4
0
0
±
0
.1
3
4
0
.5
1
2
S
F
A
3
9
.7
5
6
±
0
.7
0
2
3
8
.9
7
2
±
0
.6
3
6
0
.4
2
5
4
0
.5
8
±
1
.9
7
0
4
5
.5
9
±
1
.7
5
4
0
.0
9
9
4
0
.7
9
6
±
0
.7
8
1
3
8
.7
3
±
0
.4
5
8
0
.0
4
2
U
F
A
6
0
.2
4
3
±
0
.7
0
2
6
1
.0
2
7
±
0
.6
3
6
0
.4
2
1
5
9
.5
9
±
2
.1
2
3
5
4
.4
0
±
1
.7
5
4
0
.0
9
8
5
9
.2
0
3
±
0
.7
8
1
6
1
.2
6
2
±
0
.4
5
8
0
.0
5
1
M
U
F
A
3
7
.9
0
±
0
.6
7
4
3
6
.7
8
±
0
.5
0
6
0
.2
0
4
3
9
.3
2
±
1
.4
9
3
3
.7
5
±
1
.8
5
0
.0
5
9
3
9
.4
7
1
±
0
.6
5
9
3
7
.5
8
6
±
0
.3
3
7
0
.0
2
5
P
U
F
A
2
2
.3
3
±
0
.2
6
1
2
4
.2
4
±
0
.3
9
4
0
.0
0
3
2
0
.2
7
±
0
.9
5
8
2
0
.6
5
±
0
.2
7
4
0
.5
1
2
1
9
.7
5
±
0
.2
1
2
2
3
.6
7
6
±
0
.7
1
0
.0
0
1
P
U
F
A
n
-3
1
1
.2
9
±
0
.1
6
4
1
0
.2
1
±
0
.0
8
4
0
.1
2
3
1
1
.6
2
±
0
.3
1
8
9
.2
8
±
0
.1
0
9
0
.0
0
5
1
0
.8
3
±
0
.2
5
9
1
0
.5
9
±
0
.1
6
9
0
.4
1
3
P
U
F
A
n
-6
1
1
.0
4
±
0
.6
6
1
1
4
.0
2
±
0
.5
1
2
0
.0
0
4
9
.2
8
9
±
0
.8
3
3
1
0
.9
4
±
0
.1
4
4
0
.0
6
3
9
.1
1
6
±
0
.2
0
9
1
3
.0
6
±
0
.6
3
2
0
.0
0
1
A
C
L
1
8
.2
7
±
0
.0
3
0
1
8
.3
5
±
0
.0
1
0
0
.0
2
9
1
8
.3
1
±
0
.0
8
5
1
8
.1
6
±
0
.0
0
8
0
.0
8
1
1
8
.2
2
±
0
.0
2
4
1
8
.3
1
±
0
.0
1
7
0
.0
1
9
D
B
I
1
4
2
.3
7
±
1
.9
2
1
4
6
.3
5
±
1
.1
7
0
.0
9
5
1
3
6
.9
3
±
4
.3
5
1
3
0
.4
9
±
1
.6
9
0
.1
7
2
1
3
3
.3
2
±
1
.5
0
1
4
5
.3
6
±
2
.0
8
0
.0
0
1
P
I
1
2
2
.8
2
±
3
.8
6
1
2
5
.6
4
±
1
.6
4
0
.4
8
2
1
1
6
.5
1
±
3
.7
4
1
1
3
.4
0
±
2
.0
6
0
.5
3
8
1
1
1
.3
2
±
1
.6
0
1
2
3
.5
6
±
2
.0
6
0
.0
0
2
R
/P
U
F
A
s
1
.0
6
7
±
0
.1
4
1
0
.7
3
5
±
0
.0
4
1
0
.0
3
8
1
.2
7
0
±
0
.1
3
1
0
.8
7
7
±
0
.0
8
0
0
.0
0
6
1
.1
9
0
±
0
.0
2
2
0
.8
7
2
±
0
.0
0
9
0
.0
0
2
A
I
2
4
5
.3
5
±
7
.4
1
1
6
4
.6
±
2
.9
1
0
.0
0
1
2
1
1
.5
4
±
6
.2
6
1
5
5
.1
1
±
3
.1
2
0
.0
0
1
2
1
4
.5
0
±
3
.5
4
1
6
9
.4
±
1
3
.3
4
0
.0
1
6
p
v
al
u
e
re
fl
ec
ts
st
at
is
ti
ca
l
si
g
n
ifi
ca
n
ce
b
et
w
ee
n
d
ie
ts
b
y
S
tu
d
en
t’
s
T
te
st
Neuromol Med
123
T
a
b
le
3
F
at
ty
ac
id
co
m
p
o
si
ti
o
n
(%
o
f
ab
u
n
d
an
ce
)
an
d
d
er
iv
ed
in
d
ex
es
in
sp
in
al
co
rd
(l
u
m
b
ar
re
g
io
n
)
fo
r
fe
m
al
e
h
S
O
D
G
9
3
A
6
0
d
ay
s
9
0
d
ay
s
1
2
0
d
ay
s
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
H
ig
h
u
n
sa
t
L
o
w
u
n
sa
t
p
v
al
u
e
1
4
:0
0
.7
9
3
±
0
.0
6
8
0
.7
6
1
±
0
.0
2
5
0
.7
1
5
0
.2
0
4
±
0
.0
1
2
0
.3
6
4
±
0
.0
4
5
0
.0
1
0
0
.3
2
5
±
0
.0
4
0
0
.2
4
6
±
0
.0
1
8
0
.1
1
4
1
6
:0
2
1
.3
6
±
0
.5
1
4
1
9
.8
2
±
0
.5
0
5
0
.0
6
6
2
0
.3
0
±
0
.7
0
6
2
4
.9
6
±
0
.6
9
1
0
.0
0
2
2
1
.6
1
6
±
0
.4
6
2
2
1
.7
3
0
±
0
.1
9
9
0
.8
2
7
1
6
:1
n
-7
0
.9
0
4
±
0
.1
0
0
0
.7
4
9
±
0
.0
7
1
0
.2
7
8
0
.5
8
3
±
0
.0
2
4
0
.7
0
3
±
0
.0
4
3
0
.0
4
3
0
.9
2
0
±
0
.0
5
9
0
.8
6
9
±
0
.0
3
7
0
.4
8
8
1
8
:0
1
5
.9
0
±
0
.4
7
3
1
6
.4
4
±
0
.1
7
4
0
.3
7
9
1
8
.9
6
0
±
0
.3
2
7
1
6
.9
6
9
±
0
.2
7
3
0
.0
0
2
1
6
.4
7
6
±
0
.3
5
4
1
7
.4
9
9
±
0
.2
8
7
0
.0
5
5
1
8
:1
n
-9
3
6
.3
0
±
0
.4
8
5
3
6
.8
9
±
0
.4
5
5
0
.4
1
3
3
9
.4
5
±
0
.3
8
4
3
4
.0
3
±
0
.7
2
5
0
.0
0
1
3
9
.1
1
6
±
0
.5
5
5
3
7
.3
3
8
±
0
.3
2
5
0
.0
2
5
1
8
:2
n
-6
1
.4
0
1
±
0
.0
5
7
1
.4
1
5
±
0
.0
4
8
0
.8
6
2
0
.8
1
7
±
0
.0
0
5
0
.8
7
0
±
0
.0
3
3
0
.4
2
7
0
.8
1
6
±
0
.1
1
0
0
.8
5
0
±
0
.0
3
7
0
.7
8
3
1
8
:3
n
-3
0
.1
6
2
±
0
.0
2
2
0
.2
1
9
±
0
.0
1
2
0
.0
7
8
0
.0
9
9
±
0
.0
0
9
0
.1
0
4
±
0
.0
3
4
0
.9
6
7
0
.1
5
6
±
0
.0
1
3
0
.1
0
0
±
0
.0
1
1
0
.0
1
4
1
8
:4
n
-6
0
.4
6
1
±
0
.0
6
9
0
.4
8
1
±
0
.0
4
2
0
.8
3
0
0
.1
2
9
±
0
.0
0
9
0
.1
4
9
±
0
.0
3
5
0
.5
9
0
0
.1
8
9
±
0
.0
2
1
0
.1
3
3
±
0
.0
0
9
0
.0
4
1
2
0
:0
1
.5
8
1
±
0
.0
7
6
1
.8
6
1
±
0
.0
8
9
0
.0
3
9
1
.3
2
9
±
0
.0
5
8
1
.2
4
6
±
0
.1
1
1
0
.5
2
9
1
.1
1
5
±
0
.1
0
9
0
.9
6
7
±
0
.1
0
0
0
.3
4
8
2
0
:2
n
-6
0
.6
7
2
±
0
.0
5
7
0
.9
2
7
±
0
.0
4
1
0
.0
0
8
0
.4
6
4
±
0
.0
1
4
0
.6
7
3
±
0
.0
6
9
0
.0
1
9
0
.4
9
2
±
0
.0
2
5
0
.4
3
5
±
0
.0
3
3
0
.2
1
1
2
0
:3
n
-6
2
.1
9
3
±
0
.2
5
9
1
.7
0
4
±
0
.1
3
0
0
.1
6
9
1
.1
8
3
±
0
.1
1
9
1
.2
2
±
0
.1
2
8
0
.8
1
0
1
.5
3
7
±
0
.1
4
2
1
.6
1
1
±
0
.0
6
7
0
.6
5
5
2
0
:4
n
-6
4
.4
3
4
±
0
.2
0
0
5
.2
5
4
±
0
.0
9
8
0
.0
0
9
4
.4
6
9
±
0
.1
0
3
5
.5
0
8
±
0
.0
4
7
0
.0
0
1
4
.3
2
4
±
0
.1
5
5
6
.3
6
6
±
0
.1
7
1
0
.0
0
1
2
0
:5
n
-3
0
.1
5
4
±
0
.0
1
6
0
.0
7
6
±
0
.0
0
8
0
.0
0
5
0
.0
9
6
±
0
.0
1
3
0
.2
1
4
±
0
.0
3
3
0
.0
1
1
0
.5
5
2
±
0
.0
6
7
0
.2
1
9
±
0
.0
1
1
0
.0
0
1
2
2
:0
0
.1
1
0
±
0
.0
2
0
0
.1
4
1
±
0
.0
4
2
0
.4
8
8
0
.2
0
2
±
0
.0
1
5
0
.2
3
0
±
0
.0
3
4
0
.4
8
5
0
.2
6
9
±
0
.0
3
3
0
.1
0
2
±
0
.0
0
4
0
.0
0
1
2
2
:4
n
-6
1
.7
6
5
±
0
.0
8
6
2
.6
3
5
±
0
.1
7
9
0
.0
0
1
1
.2
3
2
±
0
.0
6
0
2
.6
3
6
±
0
.1
6
4
0
.0
0
1
1
.1
9
2
±
0
.0
8
9
2
.1
0
0
±
0
.0
8
5
0
.0
0
1
2
2
:5
n
-6
0
.5
5
7
±
0
.0
9
5
0
.5
6
4
±
0
.0
4
4
0
.9
6
0
0
.2
1
4
±
0
.0
1
0
0
.4
2
2
±
0
.0
9
0
0
.0
5
3
0
.2
9
7
±
0
.0
1
8
0
.3
2
8
±
0
.0
2
6
0
.3
6
5
2
2
:5
n
-3
0
.4
6
2
±
0
.0
7
8
0
.4
4
0
±
0
.0
3
9
0
.8
3
7
0
.8
6
3
±
0
.0
1
2
0
.2
6
9
±
0
.0
2
4
0
.0
0
1
0
.8
8
6
±
0
.0
3
0
0
.5
2
2
±
0
.0
3
4
0
.0
0
1
2
4
:0
0
.1
9
9
±
0
.0
2
1
0
.2
3
7
±
0
.0
5
9
0
.5
1
6
0
.5
3
5
±
0
.0
2
4
0
.0
2
5
±
0
.0
0
3
0
.0
0
1
0
.1
5
0
±
0
.0
3
6
0
.0
3
1
±
0
.0
1
1
0
.0
1
5
2
2
:6
n
-3
7
.9
1
6
±
0
.2
6
7
6
.7
7
0
±
0
.2
0
3
0
.0
1
0
6
.8
1
9
±
0
.2
8
9
7
.0
0
4
±
0
.0
7
9
0
.5
5
7
6
.7
2
4
±
0
.4
2
3
5
.8
5
9
±
0
.2
0
1
0
.1
0
2
2
4
:5
n
-3
0
.0
7
5
±
0
.0
1
7
0
.0
4
1
±
0
.0
0
3
0
.1
4
8
0
.1
1
8
±
0
.0
1
6
0
.1
3
7
±
0
.0
1
8
0
.4
7
2
0
.2
8
2
±
0
.0
3
6
0
.1
0
6
±
0
.0
1
3
0
.0
0
2
2
4
:6
n
-3
2
.5
7
2
±
0
.1
0
1
2
.5
3
9
±
0
.0
9
6
0
.8
6
2
1
.9
2
2
±
0
.0
4
6
6
2
.2
5
2
±
0
.1
2
4
0
.0
3
8
2
.5
7
5
±
0
.0
5
7
2
.5
8
1
±
0
.1
0
1
0
.9
6
0
S
F
A
3
9
.9
6
±
0
.9
0
1
3
9
.2
7
±
0
.3
0
7
0
.5
5
6
4
1
.5
3
±
0
.7
3
5
4
3
.7
9
±
0
.6
9
8
0
.0
5
6
3
9
.9
5
4
±
0
.5
9
8
4
0
.5
7
7
±
0
.3
1
1
0
.3
8
3
U
F
A
6
0
.0
3
±
0
.9
0
1
6
0
.7
1
±
0
.3
0
7
0
.5
5
8
5
8
.4
6
4
±
0
.7
3
5
5
6
.2
0
0
±
0
.6
9
8
0
.0
5
4
6
0
.0
4
5
±
0
.5
9
8
5
9
.4
2
2
±
0
.3
1
1
0
.3
8
2
M
U
F
A
3
7
.2
0
±
0
.4
2
2
3
7
.6
4
±
0
.5
1
7
0
.5
0
8
4
0
.0
3
4
±
0
.3
9
2
3
4
.7
3
4
±
0
.6
9
9
0
.0
0
1
4
0
.0
3
6
±
0
.5
9
2
3
8
.2
0
7
±
0
.2
9
2
0
.0
2
4
P
U
F
A
2
2
.8
2
±
0
.6
4
3
2
3
.0
3
±
0
.5
3
6
0
.7
8
1
1
8
.4
2
±
0
.4
6
9
2
1
.4
6
±
0
.2
5
3
0
.0
0
1
2
0
.0
0
±
0
.1
5
3
2
1
.2
1
±
0
.4
1
1
0
.0
2
5
P
U
F
A
n
-3
1
1
.3
4
±
0
.2
9
7
1
0
.0
9
±
0
.2
4
4
0
.0
1
2
1
0
.4
5
±
0
.3
0
9
1
0
.0
0
±
0
.1
5
6
0
.3
1
8
1
1
.3
2
±
0
.3
7
8
9
.4
2
±
0
.2
8
0
0
.0
0
4
P
U
F
A
n
-6
1
1
.4
8
±
0
.5
5
2
1
2
.9
8
±
0
.1
9
0
0
.0
5
3
8
.5
1
0
±
0
.2
0
6
1
1
.4
7
±
0
.1
0
0
0
.0
0
1
8
.8
5
2
±
0
.2
9
7
1
1
.8
5
±
0
.2
6
4
0
.0
0
1
A
C
L
1
8
.3
0
±
0
.0
3
3
1
8
.3
4
±
0
.0
2
6
0
.4
1
5
1
8
.2
5
±
0
.0
3
3
1
8
.2
1
±
0
.0
1
8
0
.3
7
5
1
8
.2
5
±
0
.0
1
9
1
8
.2
4
±
0
.0
1
6
0
.9
6
0
D
B
I
1
4
4
.2
5
±
2
.8
3
1
4
3
.0
6
±
1
.8
4
0
.7
5
7
1
2
8
.6
8
±
2
.8
5
1
3
5
.7
3
±
1
.1
7
0
.0
5
1
1
3
6
.3
±
1
.2
8
0
1
3
6
.6
±
1
.1
0
1
0
.8
4
0
P
I
1
2
5
.7
4
±
2
.9
1
6
1
2
1
.8
1
±
2
.4
1
3
0
.3
7
9
1
0
5
.5
8
±
3
.2
9
1
1
8
.7
2
±
1
.7
1
0
.0
0
8
1
1
4
.9
2
±
2
.5
6
1
1
4
.6
2
±
2
.7
2
0
.9
4
6
R
/P
U
F
A
s
1
.0
0
7
±
0
.0
5
8
0
.7
4
1
±
0
.0
0
8
0
.0
0
6
1
.2
2
7
±
0
.0
4
2
0
.8
7
1
±
0
.0
1
3
0
.0
0
1
1
.2
8
1
±
0
.0
6
8
0
.7
9
1
±
0
.0
1
0
0
.0
0
1
A
I
2
4
3
.3
8
±
6
.0
3
1
7
1
.8
8
±
1
.4
0
0
.0
0
1
2
0
0
.4
±
2
.8
1
8
1
5
8
.2
±
2
.7
9
9
0
.0
0
1
2
2
5
.7
±
1
4
.4
2
1
2
9
.2
3
±
2
.7
1
0
.0
0
1
p
v
al
u
e
re
fl
ec
ts
st
at
is
ti
ca
l
si
g
n
ifi
ca
n
ce
b
et
w
ee
n
d
ie
ts
b
y
S
tu
d
en
t’
s
T
te
st
Neuromol Med
123
surprisingly high on the spinal cord of animals under low
unsaturation diets, most probably due to an increase of 20:4
and 22:4, both from the n-6 series, specially in females.
As surrogate marker of n-3 availability, we chose syn-
taxin-3 immunoreactivity (Darios and Davletov 2006),
which showed that high unsaturated diet led to more
intense syntaxin-3 expression than low unsaturated one at
similar ages (Fig. 1k).
All in all, these data demonstrated that highly unsatu-
rated diets affected in a gender-dependent fashion the mean
survival, the disease onset and the clinical evolution in the
fALS model hSODG93A.
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Fig. 2 Dietary unsaturation influences protein oxidative damage and
ubiquitin aggregation in lumbar spinal cord. Protein carbonyls
glutamic (a, f) and aminoadipic semi-aldehydes (b, g) were influ-
enced by diet (but not GSA in males). Similarly, protein glycoxidative
markers carboxy-methyl-lysine (c, h) and carboxy-ethyl-lysine (d,
i) were influenced by age. A marker of protein lipoxidative
modification, malondialdehyde-lysine showed a paradoxical increase
in low unsaturation fed animals (e, j), specifically in females and was
the only marker affected significantly by age. In accordance with
faster rate of disease onset and proteotoxicity in highly unsaturated
diets, males (endpoint: 130 ± 7 days) showed significantly higher
ubiquitin immunostaining in lumbar spinal cords by confocal
microscopy (k) as quantified (l) in comparison to control diet. Higher
magnification images showed that ubiquitin immunostaining (arrow-
heads, m) was not restricted to SMI-32 positive neurons in anterior
ventral horn (arrows, m). *, **, ***, and ****diet-related significant
differences (p \ 0.05, 0.01, 0.001 and 0.0001, respectively) by post
hoc Bonferroni multiple comparisons after two-way ANOVA, while
as aage-related (p \ 0.05) and b,bb, bbb and bbbbdiet-related (p \ 0.05,
\0.01, \0.001 and \0.0001, respectively) significant differences by
two-way ANOVA. Bars in k and m are 500 and 50 lm, respectively.
Number of animals used for each marker measure was n = 7 for each
time point, both male and female. A total of 30 slices (n = 3 animals
per treatment) were analysed for quantification in l, with differences
evaluated by ANOVA post hoc Tukey’s multiple comparison test
Neuromol Med
123
Protein Oxidative Damage in Neuronal Tissues
of hSODG93A Transgenic Mice is Dependent
on Dietary Fatty Acid Unsaturation
Potential causes of the deleterious effect of highly unsat-
urated diets comprise their high susceptibility to oxidative
modification, though changes in DBI and PI suggested that
highly unsaturated diets actually lowered PI. As shown in
Fig. 2, the changes of unsaturation in diet induce signifi-
cant changes in protein oxidative damage. For GSA, the
most abundant marker among those detected belonging to
direct oxidation pathway, changes in diet only induced
significant effects in females, significantly lowering at
early clinical stages. For AASA, both high and low
unsaturated diets increased their concentrations, both in
females and in males, being the changes more marked with
high unsaturated diet. For CML, similar trends were seen in
males and females, again showing that dietary unsaturation
changes increased glycoxidative modifications at last
stages, with reference to control diet. For CEL, significant
increases were detected, induced by high unsaturated diet
in males. Of note, at 90 days, levels of CEL were highest in
males under high unsaturated diets, suggesting a key role
for this modification in the determination of survival, as
this is the group with faster disease progression and lower
survival. Similarly, as females under highly unsaturated
diets tended to have faster progression, significant CEL and
CML increases at 90 days reinforce the role of glycoxi-
dative modifications. Finally, for lipoxidative modifications
(MDAL), significant increases induced by low unsaturated
and high unsaturated diet were evident, in line with PI
changes. Interestingly, age was only a significant factor for
changes in MDAL concentrations. Importantly, protein
oxidative modifications are associated with aggregate
build-up and increased ubiquitination (Shang and Taylor
2011). Reinforcing the mass spectrometry findings indi-
cating protein modification with changes in unsaturation of
diets, confocal immunohistochemistry revealed increased
ubiquitin immunoreactivity in motor neurons and glial cells
(Fig. 2k–m) in comparison to control diets.
Correlation analyses of these variables revealed strong
gender specificity. In order to study the relationship
between fatty acid composition and protein oxidative
damage, we clustered all the values, irrespectively of diets.
Following these analyses, in males, protein oxidative
modification was directly correlated with survival, but not
in females (Fig. 3a, e). Similarly, the two glycoxidation
markers, CEL and CML correlated in females, but not in
males (Fig. 3b, f). Supporting a significant role of inflam-
matory potential in protein oxidative modifications, AA
content correlated with MDAL modification in females
(Fig. 3g). Finally, reinforcing the potential protective role
of DHA, its level was inversely correlated with one of the
markers of protein oxidative modification in females
(Fig. 3h).
All in all, these results suggest a lack of a general
relationship between protein oxidative modifications and
survival or disease onset. Interestingly, under control fatty
acid diets, lower lipoxidative damage (measured by MDAL
concentration) is found, in line with fatty acid
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Fig. 3 Gender specific correlation between survival, protein oxida-
tive damage and fatty acid contents. Glutamic semi-aldehyde is
correlated with survival time in males (a) but not in females (e).
Carboxy-ethyl-lysine is not correlated with carboxy-methyl-lysine
modification in males (b) in contrast with females (f). Lipoxidative
modification is not correlated with AA content in males (c) but it
shows a positive correlation in females (g). Aminoadipic semi-
aldehyde is inversely correlated with docosahexanoic acid content in
spinal cord in females (h), but not in males (d). Inset show the linear
regression statistic, with legend in h indicating the age and diets from
individuals in the analyses from c to h
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compositional changes, when compared to diets extreme in
unsaturation. Rather, a potential protective role of lipid
peroxidative-derived modifications can be defined in
females.
Dietary Fatty Acid Unsaturation Blunts
the Mitochondrial–Nuclear Crosstalk Based on Free
Radical Production and DNA Damage Response
To extend oxidative damage measurements to nucleic
acids, we evaluated the presence of 8-oxo-dG, a direct
marker of oxidative modification of DNA, focused to male
group and extreme unsaturation diets. In line with previous
data demonstrating that 8-oxo-dG levels are higher in
mitochondrial DNA than in nuclear DNA (Barja and
Herrero 2000), 8-oxo-dG immunoreactivity was mainly
localized in non-nuclear locations (Fig. 4a, c). 8-oxo-dG
immunoreactivity was significantly higher in spinal cord
from animals fed with highly unsaturated diet, reinforcing
the importance of mitochondrial DNA modification in this
transgenic model (Fig. 4a, b), in comparison to low
unsaturated diet. Recent data show the crosstalk between
mitochondrial-free radical production and nuclear DNA
damage response, mediated by cH2Ax (Passos et al. 2010).
To evaluate whether this mechanism was affected by die-
tary fatty acid unsaturation, we evaluated by confocal
microscopy the amount of cH2Ax foci, a surrogate for
DNA damage response. The results showed the the pre-
sence of cH2Ax in both non-neuronal (Fig. 4c–e) and
neuronal cells (Fig. 4f–h). Quantitative analyses of anterior
horns of whole sections (Supplemental Figure 2) showed
that dietary fatty acid unsaturation influenced the mito-
chondrial–nuclear crosstalk, as increased 8-oxo-dG
immunostaining in animals fed with high unsaturated diet
was not associated to an increase in cH2Ax staining in
ventral horn of lumbar spinal cord (Fig. 4i), as reinforced
by analyses of the cH2Ax to 8-oxo-dG immunostaining
ratio (Fig. 4j).
Discussion
The influence of dietary components in ALS progression
has been a focus of wide research. It is well accepted that
malnutrition is a negative prognostic factor (Greenwood
2013). A recent clinical trial evidence the relevant role of
nutrition in ALS (Wills et al. 2014). Furthermore, it has
been suggested (ALS Untangled 2012) that saturated fats,
such as those present in coconut oil, could alleviate the
disease course by means of increasing energy bioavail-
ability towards mitochondrial pathways. The favourable
effect of low unsaturated diet in comparison to high
unsaturated one might be attributed to enhanced calorie
availability. However, the fact that, under low unsaturated
diets, mice had lower weight gain, suggests a potential
disease-accelerating effect, even if it was not reflected in
mean survival (at least for males). Previous data have
linked fresh fish intake to ALS development (Sienko et al.
1990), although the mechanisms behind might be related to
intake of contaminants including cyanobacterial-derived
neurotoxins or metals (Roos et al. 2013; Vinceti et al.
2012). Nonetheless, a recent review reveals that PUFAs, if
appropriately protected from peroxidation (e.g. by vitamin
E) can be protective (Veldink et al. 2007). Indeed, in a
different population, epidemiological studies have revealed
that high intake of PUFAs, with other dietary fats, may
have a preventive effect in ALS (Okamoto et al. 2007).
Our data and a recent report (Yip et al. 2013) have
shown that this potential protective role is not easily
reproduced in the same murine model. Previous results,
both in the sporadic form of the disease (Ilieva et al. 2007;
Shibata et al. 2004), as well as in the murine model (Per-
luigi et al. 2005) have suggested the accrual of lipid per-
oxidation-derived aldehydes (such as 4-hydroxy-2-hexenal
or 4-hydroxy-2-nonenal), as well as the resulting modifi-
cation of specific proteins. However, our present data have
shown that the relationship between lipid peroxidation and
disease evolution is not lineal. Of note, despite diet was
effective in changing the lipid profiles of several tissues (by
comparison of previous data in liver (Herrero et al. 2001)
using the same diets), central nervous system lipids were
much more resistant to the introduced changes. Notewor-
thy, our low unsaturation diet was not intended to induce
PUFA depletion. These formulations fulfil essential fatty
acids requirements since it contained a sufficient amount of
soybean oil. Interestingly, under the low unsaturation diet,
we observed a paradoxical increase in the peroxidizability
index, which is mainly attributable to the increased levels
of AA. This increase is interpreted as an adaptive reaction
to diet and disease, since diet composition for this partic-
ular fatty acid was in fact lower in the low unsaturated one.
This may be related to the modulatory role of AA in
inflammation. In any case, increased peroxidizability index
bFig. 4 Dietary fatty acid unsaturation changes 8-oxo-dG levels and
its relationship with nuclear DNA damage response. The marker of
oxidative DNA damage 8-oxo-dG was analysed by confocal immu-
nohistochemistry in lumbar spinal cords from male mice in the
preclinical stage (90 days) (a). Quantitative analyses demonstrated
significantly decreased unsaturation in the low unsaturation group (b).
Differential inmunohistochemical pattern for cH2Ax (90 days, male).
Non-neuronal cH2Ax appears as discrete patterning (c), as heterog-
eneus foci (d) or as a single aggregate (e). Similarly, motor neuron,
(SMI-32 positive cells) had discrete foci (f) or general nuclear
staining (g and h). Quantitative analyses of cH2Ax and SMI-32
staining in whole sections are shown in the graph (i) and ratio
between cH2Ax and 8-oxo-dG in the graph (j). Bars in a and c are 10
and 5 lm, respectively. A total of 30 slices (belonging to n = 2–3
animals per treatment) were analysed for quantification in b and i,
with differences evaluated by ANOVA post hoc Tukey’s multiple
comparison test
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was associated with the increased load of protein lipoxi-
dative damage (as evidenced by mass spectrometric mea-
surements of MDAL). In contrast, the other protein
oxidative modification markers measured (arising from
direct oxidation or from glycoxidation) showed an increase
under high unsaturated diets. This suggests that protein
oxidative modifications such as GSA, AASA, CML and
CEL could be more deleterious than MDAL. As a matter of
fact, GSA shows a clear correlation with survival in males,
a fact non present in females, suggesting than in these,
protective mechanisms against protein oxidation could
operate, as it has been suggested for ALS (Cervetto et al.
2013; Eschbach et al. 2013; Li et al. 2012) and in other
diseases (Puertas et al. 2012).
Our results suggest that the relationship between lipid
peroxidation and disease pathogenesis is not lineal; i.e.
lipid peroxidation is not always noxious. Previous data
have demonstrated the important adapting role induced by
lipid peroxidation-derived aldehydes, such as 4-hydroxy-2-
nonenal and 15-deoxy-delta-12,14-prostaglandin J(2) Thus,
it is considered that lipid peroxidation may have a dual role
in the pathogenesis of several diseases (Catala´ 2009). In
addition, protective roles of specific fatty acids can operate
differently depending on diets and gender. The levels of a
carbonyl damage marker (AASA), directly related to dis-
ease evolution, were inversely related to the content of
DHA, supporting the potential protective role of this n-3
fatty acid. Docosahexanoic acid-derived molecules, such as
resolvin D1, have been shown to be potentially protective
in the process of phagocytosis which operates at later
stages of ALS (Liu et al. 2012). Furthermore, previous data
have revealed that while spinal cords with marked neuron
loss showed diminished DHA contents, the cortex of the
same individuals affected by ALS showed an increase in
DHA (Ilieva et al. 2007). Interestingly, hSODG93A female
transgenic mice at 90 d under low unsaturated diet (i.e.
living longer than males) exhibited ca 6 % more DHA than
males. However, DHA-dependent mechanisms could
operate up to a certain point of pathological burden.
Despite high unsaturated diet did not led to higher DHA
content in males, biologically these diets allowed for
higher accumulation of the DHA-dependent protein syn-
taxin-3 (Darios and Davletov 2006), supporting the notion
than enhanced availability of DHA in high unsaturation
diets may have some neurobiological impact. Our results
support the notion that a trade-off for the high content of
PUFAs in neuronal tissues, a high peroxidizability, may
have a beneficial-adaptative role (i.e. accumulation of
DHA-dependent proteins, enhanced responsiveness in
terms of antioxidant mechanisms).
A similar trade-off is also evident from examining the
potential implication of inflammation in the findings
reported in our work. Neuroinflammation, just as lipid
peroxidation, is recognized to play a dual role, being
neuroprotective in some stages to become neurotoxic in
others (Consilvio et al. 2004). Our data, demonstrating a
significant correlation between arachidonic acid content
and MDAL only in females, suggest that lipid peroxidation
adaptative mechanisms also affect arachidonic acid levels,
and, consequently, inflammatory potential. Interestingly,
reinforcing the potential protective role of neuroinflam-
mation in some stages of the disease, high unsaturated diets
in males, associated with a poor outcome-diminished sur-
vival, earlier onset, enhanced aggregation of ubiquitin
proteins in spinal cord were consistently associated with
higher anti-inflammatory index, as suggested by fatty acid
profiles.
Both inflammation and oxidative stress can be inter-
players in ageing basic mechanisms. Being ageing a clear
risk factor for ALS, we explored whether mechanisms
linking ageing, oxidative stress and inflammation could
explain part of our results. In this line, the mitochondrial–
nuclear crosstalk is relevant in cellular senescence (Passos
et al. 2010). A resulting unbalanced response includes
sustained DNA damage response and senescence-associ-
ated secretory phenotype, fuelled by mitochondrial-free
radical production dependent on p21 activation and TGFb
production. For this reason, we evaluated the presence of
cH2Ax foci, related to DNA damage, in spinal cord in this
model. The present results have shown markers of DNA
damage repairing in motor neurons and glial cells. Despite
it has been previously hypothesized that these phenomena
could be present in various in vitro models of neurode-
generation (Avramovich-Tirosh et al. 2007), our results
demonstrate an unreported variability in the immuno-
staining of cH2Ax. This morphological variety can be
attributed to the several roles of this protein in cell
homeostasis (Sharma et al. 2012) ranging from DNA rep-
lication to apoptosis, including also physiological neuronal
activity (Suberbielle et al. 2013). Previous data have
demonstrated that DNA in ALS is damaged in mitochon-
dria (Kikuchi et al. 2002) and in the nuclei (Barbosa et al.
2010; Murata et al. 2008). Interestingly, recent data suggest
a gender-specific difference in terms of DNA damage
response/repair capacity (Trzeciak et al. 2008). The finding
of increased mitochondrial DNA damage induced by high
unsaturation, without a concomitant increase in cH2Ax
suggests that the mitochondrial–nuclear crosstalk based on
p21 and free radical production is influenced by diet,
specifically by PUFAs. Previous work has related G93A
mutation to increased 8-oxo-dG accumulation (Barbosa
et al. 2010) and also data form our laboratory (Herrero
et al. 2001), revealed higher free radical production in
mitochondria from animals fed with similarly high unsat-
urated diets, a finding that fits with enhanced 8-oxo-dG
present in this work. Therefore, a logical response to
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enhanced free radical production would be increased DDR,
thought data presented here suggest that this is not the case.
Reasons for this blunted response on mitochondrial–
nuclear crosstalk may arise from several facts. It is known
that enhanced levels of n-6 fatty acids (such as those
present in low unsaturated fed animals) can be linked to
higher production of TGFb, a key factor in the mitochon-
drial–nuclear crosstalk (Harbige and Sharief 2007). Simi-
larly, it is known that docosahexanoic or eicosapentaenoic
acids change the expression of p21 (Katakura et al. 2013;
Slagsvold et al. 2010). When added to the fact that high
unsaturated diets actually decreased lipid peroxidative
modification in these experiments, our results reinforce a
potentially protective role for lipid peroxidation. Thus, low
unsaturated diets would sustain lipid peroxidation and
reinforce mitochondrial–nuclear crosstalk via increased
TGFb secretion and cH2Ax foci formation and maintaining
both an adequate antioxidant response—as evidenced by
lower protein oxidative and glycoxidative damage—as
well as diminished levels of mitochondrial DNA modifi-
cation. In contrast, high unsaturated diets could act dele-
teriously in a double fashion: by increasing p21 expression,
perhaps interfering with its activation and by increasing
free radical production without an adequate response of
cellular antioxidant systems, which will be focus of future
studies.
As limitations of the present study, we recognize that
other clinical measurements (e.g. Rotarod-based) may be
also of interest. Further, establishment of standard methods
for treatment testing is crucial in ALS models Ludolph
et al. (2007, 2010). However, we hope that measurement of
three indicators of disease evolution (i.e. weight changes,
clinical score and stride lenght) could be helpful for global
assessment of diet-induced changes. Importantly, these
analyses show that values in animals fed with control diets
were not always between the low unsaturated and high
unsaturated groups: our suggestion is that survival, in
relationship with changes in fatty acid composition present
in spinal cord suggest the importance of an adequate lipid
profile in neuronal resistance towards stressors. For
instance, levels of AA are paradoxically lower in high
unsaturated groups (irrespectively of the gender). A
potential protective role of AA-derived bioactive com-
pounds cannot be discarded based on these results. In line
with this, fatty acids with a potential neuroprotective
effects, such as DHA, are not altered in any of the groups,
suggesting their importance and resilience towards dietary
changes. We have also disclosed that in some terms, such
as DNA modification and response to it, control animals
behave differently to low unsaturated fed ones, demon-
strating the complexity of the relationships behind.
Our data reveal that intervention on dietary fat unsatu-
ration modulates the gender protective effect in females.
Highly unsaturated diet apparently diminished survival in
females, while as maintenance of a diet with a low unsat-
uration allowed to differentiate gender-specific effects in
survival of this ALS model. Taking into account the sev-
eral mechanisms studied, particularly oxidative stress, our
data suggest that despite PUFAs could have some potential
benefits in specific stages of the disease, through a sur-
prisingly protective lipid peroxidation, later on, the dis-
ease-sparing mechanisms are overwhelmed by pathology
burden. A similar mechanism could operate for neuroin-
flammation. Further, our data suggest that highly unsatu-
rated diet could blunt a mitochondria–nuclear crosstalk,
essential for cell homeostasis. Together, these results
reinforce the need for adequately defining gender as a
modifying factor in ALS models, as well as to use struc-
turally characterized and variegated markers for oxidative
damage assessment in neurodegeneration.
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 Table S1: Fatty acid composition (% of abundance) and derived indexes in spinal 
cord (lumbar region) from  hSODG93A male mice (90days).  
 Control High Unsat Low Unsat p value 
(Hi/Lo) 
p value 
(Hi/Ctl) 
p value 
(Lo/Ctl) 
       
18:0 17,72±0,11 15,86±1,05 16,59±1,68 0,676 0,297 0,495 
18:1n-9 38,91±0,269 38,76±1,57 33,04±1,86 0,017 0,942 0,011 
20:4n-6 5,44±0,100 4,73±0,289 5,29±0,126 0,048 0,017 0,548 
22:4n-6 2,34±0,074 1,39±0,088 2,26±0,126 0,001 0,001 0,543 
22:6n-3 6,79±0,117 7,40±0,490 6,62±0,278 0,101 0,189 0,688 
       
SFA 38,91±0,17 40,58±1,97 45,59±1,75 0,037 0,443 0,006 
UFA 60,92±0,25 59,41±1,97 54,40±1,75 0,037 0,489 0,007 
MUFA 41,99±0,31 39,32±1,49 33,75±1,85 0,018 0,210 0,001 
PUFA 18,93±0,16 20,08±0,86 20,65±0,27 0,416 0,116 0,020 
PUFA n-3 7,31±0,11 10,79±0,42 9,70±0,33 0,031 0,001 0,001 
PUFA n-6 11,62±0,11 9,28±0,83 10,94±0,33 0,020 0,003 0,263 
DBI 125,74±0,76 135,83±3,85 130,49±1,69 0,121 0,009 0,141 
PI 95,62±1,06 115,10±4,18 113,41±2,96 0,688 0,001 0,001 
AI 140,31±3,77 207,84±8,00 155,11±3,13 0,001 0,001 0,050 
       
P value for Bonferroni multiple comparison tests after ANOVA analyses 
 
Table S2: Fatty acid composition (% of abundance) and derived indexes in spinal 
cord (lumbar region) from  hSODG93A female mice (90days).  
 Control High Unsat Low Unsat p value 
(Hi/Lo) 
p value 
(Hi/Ctl) 
p value 
(Lo/Ctl) 
       
18:0 17,78±0,14 18,70±0,36 16,95±0,27 0,001 0,023 0,051 
18:1n-9 39,42±0,26 39,29±0,35 34,03±0,72 0,001 0,822 0,001 
20:4n-6 5,40±0,07 4,51±0,09 5,50±0,04 0,001 0,001 0,374 
22:4n-6 2,31±0,027 1,21±0,052 2,63±0,164 0,001 0,001 0,020 
22:6n-3 6,78±0,049 6,83±0,263 7,00±0,079 0,441 0,815 0,312 
       
SFA 38,97±0,23 41,35±0,063 43,79±0,69 0,006 0,005 0,001 
UFA 61,07±0,23 58,67±0,63 56,20±0,69 0,006 0,005 0,001 
MUFA 42,45±0,28 39,93±0,33 34,73±0,69 0,001 0,001 0,001 
PUFA 18,56±0,08 18,73±0,49 21,46±0,25 0,001 0,698 0,001 
PUFA n-3 7,34±0,04 10,17±0,39 9,97±0,18 0,591 0,001 0,001 
PUFA n-6 11,21±0,08 8,56±0,17 11,48±0,10 0,001 0,001 0,156 
DBI 125,54±0,27 130,22±2,79 135,73±1,17 0,046 0,063 0,001 
PI 95,47±0,53 107,88±3,40 118,55±1,32 0,001 0,004 0,005 
AI 140,28±2,42 201,46±2,52 158,20±2,79 0,001 0,001 0,001 
       
P value for Bonferroni multiple comparison tests after ANOVA analyses 
 
Table S3. Fatty acid composition (mol%) of diets.  Values are means ± SEM from n=3 samples. 
 
 High Unsat Low Unsat Control p value 
(Hi/Lo) 
p value 
(Hi/Ctl) 
p value 
(Lo/Ctl) 
14:0 10,04±0,173 29,67±0,422 0,404±0,040 0,001 0,001 0,001 
16:0 17,78±0,113 18,14±0,018 11,95±0,011 0,102 0,001 0,001 
16:1n-7 10,78±0,085 0,096±0,003 0,245±0,028 0,001 0,001 0,254 
18:0 4,184±0,021 18,75±0,333 4,430±0,046 0,001 0,381 0,001 
18:1n-9 14,44±0,012 8,854±0,062 23,88±0,629 0,001 0,001 0,001 
18:2n-6 12,71±0,217 20,64±0,034 49,73±0,122 0,001 0,001 0,001 
18:3n-3 3,397±0,069 2,987±0,032 7,501±0,085 0,064 0,001 0,001 
18:4n-6 n.d. 0,061±0,007 0,155±0,015 - - 0,047 
20:0 1,352±0,142 0,262±0,008 0,350±0,009 0,001 0,001 0,604 
20:1n-9 1,775±0,077 0,083±0,004 0,214±0,013 0,001 0,001 0,521 
20:2n-6 1,302±0,194 0,030±0,005 0,080±0,014 0,001 0,001 0,061 
20:3n-6 1,200±0,189 0,020±0,002 0,054±0,009 0,001 0,001 0,057 
20:4n-6 1,876±0,176 0,021±0,002 0,053±0,008 0,001 0,001 0,060 
20:5n-3 8,532±0,429 0,038±0,005 0,101±0,005 0,001 0,001 0,041 
22:0 0,917±0,073 0,130±0,010 0,318±0,014 0,001 0,001 0,151 
22:4n-6 0,735±0,094 0,031±0,015 n.d. 0,001 - - 
22:5n-6 0,963±0,140 0,043±0,003 0,095±0,001 0,001 0,001 0,031 
22:5n-3 1,871±0,170 0,028±0,001 0,068±0,009 0,001 0,001 0,040 
24:0 0,990±0,098 0,053±0,001 0,154±0,011 0,001 0,001 0,001 
22:6n-3 4,790±0,363 0,040±0,003 0,109±0,014 0,001 0,041 0,080 
24:5n-3 0,340±0,083 n.d. 0,024±0,002 - 0,001 - 
24:6n-3 n.d. 0,006±0,001 0,061±0,003 - - 0,001 
       
SFA 35,27±0,323 67,01±0,094 17,61±0,084 0,001 0,001 0,001 
UFA 64,72±0,320 32,98±0,095 82,38±0,084 0,001 0,001 0,001 
MUFA 25,22±0,068 8,95±0,062 24,13±0,065 0,001 0,001 0,001 
PUFA 37,75±0,457 23,95±0,043 58,04±0,155 0,001 0,001 0,001 
PUFA n-
3 
19,96±0,690 3,153±0,040 8,027±0,110 0,001 0,001 0,001 
PUFA n-
6 
18,79±0,120 20,84±0,017 50,17±0,098 0,001 0,001 0,001 
DBI 164,77±3,08 60,60±0,228 149,75±0,22 0,001 0,001 0,001 
PI 142,9±4,491 28,40±0,270 69,49±0,002 0,001 0,001 0,001 
AI 893,6±109,6 617,9±76,3 659,9±117,2 0,001 0,001 0,812 
p value reflects statistical significance between diets by Bonferroni multiple comparison test after 
ANOVA analyses. 
 
 
 
 
 
  
Supplemental Figure 1. Effect of diet and gender in median survival (A). B and 
C show the effect of experimental diets in survival curves separated by gender 
(middle for male and lower for female gender). * In A indicates significant 
difference by Bonferroni post hoc after 2 way ANOVA (p<0.05 with reference to 
control or highly unsaturated diets). * In B indicates significant differences by 
Logrank test for trend between diets in males (χ2=4.05; p<0.04). D and E show 
the effect of experimental diets in clinical onset, according to gender  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 2. Effect of dietary unsaturation in oxidative DNA 
modification (8-oxo-dG) and  its relationship with nuclear DNA damage 
response (γH2Ax). Bar is 0.5 m.  
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Abstract 
 
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with a gender bias 
towards major prevalence in male individuals. Several data suggest the involvement of 
oxidative stress and mitochondrial dysfunction in its pathogenesis, though differences between 
genders have not been evaluated by state-of-the art analytical approaches. This study aimed to 
compare mitochondrial function in male versus female in spinal cord of a mouse model of ALS 
the G93A-hSOD1 overexpressing mice, by using high-resolution respirometry. This was 
measured both in the early pre-symptomatic and pre-symptomatic stages, at onset and near 
endpoint of the disease. Subsequently, we analyzed mass-spectrometric markers of protein 
oxidative damage and tissue lipid profile. Mitochondrial respiratory chain protein expression 
and high resolution respirometry were also analysed in Neuro 2A cell cultures transfected to 
overexpress G93A-hSOD1 after pretreatment with17β-estradiol. Overexpression of G93A 
mutated human SOD1 in transgenic mice decreased efficiency of mitochondrial oxidative 
phosphorylation, revealing a temporal delay in females respect to males associated to a parallel 
increase in protein oxidative damage. Neuro 2A cells overexpressing G93A-hSOD1 showed a 
reduction in situ mitochondrial complex I O2 consumption prevented by 17β-estradiol 
pretreatment. In conclusion, ALS associated SOD1 mutation leads to a delayed mitochondrial 
dysfunction in female mice in comparison with males partially attributable to the higher 
oestrogen levels of the former. This study may be important to further understand whether 
different degrees of spinal cord mitochondrial dysfunction are related to the earlier onset and 
faster disease progression in male ALS patients than in their female counterparts. 
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Introduction 
Amyotrophic lateral sclerosis (ALS, OMIM #105400) is the motor neuron disorder with 
a higher occurrence in adult humans, characterized by a progressive loss of upper and lower 
motor neurons that leads to muscular atrophy, paralysis and death after median disease duration 
of 3 years (Leigh, 2007). The most common form of ALS is sporadic (sALS), having no 
apparent heritability, whereas the dominantly inherited familial ALS (fALS) accounts for only 
about 5 to 10% of all ALS patients (Al-Chalabi et al., 2012; Byrne et al., 2011). Among the 
genetic causes of ALS, Second to hexanucleotide repeat expansions in chromosome 9 open 
reading frame 72 (C9ORF72) (DeJesus-Hernandez et al., 2011; Renton et al., 2011), 15-20% of 
fALS cases and about 5% of sALS cases are associated to multiple mutations in the gene for 
Cu/Zn-superoxide dismutase (SOD1), which imparts a novel toxic function to this otherwise 
superoxide radical scavenging enzyme in normal condition (Rosen, 1993). Furthermore, 
mutated SOD1 forms appear misfolded, aggregated and accumulated primarily in spinal cord 
motor neurons and glial cells of ALS patients (Nagai et al., 2007). Transgenic mice 
overexpressing mutant forms of the human SOD1 (hSOD1) gene develop a progressive motor 
neuron syndrome similar to the human ALS phenotype  (Gurney et al., 1994; Turner & Talbot, 
2008) and have been extensively used as an experimental model to gain insight into ALS 
pathogenesis. Consequently, overexpression in animals and cultured cells of a mutated for of 
hSOD1 with a glycine for alanine substitution in amino acid 93 (G93A-hSOD1), has become 
the most used model to study pathophysiological ALS features. 
Gender-related differences in many neurodegenerative diseases are observed across 
epidemiologic studies, pathophysiology and treatments (Crawford & Duncan, 2012; 
Członkowska, Ciesielska, Gromadzka, & Kurkowska-Jastrzebska, 2006). ALS not being an 
exception, its incidence (average male/female ratio 1.3) and prevalence are higher in men than 
in women, with a predominance of men with younger disease onset. Clinical phenotypes are 
also different in male and female patients, especially regarding to the site of onset of weakness, 
as well as cognitive impairment (Blasco et al., 2012; Portet, Cadilhac, Touchon, & Camu, 
2001). The aforementioned gender differences have been reported in studies that included all 
ALS patients (sporadic and familial) but when fALS cases were studied separately, the gender 
ratio again was not equal to 1 (McCombe & Henderson, 2010), although according to some 
previous reports, fALS incidence was not significantly different between men and women, as 
theoretically expected with an autosomal dominant disease with complete penetrance (Orrell et 
al., 1999). However, supporting the higher occurrence of fALS in men than in women, data 
extracted from ALSoD web site (www.alsod.iop.kcl.ac.uk) revealed a c. 1.5 male/female ratio 
for most mendelian ALS-related mutant genes, including SOD1. Moreover, it has been reported 
that gender can account for variations in the course of disease in fALS (H. Y. Kim et al., 2007).  
Most of the neurodegenerative disorders involve either causally or consequently 
mitochondrial abnormalities (Federico et al., 2012; Lin & Beal, 2006; Martin, 2012) (reviewed 
in (Lezi & Swerdlow, 2012)). Although the underlying causes of motor neuron degeneration in 
ALS remain largely unknown, ALS-causing SOD1 mutations result in mitochondrial 
dysfunction, among multiple pathogenic pathways also present in sALS, such as oxidative stress 
and endoplasmic reticulum stress (Ayala et al., 2011; Cozzolino, Ferri, Valle, & Carrì, 2013; 
Ilieva et al. 2007; Rothstein, 2009). A common trait of skeletal muscle biopsies of sALS and 
fALS patients, as well as transgenic animal models of ALS, is a mitochondrial electron transfer 
chain (ETC) dysfunction, leading to an impairment of ATP synthesis, metabolic stress, 
retrograde neurodegeneration and ultimately motor neuron cell death (Bowling, Schulz, Brown 
Jr, & Beal, 1993)(Vielhaber et al., 2000; Wiedemann et al., 1998). Being not restricted to 
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muscle mitochondria, similar deficits in the mitochondrial ETC have been reported in spinal 
cord of fALS patients, due to, among other causes, mitochondrial DNA mutations or binding of 
misfolded and aggregated SOD1 mutants to the voltage-dependent anion channel, dissipating 
the mitochondrial membrane potential (Jung, Higgins, & Xu, 2002; Mattiazzi et al., 2002). 
Moreover, besides its role in bioenergetics, buffering of intracellular calcium is one of the most 
important functions of the mitochondrion (Rizzuto, De Stefani, Raffaello, & Mammucari, 
2012). Not surprisingly, mitochondrial dysfunction in spinal cord of ALS patients correlates 
with increased cytosolic calcium (Siklós et al., 1996). Likewise,SOD1-G93A transgenic mice 
exhibit a cytosolic calcium overload concomitant with a decrease in mitochondrial calcium 
loading capacity preceding neuromuscular alterations (Damiano et al., 2006) and a those 
changes are age-dependent (e.g. calpain activation and CaMKIV processing (Gou-Fabregas et 
al., 2014)).  
Mitochondrial dysfunction may also directly provoke cell death by activating the 
apoptotic cascade, due to misfolded or aggregated SOD1 that results either in aberrant 
localization and release of proapoptotic factors, or binding to apoptotic inhibitors (Redler & 
Dokholyan, 2012). Studies in different species have reported that mitochondria in females are 
more differentiated, and, as a result, the mitochondria show a higher capacity and efficiency of 
substrate oxidation than in males. These features of female mitochondria have been described in 
nervous tissue, among other organs and tissues (Colom, Oliver, Roca, & Garcia-Palmer, 2007; 
Colom, Alcolea, et al., 2007; Guevara et al., 2009; Guevara, Gianotti, Roca, & Oliver, 2011; 
Justo et al., 2005). Results of several authors suggest a greater sensitivity of males to 
mitochondrial dysfunction compared to females. This includes higher permeability of the outer 
and inner mitochondrial membranes (whose occurrence is known to be affected by Ca+2 
overload (Brustovetsky, Brustovetsky, Jemmerson, & Dubinsky, 2002)) with increased 
translocation of apoptosis-inducing factor (AIF) to the nucleus in neurons from immature rat 
brains submitted to hypoxia-ischemia (Weis et al., 2012). Moreover, male mitochondrial 
Ca+2reuptakeis known to be increased respect to females (Arieli, Gursahani, Eaton, Hernandez, 
& Schaefer, 2004). 
In brain, other mitochondrial abnormalities related to neurodegeneration and more 
pronounced in males than females are an inhibition of mitochondrial electron transport chain 
complexes activities, a diminished mitochondrial mass and a lower mitochondrial membrane 
potential (Renolleau, Fau, & Charriaut-Marlangue, 2008; Renolleau, Fau, Goyenvalle, & 
Charriaut-Marlangue, 2007; Xia, Zhou, Huang, & Xu, 2006). Further, male mesencephalic 
neurons revealed a higher vulnerability to 6-hydroxydopamine compared with female cells. This 
difference in viability could be due to higher ROS generation and a more pronounced down-
regulation of mitochondrial gene transcription, accounting for a more diminished ETC activity 
and subsequently lower ATP production in the male compared with female cells (Misiak, Beyer, 
& Arnold, 2010). Finally, focusing in gender relevance in the mitochondrial permeability 
transition pore formation in the SODG93A mouse model researchers (H. J. Kim, Magranè, 
Starkov, & Manfredi, 2012) demonstrated that deletion of cyclophilin D (a protein structurally 
linked to the mitochondrial permeability membrane transition pore (Doczi et al., 2011)) 
completely abolished the phenotypic advantage of female SODG93A, but no effect was found 
in males.  
Taking this background into account, the aim of this paper was to study gender-related 
differences in spinal cord mitochondrial function of a mouse model of ALS, including the early 
pre-symptomatic stage of the disease. Several features of mitochondrial oxidative metabolism, 
lipid profile and proteinoxidative stress markers have been analysed in SOD1-G93A transgenic 
mice and Neuro 2A cells overexpressing G93A-hSOD1. We hypothesized that differences in the 
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degree of spinal cord mitochondria dysfunction between male and female SOD1-G93A mice 
could explain, at least in part, their different clinical features. This study may be important to 
further understand whether different degrees of spinal cord mitochondrial dysfunction are 
related to the earlier onset and faster disease progression in male ALS patients than in their 
female counterparts. Moreover, understanding the causes of the sex differences in ALS could 
give clues to the pathophysiology of this devastating disease. 
 
Materials and Methods 
 
Chemicals 
All reagents, unless stated otherwise, were purchased from Sigma Aldrich (St. Louis, 
MO). Media, sera, antibiotics and other media supplements and Lipofectamine 2000,were 
obtained from Invitrogen (El Prat de Llobregat, Catalonia). 17β-estradiol (E2) was dissolved in 
ethanol at a concentration of 1 mM, further diluted to 40 µM with culture medium, aliquoted 
and stored frozen up to one month at -20ºC. E2 stock solutions were used at a final 
concentration of 10 nM. 
Animals 
A colony of the strain B6SJL-Tg (SOD1-G93A)1Gur/J (JAX catalogue stock number 
002726; from now on G93A mice) was purchased at The Jackson Laboratories (Bar Harbor, 
ME) and maintained in the B6SJL background, by male founder crossing with B6SJLF1/J 
females. All mice were genotyped as described in the Supplemental Methods section, and those 
non-transgenic littermates (from now on Control mice) where used as control. Animals were 
maintained under a constant 12h light–dark cycle in individual cages after weaning (day 21) 
with temperatures around 22±4 ºC and fed a standard rodent chow and water ad libitum. 
Animals were weighted weekly and daily for those under stride length analysis. A third-order 
polynomial curve was fitted to the age-body weight sets of data with Prism 6.0 software 
(GraphPad, La Jolla, CA) in order to calculate maximum weight and age of attaining maximum 
weight, and to interpolate age attaining a maximum weight minus 10%. Neurological scoring 
and paw print analysis were performed as previously reported (Cacabelos et al., 2014) in 
alternate days starting from day 60 and are further described in the Supplemental Methods 
section. All experimental procedures were approved by the Ethical Committee for Animal 
Testing of the Institut de Recerca Biomèdica de Lleida (IRBLleida) and were conformed to the 
Directive 2010/63/EU of the European Parliament.  
Spinal cord sample preparation and homogenization 
 Animals were sacrificed by cervical dislocation at indicated times, after being fasted 
overnight. Spinal cord lumbar sections were rapidly excised, and kept in ice-cold saline, or 
frozen in liquid nitrogen and stored at -80ºC, to perform respirometry or for other analysis, 
respectively. 
  Frozen samples were thawed on ice and homogenized at 0ºC in a buffer containing 
180mM KCl, 5 mM 3-[N-morpholino]propanesulfonic acid, 2mM ethylenediaminetetraacetic 
acid (EDTA), 1mM diethylenetriaminepentaacetic acid, 1µM freshly prepared butylated 
hydroxyl toluene (BHT), 10 µg/ml aprotinin, and 1mMphenylmethylsulfonyl fluoride (PMSF), 
at pH 7.3 using a Potter-Elvehjem motor-driven glass-Teflon homogenizer. After a brief 
centrifugation (500 x g, 5 min) to pellet cellular debris, protein concentrations were measured in 
the supernatants using the Bradford assay.   
The spinal cord slice permeabilization protocol was a modification of a previously 
published method (Safiulina et al., 2004). Fresh spinal cords were rinsed with ice-cold normal 
saline and cut into slices with a tissue chopper adjusted to a cut width of 300 µm. About 12-15 
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slices of the lumbar region were collected and transferred quickly into individual wells of a 6-
well tissue culture plate with 2 ml of ice-cold permeabilization medium (in mM: 7.23 potassium 
ethylene glycol-bis(b-aminoethyl ether)N,N,N’,N’-tetraacetate (K2 EGTA), 2.77 CaK2 EGTA, 
60 N,N-bis[2-hydroxyethyl]- 2-aminoethanesulfonic acid (BES), 5.69 MgATP, 20 taurine, 3 
K2HPO4 , 0.5 dithiothreitol and 81 potassium methanesulfonate, pH 7.1 at 25ºC), rinsed and 
immediately transferred again into another well with the same medium containing 20 µl of 
saponin stock solution (5 mg/ml; final concentration 50 µg/ml). Lumbar spinal cord slices 
(LSCS) were shaken by gentle agitation at 4ºC for 30 min. Afterwards, all samples were quickly 
transferred from the saponin permeabilization medium into 2 ml of respiration medium (in mM: 
7.23 K2 EGTA, 2.77 CaK2 EGTA, 100 potassium salt of 2-(N-morpholino)ethanesulfonic acid 
(K-MES), 1.38 MgCl2 , 20 taurine, 3 K2HPO4 , 0.5 dithiothreitol, 20 imidazole and 5 mg/ml 
bovine serum albumine (BSA), pH 7.1 at 25ºC), and shaken by gentle agitation for 10 min at 
4ºC before performing respirometry. 
High resolution respirometry 
Oxygen flux of sets of 5 mice LSCS (n=10-20 per genotype) or suspensions of Neuro-
2A cells (100,000 cells/mL) was measured at 37 °C by high-resolution respirometry using an 
Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria) with chamber volumes set at 2 mL. In 
order to avoid tissue disaggregation, LSCSC required setting a slow bar stirring speed (150 
rpm), but not too low to compromise homogeneity of substrate and oxygen concentrations in the 
measuring chambers, and therefore signal stability. Stirring speed for suspensions of Neuro-2A 
cells was set to 400 rpm after a trypan blue exclusion assay showed cell viability was > 95% 
(data not shown) after 1 h of agitation. DatLab software (Oroboros Instruments, Innsbruck, 
Austria) was used for data acquisition (2 s time intervals) and it was also used for analysis, 
which includes calculation of the time derivative of oxygen concentration and correction for 
instrumental background oxygen flux (Gnaiger, 2001). 
Respiration of LSCS and Neuro-2A cells was analysed following two standardized 
protocols. The experimental regime for intact LSCS and Neuro-2A cells started with routine 
respiration, which we defined as the oxygen flux in Hank’s balanced solution and cell culture 
medium, respectively, without additional substrates or effectors. After observing steady-state 
respiratory flux in the time interval between 5 and 10 min after closing the chamber, respiration 
was inhibited by sequential addition of rotenone at 0.5 µM (to test for the effect of inhibiting 
complex I activity) and antimycin A at 2.5 µM (inhibiting complex III). This titration method 
was completed within 30 min. In order to avoid oxygen limitations, all the experiments were 
performed above 50% oxygen saturation. Oxygen consumption was normalized by actual 
protein content and citrate synthase activity in the respirometer chambers.  
The second experimental regime required tissue or cell permeabilization before placing 
the sample in the measurement chamber. Initially, we measured endogenous respiration in the 
absence of additional substrates. For evaluation of relative contributions of mitochondrial 
complexes to oxygen consumption, several specific mitochondrial inhibitors and substrates 
added sequentially as routinely performed in our laboratory (López-Erauskin et al 2013) and 
calculated as steady-state respiratory flux in the time interval between 5 and 10 min after its 
addition. First, we added glutamate (10mM) and malate (5mM) to increase NADH levels in 
order to measure the complex I non-phosphorylative activity, or state 2. 10 mM ADP was added 
to quantify the complex I-dependent phosphorylative activity, or state 3. Immediately 
afterwards, we added succinate (10mM), which is the substrate for complex II. At this point, the 
level of oxygen consumption corresponded to complex I- and II-dependent phosphorylative 
activity. The addition of 0.5 µM rotenone inhibits complex I; therefore, oxygen consumption 
measured after the addition of rotenone only reflects complex II-dependent phosphorylative 
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activity (in absence of electron backflux to complex I). Then, complex III activity was inhibited 
with antimycin A (2.5 µM), and finally complex IV maximal activity was measured after 
addition of the non-physiological substrate N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) 
at 0.5 mM, ascorbate (2mM) and cytochrome c (10 µM). Maximal oxygen consumption rates of 
spinal cords were measured after addition of carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP). In order to avoid oxygen limitations, all the 
experiments were performed above 50% oxygen saturation. Oxygen measurements media for 
permeabilized tissue was Mir05 (Pesta & Gnaiger, 2012) Oxygen consumption was normalized 
by actual protein content in the respirometer chambers. 
Western blot analysis 
The protein levels of Neuro-2A cells mitochondrial respiratory chain complexes, were 
estimated using Western blot analysis. Equal amounts of protein (10-25 µg) were separated by 
SDS-PAGE gels. Proteins were transferred using a Mini Trans-Blot Transfer Cell (BioRad) to 
polyvinylidenedifluoride membranes (Immobilon-P, Millipore). Immunodetectionwas 
performed using specific antibodies for the 39kDa (NDUFA9; CI) subunit of complex I 
(1:1000), 70 kDa subunit (Flavoprotein) of complex II (1:500). (Ref. A21344 and A11142, 
respectively; Molecular Probes, Eugene, OR). Expression of mutant and wild type human SOD1 
in mice spinal cords was immunodetected using a monoclonal antibody specific against human 
SOD1 (Abcam AB52950). An antibody to porin (1:5000, A31855, Molecular Probes) or or -
actin (1:5000, AB20272, Abcam, Cambridge, MA)as a control for total mitochondrial mass or 
total protein charge were also used in order to determine the proportion of protein levels 
referred to total mitochondrial mass or total protein content. Appropriate peroxidase-coupled 
secondary antibodies anti-rabbit (1:40000, Pierce, Rockford, IL, USA) or anti-mouse (1:10000, 
GE Healthcare, UK) and chemiluminescence horseradish peroxidase (HRP) substrate 
(Millipore, Billerica, MA) were used for primary antibody detection. Signal quantification and 
recording was performed with Chemi-Doc equipment (Bio-Rad Laboratories, Inc., Barcelona, 
Catalonia). Protein concentration was determined by the Bradford method. Data were expressed 
as arbitrary units. 
Oxidation-derived protein damage markers measurements by GC/MS 
Gas chromatography-mass spectrometry (GC/MS) measurements of glutamic 
semialdehyde (GSA), aminoadipicsemialdehyde (AASA), Nε-(carboxyethyl)-lysine (CEL), Nε-
(carboxymethyl)-lysine (CML), and Nε-(malondialdehyde)-lysine (MDAL) concentrations in 
total proteins from mice lumbar spinal cord homogenates were measured as routinely performed 
in our laboratory (Vigerust et al., 2012) (See Supplemental Methods for further information). 
Samples were homogenized in 10 volumes of ice-cold homogenization buffer (0.32 mol/L 
sucrose, 10 mmol/L HEPES pH 7.4, 2 mmol/L EDTA, containing the protease inhibitor cocktail 
(Sigma P8340) and homogenized using 10 to 15 strokes of a motor-driven glass-Teflon 
homogenizer. Protein concentrations were measured by the Bradford method, and samples were 
stored at -80°C. Quantification was performed by external standardization using standard curves 
constructed from mixtures of deuterated and non-deuterated standards. Analytes were detected 
by selected ion-monitoring GC/MS and the amounts of products were expressed in µmol of 
analyte per mol of lysine. 
Lipid profile  
Fatty acid analysis in tissue samples and diets was performed as previously described 
(Cacabelos et al., 2014). Total lipids from homogenates were extracted with 
chloroform/methanol (2:1, v/v) (3 times) in the presence of 0.01 % butylated hydroxytoluene. 
The chloroform phase was evaporated under nitrogen, and the fatty acids were transesterified by 
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incubation in 2 ml of 5 % methanolicHCl for 90 min at 75 ºC. The resulting fatty acid 
methylesters were extracted by adding 2 ml of n-pentane and 1 ml of saturated NaCl solution. 
The n-pentane phase was separated, evaporated under nitrogen, re-dissolved in 80 µl of carbon 
disulphide, and 2 µl was used for GC analysis. Separation was performed by a DBWAX 
capillary column (30 m × 0.25 mm × 0.20 lm) in an Agilent GC System7890A with a Series 
Injector 7683B and a FID detector (Agilent Technologies, Barcelona, Spain). The injectionport 
was maintained at 220 ºC, and the detector at 250 ºC; the temperature programme was 2 min at 
100 ºC, then10 ºC/min to 200 ºC, then 5 ºC/min to 240 ºC and finally hold at 240 ºC for 10 min. 
Identification of fatty acidmethyl esters was made by comparison with authentic standards 
(Larodan Fine Chemicals, Malmö, Sweden). Results are expressed as % of analyte from the 
total % of FAMEs founded.  
Cell culture and transfection 
Neuro-2A cell line was obtained from ATCC (#CCL-131) and grown in MEM-
Advanced medium without phenol red supplemented with 10% heat inactivated foetal bovine 
serum, 2 mM L-glutamine,20 U/ml penicillin and 20 µg/ml streptomycin. Cells were kept at 37 
ºC in a humidified atmosphere with 5% CO2. Neuro-2A cell permeabilization prior to 
respirometry and sample homogenization for protein expression and activity measurements 
were performed as described above for LSCS. 
After 10 days of pre-treatment with 10nM E2 or vehicle, cells were harvested, counted, 
and subcultured in 6-well plates (200,000 cells per well) overnight. Transfection was performed 
by using Lipofectamine2000 (Invitrogen,El Prat de Llobregat, Catalonia) according to 
manufacturer instructions. Briefly, lipofectamine and selected DNA plasmids were mixed (1µg 
of DNA/1µL of lipofectamine) with Optimen medium (Invitrogen) for 20 min and the resulting 
mixture was dispensed to the cell cultures (10 µg DNA per well). The plasmids pEGFP-G93A-
hSOD1 and pEGFP-wt-hSOD1, expressing G93A mutant or wild type human SOD1 tagged 
with enhanced green fluorescent protein (EGFP) were kindly provided by Dr Josep Esquerda 
(Lleida, Catalonia). The pEGFP expression vector was used for mock transfection. 
Cytotoxicity Assay and ATP content 
Viability of Neuro-2A cells was assessed with a LDH Cytotoxicity Assay Kit (Promega, 
Madison, WI) according to manufacturer’s instructions. Briefly, the amount of lactate 
dehydrogenase (LDH) released into the culture medium is measured using an enzymatic 
reaction that results in a red formazan product which can be measured spectrophotometrically. 
Lactate dehydrogenase (LDH) is a cytosolic enzyme that is is an indicator of cellular toxicity. 
The cell viability was evaluated relative to the total LDH from whole cell lysate and the results 
were expressed as the percentage of viability versus treated with vehicle and/or mock 
transfected cells. 
Adenosine triphosphate (ATP) content in Neuro 2A cell homogenates was measured 
with the ATP Bioluminiscent Assay Kit (Sigma) according to the manufacturer’s instructions. 
Results are expressed as nanomole ATP per milligram protein. 
Statistical analysis 
All statistics were performed using the SPSS software (SPSS Inc., Chicago, IL) or the 
Prism software (GraphPadSoftware Inc.,La Jolla, CA). Differences between groups were 
analyzed by the Student's t tests or ANOVA with Post-Hoc analyses, after normality of variable 
distribution was ensured by Kolmogorov-Smirnov test. Correlations between variables were 
evaluated by the Pearson's statistic. The 0.05 level was selected as the point of minimal 
statistical significance in every comparison. 
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Results and discussion 
Disease onset, clinical evolution and survival ofG93A mice 
Our G93Amouse colony exhibited a phenotype consistent with the overexpression of 
the G93A-hSOD1 transgene (Gurney, 1997). G93A-hSOD1 protein expression in spinal cord of 
transgenic mice was verified by Western-blot analysis, using a monoclonal antibody specific 
against human SOD1, which has been shown to recognize distinct mutated human SOD1 forms, 
including G93A-hSOD1 (Sotelo-Silveira et al., 2009), Figure S0. G93A mice gained weight as 
expected, reaching a higher (p < 0.05) maximum value for males (21.1±0.2g, n=11) than for 
females (18.0±0.1g, n=12)(Figure S1A). Control and G93A mice body weight was significantly 
higher in males than in females from weaning day. However, in G93A animals this difference is 
faded out along disease, with no differences found from 107 days between sexes. In control 
animals, both sexes continued gaining weight until endpoint (Figure S1B). Food intake was not 
significantly different between G93A mice of both genders at any age, neither between male 
and female control mice (Figure S1C, Figure S1D, respectively). Onset of clinical symptoms 
occurred by approximately 70–90days of age, with body weight loss, abnormal gait, muscle 
weakness with decreased grip strength, and impaired coordination. As an estimation of disease 
onset, we used the interpolated value for age of attaining maximum weight after fitting a third-
order polynomial curve to the weight evolution data. Maximum body mass was attained at a 
significantly younger age in males (87.9±1.2 days, n=11) than in females (95.9±1.0 days, n=12; 
p < 0.05; Figure 1A, bars on the left). Female G93A mice showed a significant delay in disease 
progression, as evidenced by the later age by which they dropped to 10% below their maximum 
weight (males, 120.2±2.2 days; females, 135.5±3.9 days, P < 0.05; Figure 1A, bars on the 
right).As a second estimation of disease progression, a paw print analysis was performed to 
measure stride length, indicating again a slower disease progression in female G93A mice, as 
previously reported (Cacabelos et al., 2014). Figure 1B shows that the median value of both 
right and left stride lengths in G93A females was attained at a significantly older age (116.2±3.2 
days, on average of both hindlinbs) than in their male counterparts (107.3±4.1 days on average 
of both hindlinbs). Supporting this, overall clinical duration was greater in females (37.72±2.01 
days n=11 and 45.5±2.52 days n=12 for male and female, respectively; P < 0.001, Figure 1D). 
However, the age reaching the different clinical score status (Figure S1E, S1F and S1G, 
respectively) was similar for both sexes.The animals were euthanized when it demonstrated 
hind limb paralysis or inability to right itself when placed on its side. Female G93A mice 
survived significantly longer than males (P < 0.05), with survival times of 134.1±2.9 days 
(n=11, range 119-135) and 124.9±1.5 days (n=12, range 115-157 days), respectively (Figure 
1D).  
Disease onset, neurological scores, disease progression and survival of our G93A mice 
were consistent with those reported in the literature (Gurney, 1997), so we considered validated 
our animal model of ALS. Moreover, gender differences in the aforementioned clinical features 
of the diseased mice were also confirmed. Indeed, sex appears to modify the course of disease 
and lifespan in animal models of ALS with mutations in the hSOD1 gene, with an earlier 
disease onset in male transgenic rats and mice overexpressing G93A-hSOD1 (Suzuki et al., 
2007; Veldink et al., 2003), although sex appears to have no consistent effect on survival of 
ALS patients(Lee, Annegers, & Appel, 1995) 
Preliminary experiments performed in our laboratory displayed a peak of G93A-hSOD1 
protein expression at 60 and 90 days, and lower levels before and after (30 days and 120 days, 
respectively) in a mixed population of male and female G93A mice. After analysing separately 
male and female mice, the same pattern of mutated hSOD1 expression was observed (data not 
shown). Thus, we rule out different levels of aggregated or aberrant SOD1 activity between 
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male and female transgenic mice as the primary origin of gender differences in mitochondrial 
dysfunction and levels of protein oxidative modification markers. 
 
Oxygen consumption of mice lumbar spinal cord slices 
Respirometric analysis of mitochondrial function provides a tool to study changes in 
mitochondrial respiratory chain function and mitochondrial ATP production within tissue 
biopsies, cultured cells and isolated mitochondria (Hütter, Unterluggauer, Garedew, Jansen-
Dürr, & Gnaiger, 2006). In order to assess gender-related differences in spinal cord 
mitochondrial function of a murine model of ALS both in presymptomatic and diseased stages, 
oxygen consumption in LSCS of male and female non transgenic and transgenic mice 
overexpressing G93A-hSOD1 were analysed in two standardized experimental regimes in 30, 
60, 90 and 120 days old animals. 
First, using intact (not permeabilized) slices, and therefore resembling in vivo spinal 
cord cell conditions, we found significant differences in routine respiration (measured in Hank’s 
balanced salt solution containing 10mM Hepes, pH 7.4, without additional substrates, inhibitors 
or uncoupling agents) between control and transgenic mice at 120 days of age, with a reduced 
oxygen uptake for both genders (control vs. transgenic; males, 37.0±3.8 vs. 22.5±2.7 pmol 
O2/min×mg protein, P < 0.01; females, 40.1±1.5 vs. 31.9±2.8 pmol O2/min×mg protein, P < 
0.01; Figures S2A and S2B). Interestingly, when comparing 120 days old male and female 
G93A mice, routine respiration was 41.7% higher in females (P < 0.05), while no differences 
appeared between control mice of both sexes (Figure 2A and Figure S4A, respectively). Then, 
rotenone was added to the measurement chambers in order to inhibit the mitochondrial complex 
I, followed by the inhibitor of complex III, antimycin A. When rotenone-resistant respiration is 
subtracted to routine respiration, an estimation of the contribution of the mitochondrial chain 
complex I to cell or tissue respiration is obtained. Likewise, when antimycin-resistant 
respiration is subtracted to rotenone-resistant respiration, the resulting value is an estimation of 
the contribution of mitochondrial chain complex II to total respiration. According to the 
aforementioned calculation, the estimated complex I respiration was lower in male G93A mice 
respect to control animals by 26.0% (P < 0.05), 26.7% (P < 0.05) and 33.9% (P < 0.01) at 60, 90 
and 120 days, respectively (Figure S2C), whereas in females, complex I respiration in 
transgenic mice was significantly reduced (25.0%, P < 0.001) only at an age of 120 days, and, 
intriguingly, augmented by 28.7% (P < 0.01) at 30 days (Figure 2SD). When we compared 
complex I respiration between male and female G93A mice, the decrease in oxygen 
consumption was more pronounced in the former in all age groups, with the exception of 30 
days. Specifically, complex I respiration in G93A females was significantly higher than in 
males at 90 days (31.4%, P < 0.05) and 120 days (25.6%, P < 0.05), and also at 60 days 
(20.3%), although the difference was not significant (P = 0.0760) (Figure 2B). In control 
animals, complex I respiration was 39.6% higher (P < 0.01) in 30 day old males, whereas in 
older animals the values were similar in both genders, lacking significant differences (Figure 
S4B). Regarding complex II, its estimated oxygen uptake in control mice intact LSCS was 
significantly higher for females at 30 days (Figure S4C). However no gender differences were 
found for G93A animals (Figure 2C) along disease. Confirming this, no differences were found 
for G93A respect to control ones, neither globally, nor separated by gender (Figure S2E and 
S2F for male and female, respectively). Residual oxygen consumption is the respiration due to 
oxidative side reactions remaining after application of mitochondrial chain complex III 
inhibitors, such as antimycin A. Additionof antimycin A to the measurement chambers 
provoked a sharp fall in oxygen uptake that revealed a similar pattern for both genders 
expressing SOD1G93A, hence no differences were found between them (Figure 2D). Antimycin 
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A-resistant respiration was higher in control mice LSCS of both genders at 30 days (control vs. 
transgenic; males, 15.4±1.3 vs. 6.2±1.1 pmol O2/min×mg protein, P < 0.001; Figure S2G; 
females, 15.6±0.7 vs. 9.8±2.0pmol O2/min×mg protein, P < 0.01; Figure S2H) and 120 days 
(control vs. transgenic; males, 8.8±1.2 vs. 4.6±0.9pmol O2/min×mg protein, P < 0.01; Figure 
S2G; females, 9.7±1.2 vs. 6.7±0.7pmolO2/min×mg protein, P < 0.05; Figure S2H). Similar 
results were obtained when the total population of mice (males plus females) was analysed (data 
not shown). Interestingly, opposite results were obtained in residual respiration at 60 days and 
90 days, displaying higher rates in male G93A mice at 60 days (control vs. transgenic; 8.0±1.8 
vs. 13.7±1.0 pmol O2/min×mg protein, P < 0.01; Figure 2G) and in female G93A mice at 90 
days (control vs. transgenic; 7.2±1.2 vs. 12.0±1.0pmol O2/min×mg protein, P < 0.01; Figure 
2H). When comparing antimycin A-resistant respiration in G93A mice of both genders, this rate 
was 53.9% (P < 0.05) higher in males than in females at 60 days (data not shown). 
Consistent with previous reports (Mattiazzi et al., 2002) routine (intact tissue, without 
any inhibitor) respiration only shows evident reduction of G93A animals at end stage of disease. 
This reduction was also verified when comparison between male and female was done in G93A 
overexpressors, but was abolish for control animals all studied points, suggesting that 
differences founded are attributable to G93A overexpression. Although the routine respiration 
of intact LSCS was not significantly different in males and female G93A mice (only at 
endpoint), the higher rotenone resistant respiration in males at 60 days suggests a lower 
Complex I contribution to overall respiration, as calculated by difference respect to routine 
respiration. Since routine respiration does not vary, a compensatory stimulation of Complex II 
respiration is plausible. Hence, we could demonstrate that G93A males consumed less oxygen 
than controls form day 60 (Figure S2), but females were protected (displaying even greater 
consumption than controls at 30 days) showing only a late reduction at endpoint.  
Focusing in the G93A animals, females showed an upgraded Complex I oxygen 
consumption than males from 60 days (Figure 2). Nevertheless, this advantage was only 
significant for 90 and endpoint animals. Since rotenone mediated cytotoxicity was proved to be 
alleviated in female neuron primary cultures (Tao et al., 2012), this decreased respiration could 
lead cell survival demise in males. Studies from (Vinsant et al., 2013) showed that, in this 
mouse model, motor neuron abnormalities begins between 44 to 60 days. However, cytosol 
vacuolization and swollen and mega-mitochondrial were evident before (30 days, even P7). In 
line with this we also show in permeabilized slices early complex I dysfunction in males (Figure 
S3). On the contrary, females complex I–related reduced respiration was only evident under 
clinical symptoms. However, G93A-linked complex I malfunction was evident for early 
asymptomatic males respect to female’s counterparts (Figure 2cont).  
Underlying this gender dimorphism, studies from (Eschbach et al., 2013) show a male-
specific protective mechanism of PGC-1α (a master metabolic regulator (Chaturvedi & Flint 
Beal, 2013)) in this mouse model. Further, since PGC-1α could enhance the transcriptional 
activities sex hormone receptors(e.g. androgen receptor (Shiota et al., 2010) or estrogen receptor 
(Tcherepanova, Puigserver, Norris, Spiegelman, & McDonnell, 2000)) this may ressult in a 
feed-back loop. 
The second experimental regime required permeabilization of the LSCS with digitonin 
before the respirometry analysis in an artificial intracellular medium with sequential addition of 
mitochondrial substrates, uncouplers and inhibitors (SUIT protocol). Measurement of oxygen 
flux in permeabilized cells or tissues, in presence of saturating concentrations of substrates, 
ADP and Pi, provides an estimation of the in situ activities of the mitochondrial chain 
complexes, among other information, without the potential artefacts associated to the 
mitochondrial isolation procedure. Tissue permeabilization allows free diffusion of substances 
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through the cell membrane, while mitochondrial membrane integrity and permeability are not 
altered. Thus, the addition of substance to the measurement media allows direct manipulation of 
the chemical surround of the mitochondria. If the added substrates are added at saturating 
concentrations, its stimulating effect on its corresponding enzyme will be maximal. While this is 
not a physiological condition, it can give an estimation of the capacity of mitochondria to hold a 
metabolic challenge. Endogenous respiration is measured before addition of substrates, being 
supported by the remaining metabolites in the mitochondria, since the concentration of cytosolic 
metabolites has lowered to irrelevant levels due to its free diffusion through the permeabilized 
cell membrane. Under this situation no differences were found among male and female G93A 
overexpressors (Figure 2E), nor between control and transgenics for none sex (data not show) or 
even in control animals between sexes (Figure S4D). State 2 respiration (for Complex I) is 
achieved upon stimulation of those preparations with glutamate/malate. Hence, under this 
situation G93A females had higher oxygen consumption than G93A males only at early 
presimptomatic stages (30 days, Figure 2F). Differences between control and transgenic animals 
were also found for males (Figure S3A) and females (Figure S3E), but in this case, as expected, 
higher consumption was attributed to controls, only significant later in disease. Interestingly, 
male shows a dysfunction at 30 days which was not present in females. Finally, sexual 
dimorphism was confirmed for control animals, where at 60 and 90 days females displayed 
higher oxygen consumption (Figure S4E). Addition of ADP into the chambers reflects the 
oxygen consumption in state 3 (of complex I). Hence, in this situation, G93A females showed 
upgraded consumption compared with males all along disease (Figure 2G). Comparison of the 
overexpression separately between sexes shown G93A males (Figures S3B) underscored almost 
all along disease in contrast to females where decreased oxygen consumption was only evident 
at end stage (Figure S3F). For control animals, females showed increased complex I state 3 
levels at 60 days when compared with males (Figure S4F). Succinate (substrate for the Complex 
II) addition serves us for complex I/II state 3 measurements. Thus, estimated measures showed 
early disruption in G93A females compared with males (Figure 2H) which was faded out along 
disease. No differences were found for males and (Figure S3C) only higher consumption was 
detected in controls females (Figure S3G) when compare the transgenic effect between sexes. 
Finally, as previously commented, rotenone addition blockades complex I and an estimation of 
complex II state 3 is obtained. In this situation, at 30 days there is an almost significant 
difference (P=0.065) between males and females overexpressing G93A which disappears along 
disease (Figure 2I). Splitting measures between sexes and comparison for G93A effect showed 
no differences for males and only endpoint G93A females had a reduced oxygen consumption 
compared with control littermates (Figures S3D and S3H for male and female, respectively). 
 
Oxidative stress markers in spinal cord 
To offer an accurate quantitative measurement of protein oxidation in spinal cord 
proteins, we measured structurally defined oxidation products by isotope-dilution GC/MS 
(Pamplona et al., 2005). Proteins from spinal cord samples contain oxidation products resulting 
from metal-catalysed oxidation (MCO), glycoxidation and lipoxidation. A general trend to 
decrease spinal cord levels of the five markers analyzed (GSA, AASA, CML, CEL and MDAL) 
with age can be observed in mice of both genders, either control or transgenic, with the 
exception of AASA and MDAL in female G93A mice and male control mice, respectively, at 
120 days. (Figure 3) GSA and CML levels in transgenics of both genders were not different 
across disease (Figures S5A, S5B for males and Figures S5C and S5D for females). The 
comparison between male and female mice revealed that mutated hSOD1 overexpression was 
associated with differences in the steady-state levels of protein oxidative damage markers. 
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AASA, a MCO marker, displayed significantly 47.5% (P < 0.01; Figure 3A) and 39.5% (P < 
0.01; Figure 3D) higher levels in spinal cord proteins of G93A mice at 60 days in males, and at 
90 days in females, respectively, than in control mice. CEL is a glycoxidation marker whose 
levels were found surprisingly higher in spinal cord of female control mice at 90 days (Figure 
3E). Finally, levels of the lipoxidation marker MDAL were augmented in spinal cord of males 
by 30.5% (P < 0.01) in G93A mice at 90 days, and, unexpectedly, by 23.5% (P< 0.01) in control 
mice at 120 days (Figure 3C). 
ROS formation is particularly high when Complex I is inhibited (Votyakova & 
Reynolds, 2001). Therefore, its blockade may account for higher ROS production, and probably 
increased oxidative products accretion. Antimycin-resistant cell respiration has been used as an 
estimation of mitochondrial ROS production. In G93A mice spinal cord, the rise in AASA 
levels, a marker of metal-catalyzed oxidation (MCO) of proteins, occurred after the peak of 
antimycin-resistant respiration suggests the mitochondrion as the origin of the cellular protein 
oxidative damage. This delay in protein oxidative damage with respect to mitochondrial 
dysfunction in observed in mice of both genders. Interestingly, there is a shift of both 
mitochondrial-related and oxidative stress-related pathophysiological findings in female G93A 
mice respect to their male littermates. These results could explain, at least in part, the delayed 
clinical features observed in G93A female mice respect to male mice and, possibly, also in male 
patients respect to the female counterparts. In any case, higher oxidative damage was expected 
due to the G93A overexpression. Early studies already pointed for a nonlinear oxidative 
accretion in this animal model (accretion of MDA in spinal cord at 30 and 60 days, whole 
sections, by HPLC; greater MDA inmunoreactivity in lumbar spinal cord at 100 and 120 days 
(Hall, Andrus, Oostveen, Fleck, & Gurney, 1998); carbonylated products early accretion -30 
days- for G93A animals (Andrus, Fleck, Gurney, & Hall, 1998)) and were more recently 
confirmed (decreased ROS production for SODG93A animals in isolated mitochondrial 
preparations respect to controls, 100 days age (Vinsant et al., 2013); increased spinal cord 4-
HNE and MDA at 100 and 130 respect to controls by spectrophotometery; DNP-carbonylated 
products accumulation was similar to controls along disease; whole spinal cord sections, no 
gender consideration (Miana-Mena et al., 2011); MDA accumulation at 30 and 120 days in 
G93A respect to controls, no gender consideration, measured by colorimetry (Kirkinezos et al., 
2005)). Even when our results do not completely fit this previous findings, our measures are 
lumbar specific (nor cervical or thoracic sections), we split by gender and methodology applied 
to the measurements were different. Hence, this could explain little variations with previous 
reports. This goes in line with our previous publication (Cacabelos et al., 2014) (focusing only 
in control diet) indicating that, among oxidative modification studied, most of them (but CEL in 
females) have greater accretion at early clinical stages (90-100 days), rather than end stage. And 
in any case, one should bear in mind that those animals are overexpressing an oxidant-
scavenging enzyme (SOD1), which, even with less efficiency, is functional (Yim et al 1996). 
 
Fatty acid profile in spinal cord 
Since fatty acid profile strongly influences membrane peroxidizability, and 
consequently protein lipoxidative damage, we analysed fatty acid content in G93A mice spinal 
cord at early presymptomatic (30 and 60 days), disease onset (90 days) and symptomatic (120 
days) ages as well as in control animals for both gender. Those analyses revealed significant 
differences in the G93A-hSOD1 colony between males and females (Figure 4) as well as 
differences among overexpressors and controls (Figure S6) along disease. The two most 
remarkable changes involve the highly peroxidizables docosahexaenoic acid (DHA) and 
arachidonic acid (AA). Levels of DHA decreased along time (Figures 4A, S6B, S6E and S6F), 
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with lower levels of this fatty acid at endpoint regardless sex or transgene. Focusing in gender 
dimorphism of G93A animals, interestingly DHA levels, despite being significantly higher in 
females early in disease, this difference is faded out along it. On the other hand, for non 
transgenic animals, even when decreasing along the experiment, AA and DHA levels were 
similar for males and females (Figure S6A and S6A, respectivelly). AA levels was severely 
affected by transgen, since for both sexes at preclinical ages (30, 60 days) non trangenic animals 
accumulated more than G93A ones, but this difference turned to be the opposite at endpoint 
(Figures S6A, S6C and S6D). Furthermore, focusing in G93A animals, AA levels turned from 
being significantly lower in males at 30 days, to be significantly higher at endpoint (Figure 4B), 
respect to females. This different FA handling goes in line with previous reports indicating a 
differential n-3 synthesis for both sexes. Studies from Aessandri and collaborators showed that 
females have a preference towards n-3 synthesis. Greater circulating DHA levels were reported 
for females plasma (Astorg et al., 2008)(Welch et al., 2006) and in tissues and neuronal cell 
lines (Alessandri et al., 2008). However, for our control animals, we could not observe any 
difference across the study for this particular FA (Figure S6B). Behind this differential lipid 
metabolism could rely an altered desaturase activity for males and females, as reported Extier 
and collaborators in a model of n-3 replenishment (Extier et al., 2010). Consistent with this 
DHA spinal cord depletion in this animal model, previous ressults form our group (Ilieva et al. 
2007) had also reported decreased DHA accretion in spinal cord of patients (this study was 
carried out in ALS male patients, n=7). However in this report, even when levels are greater as 
in animals model, this deference was not significantly altered than controls.Finally,  
 
Overexpression of G93A-hSOD1 in Neuro 2A cells: cell viability and ATP content, oxygen 
consumption and mitochondrial ETC complexes protein expression.  
 
To evaluate the effect of estrogens on mitochondrial function of isolated neuronal cells 
overexpressing a mutated form of SOD1, Neuro-2A cells were treated with 17β-estradiol prior 
to transfection with aG93A-hSOD1 plasmid (for 10 days,10 nM final concentration). The G93A 
mutated form of hSOD tagged to an EGFP expression vector was transiently transfected in 
Neuro-2A cells using Lipofectamine (from now on G93A cells). Mock transfected cells 
expressing EGFP were used as a control (Control cells). Direct visualization of GFP 
fluorescence was analysed using fluorescence microscopy to ensure transfection (efficiency 
≈80-90%, data not shown) or to denote differential expression between transfectants (Figure 
S7). To evaluate the cytotoxic effect of hSOD1 and mutant hSOD1 overexpression, alone and 
combined with E2 treatment in Neuro-2A cells, we compared the viability of WT and G93A 
cells vs. mock transfected cells, pre-treated during 10 days with 10 nM E2 or vehicle, after 24h 
of transfection. We found that there was no significant difference in the cell viability between 
the three transfectants either with or without exposure to estrogen (Figure 5A). The intracellular 
ATP content measurements neither revealed variations between transfections and E2 
pretreatment or their mock and vehicle controls, respectively (Figure 5B). 
As previously shown, we analysed oxygen consumption in two standardized 
experimental regimes. Neuro 2A cells transfected with an EGFP plasmid were included as a 
second control. First, using intact (i.e. not permeabilized) cells, we did not find significant 
differences in routine respiration (measured in standard culture medium without additional 
substrates, inhibitors or uncoupling agents) or in non-phosphorylating respiration (measured 
after inhibition of mitochondrial chain complex V F0-ATP synthase with oligomycin). However, 
maximal respiratory capacity (measured after uncoupling with FCCP) in G93A cells was 
significantly reduced (P < 0.05) compared with control cells and wt cells by 27.6% and 18.2%, 
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respectively (Figure 5C). Respiration was inhibited by antimycin A to an equal extent in the 
three transfectants, pointing to a Complex I malfunction. 
To further confirm this, the second experimental regime included cell permeabilization 
with saponin before the respirometry analysis in an artificial medium with sequential addition of 
mitochondrial substrates and inhibitors, quite similar to the protocol used to analyse respiration 
in permeabilized LSCS as described above. Neither endogenous respiration (before addition of 
substrates, data not shown) nor Complex I state 2 respiration stimulated by glutamate/malate, 
were significantly different between the three transfectants (data not shown). However, after 
addition of ADP, in order to achieve complex I state 3 respiration, oxygen uptake rose to a 
lower level in G93A cells than in wtSOD cells and GFP cells (Figure 5D, Complex I). This 
respiration difference was enhanced after addition of succinate (Figure 5D, Complex I+II), but 
disappeared when rotenone was injected in the measurement chambers (Figure 5D, Complex II). 
As in the non-permeabilized cell protocol, oxygen consumption was inhibited by antimycin A to 
an equal extent in the three transfectants (data not shown). Hence, all in all, similar to the 
respirometric measurements performed with intact cells, the aforementioned differences in 
oxygen uptake dependent on ADP and glutamate/malate, or ADP and glutamate/malate plus 
succinate, were abolished when cells were pre-treated with 10nME2 before the transfection. 
In order to assess the origin of the reduced mitochondrial chain complex I state 3 
respiration in G93A cells, we estimated the protein expression of the complex I (39KDa, 
NDUFA9) as well as Complex II (70KDa, Flavoprotein ) subunits. Figure 5E shows that levels 
of expression of two peptides representative of mitochondrial chain complex I and complex II 
are not significantly different neither among transfects, nor E2 treatment.  
Because the contribution of motor neurons, despite being large cells, in whole spinal 
cord is relatively minor, these results suggest that the decrease rate of respiration in G93A mice 
is present in different cell types, and not motor neuron specific. In fact previous result from our 
group (under revision) already reported a decreased respiration in an in vitro (tissular) model of 
ALS, particularly attributed to a Complex I malfunction. In any case, most functional 
experiments performed with nervous tissue provide a mixed result arising from its two major 
cell types. While much work showing glial involvement in the pathophysiology of the SOD1-
G93A genetic mouse model has been done, the ultimate result is (motor) neuron dysfunction 
and death. On the other hand, the above-described differences in mitochondrial dysfunction 
between genders in SOD1-G93A mice could be attributable to the higher levels of estrogens in 
female mice. Taking these two points in mind, we aimed to investigate the effect of estrogen 
exposure on the mitochondrial dysfunction due to SOD1-G93A expression in neuronal cells. 
We found the mouse neuroblastoma N2A cell line a suitable model for this part of the study 
because: a) cells exhibit a differentiated neuronal phenotype (Graham, Gonatas, & 
Charalampous, 1974), b) expression of estrogen receptors (Mendez & Garcia-Segura, 2006)(Li, 
Hao, Cheng, & Li, 2014) , and c) it is a suitable transfection host. As a potential limitation of 
the present study, it may be argued that the Neuro-2A cell line is not derived from motor 
neuron. However, it has been demonstrated that not only spinal and upper motor neurons are 
degenerated in ALS, but also interneurons and glia. Here we show that SOD1 gene mutation did 
not induce harmful effects on cell viability of Neuro-2A cells under basal conditions, in 
accordance with a previous report by Pyo (Pyo et al., 2010) using stably transfected cells of the 
motoneuron–neuroblastoma hybrid (VSC 4.1) cell line. Although it has been reported that 
expression of mutant SOD1 (G37R) resulted in a time and dose-related death of differentiated 
neuroblastoma cells (Flanagan, Anderson, Ross, & Oberley, 2002; Gurney, 1997) and protein 
expression blockade (by RNAi against hSODG93A) resulted in disease alleviation (Ralph et al., 
2005).Therefore, neuro-2A cells transfected transiently with mutated SOD1 for a relatively 
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short time previous to their analysis, could be considered a model comparable to spinal cord 
neurons of early pre-symptomatic hSOD1-G93A mice. Moreover exposure to 17-β-estradiol 
during 10 days did not alter significantly cell survival. Supporting this, G93A cells did not 
exhibit differences respect to their controls in viability or metabolism, measured as 
mitochondrial function and ATP content. 
Finally, accounting the lesser extent of early oxidative damage in spinal cord of female 
G93A mice could be related to the higher levels of UCP4 protein expression compared to males. 
Thus, our results showing an increase in complex II state 3 respiration in female G93A mice, 
but not in males, and a higher efficiency in terms of ATP production in females (resulting form 
the subtraction of , altogether with the lack of difference in complex II peptide expression (at 
least in the cell line), suggest a role of UCP4 in the compensatory mechanisms against 
bioenergetic failure in spinal cord of G93A mice and possibly ALS patients. This would be a 
interesting question to be addressed since the neuroprotective effect of UCP4 and UCP5 has 
been reported in aged rat brain (Guevara et al., 2009). In this paper, researchers have found 
lower oxidative damage in proteins and lipids that correlated with higher protein levels of UCP4 
and UCP5 in female rats compared with their age-matched male littermates. On the other hand, 
as reported by Ho and colleagues, UCP4 overexpression increased ATP synthesis by 
specifically interacting with mitochondrial complex II in SH-SY5Y with complex I deficiency 
induced by 1-methyl-4-phenylpyridinium (MPP(+)) treatment (Ho et al., 2012). However, these 
results could also be related to the fact that all complex II subunits are encoded in the nuclear 
genome, and therefore its DNA would be less exposed to the ROS generated by the 
dysfunctional mitochondria, contrary to complexes I, III and IV, all of them containing several 
subunits encoded in the mitochondrial DNA. But in any case, those results in terms of an 
upgraded mitochondrial physiology, concomitant to an increased UCP decoupling mechanism 
to reduce mitochondrial ROS should be revisited in this mouse model. In a recent publication 
model (Peixoto et al., 2013) researchers co-expressed hUCP2 into the SOD1G93A mouse 
model. Even when they demonstrated a protective effect in terms of ROS production with the 
co-overexpression, they also reported shortened lifespan and worst mitochondrial dysfunction 
(more sensitive to Ca+2-induced mitochondrial depolarization, in purified brain mitochondria of 
100 day). They also showed an accelerated disease progression when co-expressed in the 
SOD1G93A background. In line with our results (even taking in to account different 
methodology were used), their G93A animals showed a decreased peroxide production respect 
to controls, when complex I is in state 2 (Figures S2A and S3B). 
However, besides UCPs, other proteins may contribute to the gender-related 
differences. In a recent publication (H. J. Kim et al., 2012) researchers focused in gender 
relevance in the mitochondrial permeability transition pore formation in the SODG93A mouse 
model. Hence, they demonstrated that ablation of cyclophilin D (a protein structurally linked to 
the mitochondrial permeability membrane transition pore (Doczi et al., 2011)) completely 
abolished the phenotypic advantage of female SODG93A, but no effect was found in males. In 
fact, they showed that 17β-estradiol protected SODG93A cortical neurons and spinal cord motor 
neurons against glutamate toxicity in brain mitochondria, but the protection was lost in neurons 
lacking cyclophilin D. 
In summary, we have described an early mitochondrial defect during the pre-
symptomatic stage associated to the expression of G93A mutated human SOD1 that appears at a 
younger age in males mice than in females, correlating with the delay in their clinical features. 
These data support a role for dysfunctional mitochondrial function control of spinal cord 
neurons in ALS pathogenesis and, in particular, the gender bias towards males observed in ALS. 
Thus, mitochondrial enzymes, such complex I or malate dehydrogenase, may represent viable 
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targets for novel treatments of a range of disorders affecting motor systems. This possibility 
underscores the importance of further studies investigating the role of sexual hormones or 
related molecules in the face of injury and disease as well as their potential contribution to 
motor recovery. 
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Figure Captions 
Figure 1.- Disease onset and progression (A), stride length analysis (B), clinical 
progression (C) and survival curves (D) of the G93A colony, depicted by sex. Bars in (A) 
represented means ± SEM of the age at maximum weight, expressed in days. Bars in (B) 
represented means ± SEM of the age of clinical onset measured after stride length analysis, 
expressed in days. Dots in (C) represented disease duration among the G93A colony, depicted 
by sex, expressed in days. (D) represented a Kaplan-Meyer survival curve. *, P<0.05, between 
male and female mice of the same age by Student’s t test. **, P<0.01 after a Kaplan-Meyer 
analysis. 
Figure 2.- Oxygen flux of sets of 5 intact lumbar spinal cord slices from male and 
female G93A mice measured at 30,60, 90 and 120 (endpoint) days of age. Experimental 
procedures allows show basal (A), complex I (B), complex II (C) or residual (D) oxygen 
consumption differences between male and female. Measurements were taken at 37 °C in 
Hank’s balanced salt solution containing 10mM Hepes, pH 7.4, and corrected for instrumental 
background oxygen flux. Values were normalized by actual protein content in the respirometer 
chambers. Means ± SEM, expressed as pmol O2/s·mg protein. *, P<0.05, between male and 
female mice of the same age by Student’s t test. 
Figure 2cont.- Oxygen flux of sets of 5 lumbar spinal cord slices from male and female 
G93A mice measured at 30,60, 90 and 120 (endpoint) days of age. Permeabilized LSCS 
measures on endogenous (E), Complex I state 2 (F), complex I state3 (G), complex I/II state 3 
(H) and complex II state3 (I) oxygen consumption conditions between males and females 
overexpressing G93A. Measurements were taken at 37 °C in Mir05 media. Values shown are 
means ± SEM expressed as pmol O2/min×·mg protein for 4-6 independent measures. *, p < 0.01 
respect to females of the same age by Student’s t test. 
Figure 3.- GC/MS analyses of protein oxidation products in LSCS from male and 
female G93A and control littermates measured at 60, 90 and 120 (endpoint) days. (A) and (D) 
represented levels of AASA, for male and female, respectively. (B) and (E) represented levels 
of CEL for male and female, respectively. (C) and (F) represented MDAL levels for male and 
female, respectively. Values shown are means ± SEM expressed as µmol of analyte per mol 
lysine. *, p < 0.01 respect to non transgenic group of the same age by Student’s t test. 
Figure 4.GC analyses of lipids in LSCS from male and female G93A measured at 30, 
60, 90 and 120 (endpoint) days. (A) Shows DHA levels along disease. (B) Shows AA levels 
along disease course. Bars represented mean values ± SEM expressed as % of abundance of 
analyte among the total FAME identified. *, p < 0.01 respect to female group, of the same age 
by Student’s t test. 
Figure 5. Overexpression of mutated SOD1in Neuro-2A cells and treatment with E2. 
Neither cell viability (A) nor ATP content (B) were altered as a consequence of transfection or 
E2 treatment. (C) Oxygen flux measurements in intact N2A cells pretreated with E2 and 
transfected with pEGFP-G93A-hSOD1 and pEGFP-hSOD-wt showed a reduction on the 
maximal oxygen capacity in G93A transfected cells which was abrogated by E2 treatment. (D) 
Oxygen flux measurements in permeabilized-above mentioned cells showed a Complex I 
impairment for cells transfected with G93A respect to control cells which was abolished by the 
E2 treatment. In the same experimental regime, western blot analysis (E) for mitochondrial 
complex protein expression (complex I and complex II) confirmed an unaltered protein 
expression among the E2 treatment and transfects. Bars in (A) represent % of survival ± SEM 
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respect to control cells for 4-6 independent experiments. Bars in (B) represented ATP mean 
values ± SEM expressed as nmol/mg protein for 4-6 independent experiments. Oxygen 
consumption in (B) was measured at 37 °C in culture medium containing 10mM Hepes, pH 7.4, 
and corrected for instrumental background oxygen flux. In (D) culture medium was MIR05. 
Values were normalized by actual protein content in the respirometer chambers, expressed as 
pmol O2/ min×mg protein. *, P<0.05; ** P<0.01;*** P<0.001 between control cells and G93A 
cells for 4-6 independent experiments. Bars in (E) represent means ±SEM densitometric 
analysis of the corresponding complexes relativized by actual porin content in each lane for 4-6 
independent experiments 
 
 
 
SUPLEMENTAL FIGURES 
 
 
Figure S0.- Time course of G93A-hSOD1 protein expression in G93A mice spinal cord. 
Western-blot analysis of transgenic male and female mice at 30 and 60 days, leads to 
the expression of a protein with an apparent MW of 16 kDa, whereas, as expected, the protein 
was not detected in control mice. Overespressors of non mutant SOD1 (WT) was used as 
control. These results provided evidence that the mutated form of the enzyme were expressed at 
similar levels in mice of both sexes, at least at preclinical ages. 
 
Figure S1.- Clinical and metabolic features of G93A colony and control littermates, depicted by 
sex. (A) Weigth evolution across the study for G93A animals. (B) Weigth evolution across the 
study for controls. (C) Food intake calculations for G93A colony. (D) Food intake calculations 
for controls. Along disease, animals were studies every other day for clinical symptoms, been 
classified accordingly. As a result (E) shows the age at which animals reached clinical score 2, 
(F) shows the age at clinical score 3 and (G) shows the age at clinical score 4. Dots represented 
means ±SEM values in grams of weakly measurements in (A to D), n=at least, 11-12. In (E-F) 
boxes represented mean ±SEM expressed in days, n=11-12. *, P<0.05 between male and age 
matched females. 
Figure S2.- Oxygen flux of sets of 5 intact LSCS from male and female G93A and 
control mice measured at 30,60, 90 and 120 (endpoint) days of age. Experimental procedures 
allows show basal (A-B), complex I (C-D), complex II (E-F) or residual (G-H) oxygen 
consumption differences between G93A and controls, depicted by sex. Measurements were 
taken at 37 °C in Hank’s balanced salt solution containing 10mM Hepes, pH 7.4, and corrected 
for instrumental background oxygen flux. Values were normalized by actual protein content in 
the respirometer chambers. Means ± SEM, expressed as pmol O2/s·mg protein. *, P<0.05, 
between male and female mice of the same age by Student’s t test. 
Figure S3.- Oxygen flux of sets of 5 LSCS from male and female G93A and control 
mice measured at 30,60, 90 and 120 (endpoint) days of age. Permeabilized LSCS measures on 
complexI state2 (A and E), Complex I state 3 (B and F), complex I/II state 3 (C and G) and 
complex II state3 (D and H) oxygen consumption conditions between G93A overexpresors and 
controls depicted by sex. Measurements were taken at 37 °C in Mir05 media. Values shown are 
means ± SEM expressed as pmol O2/min×·mg protein for 4-6 independent measures. *, p < 0.01 
respect to controls of the same age by Student’s t test. 
Figure S4.- Oxygen flux of sets of 5 LSCS from male and female control mice 
measured at 30,60, 90 and 120 (endpoint) days of age. In the upper panel, intact measures 
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showed basal (A), complex I (B) and complex II (C) oxygen consumption differences between 
males and age matched females in the control colony. Measurements were taken at 37 °C in 
Hank’s balanced salt solution containing 10mM Hepes, pH 7.4, and corrected for instrumental 
background oxygen flux. On the lower panel, permeabilized LSCS measures on endogenous 
(D), Complex I state 2 (E), complex I state 3 (F) and complex I/II state3 (G) oxygen 
consumption conditions between male and age matched females in the control colony. 
Measurements were taken at 37 °C in Mir05 media. Values shown are means ± SEM expressed 
as pmol O2/min×·mg protein for 4-6 independent measures. *, p < 0.01 respect to females of the 
same age by Student’s t test. 
Figure S5.- GC/MS analyses of protein oxidation products in LSCS from male and 
female G93A and control littermates measured at 60, 90 and 120 (endpoint) days. (A) and (C) 
represented levels of GSA, for male and female, respectively. (B) and (D) represented levels of 
CML for male and female, respectively. Values shown are means ± SEM expressed as µmol of 
analyte per mol lysine. *, p < 0.01 respect to non transgenic group of the same age by Student’s 
t test. 
Figure S6.-GC analyses of lipids in LSCS from male and female G93A and controls, 
measured at 30, 60, 90 and 120 (endpoint) days. Upper panel shows absence of sexual 
dimorphism in the control colony regarding DHA (A) or AA (B) levels in spinal cord. Lower 
panel indicates the differences founded among G93A colony and controls depicted by sex. (C) 
and (D) shows levels of AA along disease course for male and female, respectively. (E) and (F) 
shows levels of DHA along disease course in male and female, respectively. Bars represented 
mean values ± SEM expressed as % of abundance of analyte among the total FAME identified. 
*, p < 0.01 respect to female group in the upper panel and respect to the control littermate in the 
lower panel. All of them age-matched, by Student’s t test. 
Figure S6.- Phase contrast and fluorescence microscopy images of the N2A culture after 
pEGFP-hSOD-wt (A) and (C) or pEGFP-G93A-hSOD1 (B) and (D) transfection. 
Approximately, 80-90% trasfection efficiency was found. 
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Supplementary material 
 
Mice Genotyping  
Mice were identified by PCR with tail genomic DNA as templates. The REDExtract-N-Amp 
Tissue PCR Kit (XNAT; Sigma-Aldrich, St. Louis, MO) was used to extract genomic DNA from mouse 
tails and amplify targets of interest by PCR according to manufacturer’s instructions. Four primers (a pair 
for wild type forward: 5´-CTA GGC CAC AGA ATT GAA AGA TCT-3´ and reverse: 5´-GTA GGT 
GGA AAT TCT AGC ATC ATC-3´ and for G93A forward: 5´-CAT CAG CCC TAA TCC ATC TGA-3´ 
and reverse: 5´-CGC GAC TAA CAA TCA AAG TGA-3´) were used at to amplify a bands from the 
inserted targeting vector. Briefly, the DNA is released from the tail tissue by incubating the sample with a 
mixture of the Extraction Solution and the Tissue Preparation Solution at room temperature for 10 
minutes.After adding Neutralization Solution B, the extract is ready for PCR. A 4 L aliquot of the 
neutralized extract is then combined with 10 L of 2x REDExtract-N-Amp PCR Reaction Mix (buffer, 
salts, dNTPs, Taq polymerase, JumpStart Taq antibody and REDTaq® dye) and adequate volumes of 
each primer and water (PCR grade; Sigma-Aldrich, St. Louis, MO). PCR conditions were: after 1 cycle of 
5 minutes at 95°C, 35 cycles of 30 seconds at 94°C, 45 seconds at 50°C, and 4 minute at 72°C, with a 
final extension at 72°C during 7 min, using an Applied Biosystems 2740 v.2.08 (Carlsbad, CA) thermal 
cycler. As a control of effective PCR amplification, housekeeping gene interleukin 5 was used. The 
resulting PCR products were stored at 4˚C until direct loading onto an agarose gel. Products were 
electrophoresed for 30 minutes under constant voltage (100V) and imaged under UV light (302 or 365 
nm) lamp from Alpha Innotech (Santa Clara, CA) and analysed with Alpha Digidoc RT2 software (Santa 
Clara, CA). 
Neurological scoring  
Neurological scoring was performed every other day for both hind legs for each mouse from 60 
days of age. The neurological score employed a scale of 0 to 4 and was a slight variation of which was 
developed by observation at Amyotrophic Lateral Sclerosis Therapy Development Institute (ALSTDI). 
Criteria used to assign each score level were as following: score 0, full extension of hind legs away from 
lateral midline when mouse is suspended by its tail, and mouse can hold this for 2 seconds, suspended 2–
3 times; score 1, collapse or partial collapse of leg extension towards lateral midline or trembling of hind 
legs during tail suspension; score 2, toes curl at least twice during walking a distance of 40cm, or any part 
of the foot is dragged along the cage bottom or table (if one hind leg is scored as 2, food pellets are left on 
bedding and a long sipper tube is placed on the water bottle); score 3, rigid paralysis or minimal joint 
movement, foot not being used for forward motion; and, score 4, mouse cannot right itself within 30 
seconds from either side. When mice achieved a score of 4 for two alternate days, they were euthanized. 
Paw print analysis 
Mice were trained to walk freely along a U-shaped plastic corridor (5 cm wide, 70 cm long) 
three times per week before data collection (average age 70 days). Once trained, to perform stride length 
measurements, hind limbs were stained with non-toxic children paint and their tracks were imprinted on 
paper lining the floor of the corridor. Only continuous runs were selected among recorded paw prints and 
a minimum of 5-7 strides were measured per animal per day (measures were taken three times per week). 
Since animals tended to run when released and walk slowly at the end of the corridor, those sections of 
the paw print were discarded for the stride length measurements. Three stride length measurements were 
taken manually as described previously (Chiu et al., 1995) front and back stride, and front-to-back 
distance. 10 total measures were taken for each measurement. Front stride and back stride were collected 
as a straight line from paw print to the following paw print. Front-to-back distance was collected as a 
straight line from back paw print to corresponding front paw print. Correspondence was based on closest 
front footprint. The distance was recorded as length of line from paw to the stride line opposite the paw 
print. Since only number of the randomized animal and date identified the recorded tracks, measurement 
of stride length was determined in a blinded manner.As the disease progresses, the painted footprints 
became increasingly smeared on the paper, which correlated with previous results (Marx, 1994). The 
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onset of clinical weakness was quantified by determining the age at which shortening of the stride length 
was lower than 40% for two consecutive measures. 
Oxidation-derived protein damage markers measurements by GC/MS. 
Glutamic semialdehyde (GSA), aminoadipicsemialdehyde (AASA), Nε -(carboxyethyl)-lysine 
(CEL), Nε -(carboxymethyl)-lysine (CML), and Nε-(malondialdehyde)-lysine (MDAL) concentrations in 
total proteins from spinal cord homogenates were measured by gas chromatography/mass spectrometry 
(GC/MS) as previously described (Cacabelos et al., 2014). Samples containing 0.75-1 mg of protein were 
delipidated using chloroform:methanol (2:1 v/v), and proteins were precipitated by adding 10% 
trichloroacetic acid (final concentration) and subsequent centrifugation. Protein samples were reduced 
overnight with 500 mM NaBH4 (final concentration) in 0.2M borate buffer, pH 9.2, containing 1 drop of 
hexanol as an anti-foam reagent. Proteins were then reprecipitated by adding 1ml of 20% trichloroacetic 
acid and subsequent centrifugation. The following isotopically labelled internal standards were then 
added: [2H8]Lysine (d8-Lys; CDN Isotopes); [2H4]CML (d4-CML), [2H4]CEL (d4-CEL), and 
[2H8]MDAL (d8-MDAL), prepared as described (8,26); [2H5] 5-hydroxy-2-aminovaleric acid (for GSA 
quantization) and [2H4]6-hydroxy-2-aminocaproic acid (for AASA quantization) prepared as described in 
(Pamplona et al., 2005). The samples were hydrolysed at 155oC for 30 min in 1ml of 6N HCl, and then 
dried in vacuo. The N,O-trifluoroacetyl methyl ester derivatives of the protein hydrolysate were prepared 
as previously described (Pamplona et al 2005). GC/MS analyses were carried out on a Hewlett-Packard 
model 6890 gas chromatograph equipped with a 30m HP-5MS capillary column (30m x 0.25mm x 0.25 
µm) coupled to a Hewlett-Packard model 5973A mass selective detector (Agilent, Barcelona, Catalonia). 
The injection port was maintained at 275ºC; the temperature program was 5 min at 110ºC, then 2ºC/min 
to 150ºC, then 5ºC/min to 240ºC, then 25ºC/min to 300ºC, and finally hold at 300ºC for 5 min. 
Quantification was performed by external standardisation using standard curves constructed from 
mixtures of deuterated and non-deuterated standards. Analytes were detected by selected ion-monitoring 
GC/MS. The ions used were: lysine and d8-lysine, m/z 180 and 187, respectively; 5-hydroxy-2-
aminovaleric acid and d5-5-hydroxy-2-aminovaleric acid (stable derivatives of GSA), m/z 280 and 285, 
respectively; 6-hydroxy-2-aminocaproic acid and d4-6-hydroxy-2-aminocaproic acid (stable derivatives 
of AASA), m/z 294 and 298, respectively; CML and d4-CML , m/z 392 and 396, respectively; CEL and 
d4-CEL, m/z 379 and 383, respectively; and MDAL and d8-MDAL, m/z 474 and 482, respectively. The 
amounts of products were expressed as the ratio µmol GSA, AASA, CML, CEL or MDAL per mol 
lysine. 
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5. Discussion 
 
The work presented here summarized different methodological approaches aimed to shed some 
light on FA dietary interventions to better understand pathophysiology of ALS. Also relevant, 
we tried to increase the knowledge of a variety of well-established models of the disease (e.g. 
cell lines, OT, SODG93A), involving FA handling or sexual dimorphism, which were found 
altered in human patients. 
 
For this purpose, we started with a very simplistic models of biomolecule substrates (lipid but 
also proteic) trying to define and characterize a suitable natural dietary antioxidant and its 
possible improved outcome (by means of reduced oxidative accretion and upgraded cell 
survival) when being co-treated against different oxidative stimuli. As many others had pointed 
before (reviewed in (Benzie and Choi 2014)), the heterogeneity encountered, which could be 
related to the different sources of oxidative stress, made the election of a single antioxidant 
substance very complex (to protect against those multiple situations). Those variable results 
could be therefore explained in terms of altered antioxidant properties of a specific compound as 
well as the different model involved. Thus, this capacity would greatly vary, sometimes based 
on antioxidant chemical structure. In fact, hyperconjugation and proton dislocation properties, 
like those obtained thanks to orto-dihydroxyl structures (e.g. those found in secoiridoids), 
phenol radical cation and phenoxyl radical delocalization (e.g. phenolic acids) (Joshi et al. 2004) 
and/or α/β unsaturated structures (e.g. flavonoids and lignans among others) (Brown et al. 1998) 
have been proved to counteract oxidative-damage spread.  
 
Anyway, antioxidant potential would also rely on the possible interaction with the substrate 
(e.g. lipid or aqueous media) and, in a complete animal model, its inherent natural dietary bio-
availability (e.g. the chance to be in the right time and location). Therefore, the election of a 
suitable antioxidant would depend on the specific mechanism of oxidation that intercepts and 
the particular environment where it takes place, for those reasons being very difficult to find a 
broad-field one. 
 
In any case, in general, luteolin and hydroxytyrosol showed a better response to oxidative stress 
(by multiple oxidative methodological approaches), in terms of oxidative carbonylation 
accretion (as shown by WB against DNP adducts in ox LDL) and alleviated oxidative mediated-
cell death in HEMC-1 and HepG2 cell lines (tert- butoxide and Cu+2 incubation, respectively). 
But in the other hand, luteolin failed to reduce PC-oxidative derivatives (chromatographically 
measured, e.g. PLPC, SGPC, PGPC) in oxLDL, when compared, for instance, with 
hydroxytyrosol. Former specie also failed to help improving the FA preservation in the LDL, as 
was shown thanks to lipid profile measurements, with a better behavior of hydroxytyrosol, 
pinoresinol or gallic acid under those conditions. Thus, luteolin action could be more relevant in 
terms of protein modification reducer than in truly lipoxidative prevention. 
 
Interestingly, specific oxidative signature was found in vivo (as suggested by the lipidomic 
profile of hamsters’ plasma and the oxLDL GC/MS data). Hence, lipidomic analysis of hamster 
plasma revealed lower accretion of oxidized PL (e.g. PLPC, OGPC, PGPC) when animals 
consumed a polyphenol extract diet, even when total antioxidant capacity (FRAP measured) 
was unchanged. Furthermore, DNP accretion was reduced ex vivo when plasma was incubated 
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under Fe+3-Asc methodology and, similarly, human plasma was also protected with the luteolin 
incubation. 
 
Either way, this first work established a noticeable relation between oxidative status, antioxidant 
action and specific lipid signature, which was useful in further research, even when, probably 
due to its intrinsic complexity, we failed to find a universal antioxidant.  
 
Characteristic for ALS, as well as in other neurodegenerative diseases (Pamplona et al. 2008), it 
is known to have an increased oxidative accumulation (Shaw et al. 1995). Whether this fact is 
cause or consequence is still under debate, but strategies aimed reduce or control the spread of 
the damage showed positive outcomes, at least in some animal models (Gurney et al. 1996; 
Reinholz, Merkle and Poduslo 1999). Hence, for such a complex disease was worth to try to 
define a possible upgrade in terms of lipoxidative damage, both in cellular models (N2A, 
NSC34), tissular (organotypic) and animal models (SODG93A), before shifting to human scale. 
For this purpose, the election of GC/MS methodology, as well as WB against carbonylated 
adducts to assess the relevant accretion of damage to proteins was judged to be adequate. 
Moreover, we could depict the source of this damage, as we could relate it to specific metabolic 
damage vias, determining metal catalyzed -AASA and GSA- purely lipoxidative -MDAL-, 
glicoxidative -CEL-, mixed lipo-glycoxidative -CML- or even subcellular location (e.g. 
mitochondrial; 2-SC) as different origins protein oxidative damage. Furthermore, thanks to 
chromatography, whole lipidomic analysis as well as lipid percentage profiles of studied 
tissues/experimental situations we could ascertain whether “dietary” intervention is achieved 
(e.g. flux experiments, DHA accretion, AA depletion) and/or if an specific analyte is 
accumulated in response to a determined situation (e.g. NPD1, 8-iso-PGF2α). In a recent 
publication (Zhang et al. 2010) researchers showed an intriguing novel role of 15-deoxy PJ2 
(mostly derived from the AA) a PG derivative dercrived to exert anti-inflammatory actions 
(Shibata et al. 2002). They demonstrated that in vitro treatment of this PG in cell lines altered 
TDP-43 proteolysis, solubility and subcellular localizations, resulting in a general better status. 
 
Hence, these two approaches (e.g. oxidative damage to proteins and lipid composition) were 
therefore very helpful for a better description of such situations and were completed with IHQ 
analysis. Expression of a determined protein in relation to others (which could be confirmed by 
WB) is relevant for a precise description, but more complete information could be obtained 
when the expression is also localized within a cell. Hence, for most enzymes is not sufficient to 
exist, but rather to exist in the right place and this is especially relevant for CNS where very 
different cell population (with completely different functions, thus protein expression) is found. 
Finally, measures of oxygen consumption (high resolution respirometry) may help to both, 
describe a particular malfunction situation along ETC and justify a greater ROS production. 
Therefore, all those techniques, plus animal behavioral test for precise clinical evolution 
measurement, were aimed to shed some light over this devastating disease and its relation with 
lipid status. 
 
Admitting the multiple limitations of co-cultured experiments: FA/cell line; FA/primary 
cultures (e.g. multiple cell types, bioavailability, delivery, metabolic degradation, albumin 
crosslink), but aiming to minimize complexity, flux/incorporation experiments (exposure of FA 
or mixtures of them to single cell and/or organotypical cultures) were designed to ascertain 
PUFA supplementation effects in relation to various cellular functions (i.e. O2 consumption, 
antioxidant activity potential, survival against oxidative stressors, excitotoxicity, synaptic 
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protein expression, among others). In those measures, lipidic products (and antioxidants) 
dosages were designed according to an homeostatic range. Similarly, in animal models (e.g. 
hypercholesterolemic-feed hamsters supplemented with a polyphenol extract and FA 
unsaturation degree of in ALS model) isocaloric diets fulfill essential FA necessities In both 
cases, particular compositions were aimed to, up to an extent, “stretch” the metabolic 
machinery, trying to observe subtle differences rather than big dietary alterations that would 
completely change the regular functioning. Anyway, in fact, accomplishing in vivo tissular 
modification is rather difficult, especially in CNS with exquisite nutrients necessities. 
Reinforcing this, only discrete modifications were found in response to the diet (WT animals) 
and few more due to the transgene expression (WT vs. SOD1G93A, data not shown). 
 
Hence, since previous works claimed for an altered DHA homeostasis in ALS patients (Ilieva et 
al. 2007), it was interesting to pay special attention in its synthetic machinery. Interestingly, we 
found FASD1 and FASD2 altered expressions in spinal cord MNs. Further, thanks to IHQ, we 
showed a previously unreported FASD1, ACOX1 and AACA1 decrease in MN where pTDP-43 
accumulates aberrantly. Surprisingly, those findings were not so evident when total protein 
extract (WB) was used. In fact, general increased AACA1 and FASD2 accumulation, indicating 
a potential higher DHA synthesis, was insufficient (Ilieva et al. 2007), pointing that cell specific 
mechanism may be operating. Thus, by switching to cellular models, our interest was in trying 
to define how this cellular relation could be altered in terms of DHA synthetic machinery and 
surrogates (STX-3, Drebrin) status. Undoubtedly, cell lines (N2A) transfected with aggregation 
prone TDP-43 fragment suffer from FASD2 depletion. Apart from the commented conversion 
of ALA to stearidonic acid (C18:4ω-3) along the ω-3 synthesis of DHA, this enzyme is also 
responsible for the generation of DGLA (C20:3ω-6, through the previous synthesis of γ-
Linolenic -18:3ω-6) in the ω-6 series. Interestingly, DGLA derivatives (with just one double 
bound along the aliphatic residues, thus named 1 series PG, e.g. PGF1α, PGE1,) even when less 
abundant, exerted mainly anti-inflammatory properties (Fan and Chapkin 1998; Kapoor and 
Huang 2006; Xu et al. 2014). Hence, FASD2 loss could result not only in less DHA synthesis 
(and consequently its anti-inflammatory derivatives depletion) but also for reduced non-DHA-
related anti-inflammatory intermediates.  
 
Also important, drebrin (but not STX-3) expression was reduced in these cells too (WB and 
IHQ measures) in response to TDP-43 aggregation, but again, a tissular variation was found in 
human samples. Spinal cord (where DHA is depleted) demonstrated drebrin and STX-3 
reduction (the latter not significant), whereas brain cortex (with DHA accretion in patients) did 
not show those changes. However, MN drebrin reduction in patients was not linked with 
increased pTDP-43 accumulation, as shown by IHQ, even when drebrin function was altered in 
oxidative stress (Li, Wang and Zuo 2013). Furthermore, reduced mitochondrial Ca+2 buffering 
capacity was found under ω-3 supplementation (at least in in CD4+ T cells, (Yog et al. 2010)) 
although other reports showed no relation of dietary FA with the Ca+2 capacity, nor response to 
oxidative stimuli and, importantly, stress the importance of a correct dosage for supplements 
(Stavrovskaya et al., 2012). Nevertheless, altered lipid metabolism and TDP-43 have been 
recently linked (Heck et al. 2014), since deletion of the latter caused membrane alterations as 
well as fat storage disarrangements. And further, we could confirm in our model that TDP-43 
phosphorylation and aggregation preceded PUFA’s synthesis changes (measured after 2h) and 
drebrin loss, after an H2O2 challenge. 
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In more a complete model (in terms of intercellular relationships), the OT primary culture, 
increased DHA (concomitant with increased AA and a drastic depletion of ω-3 DPA, a DHA 
precursor) was found thanks to GC. Further, specific lipid signature (lipidomic measurements) 
and increased oxidative damage was confirmed under THA treatment. This is, significant 
accretion of 8-iso-PGF2α and higher NPD1 (DHA derivative) as well as a positive correlation 
among them was confirmed. Several works showed increased NPD1 production in response to 
an insult (Bazan 2013; Bazan 2005; Mukherjee et al. 2007), but to our knowledge, this is among 
the first linking exictoxicity and NPD1 production (and excitoxicity and oxygen resepirometry 
reduction too). In addition, OT tissue composition (higher DHA under THA conditions) 
supports the possibility of this production, reinforced by the fact that in a neuronal cell line 
(N2A) chooses DHA synthesis as an initial response when confronted to oxidative stress (as 
show in flux experiments) and oxidative stress and mitochondrial dysfunction is known to be 
increased in excitotoxicity (Nguyen et al. 2011). Further explanation of an increased NDP1 
production could be understood in terms of upgraded survival, which may involve PI3K/Akt 
signalling (Halapin and Bazan, 2010), know to be influenced by DHA (Akbar et al 2005) and by 
PLA2 (Lukiw et al. 2005) action too. In any case, thanks to the previous studies (Ilieva et al. 
2007), spinal cord DHA depletion was found, which is inconsistent with this increased DHA in 
cells and OT. However, this may be understood as an end point result. sALS samples are 
probably the most valuables ones since they are not a model, it’s real life. But on the other hand, 
these patients have suffered for a long period of disease. Hence, their decreased levels could 
possibly indicate an insufficient synthesis or depletion due to disease-related-expenses. Beside 
this, models would reflect a more “acute” situation, whereas a possible correction to attain a 
new homeostasis may be achieved yet. Interestingly, co-culture with precursors (linen seed fatty 
acid extract) rather than final products (fish oil extract) showed better MN preservation. 
Altogether, these two facts (increased oxidative stress and better survival with lower 
peroxidability index -PRI- and double bound index -DBI- FA mixture -e.g. linenseed extract) 
could respond to an adaptative mechanism. Hence, this fact was reinforced by the upgraded MN 
survival when those explants are co-treated with DHA plus tocopherol (optimally preserved 
from oxidation), which goes in line with a recent publication demonstrating a reduced 
neuroinflammation in terms of decreased COX-2 activation and cell death prevention in a spinal 
cord cultures co-treated with a saturated FA (instead highly unsaturated DHA) and luteolin as 
antioxidant (Paterniti et al. 2013). 
 
Finally, mitochondrial implication was proved, since lower (c.a. 30%) oxygen consumption was 
found under excitotoxicity. This may be explained in terms of complex I malfunction, because 
rotenone (complex I inhibitor) faded out this difference, but also due to oxidative modifications, 
since tocopherol treatment along the culture protected from this event. This is relevant because 
previous studies had link CI blockade with increased ROS production (Votyakova and 
Reynolds, 2001). Of note, interestingly mitochondrial permeability transition pore induction 
(discussed latter) and excitoxicity-ROS production was linked too (Hansson et al. 2008). This is 
supported by the upgraded MN survival when DHA and tocopherol are combined. Interestingly, 
UCP2 overexpression, which is been related to a ROS reduction in various systems (Andrews 
and Horvath 2009), shortened lifespan, worsens mitochondrial dysfunction and accelerates 
disease progression when co-expressed in the SOD1G93A mouse model (Peixoto et al., 2013). 
This surprising finding may indicate that a minimal oxidative damage is required and we 
probably need deeper studies for the understanding of ROS production and survival 
interdependences. 
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Gender dependence among neurodegenerative diseases is observed (Członkowska et al 2006), 
as well in ALS incidence and some animal models recapitulated this effect. Recent 
neuroimaging studies in patients showed significant gender differences in the anatomical 
patterns of cortical and subcortical pathology in ALS (mostly localizing to extramotor, 
frontotemporal and cerebellar regions; (Bedeet al. 2014)). However, specific description of this 
dimorphism was not deeply described in preclinical models. In particular, how this relation 
could be dietary modified. Similar to a recently published paper (Yip et al. 2013), we 
demonstrated that potential preventive and beneficial responses attributed to PUFA are not 
easily reproduced in the SODG93A mouse model. Hence, as previously shown (Herrero et al. 
2001), FA had an influence on the specific oxidative stress markers accretion. We demonstrate 
that this dietary difference was linked to survival differences (with high unsaturation diet 
diminishing the feminine-gender life sparing extension effect). However, one of the more 
striking results was the surprisingly lower lipoxidative damage marker founded in animals 
under lower unsaturation diet. Those animals had similar values of DHA in their spinal cords 
along disease (with a clear reduction along its course for both sexes), but in the contrary higher 
levels of AA and one of its derivatives (C22:4ω-6) and those levels raised general higher PRI 
and DBI for animals under low unsaturation diet. In a detailed vision of this FA profile, males 
under low unsaturation diet were the ones with better DHA preservation along disease 
progression (estimated as % ratio of initial DHA content-60 days- respect to endpoint; 95,57% 
and 79,65% for males under low and high unsaturation diets respectively, 84.89% and 86,56% 
for females under low and high unsaturation diets respectively) and this group corresponds with 
the one with longer survival and lower UPR response.  
 
Reinforcing this possible influence in survival with a correct DHA preservation, females, with 
general longer survival also conserve more tenaciously this FA. On the other hand, the AA 
accretion along disease of animals under low unsaturated diets should be viewed as a response 
to disease demands as well dietary influence, since this FA is in fact lower in this diet, 
compared with the high unsaturated one. Reinforcing this, results from animals under a control 
diet (the last paper) showed an increased AA accumulation latter in disease, in both genders, but 
more remarkable in males. Finally, correlation analysis showing a positive relation among 
spinal cord MDAL and AA content and a inverse relation of DHA and AASA, but just for 
females, emphasize the idea that lipoxidative damage could have a more deleterious effect in 
females even when they were preserved in terms of stride length preservation under high 
usaturation diet. Interestingly, correlation analysis of those variables in males only show a 
positive relation for GSA and survival, indicating again that deeper studies focusing in the 
oxidative modifications and survival interdependences should take gender as another variable. 
 
Further, we showed an unreported relation of diet on UPR (e.g. ubiquitin), DNA oxidation (e.g. 
8-oxo.dG) and DSB (e.g. γH2Ax) responses. Males under low unsaturation diet demonstrated 
lower DNA oxidative damage but an unaltered mitochondrial-nuclear crosstalk concomitant to a 
reduced UPR response and a slower disease progression (in terms of stride length preservation). 
All those findings could serve as an explanation for the upgraded survival of males under such 
diet. 
 
For a deeper understanding of mitochondrial function, ROS generation and damage to different 
biomolecules focusing in the sex as a modulator character we performed experiments in intact 
tissue (previous work had described mitochondrial preparation (Mattiazzi et al. 2002) but not 
intact tissue) as well as permeabilyzed fibers of spinal cords. This helped to better describe a 
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natural occurring situation as well as what happened when mitochondria functioning at maximal 
capacity. Sample collection across all animal lifetime served us to show differential (late onset 
in females) respiration defects along it and, more importantly, how those changes were related 
with increased oxidative protein modification accretion. In fact a single sample collection, 
instead a cross-sectional study would only show a static frame and not those interesting 
outcomes. 
 
Mitochondrial permeability transition pore is a protein “hole” in the inner mitochondrial 
membrane. It was originally discovered linked to neurodegeneration (Haworth and Hunter, 
1979) and upon its formation, among others features, decreased membrane potential linked to 
cell death, mitochondrial swollen and mitophagy (reviewed in (Dagda et al. 2013) is found. 
Furthermore, its occurrence is known to be affected by Ca+2 overload (Brustovetsky et al. 2002), 
and to be induced by some FA derivatives (García-Ruiz et al. 2000). Therefore, excitoxicity 
severely affects its formation and better outcomes are expected when this pore is abolish (e.g. its 
blockade -by cyclosporin A- allows complete recovery of membrane potential and therefore 
prevents cell death in cultured neurons (Schinder, Olson and Spitze 1996)). Hence 
mitochondrial pore formation could serve as a link between decreased respiration founded in the 
OT model and the exitotoxicity, and gender could modulate this. However, gender implication 
in the OT model remains to be elucidated and could be an interesting point to be address which 
could account for differential survival of the MN and impinge many other outcomes and could 
also rely under the upgraded survival and decreased oxidative modification and better 
mitochondrial function founded in females overexpressing SOD1G93A. In fact there is 
controversy whether hormones could alter this survival. A recent publication shows 
progesterone neuroprotection after spinal cord injury (Labombarda et al. 2013) but previous 
works demonstrated androgen-related positives outcomes (Hauser and Toran-Allerand 1989 and  
Levy et al. 1996). However, male Ca +2 reuptake was showed increased respect to females, 
rendering them more sensible to overload, at least in heart mitochondria (Arieli et al. 2004)). 
 
Thus, linking those issues, in a recent publication (Kim, Magranè and Manfredi 2012) 
researchers focused in gender relevance in the mitochondrial permeability transition pore 
formation in the SODG93A mouse model. Hence, they demonstrated that ablation of 
cyclophilin D (a protein structurally linked to the mitochondrial permeability membrane 
transition pore (Doczi et al. 2011)) completely abolished the phenotypic advantage of female 
SODG93A, but no effect was found in males. In fact, they showed that 17β-estradiol protected 
SODG93A cortical neurons and spinal cord motor neurons against glutamate toxicity in brain 
mitochondria, but the protection was lost in neurons lacking cyclophilin D. This could be under 
the positive outcome founded in terms of upgraded oxygen consumption in females, since our 
results showed that the mitochondrial dysfunction was not linked to specific mitochondrial 
complex protein expression (e.g. Complex I and II, at least in cell lines). Further research will 
focus in the role that uncoupling proteins and their previously commented ROS reducing 
potential. 
 
In the animal model, we found a gender-shift of both mitochondrial-related and oxidative stress-
related pathophysiological outcomes and clinical features in female G93A mice respect to their 
male littermates. This different mitochondrial dysfunction onset could be, at least in part, 
underneath the delayed clinical features observed in G93A female mice respect to males, and 
more importantly, in male patients respect to the female counterparts. From literature, a greater 
oxidative modification could be expected under G93A overexpression. However, in a closer 
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look, we are not among the first to unveil a non-linear progression in the oxidative damage for 
this model (Andrus et al. 1998; Hall et al. 1998; Vinsant et al. 2013; Miana-Mena et al. 2011; 
Kirkinezos et al. 2005; Cacabelos et al. 2014). Even when our results do not completely fit this 
previous findings, our measures are lumbar specific (nor cervical or thoracic sections), we split 
by gender and methodology applied to the measurements were different. Hence, this could 
explain little variations with previous reports. 
 
Regarding lipid measurements in this model, the most remarkable feature was the reduction 
along disease founded for DHA. Animals expressing the G93A mutation demonstrated a DHA 
reduction in spinal cord content, concomitant to an increase of AA. This fact was also present in 
the dietary study previously commented, even when for those animals; the diet was in fact 
defective in this specific FA. Taking this two fact into account, and previous findings related to 
FA synthetic machinery, altogether seems clear that particular FA composition do play a role 
along disease and it would be hot topic for research in further works. In fact, even knowing that 
females displayed a differential FA regulation and metabolism (or probably due to this) any 
information on the gender-specific disease modification is welcome to try to apply a more 
personalized treatment. 
 
Finally, trying to give some ligth regarding the estrogen interference, we used Neuro 2A cells 
overexpressing G93A-hSOD1 with a “feminization” treatment (This cell already express the 
estrogen receptor (Li, Hao and Li 2014)). Treatment with 17β-estradiol for long period of the 
culture (10 days) did not show to be detrimental in terms of survival. In the same line, 
GFPhSOD1G93A transfection do not comprise cell viability. However, estradiol treatment 
resulted in a similar oxygen consumption recovery, with “females” transfected with de G93A 
mutation showing an upgraded functionality. On the contrary, untreated “males” were 
unprotected against SODG93A-mediated mitochondrial malfunction. For this model, no protein 
expression modification was found between the mitochondrial complex subunits (I and II) to 
account for this reduced mitochondrial capacity, hence, we still miss a mechanisms to explain 
the altered functioning.  
 
However, in a recent work (Tao et al. 2012) Tao and collaborators linked mitochondrial 
malfunctioning (rotenone mediated) and estradiol signaling in neuron primary culture. Hence, 
researchers showed altered gene induction in response to mitochondrial stress for male and 
female embryos. Furthermore, they detailed an upgrade survival of female primary cultured 
neurons rather than male when submitted to rotenome mediated cytotoxicity. Interestingly, they 
proved that the N2A cell line can be protected against oxidative stress through estrogen 
signaling (although they linked to a reduction of its protein receptor expression) and that under 
rotenome cytotoxicity, estradiol treatment both gender of primary-cultured neurons were 
protected. Altogether this results support our findings of feminine gender upgraded protection 
against mitochondrial dysfunction. Further analysis of these issues in relation to ALS and its 
potential therapeutical approaches should be considered in future works. 
 
So globally, results in this thesis showed a relevant influence of sex on ALS outcome. 
FA metabolism seems to be altered (DHA and the enzymatic machinery) in patients, and 
cellular and tissular models could help to explain this difference. Furthermore, gender handling 
of FA is also different in animal models of the disease when confronted to saturated or 
unsaturated enrich diet, leading to differential survival and clinical features. Also relevant, 
oxidative modifications are dietary-altered and could help to understand survival differences 
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(lower ubiquitin inclusion, decreased 8-oxo-dG accretion upgraded DHA retention for males 
under low unsaturation diet). Finally, in line with previous works, mitochondrial implication 
was demonstrated also in intact tissue as well as in permeabilized tissue in the animal model 
(SODG93A), with a complex I deficiency, linked to a decreased oxidative accretion (MDAL) 
specially relevant in male and those reduced oxygen consumption was not attributed to a 
deficient protein expression nor activity of those. 
 
 
 
 
… but may be related to a sexual-dependence Ca+2 excitotoxy ROS-interference … which 
would be further explored. 
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6. Conclusions 
 
As a result of this research, we can consider the following conclusive statements: 
 
One.- In vitro antioxidant capacity of a given nutritionally available substance is severely 
influenced by the oxidative methodology used and its definite action upon a substrate; however, 
a specific signature in terms of oxidative modification accretion and fatty acid protection 
preference in LDL and other biomolecules, could be described. 
 
Two.- Endothelial and hepatocyte cell line cultures complement the above mentioned data for 
the biological relevance in terms of survival in front oxidative stress; hence, election of a single 
antioxidant to protect against those diverse situations can be challenging. 
 
Three.- Ex vivo oxidative accumulation in hamsters serum under a grapeseed-derived, 
poliphenol-enriched diet showed an specific lipidomic (POVPC, PGPG) and proteic (DNP 
measured) signature, whereas overall antioxidant status (FRAP measured) remains steady. 
 
Four.- sALS is associated with spinal cord specific changes in DHA synthetic machinery 
(FADS2, ACAA1, ACOX-1) and Drebrin. IHQ measurements show that these changes are 
related to TPD-43 aggregates in motor neurons. 
 
Five.- Neuron cell culture with TDP-43 aggregates partially reproduced sALS findings (reduced 
FADS2 and Drebrin). However, sALS changes are cell and site specific since WB levels do not 
correlate to IHQ.  
 
Six.- Drebrin depletion in sALS spinal cords is cell specific; in vitro experiments showed that 
oxidative-derived TDP-43 aggregates precede decreased Drebrin expression. Furthermore, DHA 
synthesis from its precursors could be trigger by H2O2 incubation.  
 
Seven.- Chronic excitoxicity in organotypic spinal cord cultures promoted lipidomic and fatty 
acid profile changes compatible with altered DHA synthesis, highlighting the relevance of this 
model to mimic the pathophysiological features that lead to motorneuron death. 
 
Eight.- Gender dimosphism is a relevant factor influencing lipid handling in the hSODG93A 
ALS animal model in terms of survival and clinical outcome. 
 
Nine.- DHA-related synaptic machinery (syntaxin3) and UPR (Ubuquitin inclusions) responses 
in hSODG93A male mice is altered in response to high unsaturation degree diet. 
 
Ten.- Dietary intervention aimed at modulating the FA composition by changes in FA sources 
evoked expected tissular FA modification and influenced protein and DNA oxidative damage 
with an altered nuclear-to-mitochondrial damage responses. 
 
Eleven.- Mitochondrial dysfunction in hSODG93A mouse model (assessed by oxygen 
consumption measurements) is variable throughout disease. Females had a later oxygen 
consumption reduction. 
 
Twelve.- Gender dimorphism in oxygen consumption correlated with female later onset and 
lower oxidative modifications as well as optimized lipid content. 
 
Thirteen.- Overexpression of mutant SOD1 in cell cultures recapitulate oxygen consumption 
reduction in hSODG93A mouse model. 
 
Fourteen.- Estrogen treatment (10nM) on those cells is able to reproduce female-outcome, 
protecting from CI dysfunction, without changes in expression of peptides belonging to CI or 
CII.  
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For further immersion on PUFA’s relevance and implications in different phatophysiological 
conditions (e.g. neurodegeneration and dietary interventions in chronic inflammatory models), 
we harvested relevant contributions for a better understanding of some hallmarks of oxidative 
reactions and its relevance in various neurodegenerative diseases in a paper entitled “Maillard 
reaction versus other nonenzymatic modifications in neurodegenerative processes”, endorsed as 
an annex at the end of this book. 
 
Furthermore, to increase the knowledge of PUFA’s influence in various biological parameters 
(e.g. oxidative status, synthesis machinery, CHO status) in animals under a distorted diet (high 
fat diet). Various experiments were performed along my stay at the University of Bergen and 
were successfully published in “Fish oil and 3-thia fatty acid have additive effects on lipid 
metabolism but antagonistic effects on oxidative damage when fed to rats for 50 weeks” and 
could be also found below. 
 
Finally, for a more comprehensive view of the pathophisiology of ALS, different models (cell 
lines confronted to oxidative and endoplasmic reticulum stressors and chronic exitotoxicity in 
OT spinal cord primary culture) as well as sALS samples were investigated trying to depict a 
new activation route which connects MN degeneration and TDP-43, together with and ER and 
oxidative stress and an unreported role calpain and CaMKIV along disease progression as 
relevant factors in ALS. The experiments performed were successfully published in “Cell stress 
induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in 
ALS”, “Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral 
sclerosis” and “Calpain activation and CaMKIV reduction in spinal cords from hSOD1G93A 
mouse model” and could be found in the annex section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
260 
 
Maillard Reaction versus Other Nonenzymatic
Modifications in Neurodegenerative Processes
REINALD PAMPLONA, EKATERINA ILIEVA, VICTORIA AYALA, MARIA JOSEP BELLMUNT,
DANIEL CACABELOS, ESTHER DALFO, ISIDRE FERRER, AND MANUEL PORTERO-OTIN
Department of Experimental Medicine, School of Medicine, University of
Lleida-IRBLLEIDA, Lleida 25008, Spain
Nonenzymatic protein modifications are generated from direct oxidation of amino acid side
chains and from reaction of the nucleophilic side chains of specific amino acids with reac-
tive carbonyl species. These reactions give rise to specific markers that have been analyzed
in different neurodegenerative diseases sharing protein aggregation, such as Alzheimer’s dis-
ease, Pick’s disease, Parkinson’s disease, dementiawith Lewy bodies, Creutzfeldt-Jakob disease,
and amyotrophic lateral sclerosis. Collectively, available data demonstrate that oxidative stress
homeostasis, mitochondrial function, and energy metabolism are key factors in determining
the disease-specific pattern of protein molecular damage. In addition, these findings suggest
the lack of a “gold marker of oxidative stress,” and, consequently, they strengthen the need for
a molecular dissection of the nonenzymatic reactions underlying neurodegenerative processes.
Key words: advanced glycation end products; advanced lipoxidation end products; Alzheimer’s
disease; amyotrophic lateral sclerosis; Creutzfeldt-Jakob disease; energy metabolism; free radi-
cals; mitochondria; oxidative stress; Parkinson’s disease; Pick’s disease; reactive carbonyl species
Nonenzymatic Oxidative Protein
Modification
As a rule, chemical reactions in living cells are un-
der strict enzymatic control and conform to a tightly
regulated metabolic program. One important factor
implicit in evolution, from a biomolecular view, is the
minimizing of unwanted side reactions. Nevertheless,
uncontrolled and potentially deleterious reactions oc-
cur, even under physiological conditions. Free radicals
(reactive oxygen species [ROS] and reactive nitrogen
species [RNS]) are generated by both enzymatic and
nonenzymatic sources and have been implicated in a
multitude of physiological processes including aging
and disease initiation and/or progression.1 Oxidative
stress occurs when the net flux of free radical produc-
tion during normal aerobic metabolism exceeds the
antioxidant defenses of the cell. Emerging evidence in-
dicates that this stress causes specific protein modifica-
tions that may lead to a change in the structure and/or
function of the oxidized protein.2,3 Carbonylation is
one of those changes, altering the conformation of the
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polypeptide chain and determining the partial or total
inactivation of proteins. This can have a wide range of
downstream functional consequences and may be the
cause of subsequent cellular dysfunctions and tissue
damage.
Structurally, carbonylationmay arise fromdirect ox-
idation of amino acid side chains, mainly Pro, Arg,
Lys, and Thr, resulting in the formation, among oth-
ers, of glutamic semialdehyde (GSA) and aminoadipic
semialdehyde (AASA), the main carbonyl products of
metal-catalyzed oxidation of proteins. In addition, car-
bonyl groups may be introduced into proteins by sec-
ondary reaction of the nucleophilic side chains of Cys,
His, and Lys residues with reactive carbonyl species
(RCS) produced during lipid peroxidation (lipoxida-
tion reactions) or generated as a consequence of the
reaction with highly reducing sugars, such as glyoxal
and methylglyoxal (an usual byproduct of glycolysis)
or their oxidation products (glycation and glycoxida-
tion reactions). Most of the biological effects of in-
termediate RCS are attributed to their capacity to
react with the nucleophilic sites of proteins, forming
advanced lipoxidation end products (ALEs) and ad-
vanced glycation end products (AGEs).2 Compared to
free radicals, RCS are stable and can diffuse within or
even escape from the cell and attack targets far from
the site of formation. Therefore, these soluble reac-
tive intermediates are not only cytotoxic per se but
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also behave as mediators and propagators of oxidative
stress and tissue damage, acting as second cytotoxic
messengers.4
Oxidative decomposition of polyunsaturated fatty
acids (PUFAs) initiates chain reactions that lead to
the formation of a variety of RCS which, by react-
ing with nucleophilic sites in proteins, generate spe-
cific ALEs, such as MDA-Lys, HNE-Lys, and Nε-
(hexanoyl)lysine, among others. These adducts have
been detected by chemical and immunohistochemi-
cal methods in a broad range of tissues and species
during physiological aging4 and specific pathological
states. The involvement of toxic RCS as products and
propagators of oxidative damage in neurodegenerative
diseases is currently under study.
The residual aldehyde group in some ALEs can fur-
ther react to give protein cross-links and fluorescent
products that are very similar to AGEs. Lipofuscin,
the nondegradable intralysosomal fluorescent pigment
that accumulates with age in postmitotic cells, is a
recognized hallmark of aging.4 Other important toxic
products formed during nonenzymatic modification of
proteins in aging and disease are referred to as “either
advanced glycation or lipoxidation end products,” so
named because they may be formed from either car-
bohydrates or lipids. N ε-(carboxymethyl)lysine (CML)
and N ε-(carboxyethyl)lysine (CEL) are, on a molar ba-
sis, the major modifications that have been measured
in tissue proteins among these mixed-origin products,
emphasizing the importance of the intersection be-
tween carbohydrate and lipid chemistry.2
Protein Damage and
Neurodegenerative Diseases
The nervous system is potentially sensitive to oxida-
tive modifications because i) the particular fatty acid
composition of neuronal tissues that is rich in PUFA
(hence easily peroxidizable); ii) the high O2 consump-
tion; and iii) the relatively poor expression antioxidant
systems.5 Also, nervous tissue is considered a postmi-
totic tissue and therefore highly susceptible to aging.6
Cells in all regions of the nervous system are affected
by aging, as indicated by the decline of sensory, mo-
tor, and cognitive functions with time. As this process
is involved as a risk factor in most neurodegenerative
diseases—there is a dramatic increase in the proba-
bility of developing a neurodegenerative disorder (e.g.,
Alzheimer’s disease [AD], Parkinson’s disease [PD],
or amyotrophic lateral sclerosis [ALS], among others)
during the sixth, seventh, and eighth decades of life—
and oxidative modifications play a key role in aging,
it is often accepted that these diseases should have in-
creased oxidative damage.
Cells in the nervous system are affected by, and re-
spond to, agingmuch as cells in other organ systems do,
and so cells in the brain experience increased amounts
of oxidative stress, impaired mitochondrial function
and perturbed energy homeostasis, accumulation of
damaged proteins, and lesions in their nucleic acids.5,6
These changes during normal aging are exacerbated
in vulnerable populations of neurons in neurodegen-
erative disorders. Therefore, some diseases might be
viewed as a syndrome of accelerated aging in selected
neurons.
The interest in the molecular dissection of each of
these three pathways (i.e., direct oxidative modifica-
tion, glycoxidation, and lipoxidation) clearly exceeds
an academic context. An appropriate knowledge in
this sense could help to rationally design therapeu-
tic approaches aimed either at diminishing oxidative
damage in a nonselective way (provided each oxida-
tive pathway is increased in a similar extent) or at pin-
pointing those processes selectively increased.With this
goal in mind, tissues from human tauopathies (AD and
Pick’s disease [PiD]), synucleopathies (PD and demen-
tia with Lewy bodies [DLB]), and other neurodegener-
ative processes linked to protein misfolding and/or de-
posits (Creutzfeldt-Jakob disease [CJD] and ALS) were
studied (TABLE 1). The concentration of selected mark-
ers of each pathway of protein oxidative damage was
analyzed by gas chromatography coupled tomass spec-
trometry by using authentic deuterated internal stan-
dards, according to previously described procedures.7
Tissues located in “target” zones of the diseases (show-
ing pathological abnormalities) and “control” zones
(without morphological changes) were evaluated in
order to offer a biochemical correlate of the disease
(TABLE 1). These diseases were chosen by the fact that
all share accumulation or involvement of structurally
modified protein deposits, which have been detected
as modified with oxidation products using immunohis-
tochemical procedures.
Tauopathies: Alzheimer’s Disease
and Pick’s Disease
Alzheimer’s disease is the more studied and preva-
lent neurodegenerative disease and is associated with
β-amyloid deposits either in neurofibrillary tangles
or hyaline bodies. The measurement of oxidative
protein modifications7 reveals that GSA and AASA
contents are higher in the frontal cortex (area 8) of
AD patients than in age- and sex-matched healthy
controls. These increases (around 50% over control
values) are larger than those present for well-known
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TABLE 1. Changes in specific markers from oxidation-, glycoxidation-, and lipoxidation-derived re-
actions in human neurodegenerative diseases: a comparative molecular pathology approach
Disease Number of cases Location GSA AASA CEL CML PI DHA MDAL
AD7 13 FC ↑ ↑↑ ↑ ↑ ↑ ↑ ↑↑
PiD8 (1) 7 FC ↑ ↑↑ ↓ ↓ ↓ ↓ ↑
7 OC ↑ ↑ ↑ ↑ ↑ ↑ ↑↑
PD10 7 SN = = = = ↓ ↓ ↑
7 FC = = ↓ = ↑ ↑↑ ↑↑
DLB10 4 FC = = ↓ = ↑ ↑ =
CJD (2) 10 FC ↑ ↑ ↑ ↑ ↓ ↓ ↑
ALS12 11 SC ↑ ↑ ↑ ↑ ↓ ↓↓ ↑↑
11 FC ↑ ↑ ↑ ↑ ↑ ↑ ↑
Abbreviations: AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; CJD, Creutzfeldt-Jakob disease; DLB, dementia
with Lewy bodies; PD, Parkinson’s disease; PiD, Pick’s disease. Location: FC, frontal cortex; OC, occipital cortex; SC, spinal
cord; SN, substantia nigra. (1) unpublished results; (2) Pamplona, Naudi, Gavin, et al., University of Lleı´da, Lleı´da Spain AASA,
aminoadipic semialdehyde; CEL, N ε-(carboxyethyl)lysine; CML, N ε-(carboxymethyl)lysine; DHA, docosahexaenoic acid; GSA,
glutamic semialdehyde; MDAL, Nε-(malondialdehyde)lysine; PI, peroxidizability index.
AGEmarkers (CELandCML),which roughly increase
15% over control values. As suggested by changes
in peroxidizability, which is significantly increased in
these AD patients (basically because of changed con-
tents of docosahexaenoic acid [DHA]), the most af-
fected marker of protein oxidative modification is Nε-
(malondialdehyde)lysine (MDAL), which doubles its
content in samples from AD patients. By using a com-
bination of two-dimensional electrophoresis, Western
blot, and peptide fingerprinting with matrix-assisted
laser desorption/ionization time-of-flight (MALDI-
TOF), several cytoesqueletal proteins, metabolic en-
zymes, and heat shock proteins were identified as mod-
ified by MDAL.7
To ascertain whether those phenomena are spe-
cific to AD, we analyzed PiD (unpublished results and
Ref. 8). PiD is another tauopathy, characterized by the
specific involvement of the frontotemporal cortex. In
common with AD, significant increases were found in
AASA, GSA, and MDAL, suggesting increased direct
oxidative and lipoxidative damage, although at a lower
extent than in AD. However, concentrations of lipox-
idative and glycoxidative protein modifications were
decreased (both CEL and CML), a fact that can be re-
lated to the loss of glycolytic potential, well described
in this disease.
The occipital cortex is usually viewed as a loca-
tion without morphological evidence of involvement of
the disease, and hence morphological evidence serves
as controls for measurements. In this case, we evi-
denced increased oxidative, glycoxidative, and lipox-
idative damage in this location, supporting the fact
that oxidative stress may be an early-stage change
in the pathogenesis of this disease. Most interestingly,
there was a direct and significant correlation between
CEL concentration and DHA levels, suggesting that
DHA is increased in response to neuronal stress. This
would involve both oxidative stress and increased gly-
colysis, leading to increased CEL through potentially
increased methylglyoxal efflux in the occipital cortex,
whereas in the frontal cortex, because of neuronal
loss and consequent decreased glycolysis, decreased
values in both DHA and CEL content are present.
Concerning the targets of oxidative damage, five dif-
ferent proteins exhibit increased anti-DNP staining:
reduced form of nicotinamide adenine dinucleotide
phosphate (NADPH) carbonyl-reductase, glial fibril-
lary acidic protein, heat shock protein 70, cathepsin
D precursor, and vesicle-fusing ATPase (unpublished
results).
Synucleopathies: Parkinson’s Disease
and Dementia with Lewy Bodies
Parkinson’s disease is the most prevalent synucle-
opathy. Despite previous results describing increased
immunoreactivity to anti-AGE and oxidative damage
adducts,9 no chemical evidence of protein oxidative
damage was available. When evaluating the content
of the above-mentioned markers in substantia nigra
from incidental DLB,10 MDAL was the only marker
that was significantly increased in PD (approximately
100%). Similar increases were also found in the frontal
cortex and amygdala, suggesting the importance of
lipoxidation. In clear contrast, CEL levels were sig-
nificantly decreased in both the amygdala and the
frontal cortex, a fact that can be in accordance with a
described loss of glycolysis in PD.11 Targets of lipox-
idative damage comprise several antioxidant enzymes,
proteasome components, α-synuclein, and other pro-
teins not shared with AD or PiD. To shed further light
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on the potential relationship of oxidative damage in
synucleopathies, we analyzed cortex samples from pa-
tients with DLB, which showed a lack of increased
MDAL content but, again, significant decreases in
CEL content.10
Other Neurodegenerative Processes Linked
to Protein Misfolding and/or Deposits
Creutzfeldt-Jakob disease is a neurodegenera-
tive spongiform disease, linked to transmissible pri-
onopathies. The protein oxidative profile in the frontal
cortex shows similarities to AD: increased direct ox-
idative, glycoxidative, and lipoxidative damage, but in
this case a decrease in n-3 fatty acids is present. (Pam-
plona,Naudi,Gavin, et al., University of Lleı´da, Lleı´da,
Spain) All increases are in the same range, suggesting
a general change in the modified protein turnover.
This would be compatible with reported alterations in
proteasome present in related prion-induced diseases.
Concerning targets of glycoxidative damage, we evi-
denced two key enzymes in glycolysis to be highlymod-
ified in CJD samples: glyceraldehyde-3-phosphate de-
hydrogenase and fructose-1,6-bisphosphate aldolase.
As the activity of this latter enzyme involves the for-
mation of a Schiff’s base in its active site, we hy-
pothesize that some of those bases may be trans-
formed, under increased oxidative conditions, to
CEL.
Amyotrophic lateral sclerosis is characterized by the
selective loss of motor neurons in spinal cord and in
brain cortex, associated with highly ubiquitinated de-
posits of proteinaceous material. Spinal cord lysates
from ALS patients showed significant increases in di-
rect oxidative, glycoxidative, and lipoxidative dam-
age.12 Analogous to samples from the brain cortex
in AD, the more sensible marker was MDAL, suggest-
ing the importance of lipoxidative modification in this
context. Similar to substantia nigra samples in PD and
frontal cortex samples in PiD, lipoxidative damage was
accompanied by a strong loss in the content of DHA.
As observed from other locations without morpholog-
ical evidence of pathology, samples from the brain cor-
tex of ALS patients also showed increased oxidation,
glycoxidation, and lipoxidation, associated with reac-
tive increases in the content of n-3 fatty acids, particu-
larlyDHA.All these features are reproducible in vitro by
the generation of chronic excitotoxicity—amechanism
linked to selective neuronal loss by disturbed intracel-
lular Ca++ homeostasis—in a spinal cord organotypic
culture, supporting the involvement of this neurode-
generative pathway in vivo.12
Final Remarks
In conclusion to these analyses, no single marker
of protein oxidative modification (among those used
here) can be viewed as a gold standard for assess-
ment of oxidative damage in neurodegenerative pro-
cesses. The same applies to targets of oxidative dam-
age that show disorder-specific differences. Moreover,
in some cases CEL levels decreased, supporting CEL
relationship with glycolysis potential. There are sig-
nificant associations between changes in fatty acid
composition (especially DHA) and protein oxidative
damage. Most interestingly, when tissue from patho-
logically preserved locations was available, the tissue
analyses indicated that protein oxidative modifications
take place before potential morphological and clini-
cal changes appear, suggesting an early involvement
of protein oxidative damage in neurodegenerative
process.
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The 3-thia fatty acid tetradecylthioacetic acid (TTA) is a synthetic modified fatty acid, which, similar with dietary fish oil (FO), influences the regulation of
lipid metabolism, the inflammatory response and redox status. This study was aimed to penetrate the difference in TTA's mode of action compared to FO in a
long-term experiment (50 weeks of feeding). Male Wistar rats were fed a control, high-fat (25% w/v) diet or a high-fat diet supplemented with either TTA
(0.375% w/v) or FO (10% w/v) or their combination. Plasma fatty acid composition, hepatic lipids and expression of relevant genes in the liver and biomarkers
of oxidative damage to protein were assessed at the end point of the experiment. Both supplements given in combination demonstrated an additive effect on
the decrease in plasma cholesterol levels. The FO diet alone led to removal of plasma cholesterol and a concurrent cholesterol accumulation in liver; however,
with TTA cotreatment, the hepatic cholesterol level was significantly reduced. Dietary FO supplementation led to an increased oxidative damage, as seen by
biomarkers of protein oxidation and lipoxidation. Tetradecylthioacetic acid administration reduced the levels of these biomarkers confirming its protective
role against lipoxidation and protein oxidative damage. Our findings explore the lipid reducing effects of TTA and FO and demonstrate that these bioactive
dietary compounds might act in a different manner. The experiment confirms the antioxidant capacity of TTA, showing an improvement in FO-induced
oxidative stress.
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Fig. 1. Average weight of rats on high-fat diets supplemented with 3-thia fatty acid TTA
and/or FO for 50 weeks. Data represent means (n=10). Values that were significantly
different from control by t test are indicted by black (TTA) or gray (TTA+FO) asterisks
(⁎Pb.05, ⁎⁎Pb.01, ⁎⁎⁎Pb.001).
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The body's inability to handle excess energy intake leads to
metabolic abnormalities such as hyperglycemia and dyslipidemia. The
coexistence of these risk factors with overweight and hypertension
represents the metabolic syndrome [1,2]. Thus, the discovery and
testing of dietary supplements that can improve lipid metabolism and
maintain homeostasis, and consequently, prevent the development of
risk factors of metabolic syndrome, is of great importance.
Both fish oil (FO) and tetradecylthioacetic acid (TTA) have been
widely used in in vivo experiments. FO has been shown to inhibit
lipogenesis and exert a hypolipidemic effect by lowering plasma
cholesterol and triacylglycerol (TAG) levels [3], as well as having an
anti-inflammatory effect beneficial against both atherosclerosis [4]
and arthritis [5,6]. The effects of FO are attributed to ω−3
polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), which are thought to bind
and activate peroxisome proliferator-activated receptors (PPARs) [7].
They act upon ligand activation by controlling networks of target
genes and therefore serve as lipid sensors because they can be
triggered by metabolic derivates of fatty acids in the body.
Tetradecylthioacetic acid, a structurally modified 16-carbon
saturated fatty acid (SFA) with a sulfur atom inserted in the third
position of the alkyl chain, has been documented as a pan-PPAR
ligand in several cell lines [8–10]. Tetradecylthioacetic acid has a
particularly high affinity for PPARα [9–11] and exerts its hypolipi-
demic effect by inducing gene expression of enzymes involved in
hepatic fatty acid β-oxidation. It thereby reduces the availability of
fatty acids for very-low-density-lipoprotein synthesis and secretion
and lowers plasma TAG and cholesterol levels. In addition, TTA has
been shown to have an important role in diminishing of inflammation
[12–16].
Both physiological processes and externally induced oxidative
stress reactions can lead to formation of reactive oxygen species
(ROS) in the body. It is well-known that dietary FO supplementation
can increase lipoxidative damage due to the high amount of
unsaturated fatty acids [17–19]. Tetradecylthioacetic acid has a
potent capacity to attenuate the oxidative stress and protect the
cellular membrane lipids from oxidative damage. Based on this, we
hypothesized that a dietary TTA supplementation to the high-fat diet
would be able to reduce the oxidative stress induced by FO.
Thus, the main focus in this 50-week-long in vivo experiment was
to investigate the effects of TTA and FO, given separately or in
combination, on body weight gain, plasma and liver lipid levels, as
well as fatty acid composition in plasma and several genes encoding
important enzymes involved in fatty acid metabolism. Further,
despite the similar ability to act through PPAR-activation, we revealed
principal differences in the mechanisms of action of TTA and FO.
Finally, we confirmed that TTA can act as an antioxidant and prevent
the FO-caused oxidative damage.
2. Methods
2.1. Animals and diets
This animal study was conducted according to the Guidelines for the Care and Use
of Experimental Animals, and the protocol was approved by the Norwegian State Board
of Biological Experiments with Living Animals. Eight- to 10-weeks-old male Wistar
rats, weighing 200–250 g, were obtained from Taconic Europe (previously Möllegaard
and Bomholtgaard, Ry, Denmark). Throughout the experiment, the rats were housed in
Makrolon III cages in an open system and kept under standard laboratory conditions
with temperature 22°C±1°C, dark/light cycles of 12/12 h, relative humidity 55%±5%
and 20 air changes per hour. The animals were housed five per cage and had free access
to food and water during the study. They were acclimatized under these conditions
with standard chow for 1 week before the experiment started. All rats were divided
into four groups. The first group of animals (control group) was fed a high-fat diet with
25% fat, consisting of 23% lard and 2% soybean oil. The second group (TTA group) was
fed a high-fat diet supplemented with TTA (0.375%). The third group (FO group) wasfed a diet supplementedwith10%FO (EPAX4020TG) (12.6% lard and2% soyoil). The fourth
group (TTA+FO group) was fed both diet supplements. The amount of ω−3 fatty acids in
FO-containing diets was 8% (where the EPA content was 4.5% and DHAwas 2.3%). All diets
were isocaloric in their energetic value (4900 kcal).
The animals were part of a larger study described elsewhere, and all animals
underwent a jejunogastric reflux surgical procedure (manuscript in preparation). An
additional 2-month feeding experiment on male Wistar rats with and without surgery
was performed to determine if the procedure had an effect on the nutritional state of
the animals. There was no difference in body weight or plasma lipids between the
groups (data not shown), and thus it could be assumed that the surgery had no adverse
effect on nutritional uptake.
Tetradecylthioacetic acid was synthesized as previously described [20]. The rats
were anaesthetized with isofluorane (Forane; Abbott Laboratories, Abbott Park, IL)
inhalation under nonfasting conditions. Blood was drawn by cardiac puncture and
collected in BD Vacutainer tubes containing EDTA (Becton-Dickinson, Plymouth, UK),
and the organs were immediately removed and frozen in liquid nitrogen.
2.2. Quantification of lipids and fatty acids
Plasma and liver lipids were measured on the Hitachi 917 system (Roche
Diagnostics, Mannheim, Germany). Quantification of TAGs and total cholesterol in
plasma and liver were obtained by using kits from Roche Diagnostics. Choline-
containing phospholipids (PLs) in plasma and liver were measured by PAP150 from
bioMérieux (Lyon, France). Hepatic lipids were analyzed in cytoplasmic extracts. Lipids
from plasma and liver were extracted before the fatty acid composition was analyzed
as described previously [21,22].
From the fatty acid profile, the double-bond index (DBI) of lipid susceptibility to
oxidative modification [23] was calculated: DBI=[(1×∑mol% monoenoic)+
(2×∑mol% dienoic)+(3×∑mol% trienoic)+(4×∑mol% tetraenoic)+(5×∑mol%
pentaenoic)+(6×∑mol% hexaenoic)].
2.3. Enzyme activities
Fresh liver tissue samples were homogenized in ice-cold sucrose medium and
centrifuged. The resulting three postnuclear fractions, a mitochondrial-enriched
fraction (M), a peroxisome-enriched fraction (L) and a cytosolic fraction (S), were
isolated as previously described and frozen at −80°C [24]. Then the activities of fatty
acyl-CoA oxidase 1 (ACOX1) [25], carnitine palmitoyltransferase II (CPT-II) [26], 3-
hydroxy-3-methylglutaryl-coenzyme A synthase (HMG-CoA synthase) [27] and fatty
acid synthase (FAS) [28,29] were measured.
2.4. Gene expression analysis
Liver samples were frozen in liquid nitrogen immediately after dissection and
stored at−80°C. Total cellular RNAwas purified from 20- to 30-mg tissue using RNeasy
Mini Kit (Qiagen). RNA was quantified spectrophotometrically (NanoDrop 1000;
NanoDrop Technologies, Boston, MA), and the quality was evaluated by capillary
electrophoresis (Agilent 2100 Bioanalyzer; Agilent Technologies, Palo Alto, CA). For
each sample, 400 ng total RNA was reversely transcribed in 20-μl reactions using
Applied Biosystem's High Capacity cDNA Reverse Transcription Kit with RNase
inhibitor according to the manufacturer's description. Real-time polymerase chain
reaction was performed with custom-made 384-well microfluidic plates [Taq-Man
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were acyl-coenzyme A dehydrogenase, medium chain (Acadm), acyl-coenzyme A
dehydrogenase, very long chain (Acadvl), carnitine palmitoyltransferase 1A and 2
(Cpt1a and Cpt2, respectively), acetyl-coenzyme A carboxylase α (Acaca), uncoupling
protein 2 and 3 (Ucp2 and Ucp3, respectively), glyceraldehyde 3-phosphate
dehydrogenase (Gapdh) and hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiola-
se/enoyl-CoA hydratase, α-subunit (Hadha). All probes and primers were obtained
from Applied Biosystems. The reference gene was chosen according to the MIQE
guidelines [30,31]. Three different control genes were included: 18s (Kit-FAM-TAMRA,
reference RT-CKFT-18s from Eurogentec, Seraing, Belgium), Gapdh (Rodent GAPDH
Control Reagents, part 4308313) and Arbp (from Applied Biosystems). In a comparative
analysis using the programs geNorm and Normfinder, Arbp was found to be the best.
The expression value of each gene in each sample was normalized against this
endogenous control.
2.5. Oxidative damage markers
Glutamic semialdehyde (GSA), aminoadipic semialdehyde (AASA), carboxy-
methyl-lysine (CML), carboxyethyl-lysine (CEL) and malondialdehyde-lysine
(MDAL) concentrations in total proteins from liver homogenates and mitochondrial
fraction were measured by gas chromatography/mass spectrometry (GC/MS) as
previously described [18]. Samples containing 0.5 mg of protein were delipidated using
chloroform/methanol (2:1, v/v), and proteins were precipitated by adding 10%
trichloroacetic acid (final concentration) and subsequent centrifugation. Protein
samples were reduced overnight with 500 mM NaBH4 (final concentration) in 0.2 M
borate buffer, pH 9.2, containing 1 drop of hexanol as an antifoam reagent. Proteins
were then reprecipitated by adding 1 ml of 20% trichloroacetic acid and subsequent
centrifugation. The following isotopically labeled internal standards were then added:
[2H8]lysine (d8-Lys; CDN Isotopes); [2H4]CML (d4-CML), [2H4]CEL (d4-CEL) and [2H8]Fig. 2. Plasma lipid concentrations in maleWistar rats after 50 weeks of high-fat diets suppleme
analyzed by ANOVA, and means with the same letter are not significantly different from eachMDAL (d8-MDAL), prepared as described [32,33]; [2H5]5-hydroxy-2-aminovaleric acid
(for GSA) and [2H4]6-hydroxy-2-aminocaproic acid (for AASA) were prepared as
described [34]. The samples were hydrolyzed at 155°C for 30 min in 1 ml of 6 HCl and
then dried in vacuo. The N,O-trifluoroacetyl methyl ester derivatives of the protein
hydrolyzate were prepared as previously described [34]. Gas chromatography/mass
spectrometry analyses were carried out on a Hewlett-Packard model 6890 gas
chromatograph equipped with a 30-mHP-5MS capillary column (30m×0.25mm×0.25
μm) coupled to a Hewlett-Packard model 5973A mass selective detector (Agilent,
Barcelona, Spain). The injection port was maintained at 275°C; the temperature
program was 5 min at 110°C, then 2°C/min to 150°C, then 5°C/min to 240°C, then
25°C/min to 300°C and finally held at 300°C for 5 min. Quantificationwas performed by
external standardization using standard curves constructed from mixtures of
deuterated and nondeuterated standards. Analytes were detected by selected ion
monitoring GC/MS. The ions used were lysine and d8-lysine, m/z 180 and 187,
respectively; 5-hydroxy-2-aminovaleric acid and d5-5-hydroxy-2-aminovaleric acid
(stable derivatives of GSA), m/z 280 and 285, respectively; 6-hydroxy-2-aminocaproic
acid and d4-6-hydroxy-2-aminocaproic acid (stable derivatives of AASA), m/z 294 and
298, respectively; CML and d4-CML,m/z 392 and 396, respectively; CEL and d4-CEL,m/z
379 and 383, respectively; andMDAL and d8-MDAL,m/z 474 and 482, respectively. The
amounts of products were expressed as the ratio of micromole of GSA, AASA, CML, CEL,
or MDAL/mol of lysine.
2.6. Statistical analysis and presentation of data
The results are presented as mean values with their standard deviations for 7 to 10
rats per group. The data were evaluated by one-way ANOVA and Tukey test or by
unpaired Student t test with the level of statistical significance set at Pb.05 (GraphPad
Prism version 4.01; GraphPad, San Diego, CA). Single outliers (significance level N0.05)
were removed using Grubb test (www.Graphpad.com).nted with 3-thia fatty acid TTA or FO. Values are means±S.D. (n=31–38). Results were
other (Tukey–Kramer test, Pb.05).
Fig. 3. Liver lipid concentrations in male Wistar rats after 50 weeks of high-fat diets supplemented with 3-thia fatty acid TTA or FO. Values are means±S.D. (n=10–11). Results were
analyzed by ANOVA and means with the same letter are not significantly different from each other (Tukey–Kramer test, Pb.05).
Table 1
Plasma fatty acid composition of male Wistar rats after 50 weeks of feeding with high-
fat (25% w/v) diets supplemented with TTA, FO or TTA+FO
Dietary supplementation
Control TTA FO TTA+FO
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3.1. Animal body weight
The addition of FO to a high-fat diet (25%) had no effect on the
growth rate of rats, while the combined treatment led to a
significant reduction in weight gain compared to the control
group already after 5 weeks of treatment (Fig. 1). Moreover, the
diet that contained both bioactive lipids seemed to reduce body
weight more than TTA alone after 50 weeks of treatment but not
significantly (P=.23). The weight loss caused by TTA stabilized over
time. In this study, all groups demonstrated the same average feed
intake. Thus, animals from TTA and TTA+FO groups had a reduced
body weight compared to control group animals with the same
energy intake over a 50-week period.SFAs 35.20±0.88a 34.98±1.36a 30.82±2.06b 32.66±1.65c
C16:0 21.22±1.49a 22.41±1.23b 17.72±1.28c 20.35±1.44a
C18:0 12.12±1.43a 10.78±0.81b 11.27±1.26b 10.40±0.96b
MUFAs 24.65±4.75a 25.87±3.73a 16.79±1.62b 20.28±2.74c
C16:1n−7 1.05±0.29a,b 1.20±0.65b 0.77±0.13c 0.91±0.18a,c
C18:1n−7 1.96±0.28a 1.65±0.29b 1.49±0.14c 1.50±0.17b,c
C20:1n−7 0.17±0.08 0.13±0.08a 0.19±0.09b 0.16±0.07
C22:1n−7 0.03±0.01a 0.02±0.01b 0.04±0.02a 0.03±0.01a
C16:1n−9 0.26±0.06a 0.36±0.07b 0.24±0.03a 0.32±0.06c
C18:1n−9 (OA) 20.46±4.23a 21.70±3.49a 12.99±1.37b 16.29±2.50c
C22:1n−9 0.02±0.00a 0.02±0.01a 0.04±0.01b 0.04±0.01b
C24:1n−9 0.27±0.11a 0.46±0.14b 0.48±0.11b 0.53±0.14b
n−9 PUFAs
C20:3n−9 (MA) 0.23±0.03a 0.85±0.33b 0.12±0.01c 0.13±0.02c
n−6 PUFAs 36.26±4.61a 33.76±3.59b 22.72±2.63c 22.38±2.50c
C18:2n−6 (LA) 17.94±1.76a 15.16±3.22b 12.32±1.03c 13.07±0.97c
C18:3n−6 0.22±0.05a 0.46±0.10b 0.11±0.02c 0.22±0.04a
C20:2n−6 0.26±0.04a 0.20±0.04b 0.16±0.03c 0.16±0.03c
C20:3n−6 0.56±0.12a 1.11±0.22b 0.37±0.08c 0.74±0.18d
C20:4n−6 (AA) 16.76±4.69a 16.57±3.69a 9.45±1.89b 7.95±1.83b
C22:4n−6 0.34±0.07a 0.14±0.03b 0.07±0.02c 0.05±0.01c
C22:5n−6 0.16±0.04a 0.12±0.06b 0.22±0.04c 0.17±0.02a
n−3 PUFAs 3.55±0.5a 2.30±1.03a 29.48±4.19b 22.90±3.14c
C18:3n−3 (ALA) 0.61±0.16a 0.45±0.16b 0.59±0.14a 0.50±0.17b
C18:4n−3 0.02±0.01a 0.01±0.02a 0.54±0.19b 0.53±0.22b
C20:4n−3 0.12±0.02a 0.09±0.02b 0.39±0.06c 0.30±0.05d
C20:5n−3 (EPA) 0.02±0.01a 0.01±0.02a 16.52±3.38b 12.58±2.82c
a b c d3.2. Plasma lipids
We studied the impact of TTA and FO on key parameters in lipid
metabolism. Analysis of plasma lipids at the end point of the
experiment demonstrated that all treatments had a substantial
lipid-lowering potential (Fig. 2). The plasma TAG level was signifi-
cantly improved by all the treatments (Fig. 2A). Only TTA and the
combination of TTA and FO were able to lower the free fatty acids
(FFAs, Fig. 2B). In contrast, FO and the combination with TTA were
able to reduce plasma PL levels by 30%, while TTA had no effect
compared to the control diet (Fig. 2C).
FO treatment alone or in combination with TTA was effective in
lowering of the total plasma cholesterol, cholesterol esters and free
cholesterol (Fig. 2D–F). While the FO-containing diet alone reduced
cholesterol by 35% compared to the control high-fat diet, the
cotreatment with TTA and FO reduced it by 49%, indicating an
additive effect of the supplements (Fig. 2D). Likewise, a significant
decrease in the cholesterol ester level was obtained after TTA+FO
treatment compared to either treatment alone (Fig. 2E). The additive
effect of TTA and FOwas mainly on LDL cholesterol (Fig. 2G) and non-
HDL cholesterol (Fig. 2I).C22:5n−3 (DPA) 0.47±0.11 0.17±0.08 1.32±0.30 0.79±0.10
C22:6n−3 (DHA) 2.01±0.49a 1.28±0.58a 9.84±2.27b 8.02±1.03c
TTA ND 1.36±0.38a ND 1.04±0.17b
TTA:1n−8 ND 0.79±0.28a ND 0.55±0.25b
n−3 PUFA/n−6
PUFA ratio
0.10±0.01a 0.07±0.03a 1.34±0.37b 1.04±0.22c
DBI 1.52±0.16a 1.43±0.13b 2.38±0.15c 2.04±0.11d
ω−3 index 2.33±0.52a 1.58±0.94a 26.36±3.83b 20.59±2.85c
Data are given as mol%±S.D. (n=31–38).
Results were analyzed by ANOVA, and means with the same letter are not significantly
different from each other (Tukey–Kramer test, Pb.05).
AA, arachidonic acid; ALA, α-linolenic acid, LA, linolenic acid; ND, not detectable; OA,
oleic acid.3.3. Liver lipids
The hepatic cholesterol concentrations had a tendency to
decrease after administration of TTA and TTA+FO (Fig. 3) but
increased significantly with FO treatment compared to control. In
addition, in rats fed a TTA diet, the total hepatic TAG concentration
was 26% lower than in control. In contrast, FO treatment did not
influence the TAG concentration in liver and caused an insignificant
rise in PL levels.3.4. Fatty acid composition in plasma
The fatty acid composition in plasma is shown in Table 1.
Compared to control animals, the plasma levels of SFAs and
monounsaturated fatty acids (MUFAs) were marginally changed by
TTA treatment alone, except for an increase in C20:3n−9 (Pb.0005).
In contrast to that, FO supplementation caused the significant
reduction in amounts of SFAs (Pb.0005), MUFAs (Pb.0005) and n−6
PUFAs (Pb.0005) in plasma from FO-treated animals. ω−3 PUFAs
Fig. 4. Effect of 3-thia fatty acid TTA and FO on hepatic fatty acid β-oxidation. (A) Gene expression of Acadm, Acadvl, Cpt1a, and Cpt2. Data are shown as relative values. (B) Activity of ACOX1, measured in postnuclear fractions, CPT-II and
HMG-CoA synthase, measured in crudemitochondrial fractions. Values aremeans±S.D. (n=8–10). Results were analyzed by ANOVA, andmeans with different letters are significantly different from each other (Tukey–Kramer test, Pb.05).
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Fig. 5. Effect of 3-thia fatty acid TTA and FO on hepatic FAS activity (A) and hepatic gene expression of Acaca (B). Values are means±S.D. (n=8–10). Results were analyzed by ANOVA,
and means with different letters are significantly different from each other (Tukey–Kramer test, Pb.05).
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−3 (DHA)] were decreased after TTA treatment [35,36], leading to a
significantly reduced DBI. We also found a significant (Pb.0005)
reduction of ω−3 PUFA in TTA+FO-treated animals compared to FO
treatment alone. However, the combined treatment increased the
n−3/n−6 PUFA ratio, as well as the ω−3 index (DHA+EPA)
(Table 1), by over 10-fold compared to TTA alone.3.5. Genes and enzymes involved in fatty acid metabolism
Several of the PPAR-controlled genes involved in the mitochon-
drial fatty acid β-oxidation pathway, such as Acadm, Acadvl, Cpt1a,
and Cpt2 were induced in liver by the TTA diet (Fig. 4A). The FO diet
seemed to give an induction of PPAR-activated genes; however, only
Cpt2 was significantly increased.
Hepatic ACOX1, CPT-II and HMG-CoA synthase activities indi-
cated a high induction of fatty acid β-oxidation after 50 weeks of
TTA diet (Fig. 4B). The addition of FO caused the less pronounced
effect on hepatic enzyme activities in combination group compared
to TTA group.
The activity of lipogenic enzyme FAS was significantly reduced by
FO administration (Fig. 5A). Tetradecylthioacetic acid gave an
insignificant increase in FAS activity and counteracted the FO effect
in the combined treatment.
We also investigated the messenger RNA (mRNA) expression of
Acaca (Fig. 5B). This gene encodes the enzyme acetyl-coenzyme A
carboxylase, which catalyzes carboxylation of acetyl-CoA to
malonyl-CoA. Acaca mRNA level in liver tended to be up-regulated
by TTA compared to control group. The FO-supplemented group
had a significantly lower Acaca mRNA expression than both TTA
group and control group (Pb.001). Also, in the TTA+FO group,Fig. 6. Effect of 3-thia fatty acid TTA and FO on the hepatic gene expression of mitochondrial un
analyzed by ANOVA, and means with different letters are significantly different from each otAcaca expression was significantly lower than in the TTA group
(Pb.01).3.6. Differential effects of TTA and FO on Ucp mRNA expression
In the liver samples, differential effects of TTA and FO were
observed on the gene expression of Ucp2 and Ucp3mRNA, which are
suggested to act as regulators of mitochondrial energy metabolism
and ROS. Both TTA and TTA+FO diets resulted in the down-
regulation of hepatic Ucp2 mRNA levels, in contrast to FO alone
(Fig. 6A). We revealed a substantial up-regulation (1500×) of Ucp3
in rats fed a TTA-supplemented diet (Fig. 6B). The combination of
TTA with FO also led to an up-regulation of Ucp3mRNA levels, while
the FO diet had no significant effect on this mitochondrial
uncoupling protein.3.7. Oxidative damage in homogenate of whole liver and mitochondria
We evaluated the relationship between different oxidative bio-
markers (representing different oxidative damage pathways) be-
tween whole-liver vs. mitochondrial fraction (Fig. 7).
γ-Glutamic semialdehyde is a marker that is related to direct
metal catalysed oxidation on proline and arginine residues in
proteins. Interestingly, the diet supplementation with FO led to
non-significantly higher levels of GSA than in the control group in
both mitochondrial extract and whole-liver homogenate, which
indicated an increase in protein oxidative damage (Fig. 7A). In
contrast to this, the dietary supplementation of TTA significantly
reduced protein oxidative damage in mitochondrial extracts obtained
from TTA- and TTA+FO-fed animals.coupling proteins Ucp3 (A) and Ucp2 (B). Values are means±S.D. (n=10). Results were
her (Tukey–Kramer test, Pb.05).
Fig. 7. Protein oxidative damage amongst different dietary interventions. GSA, AASA, CEL, MDAL and CML measured in liver (left) and liver mitochondrial homogenate (liver M-
fraction, right). Values aremeans±S.D. (n=7 or 8 animals in each group). Results were analyzed by ANOVA, andmeans with different letters are significantly different from each other
(Tukey–Kramer test, Pb.05).
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significantly higher in mitochondrial samples from the FO group than
in animals from the control group and groups treated with TTA or the
combination (Fig. 7B). The TTA supplementation led to reduction of
protein oxidative damage mitochondrial extract.
The nonenzymatic glycation and subsequent irreversible oxida-
tion of proteins cause formation of glycoxidation products. Nɛ-
Carboxymethyl-lysine is known to be formed from the oxidation of
both carbohydrates and lipids, making it a biomarker of general
oxidative stress. The whole-liver samples from the FO group showed
significantly increased lipoxidation and TTA diminished this poten-
tially deleterious effect of FO in animals from the TTA+FO group
(Fig. 7C). In mitochondrial extracts, both FO and TTA treatment
resulted in reduced levels of CML compared to the control group.
Nɛ-Carboxyethyl-lysine is a homolog of CML, which is formed by
the reaction of lysine residues in proteins with methylglyoxal as well
as with triose phosphates and other sugars. Our results showed that
FO increased oxidative (nonenzymatic) sources of methylglyoxal,
while the addition of TTA into the diets reduced CEL levels in whole-
liver homogenates (Fig. 7D). In mitochondrial extracts, both bioactive
compounds resulted in lower levels of CEL compared to control
group. The cotreatment with TTA and FO demonstrated significantly
lowered CEL compared with control, TTA, and FO groups in
mitochondrial extract.Fig. 8. Correlations for the fatty acid composition in plasma and the lipoxidative
damage marker MDAL measured in mitochondrial extracts. (A) Correlation between
DHA (C22:6n−3) and MDAL. C22:6n−3 values are shown as mole percent of the total
lipid content. (B) Correlation between the DBI and MDAL. DBI values are expressed as
∑% of unsaturated fatty acids×number of double bonds per unsaturated fatty acid.
MDAL values are expressed in μmol MDAL/mol Lys.Nɛ-Malondialdehyde-lysine is a biomarker of lipoxidation. FO
supplementation showed an increased oxidative damage compared
to control group in both whole-liver and mitochondrial homogenate
samples (Fig. 7E). We found that TTA cotreatment diminished the FO-
induced lipoxidative damage in mitochondrial homogenates.
Furthermore, there is a significant positive correlation between
MDAL concentration and the DHA content, as well as the DBI (Fig. 8).
4. Discussion
Contrary to earlier performed animal experiments on the effects of
bioactive lipids such as TTA andω−3 PUFAs, the distinguishing factor
of our study was its duration of 50 weeks. The extended duration gave
us the possibility to evaluate and compare the effectiveness of
combined treatment vs. mono supplementation with TTA or FO. The
prolonged beneficial effects observed were changes in expression of
genes involved in fatty acid metabolism and activities of correspond-
ing key enzymes, improvement of plasma lipid parameters and liver
lipid composition and not the least weight reduction. A 50-week
period of feeding with TTA resulted in a significantly reduced body
weight gain during the whole study period, apparently reflecting
increased energy expenditure due to TTA. In agreement with other
studies, FO did not affect the overall body weight of male Wistar rats
given a high-fat diet [37]. Further, the rise in activities of CPT-II, HMG-
CoA synthase and ACOX1 (Fig. 4B) combined with the enhanced
expression of hepatic Cpt1, Cpt2, Acadm and Acadvl (Fig. 4A) as well
as UCP3 (Fig. 6) suggests that TTA both increases the β-oxidation and
induces the energy consumption via intensification of uncoupling in
the liver (45).
The diets had a differential effect on the lowering of plasma lipid
levels. While the TTA diet mainly lowered TAG, FFAs and LDL
cholesterol in this long-term treatment, FO supplementation showed
substantially more lowering of TAG, PLs, cholesterol and HDL
cholesterol than TTA alone. The combined supplementation with
TTA and FO demonstrated the additive effect of both components on
the decrease in several plasma lipids and especially in a significantly
enhanced reduction in plasma cholesterol.
In agreement with the results obtained by Duan at al. [38], our 50-
weeks-long experiment showed that high-fat feeding can induce
elevation in hepatic TAG levels (Fig. 3B). The accumulation of TAGwas
probably due to inability of the liver to handle the increased import of
plasma lipids and indicated the development of liver steatosis. The
diet with TTA showed a potential to improve the hepatic TAG and
cholesterol levels, whereas the FO diet did not. This could be due to
the high induction of hepatic β-oxidation by TTA that enhances lipid
metabolism and consequently results in pronounced removal of lipids
from both plasma and liver [13]. In addition, TTA has previously been
shown to drain lipids from specific adipose tissue depots [39]. It might
be possible that both FO and TTA diets are able to increase cholesterol
and TAG transport to the liver, but animals given the FO diet are less
able to metabolize the excess hepatic lipid levels. The stimulated
activities of CPT-II and ACOX1were muchmore pronounced with TTA
than with FO feeding (Fig. 4B). Thus, TTA seemed to lower plasma
lipid levels by an increased hepatic β-oxidation, while FO redis-
tributed lipids without affecting the total lipid level and body weight.
We have revealed a tendency to decrease in the hepatic
cholesterol concentrations after administration of TTA and TTA+FO,
whereas FO supplementation alone gave a significant increase in
hepatic cholesterol compared to controls. Consequently, the observed
lowering effect of hepatic cholesterol by TTA+FO combination might
be due to the TTA effect.
In this long-term experiment, TTA supplementation caused
several changes in the plasma fatty acid composition, particularly,
the decrease in ω−3 PUFA content (Table 1). The observed reduction
in ω−3 PUFA levels can be explained by TTA-induced stimulation of
1392 N.F. Vigerust et al. / Journal of Nutritional Biochemistry 23 (2012) 1384–1393mitochondrial and peroxisomal fatty acid oxidation (36). Further-
more, the n−9 fatty acid, mead acid (MA, C20:3n−9), was up-
regulated in the plasma of TTA-fed rats (approximately fourfold).
Notably, both FO and the combined treatment led to a twofold
reduction of MA compared to control. As an increased production of
the nonessential MA may be linked to a poor PUFA status in humans
[40], the FO-induced decrease in MA supports a similar regulation of
MA in rats.
The addition of both TTA and FO to the high-fat diet induced genes
linked to fatty acid metabolism and increased the corresponding
enzyme activity levels. Tetradecylthioacetic acid was far more potent
than FO, and the combination of TTA and FO did not further increase
the effect. The pattern of enzyme activity implicated in fatty acid
metabolism was similar to previous findings [19,36,39], demonstrat-
ing that the metabolic effects of FO and TTA supplementation are
long-lasting.
Tetradecylthioacetic acid and FO seem to affect the factors
involved in lipogenesis in a different manner. The significant
reduction in hepatic FAS activity in rats fed the FO diet could
contribute to the registered changes in plasma lipid content. In
contrast, the TTA diet showed an insignificant increase in hepatic FAS
activity (P=.24). Moreover, the FO diet significantly decreased Acaca
expression in liver compared to TTA. Thus, comparing the effect of
combination of both supplements with the effect of TTA treatment,
the reduction of AcacamRNA level could be a result of the competing
modes of action of TTA and FO.
The study with Wistar rats fed a low-fat TTA-supplemented diet
for 7 days showed an enhanced Ucp2 mRNA expression in liver [41],
and it has been suggested that this early, transient induction in
hepatic Ucp2 may contribute to increased energy expenditure.
However, our long-term experiment and the 7-week study performed
by Wensaas et al. [39] demonstrated a significant decrease in Ucp2
expression caused by TTA-supplemented diets.
Ucp3 is usually not expressed in the liver, except in response to
PPAR activation during situations with a high level of fatty acid
metabolism [42]. The increase in hepatic Ucp3 mRNA expression
caused by TTA treatment alone (over 1500-fold) and the combined
treatment (over 1300-fold) was the most striking results in our
experiment. As discussed previously, the stimulated hepatic expres-
sion of Ucp3 due to TTA administration could be related to an
increased metabolism, possibly also through energy uncoupling
(Fig. 6B). Altogether, these findings indicate that the induction of
Ucp2 becomes less pronounced over a longer period, while the
induction of Ucp3 is a prolonged effect by TTA.
A hypothesis about a possible protective role of endogenous UCP3
against oxidative damage by ROS in skeletal musclemitochondria was
proposed and tested by Brand et al. [43]. They discovered that down-
regulation of Ucp3 was associated with increased oxidative damage
through higher ROS generation, while the Ucp3 up-regulation was
not. Based on findings from our study and in accordance with
previous observations [44,45], we could propose that such pro-
nounced effects might represent an adaptive response to protect the
mitochondria and their host cells from oxidative stress in situations
characterized by intensive lipid metabolism and consequently further
support the theory of the defensive role of Ucp3 against lipid-induced
mitochondrial damage.
In agreement with previous data [46–48], we confirm that dietary
FO supplementation increased lipoxidative damage. Our experiment
revealed marked changes in CML and MDAL, which are markers
related to lipoxidative status, in both liver homogenate and
mitochondrial extracts. Since liver is a crucial organ in lipid
metabolism, the fatty acid profile in liver is sometimes assumed to
reflect the fatty acid composition in plasma. Therefore, it is not
unreasonable to think that the profile might reflect the membrane
lipid composition of liver cells. From that point of view and beingdemonstrated by a 1.5-fold increase of DBI for FO-treated animals
compared with the control group (Fig. 8), one can postulate that the
different degree of unsaturation in liver membranes may account for
the increased damage observed and could achieve enough amplifi-
cation without ROS production being raised. In other words, FO diet is
not necessarily responsible for an increased ROS production but for a
major ROS susceptibility, since membrane composition is slightly
altered and the degree of unsaturation is increased. Finally, both CML
and MDAL were reduced by addition of TTA into the diets. Thus, TTA
was able to partially prevent those FO-induced changes. This fully
agrees with the hypothesis of TTA as an antioxidant.
The results also demonstrate that a dietary manipulation com-
prising changes in the amount of fatty acids induce a significant
change in the steady state levels of GSA and AASA, markers of direct
oxidative damage. Reinforcing the implication of mitochondria in this
change, only mitochondrial proteins show those changes, whereas
liver homogenates did not. Fish oil effects could be due to increased
free radical production as recently demonstrated in other tissues and
experimental models, implicating Ca+2 transit betweenmitochondria
and endoplasmic reticulum [49–51]. Most interestingly, the fact that
TTA significantly lowers direct oxidative damage supports the notion
that TTA increases mitochondrial efficiency (irrespectively of FO) and
may reproduce beneficial effects of caloric restriction.
To conclude, this study provides evidence that the long-term
effects of TTA are similar to those seen in experiments of shorter
duration. We report that TTA and FO are efficient dietary
supplements in improvement of plasma lipid profile, despite
differences in their mechanisms of action. While TTA increased
energy expenditure and lipid metabolism, FO seemed to lower
plasma lipid levels mainly by a redistribution of lipids, as well as a
reduced fatty acid synthesis. Through our experiment, we con-
firmed that, during long-term FO diets, the proper supplementation
of antioxidants, such as TTA, is essential.
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Abstract TDP-43 has been implicated in the pathogen-
esis of amyotrophic lateral sclerosis and other
neurodegenerative diseases. Here we demonstrate, using
neuronal and spinal cord organotypic culture models, that
chronic excitotoxicity, oxidative stress, proteasome dys-
function and endoplasmic reticulum stress mechanistically
induce mislocalization, phosphorylation and aggregation of
TDP-43. This is compatible with a lack of function of this
protein in the nucleus, specially in motor neurons. The
relationship between cell stress and pathological changes
of TDP-43 also includes a dysfunction in the survival
pathway mediated by mitogen-activated protein kinase/
extracellular signal-regulated kinases (ERK1/2). Thus,
under stress conditions, neurons and other spinal cord cells
showed cytosolic aggregates containing ERK1/2. More-
over, aggregates of abnormal phosphorylated ERK1/2 were
also found in the spinal cord in amyotrophic lateral scle-
rosis (ALS), specifically in motor neurons with abnormal
immunoreactive aggregates of phosphorylated TDP-43.
These results demonstrate that cellular stressors are key
factors in neurodegeneration associated with TDP-43 and
disclose the identity of ERK1/2 as novel players in the
pathogenesis of ALS.
Keywords Oxidative stress  Proteasome stress 
Endoplasmic reticulum stress  Excitotoxicity  ALS 
TDP-43  ERK1/2
Introduction
Transactive response DNA binding protein (TDP-43) is a
414-amino acid protein with two highly conserved RNA
recognition motifs, a nuclear localization signal at the protein
N-terminus, and a glycine-rich region mediating protein–
protein interactions at the C-terminus [8, 9, 29, 31, 38].
TDP-43 was discovered as the gene encoding a 43-kDa pro-
tein that binds to the transactive response DNA sequence of
human immunodeficiency virus type 1 [38]. Subsequently, it
was demonstrated that TDP-43 regulates DNA transcription,
RNA splicing and microRNA biogenesis in physiological
conditions [9]. Recently, the discovery of TDP-43 cytosolic
aggregates in sporadic amyotrophic lateral sclerosis (ALS),
a progressive and deadly motor neuron disease, has pro-
mpted its research in neurodegeneration [2, 35]. TDP-43
ALS-associated forms characteristically exhibit ubiquitina-
tion, phosphorylation and fragmentation, together with
abnormal subcellular localizations [35].
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Neurodegeneration in ALS involves many different cellular
stress mechanisms: oxidative stress, mitochondrial dysfunc-
tion, endoplasmic reticulum (ER) stress, proteasome stress and
protein aggregation, glutamate excitotoxicity, cytoskeletal
dysfunction, malfunctioning non-neuronal cells in the vicinity
of motor neurons, and abnormal RNA processing [4, 14, 20, 22,
23, 25, 33, 47]. Some of them also originate after excitotoxicity
caused by dysregulation of glutamate signaling [40]. In addi-
tion to ALS, there is a wide variety of neurodegenerative
diseases (such as Alzheimer’s, Parkinson’s and Huntington’s),
that also show TDP-43 pathological forms, suggesting a
potential association between TDP-43 and neurodegenerative
processes [1, 15, 21, 34, 35, 42].
We have previously shown that ER stress, increased
ubiquitination, protein oxidative damage and changes in fatty
acid profile are associated with chronic excitotoxicity in or-
ganotypic spinal cord cultures [23], a well-supported model of
the sporadic form of ALS [39]. However, it is not known if
excitotoxicity or other ALS-involved cellular stressors induce
TDP-43 pathological changes. Here, we report that oxidative,
endoplasmic reticulum (ER) stress and proteasome dysfunc-
tion induce those changes. Furthermore, excitotoxicity leads
to TDP-43 accumulation resembling the pathological aggre-
gates shown in human disease. As oxidative stress impairs
protein nuclear import, and this involves mitogen-activated
protein kinase/extracellular signal-regulated kinases (ERK1/
2) activation [11], we also investigated whether oxidative, ER
and proteasome stress cause a ERK1/2 activation leading to
cytosolic TDP-43 aggregation in neuronal cell lines. Para-
doxically, the results indicate that inhibition of TDP-43
nuclear import associated with stress involves the inhibition of
ERK1/2, which interestingly are also aggregated. Further-
more, we show the presence of abnormal phosphorylated
ERK1/2 aggregates in motor neurons with p-TDP-43-positive
inclusions in ALS.
Materials and methods
Cell culture
Neuro-2A and SH-SY5Y cell lines were incubated as
detailed in the Supplementary material. To study the
effects of oxidative stress, alteration of endoplasmic
reticulum and inhibition of proteasome activity, cells were
treated with 10 lM H2O2 (Sigma), 5 lM thapsigargin
(Thp) (Sigma), or 2.5 lM epoxomicin (Epox) (Sigma),
respectively, for 2 or 4 h. Similarly, the cells were incu-
bated with 20 lM PD98059 (Sigma) for 2 h before any
stress to specifically inhibit the ERK1/2 pathway. To avoid
the influence of growth factors present in the fetal bovine
serum on the results, the normal culture medium was
replaced by Optimem (Invitrogen, Carlsbad, CA, USA)
12 h before all the assays. Cell viability was evaluated
using the crystal violet assay as previously described [19]
and detailed in the Supplementary material section.
Spinal cord organotypic cultures
Spinal cord cultures were prepared from lumbar spinal cord
of postnatal day 8 rat pups as previously described [23, 39]
and maintained in culture media as described in the Sup-
plementary material section. One week after plating, to
induce excitotoxicity the slices were incubated with the
glutamate transport inhibitor D,L-threo-hydroxyaspartate
(THA) (Sigma, St. Louis, MO, USA) at 100 lM. This
treatment injures motor neurons with a morphology typical
of excitotoxic degeneration after 3 weeks of treatment.
Experiments for each condition (n = 30 slices per experi-
mental group) were repeated at least three times. All
animal experiments were approved by the Institutional
Animal Care and Experimentation Committee.
Patients’ information
The human spinal cord samples were from six males and
five females aged between 54 and 76 years (mean age 62)
affected with typical neurological and neuropathological
characteristics of sporadic ALS. The post-mortem delay
between death and tissue processing was between 3 and
13 h. Age- and gender-matched controls (n = 11) with no
neurological disease and normal neuropathological study
were processed in parallel. All samples were obtained from
the Institute of Neuropathology and University of Barce-
lona Brain Bank following the guidelines of the local ethics
committees. Extensive pathological studies were done for
ALS diagnosis as previously described [23].
Immunohistochemical analysis
Detailed procedures, following previously described
methods [23] for immunohistochemistry analysis of orga-
notypic spinal cord cultures, cell lines and human samples
are described in the Supplementary material section.
Immunohistochemical controls, performed by omitting the
primary antibodies, resulted in the abolition of the immu-
nostaining in all cases. For quantitation of p-TDP-43 or
p-ERK1/2 aggregates a minimum number of 1,000 cells
were counted in each experimental situation.
Cell fractionation, protein electrophoresis and western
blot
Tissue and cell lysis, protein electrophoresis and western
blot were performed as previously described [23]. For
details see the Supplementary material section.
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Equal loading of western blot was ensured by b-actin or
a-tubulin and blot quantification was carried out using the
ChemiDoc XRS system and the softwares Quantity One
(BioRad, Hercules, CA, USA) and Scion Image (Scion
Corp., Frederick, MD, USA).
Statistical analysis
All statistics were performed using the SPSS software
(SPSS Inc., Chicago, IL, USA). Differences between
groups were analyzed by the Student’s t tests or ANOVA
analysis, once normality of variables was tested by
Kolmogorov–Smirnov test. The 0.05 level was selected as
the point of minimal statistical significance in every
comparison.
Results
TDP-43 pathogenic alteration is induced by different
ALS-related stressors in different neuronal cell lines
Previous results from our group showed that sporadic ALS
is associated with increased protein oxidation, loss of
proteasome activity and ER stress contributing to motor
neuron death [23]. ALS-associated TDP-43 changes
include increased fragmentation, increased cytosolic
localization and aggregate formation with concurrent
phosphorylation. To validate the relationship between cell
stress and TDP-43 changes we measured TDP-43 changes
in accepted models of each of those stress types in neuronal
cell lines. Neuro 2A cultures were treated with either H2O2
to induce oxidative stress, thapsigargin to induce endo-
plasmic reticulum stress, or with epoxomicin to inhibit
proteasome activity. Treatments were sublethal (Fig. 1a),
so the presented changes in TDP-43 are not directly related
to immediate cell death. Furthermore, none of the stress
conditions used here increased cleaved caspase-3 levels
(data not shown).
Western blot using the polyclonal antibody anti-
TDP-43 (Sigma ref HPA017284), extensively validated
in the Human Protein Atlas (http://www.proteinatlas.org/),
showed a transient increase of an anti-TDP-43 immuno-
reactive 37-kDa band (putatively a TDP-43 fragment) after
each one of the stress inducers for 2 h (Fig. 1b, c). All the
stressors induced a significant increase in TDP-43 phos-
phorylation versus control cells, measured by using an
antibody against the phospho-Ser410/409 in TDP-43
(p-TDP-43). In the case of a 25-kDa phosphorylated frag-
ment, its presence was sustained after 4 h (Fig. 1b, d).
According to p-TDP-43 immunoreactivities a general
increase was seen at fragments with apparent molecu-
lar weights between 32–37 kDa and 22–25 kDa, even
comprising a very low molecular weight fragment of
15-kDa (Fig. 1b, d).
Subcellular fractionation and immunohistochemistry
demonstrated that these stress inducers led to the accu-
mulation of TDP-43 and p-TDP-43 in the cytosolic
fractions (Figs. 1e–g, 2). Specifically, in the case of ep-
oxomicin treatment, practically all TDP-43 were
fragmented (37 kDa band) and localized in the cytosol
after 4 h, as the TDP-43 immunoreactivity was practically
lost in nuclear fractions of epoxomicin treated cells. Pro-
teasome inhibition led to the highest accumulation of non-
phosphorylated TDP-43 (Fig. 2a, b). In addition, both
proteasome and ER stress inducers generated a high level
of cytosolic p-TDP-43 aggregates (Fig. 2a, c). The highest
labeling of epoxomicin is coincident with the suggestion
that TDP-43 or some of its fragments are degraded by
proteasome [37]. These results also show that TDP-43
phosphorylation is not always related to its cytosolic
aggregation under cell stress. Most of these results were
also observed in a human cell line (differentiated SHSY-
5Y neuroblastoma cells), suggesting that oxidative, ER and
proteasome stress-induced neuronal TDP-43 pathological
changes are common mechanisms across different species
(Fig. S1).
In summary, these data show that oxidative, ER and
proteasome stress induce ALS-related TDP-43 pathogenic
changes in neuronal cell lines. These include increased
TDP-43 fragmentation, increased cytosolic localization
and aggregate formation with concurrent phosphory-
lation.
Involvement of ERK1/2 in stress-induced ALS-related
TDP-43 changes
ERK1/2 pathway is implicated in cellular death/survival
signaling and is activated in response to certain situations
of cellular stress [6]. Moreover, previous data have
described that oxidative stress prevents nuclear import of
transcription factors by activating ERK1/2 [11]. So this
phenomenon could partially explain TDP-43 cytosolic
accumulation observed after oxidative and ER stress, and
proteasome inhibition. To demonstrate this hypothesis, the
degree of ERK1/2 activation in all stress situations was
analyzed and it was demonstrated that all cell stress—
though at different rates—activated initially ERK1/2
(Fig. 3a–d). In fact, ERK1/2 inactivation by the specific
inhibitor PD98059, not only failed to prevent TDP-43
abnormal distribution associated to stress, but it also
increased cytosolic p-TDP-43 aggregation (Fig. 3e–h, S2)
and it induced p-ERK1/2 aggregation (Fig. 3h, S2). Note-
worthy, epoxomicin induced a cytosolic accumulation of
p-ERK1/2 (Fig. 3h, Fig. S2), coincident (but not colocal-
izing) within cells showing p-TDP-43 aggregates. These
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data suggest that p-TDP-43 and p-ERK1/2 deposits may be
present in different cellular compartments in the same cell.
Importantly, those p-ERK1/2 cytosolic aggregates coin-
cided with the lowest degree of ERK1/2 activation
(Fig. 3a, b, h). These data suggest an association between
aggregation/inactivation of ERK1/2 and TDP-43 abnormal
localization. Noteworthy, cytosolic p-ERK1/2 did not
colocalize with stress granules (anti-TIA immunoreactivity
in cells treated with thapsigargin, Fig. S3).
To directly prove that ERK1/2 inactivation is sufficient
for TDP-43 alteration, we submitted cells to pharmaco-
logical ERK1/2 inactivation without further stress, leading
to a clear increase in nuclear TDP-43 fragmentation as well
as an accumulation of total levels of cytosolic TDP-43
(Fig. 4a, b) and their appearance as perinuclear p-TDP-43
aggregates (Fig. 4c). Globally, these data demonstrate that
ERK1/2 inactivation does not prevent the stress-induced
changes in TDP-43. Furthermore, ERK1/2 inactivation is
sufficient for ALS-related TDP-43 pathological changes in
neurons (Fig. 4).
Chronic excitotoxicity leads to ALS-related TDP-43
pathogenic changes and ERK1/2 aggregation
Cell phenotype in neuronal lines is quite different from the
spinal cord neurons. Moreover, these neuronal cell lines are
grown in the absence of a natural cellular milieu (astro-
cytes, microglia), which plays a role in the development of
ALS. Organotypic spinal cultures could solve these limi-
tations, as glutamate excitotoxicity, a well-recognized
mechanism of motor neuronal death in sporadic ALS, can
be reproduced in vitro by exposing lumbar cord slices to
the glutamate-uptake inhibitor THA [39]. We have previ-
ously shown that chronic excitotoxicity in this model
induces ER stress, increased ubiquitination, protein oxi-
dative damage and changes in fatty acid profile [23]. To
evaluate whether cell stress-induced TDP-43 pathological
changes were also present in chronic excitotoxicity, we
measured potential fragmentation, cytosolic localization
and aggregate formation of TDP-43 with concurrent
phosphorylation with different antibodies, to avoid non-
Fig. 1 TDP-43 pathogenic alteration is induced by different ALS-
related stressors in neurons. a Treatments with oxidative stress,
proteasome stress and ER stress did not induce a significant change in
neuron cell line viability (neither at 2 nor at 4 h). b Representative
immunoblots of TDP-43 and p-TDP-43 immunoreactivities of Neuro
2A cell lysates after induction of oxidative stress (10 lM H2O2),
proteasomal inhibition (2.5 lM Epoxomicin, Epox) and endoplasmic
reticulum stress (5 lM Thapsigargin, Thp). Densitometric analysis of
the anti-TDP-43 (c) and anti-p-TDP-43 (d) bands, adjusted to actin
content, being the differences analyzed with reference to unstressed
cells. e Representative immunoblots of cytosolic (C) and nuclear
(N) fractions of Neuro 2A cells after induction of the above referred
stress. Anti-growth factor receptor-bound protein 2 (Grb2)
immunoreactivity was used for ensure specificity of cytosolic
isolation and anti-Poly (ADP-ribose) polymerase 1 (PARP1) immu-
noreactivity for nuclear isolation. Densitometric analyses of the anti-
TDP-43 immunoreactivity (f) and anti-p-TDP-43 (g) in cytosolic
fractions showed increased amount of TDP-43 protein (both phos-
phorylated and non-phosphorylated) after each stress with significant
changes with reference to unstressed cells. Differences between
control and H2O2, Epox and Thp-treated samples were analyzed by
Student’s t test being *p \ 0.01 (for different treatments) and a
p \ 0.01 (for differences between 2 and 4 h). Arrows at left of blots
indicate bands whose intensity was quantified. Total in d indicates the
summatory of individual immunoreactivities of anti-p-TDP-43 in b
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specific recognition. This approached revealed different
patterns of TDP-43 distribution in organotypic spinal cord
culture. The use of the polyclonal antibody anti-TDP-43
(Sigma ref HPA017284) revealed decreased TDP-43
immunostaining, specifically in the nucleus of neuronal
cells, compatible with the above-mentioned nuclear loss of
TDP-43 induced by cell stressors. These neurons, localized
in the ventral horn, show a morphology and SMI-32
immunoreactivity compatible with its identity as motor
neurons and they exhibited a near-complete depletion of
TDP-43 (Fig. 5a, Fig. S4). In contrast, glial cells do not
exhibit this TDP-43 loss (Fig. S4). The use of another
antibody raised against a peptide comprising the N-termi-
nal region (1-261 aminoacids, Abnova ref H00023435-
A01) evidenced TDP-43 accumulation in the cytoplasm
after THA treatment (Fig. 5b), also showing a nuclear loss.
Interestingly, in those cells with nuclear TDP-43 depletion,
TDP-43 immunoreactivity was present in the cytoplasm,
both in perinuclear areas and dendritic terminals (small
panels, Fig. 5b). Strikingly, while as TDP-43 nuclear loss
was neuron specific, cytosolic immunoreactivity was
extended to both neuronal and glial cells.
Western blot analysis disclosed two major bands: a
43-kDa (native) and the 37-kDa (Fig. 5c). Densitometric
analysis demonstrated that excitotoxicity significantly
increased the levels of this TDP-43 fragment while 43-kDa
band tended to decrease, albeit non-significantly (Fig. 5d),
a fact that might be explained by the contribution of non-
neuronal TDP-43.
Chronic excitotoxicity also leads to increased p-TDP-43,
specifically in the cytoplasm of cells in the ventral horn of
spinal cord cultures (Fig. 6a–d). The resulting increased
p-TDP-43 immunostaining showed two patterns: an aggre-
gated and a diffuse one. Aggregates were not colocalized
with ubiquitin (Fig. 6b upper panel), though they were
restricted to cells showing ubiquitin inclusions. In contrast,
the p-TDP-43 diffuse pattern was present in cells without
increased protein ubiquitination (Fig. 6b lower panel).
Western blot analysis evidenced that the presence of vari-
ous immunoreactive bands, similar to neuronal cell lines
(at apparent molecular weight 43, 37, 29, 25, 23 and
15 kDa), increased significantly after THA treatment,
except the unfragmented 43-kDa band (Fig. 6c, d).
P-ERK1/2 analyses revealed that chronic excitotoxicity
increased extranuclear p-ERK1/2 immunoreactivity toge-
ther with p-TDP-43 aggregates. p-ERK1/2 aggregates
showed both fine granular and meshwork-like morpholo-
gies (Fig. 6e). In this specific case, and based on cell
Fig. 2 TDP-43 cytosolic aggregation and phosphorylation is induced
by different ALS-related stressors in neurons. a Both TDP-43 (green)
and p-TDP-43 (red) aggregates were observed in Neuro 2A cells 2 h
after induction of oxidative stress (10 lM H2O2), proteasomal
inhibition (2.5 lM Epoxomicin, Epox) and endoplasmic reticulum
stress (5 lM Thapsigargin, Thp). Nuclei were stained with DAPI
(blue). b Evidences the effect of cell stress in anti-TDP-43
immunoreactivity and c shows the effect of stress inducers in the
number of cellular anti-p-TDP-43 immunoreactive granules (number
of aggregates for each 100 cells: 11.5 ± 1.6; 26.6 ± 5.8 and
30.3 ± 7.6, mean ± SD for H2O2, Epox and Thp-treated cells,
respectively). Differences between control and H2O2, Epox and Thp-
treated samples were analyzed by Student’s t test being *p \ 0.01 (for
different treatments). Scale bars: white 50 lm; yellow 10 lm; red
25 lm
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abundance, p-ERK1/2 aggregates were present in both
neuronal and non-neuronal cells in ventral horn (Fig. 6f).
Importin beta, a protein implicated in nucleocytoplasmic
transport, was studied by immunostaining, showing that
this protein is absent in cells showing p-ERK1/2 aggre-
gates in THA-treated organotypic cultures (Fig. S5).
This supports the hypothesis that impaired nuclear
import due to excitotoxicity may be related to p-ERK1/2
aggregation.
Globally, these results demonstrate that chronic excito-
toxicity, which is known to induce ER, proteasome and
oxidative stress, leads to TDP-43 pathogenic changes,
namely increased fragmentation, increased cytosolic
localization and aggregate formation with concurrent
phosphorylation in cells of the ventral horn of lumbar
spinal cord. Furthermore, increased p-ERK1/2 deposition is
also present, coincident with p-TDP-43 aggregates.
Altered p-ERK1/2 deposition is restricted to motor
neurons with p-TDP-43 immunoreactive deposits
in ALS
As already reported, TDP-43 immunoreactivity in normal
motor neurons of the spinal cord was characterized as fine
granular precipitate localized in the nuclei. However, TDP-
43 immunoreactivity was altered in many motor neurons in
ALS as fine granular deposits, skein-like inclusions and
globular inclusions in the cytoplasm, at the time that TDP-
43 immunoreactivity vanished in the nuclei of the same
neurons, reproducing what is observed in the spinal cord
Fig. 3 Involvement of ERK1/2 in stress-induced ALS-related TDP-
43 changes. a Representative immunoblots of total ERK1/2 and
p-ERK1/2 immunoreactivities of Neuro 2A cell lysates after induc-
tion of oxidative stress (10 lM H2O2), proteasomal inhibition
(2.5 lM Epoxomicin, Epox) and endoplasmic reticulum stress
(5 lM Thapsigargin, Thp). b Densitometric analysis of p-ERK1/2
bands, adjusted to total ERK1/2 content, being the differences
analyzed with reference to untreated cells. c Time course analyses
show that in the case of epoxomicin, 2 h inactivation (shown in a)
was preceded by a marked acute activation of p-ERK1/2, with a
maximum at 30 min, as evidenced by the densitometric analysis (d).
e Representative immunoblots of cytosolic (C) and nuclear
(N) fractions of Neuro 2A cells after induction of the above referred
stress under previous ERK1/2 inhibition induced by PD98059
treatment for 2 h. Densitometric analysis of the anti-TDP-43 immu-
noreactivity in cytosolic (f) and nuclear fractions (g). In the case of
oxidative stress, PD98059 treatment increased nuclear TDP-43
fragmentation as evidenced by the accrual of a 25 kDa anti-TDP-43
reactive fragment (e, g). h Proteasome stress led to p-ERK1/2
aggregation (green) in association with p-TDP-43 aggregation (red),
with some cells showing colocalization of both aggregates (arrows).
Differences between control and H2O2, Epox or Thp-treated samples
were analyzed by Student’s t test being *p \ 0.01 (for different
treatments). Scale bars: white 50 lm; red 10 lm
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organotypic cultures. Similar results were obtained with the
two anti-TDP-43 antibodies used in samples from ALS
patients (data not shown).
Phosphorylated form of TDP-43, as observed with both
anti-p-TDP-43 antibodies, was only found in pathological
inclusions whereas the normal nuclei were not stained.
Thus, p-TDP-43 was a marker of altered TDP-43 locali-
zation in ALS motor neurons (data not shown). In those
sections, p-ERK1/2 immunoreactivity was present in the
nuclei of motor neurons in normal spinal cords and in
apparently non-altered motor neurons in samples from ALS
patients (Fig. 7a). Yet several motor neurons in the ALS
showed abnormal p-ERK1/2 deposits in the form of dense
nuclear aggregates (Fig. 7b, c) or dense (Fig. 7d–f), fine
granular or rectilinear (Fig. 7g, h), skein-like (Fig. 7i, j) or
meshwork-like (Fig. 7k, l) cytoplasmic inclusions. These
were accompanied by a decrease or absence of nuclear
p-ERK1/2 immunoreactivity.
Double-labeling immunofluorescence and confocal
microscopy showed altered p-ERK1/2 deposition restricted
to motor neurons with p-TDP-43 immunoreactive deposits
in ALS cases (Fig. 7m–r). Subcellular colocalization of
abnormal p-ERK1/2 and p-TDP-43 was also occasionally
observed (Fig. 7s–x). These data reinforce a potential role
for ERK1/2 dysfunction in ALS pathogenesis related to
TDP-43 alterations, as the same motor neurons show both
TDP-43 and p-ERK1/2 aggregates.
Discussion
Data presented here demonstrate that different paradigms
of sporadic ALS, including organotypic culture of lumbar
spinal cord slices under excitotoxic conditions [23, 39]
reproduce TDP-43 abnormalities observed in sporadic ALS
and frontotemporal lobar degeneration. In both diseases,
TDP-43 shows increased fragmentation, hyperphosphory-
lation and ubiquitination [35]. Furthermore, its subcellular
localization is changed from its physiological preferential
nuclear localization to a cytosolic one, even showing
aggregates [2, 3, 35]. Our data reinforces both the useful-
ness of organotypic culture as a valid model for sporadic
ALS and the fact that chronic excitotoxicity could repro-
duce TDP-43 pathological findings in vitro.
Nuclear TDP-43 protein is decreased in ventral horn of
glial and motor neurons of THA-treated cultures. ALS-
associated extranuclear localization has been described in
several subcellular fractions, including cytosol and ER [18,
41], concurrent with a loss in nuclear TDP-43 localization,
potentially compatible with an impairment in its functions,
mainly in the nucleus. Accordingly, in control conditions
of organotypic cultures, nuclear TDP-43 seems consider-
ably more accumulated in motor neurons than in other
surrounding cells. This may be consistent with a neuron-
selective functional dependency of TDP-43 [43]. Loss of
nuclear TDP-43 in excitotoxic conditions may be related to
Fig. 4 ERK1/2 inactivation
leads to ALS-related TDP-43
changes. a Representative
immunoblots of cytosolic
(C) and nuclear (N) fractions of
Neuro 2A cells untreated after
ERK1/2 inhibition by PD98059
treatment for 2 h.
b Densitometric analysis of the
anti-TDP-43 immunoreactivity
in cytosolic and nuclear
fractions. c ERK1/2 inactivation
induces p-TDP-43 cytosolic
aggregation, shown by arrows.
Nuclei were stained with DAPI
(blue). d Effect of ERK1/2
inhibition in the number of cell
anti-p-TDP-43 immunoreactive
granules (number of aggregates
for each 100 cells: 16.1 ± 1.2
and 25.6 ± 5.8 for control and
PD98059 treated cells,
respectively). Differences
between control and PD98059-
treated samples were analyzed
by Student’s t test being
*p \ 0.01 Scale bars: white
50 lm, red 10 lm
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TDP-43 fragmentation by excitotoxic phenomena, con-
currently to both native TDP-43 (43-kDa) diminished
levels and increased amount of lower molecular weight
TDP-43 fragments. In this sense, recent data supported the
pathogenic importance of TDP-43 fragments, specially
those of 25-kDa in nuclei [7, 13, 46]. Most interestingly,
these nuclear fragments were also present in neuronal cell
cultures under the stressors evaluated here, including
ERK1/2 inhibition. These results reinforce the potential
interaction between cell stress and TDP-43 pathology,
independently on the neurodegenerative paradigm chosen.
Using other antibodies for p-TDP-43, chronic excitotoxic-
ity was associated with increased diffuse and aggregate
cytoplasmic p-TDP-43 immunoreactivity. Cytosolic
p-TDP-43 aggregates did not show a constant colocaliza-
tion with ubiquitin, another marker of ALS. However, only
cells showing increased ubiquitin immunostaining dem-
onstrated cytosolic p-TDP-43 aggregation, suggesting a
close link between these two phenomena (e.g. by prote-
asomal dysfunction).
It is accepted that oxidative stress could influence pro-
teasome activity [24]. In turn, proteasomal stress is one of
the potential causes of ER stress [10]. In accordance with
this, the increased TDP-43 aggregation linked to its frag-
mentation and cytosolic location which is observed in
Neuro2A and SH-SY5Y cell lines could be explained by a
combined effect of proteasomal dysfunction, oxidative and
ER stress. Nevertheless, proteasomal activity impairment
seems to be a key factor, as it induces the highest aggre-
gation (in terms of immunohistochemical evidences) of
both TDP-43 and its phosphorylated form, according to
previous reports indicating TDP-43 fragmentation occurs
mainly via proteasome [49], reproducing both the human
disease and the organotypic culture under excitotoxicity.
The presented results demonstrate increased levels of
p-TDP-43 induced by cell stress in several experimental
models: chronic excitotoxicity (in spinal cord organotypic
culture), and oxidative, ER and proteasome stress (in
Neuro-2A and SH-SY5Y), suggesting that TDP-43 phos-
phorylation is a common feature in the potential for
pathogenesis exhibited by this protein in stress-associated
neurodegenerative disorders [17]. These results could be
derived both from increased TDP-43 phosphorylating
activity, depending on casein-kinase I or decreased
Fig. 5 Chronic excitotoxicity leads to ALS-related TDP-43 patho-
genic changes. a Representative confocal microscope images showing
decreased TDP-43 immunoreactivity in ventral horns of spinal cord
slices cultured for 21 days with 100 lM D,L-threo-hydroxyaspartate
(THA) (lower panel) or vehicle (upper panel) using rabbit anti-TDP-
43 (red). Immunostaining was combined with anti-SMI-32 (green) to
visualize motor neurons. b Using a mouse anti-TDP-43 antibody
(green), immunoreactivity distribution was markedly changed by
THA treatment. Smaller panels in b show that in some cells TDP-43
immunoreactivity is present in the cytoplasm, excluding DAPI stained
nuclei (blue). c Representative immunoblots of spinal cord homog-
enates using rabbit anti-TDP-43 show that THA induced a significant
increase in the levels of a 37-kDa band. d Densitometric analysis of
the bands, adjusted to actin content, being the differences analyzed
with reference to control values. Scale bars a 50 lm; b 25 lm.
Differences between control and THA-treated samples were analyzed
by Student’s t test being *p \ 0.01
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phosphatase responses, depending on yet ill defined factors
[26]. Furthermore, the relationship of TDP-43 aggregation–
fragmentation and phosphorylation is still under evalua-
tion, with recent data showing that p-TDP-43 (at Ser
409/410) is closely associated to aggregation [7]. However,
we also evidence that increased phosphorylation is not
always correlated with p-TDP-43 aggregation (e.g. while
all stressors evaluated increased cytosolic p-TDP-43 levels,
H2O2 failed to show increased aggregation by immuno-
histochemistry). This suggest the existence of stress-
specific trends for TDP-43 pathogenetical changes. We
recognize, as limitation of the cellular models used here,
the fact that p-TDP-43 expression is present in ‘‘control’’
conditions. Nevertheless, in the tissular (organotypic)
model and specially, in the human samples, p-TDP-43
expression is mostly restricted to the pathological condi-
tions. Previous data show that SHSY-5Y cell lines using
western blot reveal a very small, though visible, immuno-
reactivity over anti-p-TDP-43 in control conditions [5, 37,
48]. The mechanisms leading to this increased phosphor-
ylation in cell lines are not currently known, but they may
be related to the protecting role of TDP-43 over apoptosis
in human cells, accounting the fact that TDP-43 deletion
increases p-Rb-mediated cell death [5].
In any case, the present report linking neurodegener-
ation-basic mechanisms to TDP-43 abnormalities
supports the notion that TDP-43 mutations are not nec-
essary for its pathological role. Thus, in rodent models,
TDP-43 overexpression leads to TDP-43 inclusions and
neurodegenerative phenotypes compatible with sporadic
ALS [45, 46]. Furthermore, previous results demonstrat-
ing colocalization of ‘‘stress granules’’ with mutated
TDP-43 [12, 16, 30, 32] are extended in the present study,
where it is clearly shown that cell stress leads to native
TDP-43 pathogenical changes, without apparent partici-
pation of ‘‘stress granules’’. Thus, neither p-ERK1/2 nor
TDP-43 aggregates were colocalized with TIA-1 immu-
nostaining, a marker of stress granules, in any of the
stress conditions examined. The relationship between
those different aggregates linked to pathology will be the
focus of future studies. Nevertheless, our results with
chronic excitotoxicity in organotypic cultures of spinal
cord and stress induction in different neuronal cell lines
from different species allows to propose their use as
Fig. 6 Increased TDP-43 phosphorylation is associated with cyto-
solic p-ERK1/2 aggregation. a Representative confocal microscope
images showing increased cytoplasmatic TDP-43 phosphorylation in
ventral horns of spinal cord slices under chronic excitotoxicity.
b Increased p-TDP-43 immunoreactivity was present both in aggre-
gate form (upper panel, green) and in a diffuse pattern (lower panel,
green), with no ubiquitin colocalization (red). Nuclei were stained
with DAPI (blue). c Representative immunoblots of spinal cord
homogenates using anti-p-TDP-43 shows that THA induced a
significant increase in the levels of several bands. d Densitometric
analysis of the bands, adjusted to actin content, being the differences
analyzed with reference to control values. At least 30 hemi-slices
from each condition were examined throughout the different
experiments. e Increased p-ERK1/2 immunoreactivity after THA
treatment was distributed following cytosolic location (arrowheads,
upper panels) or granular-globular patterns (arrows, lower panels),
some showing colocalization with TDP-43 immunoreactivity (f).
Increased p-ERK1/2 immunoreactivity (red) after THA treatment was
distributed among SMI-32 positive cells (identified as neurons,
arrowheads) and preferentially in non SMI-32 positive cells (arrows).
Nuclei were stained with DAPI (blue). Scale bars: a 50 lm; b 20 lm;
(e upper panel) 25 lm; (e lower panel) 10 lm; f 50 lm. Arrows at
left of blots indicate bands whose intensity was quantified. Differ-
ences between control and THA-treated samples were analyzed by
Student’s t test being *p \ 0.01
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preclinical model in the screening of agents potentially
affecting TDP-43 pathogenic changes.
An impairment of nuclear import mechanisms could
play an important role in ALS pathogenesis, based on
abnormal location of TDP-43 (a nuclear factor) [28, 36].
As it is known that oxidative stress impairs nuclear import
by a mechanism depending on ERK1/2 activation [11], we
tested whether ERK1/2 activation is related to TDP-43
pathogenic changes observed in our neuronal cell models
exposed to different stress conditions. If this was the case,
ERK1/2 pathway inhibition could relieve stress-associated
TDP-43 pathogenicity. Oxidative and ER stress induced
increased levels of p-ERK1/2 in a transient or sustained
manner, in accordance with this hypothesis. However,
inhibition of these kinases, far from avoiding these chan-
ges, exacerbated them, even in control conditions. In the
case of proteasome stress, depletion of p-ERK1/2 is
strongly associated with TDP-43 pathogenic phenomena.
Our results suggest that ERK1/2 plays a previously unre-
ported significant role in TDP-43 cellular homeostasis and
cellular wellness, as specific ERK inhibition leads to TDP-
43 fragmentation, cytosolic aggregation and increased
phosphorylation. So the initial activation of ERK1/2 pro-
moted by cell stress in both neuronal cell lines could be
related to the first cellular response to a stress situation,
since its modulation has been associated with protection
mechanisms in others neuronal cell lines [44]. These results
are also compatible with the known physiological role of
ERK1/2 regulated pathways, acting to promote survival or
death, depending upon the cellular context in which they
are activated [27]. In fact, our results show that ERK1/2
activation is needed for cell survival under stress, as shown
by viability assays. Several neurological insults linked to
excessive release of glutamate and neuronal death result in
tyrosine kinase activation, including ERK1/2. Furthermore,
oxidative stress is a known activator of ERK1/2 pathway
[27] as in our hands seems to be ER stress [2] and pro-
teasome stress. In line with the observations in vitro, the
present study has also evidenced, for the first time,
aggregation of phosphorylated ERK1/2 in motor neurons in
ALS, with a close relationship with TDP-43 inclusions.
Thus, abnormal p-ERK1/2 is only found in motor neurons
with altered TDP-43 deposition, further supporting an
association but not necessarily a causal relationship
Fig. 7 Altered p-ERK1/2 deposition is restricted to motor neurons with
p-TDP-43-immunoreactive deposits in ALS. Left panel p-ERK1/2
immunoreactivity in the nucleus of motor neurons in normal spinal cord
(a) and abnormal, globular nuclear p-ERK1/2 inclusions in motor
neurons in ALS (b, c), dense (e, f), fine granular or rectilinear (g, h),
skein-like (i, j) or meshwork-like (k, l) cytoplasmic inclusions,
accompanied by decreased or absence p-ERK1/2 immunoreactivity only
in spinal cord motor neurons in ALS cases. Paraffin sections slightly
counterstained with hematoxylin. Right panel Double-labeling immu-
nofluorescence and confocal microscopy showing altered p-ERK1/2
deposition in ALS motor neurons with p-TDP-43 immunoreactive
deposits (m–r). Sub-cellular co-localization of abnormal p-ERK1/2 and
p-TDP-43 is also observed in altered ALS motor neurons (s–x). Nuclei
were stained with DAPI (blue). Scale bars 30 lm
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between abnormal TDP-43 expression and ERK1/2 sig-
naling in this disease. Concerning a potential direct
interaction between TDP-43 and ERK1/2, it has been
recently shown that interactome of TDP-43 consists of
proteins implicated in pre-mRNA splicing and RNA sta-
bility and transport, as well as other neuron-enriched
proteins, methyl CpG-binding protein 2 and polypyrimi-
dine tract-binding protein 2, besides others. Nevertheless,
no direct interaction with ERK1/2 was reported [43]. These
data do not exclude that these identified proteins may
interact with TDP-43 and ERK1/2, an issue that merits
further exploration.
In conclusion, the present work evidences interactions
between TDP-43 and stress mechanisms involved in ALS
development. Furthermore, a novel finding, implicating
ERK1/2 inhibition as a potential contributor to TDP-43
pathogenetical changes, is presented for explaining
p-ERK1/2 aggregates in human motor neuron disease.
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The occurrence of endoplasmic reticulum (ER) stress in the sporadic form of amyotrophic lateral sclerosis (ALS)
is unknown, despite it has been recently documented in experimentalmodels of the familial form.Herewe show
that spinal cord from patients with sporadic ALS showed signs of ER stress, such as increased levels of ER
chaperones such as protein-disulfide isomerase, and increased phosphorylation of eukaryotic initiation factor
2a (eIF2a). Among the potential causes of such ER stress proteasomal impairment was confirmed in the same
samples by demonstrating increased ubiquitin immunoreactivity and increased protein lipoxidative (125%), gly-
coxidative (55%) and direct oxidative damage (62%) over control values, as evidenced bymass-spectrometry and
immunological methods. We found that protein oxidative damage was strongly associated to ALS-specific
changes in fatty acid concentrations, specifically of n-3 series (as docosahexaenoic acid), and in the amount of
mitochondrial components as respiratory complexes I and III, suggesting a mitochondrial dysfunction leading to
increased free radical production. Oxidative stress was also evidenced in frontal cortex, suggesting that this
region is affected early in ALS. As those events were partially reproduced by threohydroxyaspartate exposure
in organotypic spinal cord cultures, we concluded that changes in fatty acid composition, mitochondrial function
and proteasome activity, whichmay be driven by excitotoxicity, lead to oxidative stress and finally contribute to
ER stress in sporadic ALS.
Keywords: Proteasome; glycation; lipoxidation; mitochondria; motor neuron
Abbreviations: ER=endoplasmic reticulum; GSA=glutamic semialdehyde; AASA=aminoadipic semialdehyde
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Introduction
Amyotrophic lateral sclerosis is a multifactorial disease
whose pathophysiological mechanisms include decreased
availability to neurotrophic factors, disturbances in calcium
metabolism, increased neuroinflammatory status, cytoskel-
etal changes and oxidative stress (Dupuis et al., 2004; Rao
and Weiss, 2004; Strong et al., 2005; Boillee et al., 2006).
Recent data indicate (Atkin et al., 2006; Turner and Atkin,
2006) that endoplasmic reticulum (ER) stress may be also
involved in the familial form of the disease. ER stress, a
complex pattern involving highly specific signalling path-
ways, ensures through the so-called unfolded protein
response that protein folding capacities of ER are not
overwhelmed. However, prolonged ER stress could con-
tribute to cell death, both by mitochondria-dependent and
independent pathways (Lindholm et al., 2006). In contrast
with the familial form, no data was available on the
occurrence of ER stress in the more common, sporadic
form of the disease.
Some of the pathological hallmarks of ALS, such as
increased ubiquitinated bodies, neuronal and astrocytic
hyaline inclusions as well as axonal spheroids are protein
aggregates that may be related to ER and oxidative stress.
This fact is based on the relationship between protein
oxidative damage and proteasomal activity following an
inverted U shape, i.e. while moderate oxidative
doi:10.1093/brain/awm190 Brain (2007), 130, 3111^3123
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modification of proteins increases their susceptibility for
proteasome clearance, higher rates of oxidative modifica-
tion actually inhibit proteasome activity (Grune et al., 1996;
Sitte et al., 2000; Grune et al., 2004). Such a decreased
proteasomal activity has been previously recognized in other
neurodegenerative processes, and it may explain ALS-
characteristic increased ubiquitination and presence of
proteinaceous aggregates. The disruption of the ER-associated
degradation, a pathway which helps to clear misfolded protein
species from ER, is a potential consequence of such
proteasomal impairment, finally contributing to ER stress
(Marciniak and Ron, 2006; Oyadomari et al., 2006; Zhang and
Kaufman, 2006).
Despite these data suggesting the importance of protein
oxidative damage in ALS, its study by using selective,
chemically characterized markers has not been reported,
though immunohistochemical evidences support ALS-
induced increased oxidative damage (Ferrante et al., 1997;
Pedersen et al., 1998; Shibata et al., 1999; Kato et al., 2000;
Kikuchi et al., 2000; Shibata et al., 2000; Kikuchi et al., 2002).
Such molecular dissection, allowing quantitative analyses of
oxidative pathways should be useful for diagnostic and
therapeutic approaches. The use of highly selective mass
spectrometry-based techniques could help to further delineate
the potential pathogenic role of oxidative stress in ALS.
Several markers could be used, such as glutamic semialdehyde
(GSA), which derives from the metal-catalysed oxidation of
proline and arginine; or aminoadipic semialdehyde (AASA)
which results from lysine oxidation (Requena et al., 1997,
2001, 2003; Dalfo et al., 2005). Besides these direct modifica-
tions of protein structures, the effects of free radical efflux
in proteins could also involve third-party molecules which
also give rise to increased damage, such as carbohydrates
and/or lipids, in processes termed glycoxidation and
lipoxidation, respectively (Requena et al., 1997; Baynes,
2003). Both carbohydrates and polyunsaturated fatty acids,
when reacting with free radicals generate highly reactive
dicarbonyl compounds, such as glyoxal, methylglyoxal,
4-hydroxynonenal and malondialdehyde, among others.
These reactive carbonyl compounds can generate specific
non-enzymatic adducts when reacting with proteins, such as
N"-carboxymethyl-lysine (CML), N"-carboxyethyl-lysine
(CEL) and N"-malondialdehyde-lysine (MDAL) (Baynes
and Thorpe, 2000). The high content of polyunsaturated
fatty acid in central nervous system and its elevated oxygen
consumption support the possible significance of lipid
peroxidation-derived processes in neurodegeneration, includ-
ing ALS. However, there is no chemical evidence for
lipoxidative or glycoxidative damage of proteins in sporadic
or familial ALS based on structural identification and
supported by mass-spectrometry.
For these reasons, in this work we have studied the
development of ER stress in sporadic ALS. We examined
ER stress causal factors such as proteasome function,
protein oxidative damage, fatty acid composition and
potential disturbances in mitochondrial respiratory
complexes (as the major sources of free radical efflux).
These changes have been evaluated in human samples and
in lumbar spinal cord organotypic cultures under chronic
excitotoxicity, a well-supported model of the sporadic form
of ALS (Rothstein et al., 1993).
Patients and methods
Human spinal cord and brain specimens
Brain and spinal cord samples were obtained from the Institute of
Neuropathology Brain bank following the guidelines of the local
Ethics Committee. The brains and spinal cords of seven men and
five age-matched controls (four men and one woman) were
obtained from 3 to 6 h after death, and were immediately prepared
for morphological and biochemical studies. The agonal state was
short with no evidence of acidosis or prolonged hypoxia. The pH
of the post-mortem brain was between 7 and 7.4. All ALS patients
had suffered from clinical signs and symptoms of lower and upper
motorneuron disease, finally involving motor nuclei of the
medulla oblongata. Importantly, none of these patients had
cognitive impairment or dementia. Although variable from one
case to another, the terminal stage of the disease was characterized
by predominant bulbar failure manifested as impaired swallowing
and usually complicated by aspiration pneumonia, or by
dominant respiratory insufficiency. Age-matched controls did
not show clinical and neuropathological anomalies. Frozen
samples of the spinal cord (lumbar enlargement) and frontal
cortex area 8 were used for biochemical studies. Samples of
control and diseased spinal cords and brains were processed in
parallel. Summary of the main clinical and neuropathological
aspects is shown in Table 1.
Organotypic cultures
Spinal cord cultures were prepared from lumbar spinal cord of
postnatal day 8 rat pups as previously described (Rothstein et al.,
1993) and maintained in 50% minimal essential medium, 25mM
Hepes, 25% Hanks balanced salt solution with D-glucose 25.6mg/l,
25% heat-inactivated horse serum, 2mM L-glutamine. Incubation
at DIV7 of the slices with the glutamate transport inhibitor D,L-
threo-hydroxyaspartate (THA) at 200 mM injures motorneurons
with a morphology typical of excitotoxic degeneration after
several weeks of treatment. In selected experiments, slices were
also incubated with the ER stress inducers thapsigargin (32 ng/ml)
and tunicamycin (500 and 5 ng/ml). After 15 or 30 days of
treatment, cultures were harvested and fixed in 4% paraformalde-
hyde in 0.1M phosphate buffer, pH 7.4, overnight at 4C and
processed for immunocytochemistry. For western-blot and mass-
spectrometric measurements slices were washed with PBS contain-
ing 1mM diethylenetriaminepentaacetic acid and 1 mM butylated
hydroxyl toluene, harvested and frozen at 80C. Experiments for
each condition (n= 30 slices per experimental group) were
repeated at least three times.
Immunohistochemistry
De-waxed sections 5-mm-thick of the spinal cord were processed
for immunohistochemistry following the streptavidin LSAB
method (Dako). After incubation with methanol and H2O2 in
PBS and normal serum, the sections were incubated with anti-
phosphorylated eukaryotic initiation factor 2 (eIF2) (1:100,
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Abcam, UK). Following incubation with the primary antibody, the
sections were incubated with LSAB for 15min at room
temperature. The peroxidase reaction was visualized with diami-
nobenzidine and H2O2. Control of the immunostaining included
omission of the primary antibody; no signal was obtained
following incubation with only the secondary antibody. Sections
were slightly counterstained with haematoxylin.
Confocal immunocytochemistry
The antibodies used are listed in the supplementary information
(Table S1). Fluorescein-conjugated Bandeiraea simplicifolia lectin
(type I) was used as a label for microglia. Appropriate secondary
antibodies: Alexa Fluor 488 F(ab)2 fragment of goat anti-mouse IgG
(1:500, Molecular Probes, USA) and Alexa Fluor 546 goat anti-rabbit
IgG (1:500, Molecular Probes, USA) were used for immunofluores-
cence. Image analyses were carried out by a single investigator
who was blinded to the experimental conditions. Large (>25mm in
diameter) SMI-32-immunopositive neurons were identified as
motorneurons. Immunocytochemical controls were performed by
the omission of the primary antibodies, resulting in a negative
immunostaining in all cases studied. Mounted slices were examined
under a FluoView 500 Olympus confocal laser scanning microscope
(Hamburg, Germany).
Protein electrophoresis and western blot
Samples (spinal cord, frontal cortex or organotypic spinal cord
cultures) were homogenized in a buffer containing 180mM KCl,
5mM 3-[N-morpholino]propanesulfonic acid, 2mM ethylenedia-
minetetraacetic acid (EDTA), 1mM diethylenetriaminepentaacetic
acid and 1 mM butylated hydroxyl toluene, 10 mg/ml aprotinin,
1mM phenylmethylsulfonyl fluoride, pH 7.3 with a Potter–
Eljeveim device at 4C. After a brief centrifugation (500 g,
5min) to pellet cellular debris, protein concentrations were
measured in the supernatants using the Lowry assay (BioRad
Laboratories, Mu¨nchen, Germany).
For detection of protein carbonyls, and prior to electrophoresis,
samples were derivatized with 2,4-dinitrophenylhydrazine (DNP)
as previously described (Pamplona et al., 2005). Briefly, to 15 ml
homogenates adjusted to 3.75mg/ml protein SDS was added to a
final concentration of 6%, and, after boiling for 3min, 20 ml of
10mM DNP in 10% trifluoroacetic acid were added. After 7min
at room temperature, 20ml of a solution containing 2M Tris base,
30% glycerol and 15% b-mercaptoethanol were added for
neutralization and sample preparation for loading onto SDS–
PAGE gels.
For immunodetection, after SDS–PAGE, proteins were trans-
ferred using a Mini Trans-Blot Transfer Cell (BioRad) to PVDF
membranes (Immobilon-P Millipore, Bedford, MA).
Immunodetection was performed using as primary antibodies
those listed in supplementary information (Table S1): (i) for ER
stress and proteasome function assessment: anti-KDEL, which
recognizes KDEL-sequence containing proteins such as ER chaper-
ones as protein disulfide isomerase (PDI), GRP78 and GRP94; anti-
eIF2 anti-GRP78, anti-phosphorylated eIF2 (S52), anti-PDI and
anti-ubiquitin; (ii) for protein oxidative damage: anti-DNP anti-
body, anti-CML, anti-neuroketal and anti-MDAL; and (iii) for
mitochondrial studies: anti-NDUFA 9 antibody for respiratory
complex I, anti-core II antibody for respiratory complex III and
anti-apoptosis inducing factor (AIF) antibody. For detection of
primary antibodies, the following peroxidase-coupled secondary
antibodies were used: sheep anti-mouse (1:30 000, Amersham,
USA); anti-rabbit (1:40 000, Pierce, USA) and anti-goat (1:7500,
Abcam, Cambridge, UK) antibodies. Luminescence was recorded
and quantified in a Lumi-Imager equipment (Boehringer,
Mannheim, Germany), using the Lumianalyst software. Control
experiments showed that omission of primary or secondary
antibody addition produced blots with no detectable signal.
Measurement of specific, protein-oxidation-
derived markers: GSA, AASA,CML,CEL
and MDAL
GSA, AASA, CML, CEL and MDAL concentrations in total proteins
from spinal cord, frontal cortex or organotypic culture homogenates
were measured by isotope-dilution gas chromatography/mass
spectrometry (GC/MS) as previously described (Pamplona et al.,
2005). Samples containing 500mg of protein were delipidated using
chloroform:methanol (2:1 v/v), and proteins were precipitated by
adding 10% trichloroacetic acid (final concentration) and subse-
quent centrifugation. Protein samples were reduced overnight with
500mMNaBH4 (final concentration) in 0.2M borate buffer, pH 9.2,
containing 1 drop of hexanol as an anti-foam reagent. Proteins were
then reprecipitated by adding 1ml of 20% trichloroacetic acid and
subsequent centrifugation. The following isotopically labelled
internal standards were then added: [2H8]Lysine (d8-Lys; CDN
Isotopes); [2H4]CML (d4-CML), [
2H4]CEL (d4-CEL) and
[2H8]MDAL (d8-MDAL); [
2H5] 5-hydroxy-2-aminovaleric acid
(for GSA analysis) and [2H4]6-hydroxy-2-aminocaproic acid
(for AASA analysis). The samples were hydrolysed at 155C for
30min in 1ml of 6N HCl, and then dried in vacuo. The
N,O-trifluoroacetyl methyl ester derivatives of the protein hydro-
lysate were prepared and GC/MS analyses were carried out on a
Hewlett-Packard model 6890 gas chromatograph equipped with a
30m HP-5MS capillary column (30m 0.25 mm 0.25 mm)
coupled to a Hewlett-Packard model 5973A mass selective detector
(Agilent, Barcelona, Spain). The injection port was maintained at
Table 1 Summary of clinical and pathological data in the
present series
Case Age Gender Diagnosis Duration Cause of death p-m
delay
1 41 M ALS 3 Dysphagia,
bronchopneumonia
3
2 68 M ALS 5 Respiratory failure 3
3 76 M ALS 4 Dysphagia,
bronchopneumonia
3
4 69 M ALS 4 Dysphagia,
bronchopneumonia
2
5 40 M ALS 3 Respiratory failure 2
6 73 M ALS 4 Dysphagia,
bronchopneumonia
4
7 71 M ALS 4 Respiratory failure 6
8 75 M Control Neoplasia 6
9 76 M Control Cardiac infarction 4
10 67 F Control Cardiac infarction 3
11 51 M Control Bronchopneumonia 4
12 68 M Control Neoplasia 6
Note: ALS: amyotrophic lateral sclerosis; p-m delay: post-mortem
delay (in hours); age and duration are in years.
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275C; the temperature program was 5min at 110C, then 2C/min
to 150C, then 5C/min to 240C, then 25C/min to 300C and
finally hold at 300C for 5min. Quantification was performed by
external standardization using standard curves constructed from
mixtures of deuterated and non-deuterated standards. Analytes were
detected by selected ion-monitoring GC/MS. The ions used were:
lysine and d8-lysine, m/z 180 and 187, respectively; 5-hydroxy-
2-aminovaleric acid and d5-5-hydroxy-2-aminovaleric acid (stable
derivatives of GSA), m/z 280 and 285, respectively; 6-hydroxy-
2-aminocaproic acid and d4-6-hydroxy-2-aminocaproic acid (stable
derivatives of AASA), m/z 294 and 298, respectively; CML and d4-
CML, m/z 392 and 396, respectively; CEL and d4- CEL, m/z 379 and
383, respectively; and MDAL and d8-MDAL, m/z 474 and 482,
respectively. The amounts of products were expressed as the ratio
mmol GSA, AASA, CML, CEL or MDAL/mol lysine.
Fatty acid analysis
Distributional analysis of fatty acids was performed as previously
described (Dalfo et al., 2005; Pamplona et al., 2005). Total lipids
from spinal cord, frontal cortex or organotypic cultures were
extracted with chloroform:methanol (2:1, v/v) in the presence of
0.01% butylated hydroxytoluene to avoid artifactual oxidation.
The chloroform phase was evaporated under nitrogen, and
the fatty acids were transesterified by incubation in 2.5ml of
5% methanolic HCl for 90min at 75C. The resulting fatty
acid methyl esters were extracted by adding 2.5ml of n-pentane
and 1ml of saturated NaCl solution. The n-pentane phase
was separated, evaporated under nitrogen, re-dissolved in
75 ml of hexane and 1 ml was used for GC/MS analysis.
Separation was performed in a SP2330 capillary column
(30m 0.25mm 0.20 mm) in a Hewlett Packard 6890 Series II
gas chromatograph (Agilent, Barcelona, Spain). A Hewlett Packard
5973A mass spectrometer was used as detector in the electron-
impact mode. The injection port was maintained at 220C, and
the detector at 250C; the temperature program was 2min at
100C, then 10C/min to 200C, then 5C/min to 240C and
finally hold at 240C for 10min. Identification of fatty acid methyl
esters was made by comparison with authentic standards and
based on mass spectra. Results are expressed as mol%.
From fatty acid composition, the following indexes were
calculated: saturated fatty acids (SFA)=
P
% of saturated fatty
acids; unsaturated fatty acids (UFA)=
P
% unsaturated fatty acids;
monounsaturated fatty acids (MUFA)=
P
% of monoenoic fatty
acids; polyunsaturated n-3 fatty acids (PUFAn-3)=
P
% of poly-
unsaturated fatty acids n-3 series; Polyunsaturated n-6 Fatty Acids
(PUFAn-6)=
P
% of polyunsaturated fatty acids n-6 series; average
chain length (ACL)= [(
P
%Total14 14)+ + (
P
% Totaln n)]/
100 (n=carbon atom number); peroxidizability index (PI) = [(
P
mol% Monoenoic 0.025)+ (P mol% Dienoic 1)+ (P
mol% Trienoic 2)+ (P mol% Tetraenoic 4)+ (P mol%
Pentaenoic 6)+ (P mol% Hexaenoic 8)].
Statistical analyses
All statistics were performed using the SPSS software (SPSS Inc.,
Chicago, IL). Once normality of distribution was assessed by
Kolmogorov–Smirnov test, differences between groups (ALS
samples versus control; THA treated versus vehicle) were analysed
by the Student’s t-tests and correlations between variables
were evaluated by the Pearson’s statistic. The 0.05 level was selected
as the point of minimal statistical significance in every comparison.
Results
Samples from ALS patients evidence signs
of ER stress: proteasomal impairment
as a potential mechanism
Since ER stress has been implied in ALS experimental
models we examined signs of ER stress by western-blot and
immunohistochemistry in samples from ALS patients. The
results demonstrated ER stress in ALS samples (Fig. 1).
Thus, increased expression of chaperones PDI and KDEL-
containing proteins were found in spinal cord from ALS
patients (Fig. 1A), but not in frontal cortex samples (not
shown). This was accompanied by a marked increase in
eIF2 phosphorylation (a sign of protein synthesis control
after ER stress), both in spinal cord lysates (Fig. 1A) and in
remaining neuronal bodies in spinal cord (Fig. 1B).
As proteasome is responsible for degradation of ER
misfolded proteins, we examined whether its function was
preserved. Accounting that ubiquitin-modified proteins are
degraded by the proteasome, its function can be inferred by
western-blot and immunohistochemical analyses of ubiqui-
tin-modified proteins. The results of such approach
showing increased protein ubiquitination in spinal cord
from ALS patients, but not in frontal cortex, are compatible
with compromised proteasomal function (Fig. 1C).
It should be also considered that increased protein turnover
due to massive protein degradation could saturate
the ubiquitin-proteasome system in spite of proteasome
preserved activity.
Proteins from spinal cord and frontal cortex
present structurally characterized oxidation
products and the amount of these modifica-
tions increases with ALS, favoured by
changes in fatty acid composition
While moderate oxidative modification of proteins
increases their susceptibility for proteasome clearance,
higher rates of oxidative modification actually inhibit
proteasome activity. Therefore, we evaluated protein
oxidative damage in spinal cord and frontal cortex samples,
to ascertain whether proteasomal dysfunction could be
related to increased protein oxidative damage. GC/MS
analyses demonstrated that those proteins contained oxida-
tion-derived products resulting from metal-catalysed oxida-
tion, glycoxidation and lipoxidation. The more abundant
products were those derived from metal-catalysed oxida-
tion, AASA and GSA assuming almost 95% of measured
markers. GSA stood as the more frequent modification,
with levels being 30-fold higher than of those of AASA. The
concentrations of both GSA and AASA were significantly
higher in proteins from spinal cord (P< 0.001) and frontal
cortex (P< 0.01) samples of ALS patients than in control
age-matched individuals (Fig. 2A). Similarly to specific
oxidation products, the concentrations of CEL and CML,
glycoxidation products, were also significantly higher in
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Fig. 1 ER stress and protein ubiquitination in spinal cords from ALS patients. (A) Representative western blot of spinal cord homogenates
showing increased content of ER resident proteins containing KDEL motifs, PDI and phosphorylated eIF2 in samples from ALS patients.
(B) Representative immunohistochemical image of phosphorylated eIF2 in the motor column of human lumbar spinal cords, showing
increased staining in ALS samples. (C) Representative western blot of anti-ubiquitin, suggesting decreased ubiquitin degradation in spinal
cord samples from ALS patients and control individuals, but not in frontal cortex. Right numbers of the blot indicate apparent molecular
weight. Immunoblotting of actin is also shown.The lower panels shows the quantitation of those blots by densitometry, adjusted to actin
content and differences were analysed respect to control group by Student’s t-test being

P< 0.01 and
P< 0.001.
Fig. 2 Proteins from ALS samples show significant increases in the amounts of oxidation markers and changes in fatty acid composition.
A^C show GC/MS analyses of GSA and AASA (markers of MCO), CML and CEL (arising from glycoxidation and lipoxidation) and MDAL,
originated from lipoxidation. (D) Changes in PI and DHA levels associated with ALS in spinal cord differ from those present in frontal
cortex. (E) ALS also leads to organ-specific changes in desaturation indexes (18:1/18:0) and n6/n3 ratios.Values shown are% changes of
mean SE over values from control samples (in spinal cord GSA: 21498 619mmol/mol lysine; AASA: 102 7mmol/mol lysine; CEL:
385 57mmol/mol lysine; CML: 52130mmol/mol lysine and MDAL: 258 48mmol/mol lysine; PI: 116.24 4.23; DHA: 10.89 0.20%;
18:1/18:0 ratio:1.36 0.025; n6/n3 ratio: 0.670.04; in frontal cortex GSA: 20512 638mmol/mol lysine; AASA: 824mmol/mol lysine;
CEL: 24916mmol/mol lysine; CML: 522 37mmol/mol lysine MDAL: 1976mmol/mol lysine; PI: 155.311.55; DHA: 12.35 0.17; 18:1/18:0
ratio: 0.75 0.01; n6/n3 ratio: 1.10.034). P< 0.01 and P< 0.001 respect to control group by Student’s t-test.
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proteins from spinal cord (P< 0.001) and frontal cortex
(P< 0.01) of ALS patients than in control individuals
(Fig. 2B). The concentration of MDAL, a lipoxidation
product, was also increased in samples from ALS patients,
both in spinal cord (P< 0.001) and in frontal cortex
(P< 0.01) compared to control individuals (Fig. 2C).
Nonetheless, the magnitude of difference between ALS
and control samples was considerably higher in spinal cord
(120%) than in frontal cortex (50%).
As fatty acid profile strongly influences membrane
peroxidizability, and consequently protein lipoxidative
damage, we analysed fatty acid content in ALS samples.
Those analyses revealed significant differences associated
with ALS in spinal cord and frontal cortex, both in
individual fatty acids and in global indexes (Table 2).
The most remarkable change involves the highly peroxidiz-
able docosahexaenoic acid (DHA), which showed a
significant decrease in spinal cord samples with ALS
(P< 0.01), contrasting with the significant increase
observed in frontal cortex (P< 0.01; Fig. 2D). With
reference to the fatty-acid-derived indexes, spinal cords
from ALS patients showed significant decreases in the
content of PUFA of the n-3 family (P< 0.001; Table 2),
while increases of this parameter were detected in frontal
cortex (P< 0.006; Table 2). Changes in fatty acid profile led
to significant changes in double bond index (P< 0.004;
Table 2), PI (P< 0.003; Fig. 2D), 9-desaturase estimation
(P< 0.01; Fig. 2E) and n6/n3 ratio (P< 0.001; Fig. 2E).
Overall, these indexes could reflect the potential vulner-
ability of membranes to peroxidative damage. Since changes
in double bond and PI in spinal cord were inverse to those
observed in frontal cortex, these data suggest that spinal
cord membranes are actively producing substrates for
peroxidative modification of proteins, while as frontal
cortex are not under this circumstance. Accordingly,
analysis of MDAL/PI ratio, suggest that for a given PI,
rates of MDAL formation are 3-fold higher in spinal cord
than in frontal cortex from ALS patients.
Different kinds of protein oxidative damage
are correlated together and are associated to
changes in fatty acid content
After quantitations of protein oxidation and fatty acid
analyses, several significant correlations were present among
anatomically different locations (Fig. 3). GSA levels
correlated significantly with AASA (r= 0.918; P< 0.0001;
Fig. 3A), with MDAL (r= 0.865; P< 0.0001; Fig. 3B), with
CEL (r= 0.716; P< 0.002) and with CML (r= 0.878;
P< 0.0001). This suggests that protein carbonyl formation
Table 2 Fatty acid composition (mol%) of total lipids from spinal cord and frontal cortex
Frontal cortex Spinal cord
CTL ALS P< CTL ALS P<
14:0 0.50 0.03 0.59 0.05 0.234 0.49 0.04 0.58 0.01 0.112
16:0 24.570.48 23.970.35 0.352 14.610.25 15.470.23 0.02
16:1n-7 1.63 0.15 1.64 0.25 0.980 10.07 1.53 0.15 0.005
18:0 25.20 0.40 22.92 0.39 0.007 23.95 0.23 22.34 0.68 0.027
18:1n-9 19.09 0.15 19.90 0.45 0.141 30.15 0.25 32.82 0.25 0.001
18:2n-6 1.02 0.28 0.770.13 0.458 0.33 0.03 0.62 0.05 0.001
18:3n-3 n.d n.d ^ 0.24 0.02 0.270.001 0.254
20:0 0.88 0.20 0.570.04 0.190 7.05 0.43 6.28 0.25 0.117
20:1 n.d n.d ^ 0.54 0.03 0.78 0.07 0.016
20:2n-6 0.470.16 0.29 0.07 0.345 0.310.03 0.310.05 0.997
20:3n-6 0.36 0.04 0.25 0.05 0.210 0.6 0.08 0.98 0.25 0.137
20:4n-6 7.39 0.23 8.70 0.22 0.007 2.9 0.17 3.15 0.11 0.508
22:4n-6 4.16 0.22 3.78 0.42 0.460 2.86 0.05 3.05 0.14 0.289
22:5n-6 0.72 0.14 0.66 0.18 0.794 0.270.03 0.22 0.03 0.173
22:5n-3 0.170.01 0.20 0.01 0.170 0.14 0.02 0.19 0.03 0.118
24:0 0.610.07 0.54 0.04 0.466 0.910.13 0.810.15 0.600
24:1n-9 0.470.14 0.56 0.05 0.557 2.26 0.10 2.23 0.10 0.793
ACL 18.410.02 18.49 0.02 0.055 18.670.01 18.510.01 0.001
SFA 51.78 0.58 48.60 0.56 0.008 46.210.37 44.55 0.65 0.001
UFA 48.210.58 51.39 0.56 0.008 52.59 0.35 54.92 0.45 0.001
MUFA 21.20 0.04 22.110.73 0.263 33.84 0.31 37.6 0.46 0.001
PUFA 27.00 0.58 29.28 0.60 0.037 18.70.22 16.610.4 0.002
PUFA n-6 14.13 0.33 14.470.69 0.676 7.46 0.18 8.39 0.19 0.005
PUFA n-3 12.870.40 14.810.22 0.006 110.15 8.63 0.12 0.001
DBI 152.18 2.68 166.921.70 0.004 127.821.58 119.691.59 0.003
Note: Values: mean  SEM. N  group: for brain cortex (n=4); for spinal cord (n=5 for control and n=7 for ALS). ACL, average chain
length; SFA, saturated fatty acids; UFA, unsaturated fatty acids; PUFA n-6/n-3, polyunsaturated fatty acids n-6 or n-3 series; MUFA,
monounsaturated fatty acids; DBI, double bond index; Docosahexaenoic acid levels are shown in Fig. 1.
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is also associated to glycoxidative and lipoxidative mod-
ifications in spinal cord and frontal cortex. Furthermore,
peroxidizability index was inversely correlated with CEL
(r=0.816; P< 0.0001) and MDAL (r=0.685; P< 0.003)
concentrations, suggesting an association between lipid
peroxidizability, glycoxidation and lipoxidation modifica-
tions. Interestingly, levels of MDAL display a second-order
relationship with DHA levels (r= 0.961; P< 0.0001; Fig. 3D),
suggesting an intimate interplay between these two factors.
Protein oxidative damage, showing
preferential targets in ALS spinal cord
proteins can be associated to mitochondrial
disturbances
It is known that an important determinant for oxidative
damage of proteins, besides fatty acid content, is the
mitochondrial free radical production. Therefore, we
analysed the expression of representative subunits of
mitochondrial respiratory complexes I and III, whose
activity is counted among the major sources for mitochon-
drial free radical production (Herrero and Barja, 2000;
Chen et al., 2003), as well as the levels of AIF, shown
recently to enhance the functional stability of complex I
(Vahsen et al., 2004). These analyses demonstrated that
both complex I and III concentrations are significantly
decreased in spinal cord samples from ALS patients
(P< 0.01; Fig. 4A) while AIF expression is not changed in
ALS (Fig. 4A). Reinforcing an apparently different pace of
ALS-induced changes between frontal cortex and spinal
cord, these effects were not present in frontal cortex from
ALS patients (data not shown).
Western-blot analyses of frontal cortex and spinal cord
proteins showed differences in the distribution of oxidation
(DNP-reactive), glycoxidation (anti-CML) and lipoxidation-
derived (anti-neuroketal) protein modifications (Fig. 4B)
supporting both diversity and specificity of protein oxidative
damage. These findings agree with quantitative analyses by
GC/MS as densitometric measurements revealed increased
oxidative damage in ALS samples. Major targets of glycoxida-
tion were proteins with apparent molecular weights ranging
from 35 to 55 kDa, partially coincident with anti-DNP
immunoreactivity (which was also evident for high-molecular
weight bands). This pattern differs from targets of neuroketal
formation (Fig. 4B), which showed more discrete targets
(being targets of 40 and 60 kDa the more prominent). These
differences were not present in frontal cortex samples (data
not shown).
Chronic excitoxicity in organotypic spinal
cord cultures leads ER stress, ubiquitin
alterations, protein oxidative damage and
changes in fatty acid profile
Chronic excitotoxicity has been implied in the pathogenesis
of ALS (Rothstein et al., 1993; Boillee et al., 2006). This can
be reproduced in vitro by treatment with the pre-synaptic
Fig. 3 Changes inprotein oxidation indexes and fatty acidcontents are stronglycorrelated. Indexes ofproteincarbonylGSA andAASA are
stronglycorrelated (upperpanel, left; r=0.92;P< 0.0001).Protein oxidative damage is also correlatedwithprotein lipoxidative damage (upper
panel, right; r=0.865;P< 0.0001).Protein lipoxidative damage is correlated to glycoxidativemodifications (lowerpanel, left; r=0.865;
P< 0.0001).DHAcontent shows a quadratic relationshipwithprotein lipoxidative damage (lowerpanel, right; r=0.95;P< 0.0001;
model:[MDAL]=17.3[DHA]2-440.3[DHA]+2977).Triangles (%) representvalues from spinal cord samples andcircles () representvalues
from frontal cortex.Results are only shown for those sampleswereboth frontal cortex and spinal cordwere available (n=4 for eachgroup).
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glutamate transport inhibitor THA, leading to losses in the
number of motorneurons, as assessed by SMI-32 immu-
noreactivity (data not shown). In accordance to findings in
ALS samples, signs of ER stress were also found in spinal
cord slices under chronic excitotoxicity after a 30-day
period (Figs. S1A and S2A). Although eIF2 phosphoryla-
tion was present in neuronal bodies of vehicle-treated slices,
increased immunoreactivity was found along neuritic
processes as well as in small cellular populations morpho-
logically compatible with glia on THA-treated slices.
Furthermore, demonstration of a markedly increased
intracellular ubiquitin immunoreactivity excluding nucleus
(Fig. S1B) suggest a role of proteasomal dysfunction in this
phenomena at an earlier stage. Furthermore, incubation
with the ER stress inducing agents tunicamycin and
thapsigargin led to increases in chaperone expression
(Fig. S2A) and to a marked decrease in the number of
motorneurons, suggesting its preferential sensitivity to ER
stress (Fig. S2B).
Since those analyses revealed ER stress and proteasome
dysfunction in chronic excitotoxicity, we analysed whether
protein oxidative damage was also increased in these
conditions. The results demonstrated that protein oxidative
damage is increased by excitotoxicity (Fig. S3). All
measured markers of oxidation, glycoxidation and lipox-
idation, increased significantly after THA treatment
(P< 0.001, Fig. S3A). As in the ALS cases, these increases
in protein oxidative modifications were associated to
changes in fatty acid composition (Table S2, Fig. S3B).
Noteworthy, THA-induced changes resembled those present
in frontal cortex, with 2-fold increases in the DHA content
(P< 0.0001, Fig. S3B), PI increases—150% respect vehicle-
treated slices—(P< 0.0001, Fig. S3B) and decreased n6/n3
ratios (P< 0.0001, Fig. S3B). Confocal microscopy of the
most THA-sensitive marker, CEL, revealed that proteins
modified with this product were present, in increased
amounts, throughout glial and neuronal populations
(Fig. S3C). Neuropil and star-shaped cells resembling
microglia were major distribution sites of CEL immuno-
reactivity in THA-treated slices. Co-localization studies
with Bandairaea Simplicifolia lectin supported the
microglial origin of some of those cells (Fig. S3C).
Fig 4 ALS-inducedmitochondrial changes andprotein-oxidation-specific targets in spinal cord. (A) Representativewesternblotofpeptides
NDUFA9 andcore 2 subunits ofmitochondrialrespiratorychaincomplexes I and III, respectively, suggestingdecreasedcomplex III contentin
spinal cord samples fromALSpatients compared to control individuals.Thiswasnot associatedwith increased amountof apoptosis-inducing
factor (AIF).The lowerpanel shows the quantitationof theseblotsbydensitometry, adjusted toporindensity anddifferenceswere analysed
respect to controlgroupby Student’s t-testbeing P< 0.01. (B)Westernblot formixedglycoxidation/lipoxidation (CML),MCO(DNP) and
lipoxidation [neuroketal (NKTL)] revealeddifferential targets foreachof these oxidativepathways.Rightnumbers of theblots indicate apparent
molecularweight.The lowerpanels show the quantization of theseblotsbydensitometry, afterdensities ofbands (rangingbetween30 and 220
kDa)or actin (not shown, forB), anddifferenceswere analysedrespect to controlgroupby Student’s t-testbeing P< 0.01and P< 0.001.
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Nevertheless, chronic excitotoxicity also led to increased
AIF immunoreactivity in a non-nuclear distribution,
suggesting common basis for mitochondrial dysfunction
between sporadic ALS and chronic excitotoxicity both in
neuronal and glial cells (Fig. S1C).
Discussion
Cells facing protein misfolding in the ER initiate the so-
called unfolded protein response. As a part of this unfolded
protein response, the initiation process in global protein
synthesis is repressed by eIF2 phosphorylation via PERK
kinase. There is also increased expression of ER chaperones
and, if ER stress cause is not corrected, apoptosis is induced
(Marciniak and Ron, 2006; Zhang and Kaufman, 2006).
The results reported here, showing both increased phos-
phorylation of eIF2 and increased expression of ER
chaperones (PDI and KDEL-containing proteins), strongly
support the participation of ER stress in ALS pathogenesis.
The relevance of this pathway was also evident in the
chronic excitotoxicity paradigm, where both motorneurons
and glial cells were stained for anti-phosphorylated eIF2.
Noteworthy, the importance of this pathway is also
demonstrated by immunohistochemical analyses, where
remaining neuronal bodies of spinal cord ventral horns in
ALS show intense anti-phosphorylated eIF2. Our data
suggest that ER stress arises from oxidative stress and from
a mitochondrial disturbance. Based on correlative data, we
propose that this is a late phenomenon, when compared
with protein oxidative damage, as we are able to detect
increased protein oxidative damage, increased DHA
amount and other fatty acid changes in brain cortex,
without increased ubiquitination or any other noticeable
change. Recent data demonstrates the occurrence of ER
stress in familial ALS paradigms, associating PDI and
mutated SOD in motorneurons (Atkin et al., 2006;
Furukawa et al., 2006), showing also caspase-12 activation
(Wootz et al., 2004; Turner and Atkin, 2006). More
interestingly, chronic excitotoxicity leads to protein aggre-
gation in ER from motorneurons (Tarabal et al., 2005),
without inducing an upregulation of heat-shock proteins, as
those cells have a characteristically high threshold for heat-
shock proteins induction (Batulan et al., 2003). This fact,
when added to the increased chaperone expression and
immunohistochemical data on organotypic cultures,
strongly suggest that ER stress is also taking place in glial
cells. Due to the important role of the proteasome in
ER-directed disposal of misfolded proteins, ER stress could
be caused by decreased ER-associated degradation (Bush
et al., 1997; Obeng et al., 2006; Yamamuro et al., 2006).
In agreement with our findings, previous data indicate a
potential loss of proteasome activity in ALS (Urushitani
et al., 2002; Cheroni et al., 2005; Ahtoniemi et al., 2006;
Basso et al., 2006; Kabuta et al., 2006; Koyama et al., 2006;
Mendonca et al., 2006), specially in the familial forms of
the disease. In vitro experiments and in vivo data show that
mutated SOD is associated with decreased amount of
specific proteasome subunits, particularly LMP7 (Allen
et al., 2003). Furthermore, proteasome inhibition leads to
the reproduction of the abnormal solubility properties
shown by mutated SOD in vivo (Koyama et al., 2006).
However, the role of proteasome in sporadic ALS has
received less attention. Recent data demonstrate increased
proteasome immunoreactivity both in glia and motorneu-
rons from spinal cords in sporadic ALS (Mendonca et al.,
2006). Accordingly, findings reported here, demonstrating
increased amount of ubiquitinated proteins in spinal cord
samples, is compatible to such proteasomal involvement.
It should be recalled that ubiquitinated lesions are
prominent in ALS morphology. Noteworthy, this increased
ubiquitination was also evident under chronic excitotoxi-
city, being present both in neuronal and non-neuronal
populations. This agrees with the previous works, showing
that proteasome inhibition in organotypic cultures induce
selectivity damage to motorneurons, as chronic excitotoxi-
city does (Tsuji et al., 2005). As chronic excitotoxicity leads
to increased oxidative damage (Rao and Weiss, 2004; Rival
et al., 2004), our data suggest that this condition could
contribute to proteasome inhibition. Relating differences
with frontal cortex, western-blot analyses did not reveal
such changes in this latter location. Once a given protein is
modified by oxidation, it is degraded by 20S proteasome in
an ATP and ubiquitin-independent fashion (Shringarpure
et al., 2003; Grune et al., 2005), as recently shown for
metal-free SOD (Di Noto et al., 2005). Nevertheless, a high
degree of oxidative modification could even decrease
proteasome activity (Sitte et al., 2000).
For these reasons we evaluated whether, by using novel
mass spectrometry measurements, ALS samples presented
increases in protein oxidative damage, both in spinal cord
and in frontal cortex. Nonetheless, the magnitude of
changes with reference to control was higher in spinal
cord than in frontal cortex. These results suggest an early
selective involvement of oxidative stress in spinal cord
during ALS pathogenesis. In addition, the involvement of
frontal cortex agrees with previous reported data in other
neurodegenerative diseases, such as Alzheimer disease or
Parkinson disease, where pathologically preserved locations
of nervous system show incipient increases in protein
oxidative damage, thought at a lower extent than classical
targets of disease (Dalfo et al., 2005; Pamplona et al., 2005).
Cognitive dysfunction and dementia have been reported as
complications in a subgroup of patients with ALS, the
majority of them presenting atrophy, neuronal loss and
reactive gliosis in the frontal and temporal lobes (Kato
et al., 2003). Although the present study is not focused on
ALS cases with frontotemporal dementia, these results
point to the suggestion that frontal cortex is a vulnerable
region to ALS. As a working hypothesis it can be proposed
that modifications in the levels of certain lipids are
predisposing factors to further cellular damage.
Nevertheless, data presented here support the notion that
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lipid peroxidation-associated processes seem to be the more
sensible cellular oxidative phenomenon, based on MDAL
values. Previous immunohistochemical evidences demon-
strate increased lipid peroxidation in ALS (Hall et al., 1998;
Pedersen et al., 1998). Furthermore, recent data showing
accumulation of 4-oxo-2-nonenal DNA etheno adduct in
brain cortex from ALS patients support the importance of
lipid peroxidation-derived pathways (Shibata et al., 2006).
Interestingly, while PI is still increased in frontal cortex,
basically due to increases in DHA content, a potential
defensive response of nervous tissue (Akbar et al., 2005),
these indexes were decreased in spinal cord, suggesting a
functional collapse and/or a lower content of neurons.
Thus, while brain cortex could produce n-3-derived anti-
inflammatory resolvins and docosatrienes (Hong et al.,
2003), spinal cord neurons would have decreased DHA
availability due to increased lipoxidative consumption.
Rather than being a general phenomena, the selectivity for
changes in n-3 strongly suggest specific mechanisms of the
disease depending on these fatty acids, maybe affecting
biosynthetic pathways and/or membrane remodelling sys-
tems that deserve further studies. Nonetheless, long-chain
unsaturated fatty acids contribute to the formation of
cytotoxic aggregates of ALS-linked superoxide dismutase-1,
thereby stressing the importance of fatty acid changes in
ALS pathogenesis (Kim et al., 2005). To shed further light
on these issues we analysed a chronic excitotoxicity
paradigm. The results demonstrated—at an early stage of
the excitotoxic paradigm—changes partially resembling
those present in frontal cortex, e.g. increases in all oxidative
markers and increases in DHA content and PI. This was
present at a time when motorneuron death is still not
evident. In line with this, DHA induces resistance against
excitotoxic degeneration of cholinergic neurones in vivo,
leading to higher survival, lower dendritic involution and
decreased axon degeneration (Hogyes et al., 2003). Globally,
these results suggest a pathological spectrum, driven by
excitotoxicity, ranging between overt pathological manifes-
tation (present in spinal cord) and more subtle changes,
with variations in fatty acids as reactive changes and protein
oxidative modifications as important signals of disease.
The significant correlations found between different types
of protein oxidative damage suggest that ALS could
influence general mechanisms determining protein oxida-
tive modifications, such as free radical production
(Pamplona and Barja, 2006). In most cells, the major
sources of free radical production are mitochondrial
respiratory complexes I and III (Herrero and Barja, 2000)
although in brain some mitochondrial matrix enzymes also
contribute to free radical production (Starkov et al., 2004;
Tretter and Adam-Vizi, 2004). The analyses performed in
spinal cords suggest decreases in both respiratory com-
plexes, as well to qualitative changes in complex III
distribution. Due to the role of complex I and III as free
radical generators (Chen et al., 2003), the results may be
compatible with increased free radical efflux by incorrect
assembly of complexes or to metabolic reprogramming
(Iuso et al., 2006). These data complements previous
reports demonstrating decreased activities of respiratory
chain complexes I + III, II + III and IV, suggesting a loss of
mitochondria in spinal cords from ALS patients
(Wiedemann et al., 2002). Moreover, specific decreases in
the activities of complexes II are observed in a mutated
SOD transgenic model (Jung et al., 2002). Furthermore,
losses of complex IV activity are present in the Wobbler
mouse (Xu et al., 2001). It may be suggested that ALS
samples presented a defect in the assembly of mitochondrial
respiratory complexes, that would lead to changes in free
radical production (Rana et al., 2000; Sellem et al., 2005).
It may be also hypothesized that this scenario could
contribute to a more reduced state of Fe-S clusters, leading
to increased free radical efflux (Herrero and Barja, 2000).
In this line, the amount of AIF, a bifunctional flavoprotein
with NADH oxidase activity involved in mitochondrial
respiration and caspase-independent apoptosis, was
unchanged in spinal cords. Besides an ALS-induced
increased apoptotic rate in this tissue (Oh et al., 2006),
AIF could be also considered as a part of an adaptation
response to increased free radical production (Zhu et al.,
2003; Cande et al., 2004) or to decreased respiratory
activities. Changes in AIF are not evident in ALS samples
when compared to data in the in vitro paradigm: AIF
presenting increased non-nuclear staining in THA-treated
slices suggests an important role of this protein in the
response to excitotoxicity, that may be focus of future
studies. Therefore, it could be suggested that increased free
radical production, arising from complex I and III
suboptimal assembly, together with unchanged or even
increased AIF expression, contributes to protein oxidative
damage specifically in spinal cords, being those changes
absent in frontal cortex. Despite such an increased
mitochondrial leak could lead to potentially extensive
protein modifications, western-blot analyses revealed that
there are specific targets for oxidative, glycoxidative and
lipoxidative damage that will be the focus of future studies.
To summarize, the present data demonstrate that there is
increased protein oxidative modification in spinal cords and
frontal cortex from ALS cases, together with changes in
lipid composition. Concerning cellular targets of those
phenomena, we have demonstrated a motorneuron involve-
ment, but it should be remarked that glial cells are the
major contributors to protein mass in spinal cords.
Therefore, it is feasible to assume that many of the changes
observed here respond to changes in both (or mainly) glial
cell and neuronal populations. In this line, it should be
recalled the importance of glial support and trophic
environment for motorneurons, so any given change to
glial population could contribute to motorneuron loss.
In spinal cords, where loss of motorneurons was evident,
build up of oxidatively damaged proteins was linked to
changes in mitochondrial respiratory complexes and to
increased ubiquitination, potentially linked to impaired
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proteasome function. More importantly, this was associated
to changes in ER proteins suggesting the occurrence of ER
stress. Since those changes were reproducible by an
excitotoxic paradigm at an early stage, it can be suggested
that excitotoxicity leads to increased protein oxidation,
proteasomal dysfunction and ER stress in neuronal and
non-neuronal cells, potentially contributing to motor-
neuron death in ALS.
Supplementary material
Supplementary material is available at Brain online.
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hSOD1G93AAmyotrophic Lateral Sclerosis (ALS), a severe neurodegenerative disease, affects the upper and lowermotor neu-
rons in the brain and spinal cord. In some studies, ALS disease progression has been associatedwith an increase in
calcium-dependent degeneration processes.Motoneurons are speciﬁcally vulnerable to sustainedmembrane de-
polarization and excessive elevation of intracellular calcium concentration. The present study analyzed intracel-
lular events in embryonic motoneurons and adult spinal cords of the hSOD1G93A ALS mouse model. We
observed activation of calpain, a calcium-dependent cysteine protease that degrades a variety of substrates,
and a reduction in calcium–calmodulin dependent protein kinase type IV (CaMKIV) levels in protein extracts
from spinal cords obtained at several time-points of hSOD1G93Amice disease progression. However, in cultured
embryonic motoneurons these differences between controls and hSOD1G93A mutants are not evident. Our re-
sults support the hypothesis that age-dependent changes in calcium homeostasis and resulting events,
e.g., calpain activation and CaMKIV processing, are involved in ALS pathogenesis.
© 2014 Elsevier Inc. All rights reserved.Introduction
Amyotrophic Lateral Sclerosis (ALS) is a fatal, adult-onset, neurode-
generative disease causing the degeneration of cranial and spinal cord
motor neurons (MNs),which leads tomuscle atrophy and paralysis. Nu-
merous ALS studies have analyzed subgroups of familial cases originat-
ing from mutations in the SOD1 gene (Rosen et al., 1993). The precise
mechanisms whereby mutant SOD1 is toxic to MNs are not deﬁned.
However, studies in mutant hSOD1 transgenic mice have revealed
many pathogenic changes in degenerating MNs, including hyper-
excitability, disturbed calciumhomeostasis, SOD1 aggregation, and acti-
vation of cell death signals (Bento-Abreu et al., 2010; Cleveland and
Rothstein, 2001; Pasinelli and Brown, 2006). Several of these pathogenic
changes are related to calcium deregulation in neurons. Unfortunately,N, spinal cord motor neurons;
MKIV, calcium–calmodulin de-
NF, brain derived neurotrophic
NTF, ciliary neurotrophic factor;
, wild type.
niversitat de Lleida-IRBLLEIDA,
al Research Institute, Hasseltwhether these are primary or secondary events or represent compensa-
tory mechanisms remains unknown.
MNs are speciﬁcally vulnerable to membrane depolarization and in-
creased intracellular calcium concentration (Arakawa et al., 2002).
Levels of intracellular calcium determine neuronal dependence on neu-
rotrophic factors and susceptibility to cell death, although how calcium
induces MN cell death is not fully understood. Diverse molecular mech-
anisms that lead to neuronal degeneration and death in response to ex-
cessive calcium inﬂux are being elucidated, among them the activation
of speciﬁc enzymes such as protein phosphatases, endonucleases, or
proteases. One of these enzymes is calpain, the calcium-sensitive prote-
ase that mediates cell death when intracellular calcium is increased
(Das et al., 2005).
Previous results from our group and others have shown that chron-
ically depolarizing conditions induces cell death in mouse MNs through
increased intracellular calcium and calpain activation (Gou-Fabregas
et al., 2009; Kaiser et al., 2006). This protease can become over-
activated under extreme conditions — for example, as a consequence
of sustained elevation of cytosolic calcium levels, which in turn is asso-
ciated with apoptotic or non-apoptotic cell death (Wang, 2000). In the
central nervous system, calpain activation is related to neuronal damage
in ischemia, stroke, and Alzheimer and Huntington diseases (Cowan
et al., 2008; Shields et al., 2000; Yamashima, 2013). One of these calpain
substrates is the calcium–calmodulin dependent protein kinase type IV
(CaMKIV). This kinase is highly expressed in the nervous system and is
220 M. Gou-Fabregas et al. / Molecular and Cellular Neuroscience 61 (2014) 219–225involved in neuronal survival and development (Bok et al., 2007;
Perez-Garcia et al., 2008; See et al., 2001). Under conditions of sustained
calcium inﬂux, CaMKIV and associated signalingmolecules can be proc-
essed by activated calpain (McGinnis et al., 1998; Tremper-Wells and
Vallano, 2005).
In the present study, we investigated the hypothesis that processes
resulting from intracellular calcium increase, such as calpain activation
and CaMKIV processing, are involved in ALS pathogenesis. We studied
CaMKIV levels under culture conditions that are known to activate
calpain protease activity in MNs. Results obtained indicate that mem-
brane depolarization activates calpain and reduces CaMKIV protein
level. We further analyzed calpain activation in cultured hSOD1G93A
embryonic MNs and their vulnerability in response to membrane depo-
larization. No differences were found, compared to the control cultures.
However, analysis of protein extracts from adult SOD1G93Amutant spi-
nal cords revealed calpain activation and CaMKIV reduction, in support
of our hypothesis.
Results
Effect of high-potassium medium on CaMKIV protein level in cultured
mouse MNs
Addition of high potassium to the culture medium induces chronic
depolarization of the neuronal plasma membrane, resulting in calcium
inﬂux and elevation of intracellular calcium concentration. Mouse spi-
nal cord MNs are speciﬁcally vulnerable to this calcium increase and
high-potassium treatment induces cell death. This cell death process is
dependent on calpain activation (Gou-Fabregas et al., 2009). Under cer-
tain depolarizing conditions, calpain induces CaMKIV proteolysis
(Tremper-Wells and Vallano, 2005), and CaMKIV is involved in neuro-
nal survival (Hansen et al., 2003; Perez-Garcia et al., 2008; See et al.,
2001).
To testwhethermembrane depolarization treatment induces chang-
es in CaMKIV protein level, isolatedMNs from E12.5 CD1mouse embry-
os were cultured in the presence of neurotrophic factors with or
without high potassium (see Experimental methods section). Three
days after treatment, samples were collected and submitted to western
blot. To determine calpain activation, we analyzed the presence of
the calpain-speciﬁc 150/140 kDa α-fodrin fragment using an anti-α-
fodrin antibody. As we reported previously (Gou-Fabregas et al.,
2009), under depolarizing conditions the level of 140/150 kDa product
was 1.7 times higher than observed in the NTF-treated control condi-
tion, indicating the activation of calpain. CaMKIV protein was also
analyzed using an anti-CaMKIV antibody. The levels of CaMKIV protein
in depolarized cultures were signiﬁcantly lower than in controls
(Fig. 1A). Together, these results suggest that depolarizing conditions
in MNs induce an increase of calpain activity that can lead to CaMKIV
proteolysis. Fodrin proteolysis and CaMKIV protein reduction are indi-
cators of calcium dysregulation.
Effect of high-potassium treatment on cultured hSOD1G93A mutant MNs
In hSOD1 transgenic mice, intracellular calcium increase contributes
to MN degeneration (Kaiser et al., 2006). High potassium treatment
causes intracellular calcium increase and cell degeneration in cultured
embryonic CD1MNs. In order to establishwhether there are differences
between control and hSOD1MNs,we decided to analyze the response of
hSOD1-mutated MNs to depolarization. We obtained E12.5 embryos by
crossing B6SJL-Tg (SOD1*G93A)1Gur/J (hSOD1G93A) mutants and
B6SJL females. After genotyping, spinal cords fromWT and hSOD1G93A
mutants were dissected and MNs were isolated as described in the
Experimental methods section. Cells were plated in 4-well dishes. Cul-
ture medium was supplemented with NTFs with or without 30 K.
Three days after treatment, cell survival was evaluated. The percentage
of surviving cells in 30 K conditions (WT and hSOD1G93A) wassigniﬁcantly lower than in NTFs' controls (51.1 ± 5.5% 30 K-treated
WT and 44.8 ± 4.6% 30 K-treated hSOD1, p b 0.005; Fig. 1B). However,
there were no signiﬁcant survival differences between WT and
hSOD1G93A cells under 30 K-treated conditions. This result shows
that hSOD1G93A embryonic MNs are vulnerable to extracellular potas-
sium increase in culture, but this vulnerability is comparable to cells
fromWT controls.
We also sought to analyze whether high-potassium treatment
induces calpain activation and CaMKIV decrease. To this end, MNs
were isolated from WT and hSOD1G93A mutants and cultured in the
presence or absence of 30 K. Three days later, protein extracts were ob-
tained and submitted to a western blot analysis using anti-α-fodrin and
anti-CaMKIV antibodies. Results shown in Fig. 1C demonstrate an in-
crease of 150/145 kDa-speciﬁc fodrin breakdown products and a reduc-
tion of CaMKIV protein levels in 30 K-treated hSOD1G93A MNs. Both
parameters are also altered in theWT condition. These results together
indicate that embryonic WT and hSOD1G93A mutant MNs show the
same vulnerability in response to depolarizing conditions.
Fodrin cleavage and CaMKIV reduction in spinal cords from adult
hSOD1G93A mice
Because isolated embryonic hSOD1G93A MNs did not show differ-
ences compared toWT embryonic MNs, we decided to analyze changes
in calpain activity and CaMKIV protein level in adult spinal cords from
hSOD1G93A mice. As described in the Experimental methods section,
we obtained two sets of pooled protein extracts from spinal cord frag-
ments, dissected from 30, 60, 90, and 120-day-oldWT and hSOD1G93A
mice. Protein extracts were obtained and submitted to western
blot analysis using antibodies against α-fodrin or CaMKIV. We
observed a signiﬁcant increase of 150/145 kDa fodrin product in 90-
and 120-day-old hSOD1G93A mutant samples compared to the WT
condition (Fig. 2). The increase of fodrin products is time-dependent.
Sixty-day-old samples show a slight but non-signiﬁcant increase of
140/150 kDa product and no differences were observed in 30-day-old
samples. The same protein extracts were probed using the CaMKIV an-
tibody. Decreases in CaMKIV protein level are time-dependent. Accord-
ingly, no differences were observed in 30-day-old samples, 60-day-old
samples showed a slight but non-signiﬁcant reduction, and 90-day-old
and 120-day-old samples showed a signiﬁcant reduction.
To determine whether calpain activation and CaMKIV measures dif-
fered by spinal cord section, 90-day-oldWT or hSOD1G93A spinal cords
were dissected in cervical or lumbar fragments and protein extracts
were submitted to western blot. As observed in protein extracts obtain-
ed from the whole spinal cord, both cervical and lumbar hSOD1G93A
samples showed increased fodrin products and reduced CaMKIV pro-
tein levels compared to WT controls (Fig. 3). However, there were no
signiﬁcant differences between cervical and lumbar samples, suggesting
that these sections of the spinal cord undergo similar changes in fodrin
and CaMKIV parameters at this period of disease evolution.
Discussion
The results obtained from the present work allow us to make two
important contributions to the hSOD1G93A ALS mouse model. First,
we report that embryonic cultured MNs did not differ from controls in
their response to high-potassium treatment, and second, we propose
that CaMKIV protective effects may be impaired during disease
progression.
The increased presence of calpain-speciﬁc degradation products in
protein extracts from adult spinal cords of SOD1 mutant mice indicates
increased calpain activity. The observed calcium-dependent protease
activation can be a consequence of either neuronal hyperexcitability
or cytotoxic pathological conditions. We previously demonstrated that
increased calpain activity induces MN cell death as a consequence of
the speciﬁc vulnerability of these cells to high extracellular potassium
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Fig. 1. Effect of 30 K treatment on embryonic MN survival, calpain-dependent α-fodrin cleavage, and CaMKIV protein level. MNs were cultured in the presence of NTFs (1 ng/mL BDNF;
10 ng/mL of GDNF, CNTF, CT-1, and HGF) or in the presence of NTFs plus 30 mM potassium (NTFs + 30 K). A) Total cell lysates of NTFs and NTFs + 30 K treated cultures
were analyzed by western blot using anti-α-fodrin or CaMKIV antibodies. Membranes were re-blotted with α-tubulin antibody used as a loading control. Graphs represent the
quantiﬁcation of the 145/150 kDa band and CaMKIV from 3 or more independent experiments. Asterisk indicates signiﬁcant differences between the 3 independent experiments using
Student t test (*p b 0.0007 for 145/150 and p b 0.0005 for CaMKIV). B) The graph shows survival levels of MNs from WT or hSOD1G93A in the absence of NTFs or in the presence of
NTFs with or without 30 K. Values are the mean of 3 independent wells for each condition ± SEM (error bars) of a representative experiment repeated at least 3 times, with comparable
results. Asterisk indicates signiﬁcant differences between NTFs treatment in the presence or absence of 30 K of 3 independent experiments using two-way ANOVA test (*p b 0.005). Rep-
resentative microscope images of WT and hSOD1G93Amouse MNs' cultures under control (NTFs) and high-potassium (NTFs + 30 K) conditions. C) Representative western blot images
from protein extracts of embryonic WT or hSOD1G93A MN cultures using antibodies against α-fodrin and CaMKIV. Coomassie staining was used as a loading control. The graphs show
relative protein quantiﬁcation levels of the 145/150 kDaα-fodrin fragment and CaMKIV levels. Asterisk indicates signiﬁcant differences betweenNTFs treatment in the presence or absence
of 30 K of 3 independent experiments using two-way ANOVA test (*p b 0.005).
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Fig. 2. Calpain-speciﬁc cleavage of α-fodrin and CaMKIV reduction in spinal cords from adult WT and SOD1G93A mice. Representative western blot images of protein extracts were ob-
tained from pooled spinal cord fragments of WT or SOD1G93A transgenic mice. Each pool contains fragments of 5 spinal cords dissected from 30-, 60-, 90- or 120-day-old animals. Mem-
branes were probed with an anti-α-fodrin antibody or anti-CaMKIV antibody and reprobed with an anti-α-tubulin antibody, used as a loading control. The graphs show the relative
measures of theα-fodrin 145–150 kDa fragment or the CaMKIV levels from 3 separate experiments obtained from 3 independentWT or hSOD1G93A spinal cord pools. Asterisk indicates
signiﬁcant differences when comparing the data from the 3 independent experiments using Student t test (*p b 0.05).
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corrected, this causes continued neuronal depolarization and hyper-
excitability (Gou-Fabregas et al., 2009).
Although it is technically difﬁcult to directly determine the potassi-
um concentration in local MN compartments of the spinal cord, some
information from mouse models is available. For example, in the SOD1
transgenic model, the glial inwardly rectifying potassium channels
(Kir 4.1) are decreased in the brain and ventral horn of the spinal cord
of SOD1mutants (Kaiser et al., 2006). These observations strongly sup-
port that potassium accumulation in perineuronal compartments of the
spinal cord is a likely mechanism of MN excitotoxicity in the SOD1
transgenic model of ALS. Clearance of potassium from the extracellular
space (potassium spatial buffering) is considered an important function
of astrocytes. A number of studies have suggested that astrocyte main-
tenance of extracellular potassium levels is mediated by potassium up-
take through the Kir4.1 channels. Thus, the loss of these channels
impairs perineuronal potassium homeostasis and may contribute to
MN degeneration by excitotoxic mechanisms (Kaiser et al., 2006;
Kofuji et al., 2000, 2002; Neusch et al., 2001). The consequence of extra-
cellular potassium accumulation is continued membrane depolariza-
tion, which induces an increase in intracellular calcium concentration.
It is well-known that calpain regulates cell survival in response to
calcium signals and can be over-activated under extreme conditions
as a result of sustained elevation of cytosolic calcium levels (Das et al.,
2005; Stifanese et al., 2010; Wang, 2000). Calpain protease has several
substrates (Wang, 2000). One of them, α-fodrin, has been extensively
used as a marker of calpain protease activity. The speciﬁc degradation
products (150/145 kDa) of α-fodrin have been attributed to theactivation of calpain, whereas the 120 k Da fragment indicates caspase
activation (Nath et al., 1996). Our previous work showed that sustained
intracellular calcium increase causes calpain activation, elevation of
150/145 kDa fragments and MN cell death. This cell-death effect can
be counteracted using calpain inhibitors or calpain gene silencing
(Gou-Fabregas et al., 2009). Other calpain substrates have been related
to the ALS pathology. It has been recently reported that calpain activa-
tion generates carboxy-terminal-cleaved TDP-43 fragments and causes
mislocalization of TDP-43 in the MNs of a mouse model of ALS. The
calpain-dependent TDP43 fragments have been found in the spinal
cord and brain of ALS patients, supporting the crucial role of calpain-
dependent cleavage of TDP43 in the ALS pathology (Yamashita et al.,
2012).
Our results also demonstrate that CaMKIV protein levels are reduced
in spinal cord protein extracts of adult SOD1 mutant mice. CaMKIV, a
protein kinase involved in MN survival and a calpain substrate, has
been reported to protect NSC34MN-like cells fromdegeneration caused
by transgenic SOD1 over-expression (Chiba et al., 2004). CaMKIV is also
known to associate with the p85 subunit of PI 3-kinase and regulate PI
3-kinase/Akt pathway activity (Perez-Garcia et al., 2008), and a recent
study reported that speciﬁc expression of constitutively active Akt3 in
MNs prevents neuronal loss induced by hSOD1G93A (Peviani et al.,
2013). A decade ago, Chiba and collaborators reported that activity-
dependent neurotrophic factor protection (ADNF) against cell death
caused by mutant SOD1 overexpression depends on CaMKIV and cer-
tain tyrosine kinase activity (Chiba et al., 2004). This suggests CaMKIV
involvement in ALS pathogenesis through its role in regulating the PI
3-kinase/Akt survival pathway. Even though CaMKIV knockout mice
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Fig. 3.α-Fodrin and CaMKIV levels in cranial and lumbar fragments of spinal cords of WT
and hSOD1G93A mice. Representative western blot images of protein extracts obtained
from pooled cervical or lumbar spinal cord fragments of WT or SOD1G93A transgenic
mice. Each pool contains fragments of 5 spinal cords dissected from 90-day-old animals.
Membranes were probed with an anti-α-fodrin antibody or anti-CaMKIV antibody and
reprobed with an anti-α-tubulin antibody, used as a loading control. The graph shows
the relative measures of the α-fodrin 145–150 kDa fragment or the CaMKIV levels from
2 separate experiments obtained from 2 independent WT or SOD1G93A spinal cord
pools. Asterisk indicates signiﬁcant differences when comparing the data from the 2
independent experiments using one-way ANOVA test (*p b 0.05).
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2000; Ribar et al., 2000), under pathologic conditions it is probable
that deﬁciency or reduced activity of the protein could exacerbate de-
generation processes that result from excitotoxic mechanisms or mu-
tant SOD1 over-expression.
Our results from in vitro studies showed no speciﬁc differences in
embryonic hSOD1G93AMNs compared to embryonicWT cells. This ob-
servation suggests that cell vulnerability to high potassium treatment is
not affected by mutant SOD1 overexpression in embryonic MNs. Celldeath, increasedα-fodrin products and reduced CaMKIVwere observed
after high potassium treatment, but differences between embryonic
hSOD1G93A MNs and control cells were not signiﬁcant. However, sig-
niﬁcant differences were observed in proteins related to high calcium
toxicity in spinal cords from symptomatic mice. Our results do not
show whether these differences are located speciﬁcally in MNs, but do
clearly demonstrate a deregulation of the level of these proteins,
supporting the hypothesis that calcium homeostasis can be altered
during disease progression (Grosskreutz et al., 2010; Kawamata
and Manfredi, 2010). Further research is needed to determine whether
CaMKIV reduction is directly caused by calpain activation inMNs and/or
other spinal cord cells. The use of calpain inhibitors and a comparative
analysis between events occurring in dorsal vs ventral spinal cord pro-
tein homogenates could provide valuable information.
Earlier theories suggested thatMN degeneration during disease pro-
gressionmay be caused by alterations in the surrounding cells andMNs
environment (Ilieva et al., 2009; Liao et al., 2012; Phatnani et al., 2013;
Wang et al., 2011). This observation is further supported by the reduc-
tion of glial Kir4.1 channel observed in ALS, which contributes to devel-
oping an environment that is toxic to the MNs (Bataveljic et al., 2012;
Kaiser et al., 2006). Thus, modiﬁcation of calcium homeostasis in ALS
MNs and surrounding cells is also supported by calpain activation and
CaMKIV reduction in the adult symptomatic SOD1 mutant.
In summary, our study demonstrates calpain activation and reduced
levels of CaMKIV protein in damagedMNs.We report calpain activation
– assessed as calpain-speciﬁc processing of the cytoskeleton substrate
α-fodrin (145/150 kDa fragment) – and decreased CaMKIV levels after
30 K treatment inWT andhSOD1G93AmutantmouseMNcultures. Pro-
tein extracts of adult hSOD1G93A spinal cord analysis revealed similar
signs of calcium dysregulation, increased calpain-processed substrates,
and reduced CaMKIV levels. These observations suggest the role of
intracellular calcium changes in ALS pathogenesis and of calpain
and CaMKIV mediation in this process (Fig. 4). Therefore, calpain and
CaMKIV can be considered therapeutic targets in future ALS interven-
tion strategies.Experimental methods
Animals
Care and use of rodents followed the Spanish Council on Animal Care
guidelines and was approved by the University of Lleida Advisory Com-
mittee on Animal Services. Transgenic mice expressing high copy num-
bers of the mutated (glycine 93 to alanine) form of human SOD1
(hSOD1), B6SJL-Tg(SOD1*G93A)1Gur/J (hSOD1-G93A), were pur-
chased from The Jackson Laboratories (Bar Harbor, Maine, USA). The
colony was maintained by breeding male hemizygous carriers with
non-transgenic B6SJL females. Offspring were identiﬁed by PCR and
non-transgenic G93A littermateswere used aswild-type (WT) controls.
For PCR analysis, genomicDNAwas extracted frommice tails (adults) or
heads (embryos) by proteinase K overnight digestion or REDExtract-N-
Amp Tissue PCR Kit (Sigma), respectively. Primer pairs were the follow-
ing: forward 5′-CTAGGCCACAGAATTGAAAGATCT-3′ and reverse 5′-
GTAGGTGGAAATTCTAGCATCATCC-3′, both of which amplify a product
of 324 bp from the endogenous interleukin2 gene, used as positive con-
trol for DNA ampliﬁcation, and forward 5′-CATCAGCCCTAATCCATCTGA-
3′ and reverse 5′-CGCGACTAACAATCAAAGTGA-3′, which amplify a
product of 236 bp of exon4 from the hSOD1 gene within the transgene.
Spinal cords of 30, 60, 90, or 120-day-old genotyped mice were
dissected and protein extracts were obtained. At the 90-day-old
stage, hSOD1-G93A mutants show clinical symptoms. Protein extracts
from 5 genotyped animals (hSOD1-G93A or WT) of each age were
pooled and submitted to western blot using several antibodies. Two or
three separate pools of hSOD1-G93A or WT protein extracts were
analyzed.
[K+]
Membrane  depolarization
[ Ca2+]
Calpain
CaMKIV
hSOD1G93A 
MN degeneration
Kir 4.1
Fig. 4. Schematic model showing the proposed intracellular events of extracellular potassium increase and/or expression of mutated SOD1. Both mechanisms induce MN intracellular
calcium overload, calpain activation, and reduction of CaMKIV protein levels. In ALS disease model, extracellular potassium increase can be a consequence of the reduction of the inward
rectifying potassium channel, Kir 4.1. These mechanisms together or separately can contribute to MN hyperpolarization and degeneration.
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MN cultures were prepared from embryonic 12.5-day (E12.5) CD1
or transgenic mice spinal cord, essentially as described (Arce et al.,
1999; Gou-Fabregas et al., 2009). After genotyping, WT and hSOD1-
G93A embryos were submitted to spinal cord dissection and MN isola-
tion following the same puriﬁcation protocol. The isolated cells were
collected in a tube containing culturemedium and distributed in the tis-
sue culture dishes. Enriched cultured MNs are clearly identiﬁed
by morphological criteria (Fig. 1) and more than 80% of the cells are
MNs identiﬁed by immunoﬂuorescence using Islet-1/2 antibodies
(Gou-Fabregas et al., 2009).
Isolated MNs were plated in 4-well tissue-culture dishes (Nunc,
Thermo Fisher Scientiﬁc, Madrid, Spain) for survival experiments
(1500 cells per well) and western blot (50,000 cells per well).
Culture medium was NBMc (Neurobasal (Gibco, Invitrogen, Paisley,
UK) supplemented with B27 (Gibco; Invitrogen), horse serum (2% v/v),
L-glutamine (0.5 mM), and 2-mercaptoethanol (25 μM)). Cells were
plated with complete medium containing a cocktail of recombinant
NTFs (1 ng/mL BDNF; 10 ng/mL GDNF, 10 ng/mL CNTF, 10 ng/mL CT-1,
and 10 ng/mL HGF; Peprotech, London, UK).
Western blot analysis
Western blots were performed as described (Gou-Fabregas et al.,
2009; Perez-Garcia et al., 2004). Total cell lysates were resolved
in sodium dodecyl sulfate-polyacrylamide gels and transferred onto
polyvinylidene diﬂuoride Immobilon-P transfer-membrane ﬁlters
(Millipore, Billerica, MA, USA) using an Amersham Biosciences
(Piscataway, NJ, USA) semidry Trans-Blot. Themembraneswere blotted
with anti-SOD1 antibody (1:2000) (Millipore, Billerica, MA, USA), anti-
alpha-Fodrin antibody (1:2000) (Biomol International Inc., Exeter, UK),
and anti-CaMKIV antibody (1:1000) (BD, Transduction Laboratories,
Franklin Lakes, NJ, USA). To control the speciﬁc protein content per
lane, membranes were reprobed with a monoclonal anti-α-tubulin an-
tibody (Sigma) or Coomassie stain. Blots were developed using the
Super Signal chemiluminiscent substrate (Pierce, Rockford, IL, USA).
Statistical analysis
All experiments were performed at least 3 times. Values were
expressed asmean± SEM. The data obtained from the independent ex-
periments were used for statistical analysis. We used one-way or two-wayANOVA to assess differences between treated anduntreated groups
and for transgenic and control cultures. If the ANOVA test was statisti-
cally signiﬁcant, we performed post-hoc multiple comparisons using
Bonferroni test; p values below 0.05 were considered statistically
signiﬁcant.
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